<html class="js" dir="ltr" lang="en" xmlns:article="http://ogp.me/ns/article#" xmlns:book="http://ogp.me/ns/book#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/terms/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:og="http://ogp.me/ns#" xmlns:product="http://ogp.me/ns/product#" xmlns:profile="http://ogp.me/ns/profile#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:video="http://ogp.me/ns/video#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#"><head profile="http://www.w3.org/1999/xhtml/vocab">
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<link href="http://www.cidrap.umn.edu/sites/default/themes/siteskin/inc/images/apple-touch-icon.png" rel="apple-touch-icon"/>
<meta content="True" name="HandheldFriendly"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="http://www.cidrap.umn.edu/sites/default/themes/siteskin/favicon.ico" rel="shortcut icon" type="image/vnd.microsoft.icon"/>
<meta content="http://www.cidrap.umn.edu/sites/default/files/public/styles/thumbnail/public/images/news/papr-crop_1.jpg?itok=ZpsX_1R-" property="og:image"/>
<meta content="We believe there is scientific and epidemiologic evidence to recommend respirators for all patient care, and a PAPR would be the best option." name="description"/>
<meta content="Drupal 7 (http://drupal.org)" name="generator"/>
<link href="http://www.cidrap.umn.edu/news-perspective/2014/09/commentary-health-workers-need-optimal-respiratory-protection-ebola" rel="canonical"/>
<link href="http://www.cidrap.umn.edu/node/84276" rel="shortlink"/>
<meta content="CIDRAP" property="og:site_name"/>
<meta content="article" property="og:type"/>
<meta content="http://www.cidrap.umn.edu/news-perspective/2014/09/commentary-health-workers-need-optimal-respiratory-protection-ebola" property="og:url"/>
<meta content="COMMENTARY: Health workers need optimal respiratory protection for Ebola" property="og:title"/>
<meta content="We believe there is scientific and epidemiologic evidence to recommend respirators for all patient care, and a PAPR would be the best option." property="og:description"/>
<title>COMMENTARY: Health workers need optimal respiratory protection for Ebola | CIDRAP</title>
<link href="http://www.cidrap.umn.edu/sites/default/files/public/css/css_xE-rWrJf-fncB6ztZfd2huxqgxu4WO-qwma6Xer30m4.css" media="all" rel="stylesheet" type="text/css"/>
<link href="http://www.cidrap.umn.edu/sites/default/files/public/css/css_0rdNKyAx9df4tRKovKjnVDsGvZwVuYAKO-m17AAJ1Dk.css" media="all" rel="stylesheet" type="text/css"/>
<link href="http://www.cidrap.umn.edu/sites/default/files/public/css/css_U1Y_aLsYaEGv095vd2gmwLzS5fbByELvIj07YwOd4tY.css" media="all" rel="stylesheet" type="text/css"/>
<link href="http://www.cidrap.umn.edu/sites/default/files/public/css/css_mYG2Tz1T7NOV9wJ061ADtmPhlIhaDBbyndjJ4qzfAq0.css" media="all" rel="stylesheet" type="text/css"/>
<link href="http://www.cidrap.umn.edu/sites/default/files/public/css/css_obwa_tj0E1Dffu30xe5GE7B7tI-CUnFeGu-eF8jIa4w.css" media="all" rel="stylesheet" type="text/css"/>
<link href="http://www.cidrap.umn.edu/sites/default/files/public/css/css_-VKpLOtBXQiVKGzzw01t_22HUrF7ayqgmJRvh2Dp8S0.css" media="print" rel="stylesheet" type="text/css"/>
<!--[if lte IE 8]>
<link type="text/css" rel="stylesheet" href="http://www.cidrap.umn.edu/sites/all/themes/derma/inc/css/ie.css?punmf9" media="all" />
<![endif]-->
<!--[if lte IE 9]>
<link type="text/css" rel="stylesheet" href="http://www.cidrap.umn.edu/sites/default/themes/siteskin/inc/css/ie9.css?punmf9" media="all" />
<![endif]-->
<!--[if lte IE 8]>
<link type="text/css" rel="stylesheet" href="http://www.cidrap.umn.edu/sites/default/themes/siteskin/inc/css/ie8.css?punmf9" media="all" />
<![endif]-->
<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="http://www.cidrap.umn.edu/sites/default/themes/siteskin/inc/css/ie7.css?punmf9" media="all" />
<![endif]-->
<script async="" src="//www.google-analytics.com/analytics.js"></script><script src="http://www.cidrap.umn.edu/sites/default/files/public/js/js_FXMiCtKmnAub91cxs3QG8Y9hQsrnYxLxtonYpxnbYIU.js" type="text/javascript"></script>
<script src="http://www.cidrap.umn.edu/sites/default/files/public/js/js_PnmDmSlBbqTMqptqIXUcXSs5xUsO-fXSpDeSkM6JDBc.js" type="text/javascript"></script>
<script src="http://www.cidrap.umn.edu/sites/default/files/public/js/js_NpX2cwCeepkWZZ194B6-ViyVBHleaYLOx5R9EWBOMRU.js" type="text/javascript"></script>
<script type="text/javascript">
<![CDATA[//><!--
var topics = "ebola vhf ";
//--><!]]>
</script>
<script type="text/javascript">
<![CDATA[//><!--
var program = "News";
//--><!]]>
</script>
<script src="http://www.cidrap.umn.edu/sites/default/files/public/js/js_AjwHrfk83nbDGnK_QduyCNHz8ewBb6HmQqOxNZF7iSk.js" type="text/javascript"></script><script src="http://cdn.printfriendly.com/printfriendly.js" type="text/javascript"></script>
<script type="text/javascript">
<![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-1641608-2", {"cookieDomain":"auto"});if (typeof(program) !== 'undefined') { ga('set', 'dimension1', program); }
if (typeof(topics) !== 'undefined'){ ga('set', 'dimension3', topics);}ga("send", "pageview");
//--><!]]>
</script>
<script src="http://www.cidrap.umn.edu/sites/default/files/public/js/js_ndXOP5-GHchtFDdxS3vOAQjq4xx6A0MSX0p9DPfaebM.js" type="text/javascript"></script>
<script type="text/javascript">
<![CDATA[//><!--
jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"siteskin","theme_token":"olrx67UBuwsZDlWmijZ2iFWrtvQfoILGOP_HTom0III","js":{"sites\/all\/modules\/jquery_update\/replace\/jquery\/1.5\/jquery.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"misc\/ui\/jquery.ui.core.min.js":1,"misc\/ui\/jquery.ui.widget.min.js":1,"sites\/all\/libraries\/skatejs\/src\/skate.js":1,"sites\/all\/libraries\/ui.slides\/ui.slides.js":1,"sites\/all\/libraries\/ui.slides\/ui.slidetabs.js":1,"sites\/all\/modules\/extlink\/extlink.js":1,"0":1,"1":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/colorbox\/styles\/default\/colorbox_style.js":1,"sites\/all\/themes\/derma\/inc\/js\/inputhelp.js":1,"sites\/all\/themes\/derma\/inc\/js\/derma.flyout.js":1,"sites\/default\/modules\/custom\/site_custom\/printfriendly.js":1,"sites\/all\/modules\/google_analytics\/googleanalytics.js":1,"2":1,"sites\/default\/themes\/siteskin\/inc\/js\/cidrap.tabs.js":1,"sites\/all\/modules\/field_slidetabs\/field_slidetabs.js":1,"sites\/default\/themes\/siteskin\/inc\/js\/cidrap.responsive.js":1,"sites\/default\/themes\/siteskin\/inc\/js\/cidrap.facets.js":1,"sites\/default\/themes\/siteskin\/inc\/js\/lodash.js":1,"sites\/default\/themes\/siteskin\/inc\/dist\/cidrap.diagnostics.js":1},"css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"modules\/comment\/comment.css":1,"sites\/all\/modules\/date\/date_api\/date.css":1,"sites\/all\/modules\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/extlink\/extlink.css":1,"sites\/all\/modules\/views\/css\/views.css":1,"sites\/all\/modules\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/forward\/forward.css":1,"sites\/default\/modules\/print\/print_ui\/css\/print_ui.theme.css":1,"sites\/all\/modules\/ss_date\/ss_date.css":1,"sites\/all\/modules\/field_slidetabs\/field_slidetabs.css":1,"sites\/all\/modules\/fieldlayout\/fieldlayout.css":1,"sites\/all\/themes\/derma\/inc\/css\/default.css":1,"sites\/default\/themes\/siteskin\/inc\/css\/site.css.less":1,"sites\/default\/themes\/siteskin\/inc\/css\/mediaqueries.css.less":1,"sites\/all\/themes\/derma\/inc\/css\/print.css":1,"sites\/default\/themes\/siteskin\/inc\/css\/print.css.less":1,"sites\/all\/themes\/derma\/inc\/css\/ie.css":1,"sites\/default\/themes\/siteskin\/inc\/css\/ie9.css":1,"sites\/default\/themes\/siteskin\/inc\/css\/ie8.css":1,"sites\/default\/themes\/siteskin\/inc\/css\/ie7.css":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"extlink":{"extTarget":"_blank","extClass":0,"extLabel":"(link is external)","extImgClass":0,"extSubdomains":1,"extExclude":"","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":0,"extAlertText":"This link will take you to an external web site. We are not responsible for their content.","mailtoClass":"mailto","mailtoLabel":"(link sends e-mail)"},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1},"field_slidetabs":{"field-slidetabs-1":{"pager_items":[{"fid":"20351","uid":"801","filename":"papr.jpg","uri":"public:\/\/media\/article\/papr_0.jpg","filemime":"image\/jpeg","filesize":"52939","status":"1","timestamp":"1411044209","type":"image","uuid":"2858d463-8f51-4409-99b6-72777b4492a3","field_file_image_alt_text":{"und":[{"value":"PAPR - powered air-purifying respirator","format":null,"safe_value":"PAPR - powered air-purifying respirator"}]},"field_file_image_title_text":{"und":[{"value":"A powered air-purifying respirator (PAPR).","format":null,"safe_value":"A powered air-purifying respirator (PAPR)."}]},"field_credit":{"und":[{"value":"Courtesy of 3M Company","format":null,"safe_value":"Courtesy of 3M Company"}]},"rdf_mapping":[],"metadata":[],"alt":"PAPR - powered air-purifying respirator","title":"A powered air-purifying respirator (PAPR).","display":"1","description":null,"content":{"entity":[{"file":{"#theme":"image_style","#style_name":"detail","#path":"public:\/\/media\/article\/papr_0.jpg","#width":null,"#height":null,"#alt":"PAPR - powered air-purifying respirator","#title":"A powered air-purifying respirator (PAPR)."},"field_file_image_title_text":{"#theme":"field","#weight":"2","#title":"Caption\/Title Text","#access":true,"#label_display":"hidden","#view_mode":"full","#language":"und","#field_name":"field_file_image_title_text","#field_type":"text","#field_translatable":"0","#entity_type":"file","#bundle":"image","#object":{"fid":"20351","uid":"801","filename":"papr.jpg","uri":"public:\/\/media\/article\/papr_0.jpg","filemime":"image\/jpeg","filesize":"52939","status":"1","timestamp":"1411044209","type":"image","uuid":"2858d463-8f51-4409-99b6-72777b4492a3","field_file_image_alt_text":{"und":[{"value":"PAPR - powered air-purifying respirator","format":null,"safe_value":"PAPR - powered air-purifying respirator"}]},"field_file_image_title_text":{"und":[{"value":"A powered air-purifying respirator (PAPR).","format":null,"safe_value":"A powered air-purifying respirator (PAPR)."}]},"field_credit":{"und":[{"value":"Courtesy of 3M Company","format":null,"safe_value":"Courtesy of 3M Company"}]},"rdf_mapping":[],"metadata":{"width":null,"height":null},"alt":"PAPR - powered air-purifying respirator","title":"A powered air-purifying respirator (PAPR).","display":"1","referencing_entity":{"vid":"197071","uid":"801","title":"COMMENTARY: Health workers need optimal respiratory protection for Ebola","log":"","status":"1","comment":"0","promote":"0","sticky":"1","vuuid":"a32af743-a649-4c4c-afd1-8e1ae959c714","nid":"84276","type":"ss_news","language":"und","created":"1410995616","changed":"1420487195","tnid":"0","translate":"0","uuid":"c815f393-5cac-4094-8891-027c1ae7eec3","revision_timestamp":"1420487195","revision_uid":"30796","field_date":{"und":[{"value":"2014-09-17 00:00:00","timezone":"America\/Chicago","timezone_db":"America\/Chicago","date_type":"datetime"}]},"field_body":{"und":[{"value":"\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note \u003Cstrong\u003E\u003Cem\u003E(Oct 16)\u003C\/em\u003E\u003C\/strong\u003E:\u0026nbsp; \u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003ESee the \u003C\/em\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/response-statements-falsely-attributed-cidrap-regarding-ebola-transmission\u0022 target=\u0022_blank\u0022\u003E statement\u003C\/a\u003E released today by CIDRAP related to this commentary.\u003C\/em\u003E\u003Cstrong\u003E\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note (Sep 17):\u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003E Today\u0027s commentary was submitted to CIDRAP by the authors, who are national experts on respiratory protection and infectious disease transmission. In May they published a \u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003E\u003Cem\u003Esimilar commentary on MERS-CoV\u003C\/em\u003E\u003C\/a\u003E\u003Cem\u003E. Dr Brosseau is a Professor and Dr Jones an Assistant Professor in the School of Public Health, Division of Environmental and Occupational Health Sciences, at the University of Illinois at Chicago.\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003E\u003Cstrong\u003EAuthors\u0027 disclaimer:\u003C\/strong\u003E\u003C\/em\u003E\u003Cem\u003E This commentary reflects the personal opinions of the authors. It does not represent the opinion of the University of Illinois at Chicago or any other organization. The authors have not received any compensation for the preparation of this commentary or any associated public statements. The authors do not endorse any specific manufacturer or brand of personal protective equipment (PPE) and have no direct or indirect financial interest in the use of a specific brand of PPE. In the past one or both of the authors have received research funding from numerous government agencies and organizations, including 3M.\u003C\/em\u003E\u003C\/p\u003E\u003Chr \/\u003E\u003Cp\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cdiv\u003EHealthcare workers play a very important role in the successful containment of outbreaks of infectious diseases like Ebola. The correct type and level of personal protective equipment (PPE) ensures that healthcare workers remain healthy throughout an outbreak\u2014and with the current rapidly expanding Ebola outbreak in West Africa, it\u0027s imperative to favor more conservative measures.\u003C\/div\u003E\u003Cdiv\u003E\u0026nbsp;\u003C\/div\u003E\u003Cdiv\u003EThe precautionary principle\u2014that any action designed to reduce risk should not await scientific certainty\u2014compels the use of respiratory protection for a pathogen like Ebola virus that has:\u003C\/div\u003E\u003Cdiv\u003E\u0026nbsp;\u003C\/div\u003E\u003Cul\u003E\u003Cli\u003ENo proven pre- or post-exposure treatment modalities\u003C\/li\u003E\u003Cli\u003EA high case-fatality rate\u003C\/li\u003E\u003Cli\u003EUnclear modes of transmission\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003EWe believe there is scientific and epidemiologic evidence that Ebola virus has the potential to be transmitted via infectious aerosol particles both near and at a distance from infected patients, which means that healthcare workers should be wearing respirators, not facemasks.\u003Csup\u003E1\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EThe minimum level of protection in high-risk settings should be a respirator with an assigned protection factor greater than 10. A powered air-purifying respirator (PAPR) with a hood or helmet offers many advantages over an N95 filtering facepiece or similar respirator, being more protective, comfortable, and cost-effective in the long run.\u003C\/p\u003E\u003Cp\u003EWe strongly urge the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to seek funds for the purchase and transport of PAPRs to all healthcare workers currently fighting the battle against Ebola throughout Africa\u2014and beyond.\u003C\/p\u003E\u003Cp\u003EThere has been a lot of on-line and published controversy about whether Ebola virus can be transmitted via aerosols. Most scientific and medical personnel, along with public health organizations, have been unequivocal in their statements that Ebola can be transmitted only by direct contact with virus-laden fluids\u003Csup\u003E2,3\u003C\/sup\u003E and that the only modes of transmission we should be concerned with are those termed \u0022droplet\u0022 and \u0022contact.\u0022\u003C\/p\u003E\u003Cp\u003EThese statements are based on two lines of reasoning. The first is that no one located at a distance from an infected individual has contracted the disease, or the converse, every person infected has had (or must have had) \u0022direct\u0022 contact with the body fluids of an infected person.\u003C\/p\u003E\u003Cp\u003EThis reflects an incorrect and outmoded understanding of infectious aerosols, which has been institutionalized in policies, language, culture, and approaches to infection control. We will address this below. Briefly, however, the important points are that virus-laden bodily fluids may be aerosolized and inhaled while a person is in proximity to an infectious person and that a wide range of particle sizes can be inhaled and deposited throughout the respiratory tract.\u003C\/p\u003E\u003Cp\u003EThe second line of reasoning is that respirators or other control measures for infectious aerosols cannot be recommended in developing countries because the resources, time, and\/or understanding for such measures are lacking.\u003Csup\u003E4\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAlthough there are some important barriers to the use of respirators, especially PAPRs, in developing countries, healthcare workers everywhere deserve and should be afforded the same best-practice types of protection, regardless of costs and resources. Every healthcare worker is a precious commodity whose well-being ensures everyone is protected.\u003C\/p\u003E\u003Cp\u003EIf we are willing to offer infected US healthcare workers expensive treatments and experimental drugs free of charge when most of the world has no access to them, we wonder why we are unwilling to find the resources to provide appropriate levels of comparatively less expensive respiratory protection to every healthcare worker around the world.\u003C\/p\u003E\u003Ch3\u003EHow are infectious diseases transmitted via aerosols?\u003C\/h3\u003E\u003Cp\u003EMedical and infection control professionals have relied for years on a paradigm for aerosol transmission of infectious diseases based on very outmoded research and an overly simplistic interpretation of the data. In the 1940s and 50s, William F. Wells and other \u0022aerobiologists\u0022 employed now significantly out-of-date sampling methods (eg, settling plates) and very blunt analytic approaches (eg, cell culturing) to understand the movement of bacterial aerosols in healthcare and other settings. Their work, though groundbreaking at the time, provides a very incomplete picture.\u003C\/p\u003E\u003Cp\u003EEarly aerobiologists were not able to measure small particles near an infectious person and thus assumed such particles existed only far from the source. They concluded that organisms capable of aerosol transmission (termed \u0022airborne\u0022) can only do so at around 3 feet or more from the source. Because they thought that only larger particles would be present near the source, they believed people would be exposed only via large \u0022droplets\u0022 on their face, eyes, or nose.\u003C\/p\u003E\u003Cp\u003EModern research, using more sensitive instruments and analytic methods, has shown that aerosols emitted from the respiratory tract contain a wide distribution of particle sizes\u2014including many that are small enough to be inhaled.\u003Csup\u003E5,6\u003C\/sup\u003E Thus, both small and large particles will be present near an infectious person.\u003C\/p\u003E\u003Cp\u003EThe chance of large droplets reaching the facial mucous membranes is quite small, as the nasal openings are small and shielded by their external and internal structure. Although close contact may permit large-droplet exposure, it also maximizes the possibility of aerosol inhalation.\u003C\/p\u003E\u003Cp\u003EAs noted by early aerobiologists, liquid in a spray aerosol, such as that generated during coughing or sneezing, will quickly evaporate,\u003Csup\u003E7\u003C\/sup\u003E which increases the concentration of small particles in the aerosol. Because evaporation occurs in milliseconds, many of these particles are likely to be found near the infectious person.\u003C\/p\u003E\u003Cp\u003EThe current paradigm also assumes that only \u0022small\u0022 particles (less than 5 micrometers [mcm]) can be inhaled and deposited in the respiratory tract. This is not true. Particles as large as 100 mcm (and perhaps even larger) can be inhaled into the mouth and nose. Larger particles are deposited in the nasal passages, pharynx, and upper regions of the lungs, while smaller particles are more likely to deposit in the lower, alveolar regions. And for many pathogens, infection is possible regardless of the particle size or deposition site.\u003C\/p\u003E\u003Cp\u003EIt\u0027s time to abandon the old paradigm of three mutually exclusive transmission routes for a new one that considers the full range of particle sizes both near and far from a source. In addition, we need to factor in other important features of infectivity, such as the ability of a pathogen to remain viable in air at room temperature and humidity and the likelihood that systemic disease can result from deposition of infectious particles in the respiratory system or their transfer to the gastrointestinal tract.\u003C\/p\u003E\u003Cp\u003EWe recommend using \u0022aerosol transmissible\u0022 rather than the outmoded terms \u0022droplet\u0022 or \u0022airborne\u0022 to describe pathogens that can transmit disease via infectious particles suspended in air.\u003C\/p\u003E\u003Ch3\u003EIs Ebola an aerosol-transmissible disease?\u003C\/h3\u003E\u003Cp\u003EWe recently published a \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003Ecommentary\u003C\/a\u003E on the CIDRAP site discussing whether Middle East respiratory syndrome (MERS) could be an aerosol-transmissible disease, especially in healthcare settings. We drew comparisons with a similar and more well-studied disease, severe acute respiratory syndrome (SARS).\u003C\/p\u003E\u003Cp\u003EFor Ebola and other filoviruses, however, there is much less information and research on disease transmission and survival, especially in healthcare settings.\u003C\/p\u003E\u003Cp\u003EBeing at first skeptical that Ebola virus could be an aerosol-transmissible disease, we are now persuaded by a review of experimental and epidemiologic data that this might be an important feature of disease transmission, particularly in healthcare settings.\u003C\/p\u003E\u003Ch3\u003EWhat do we know about Ebola transmission?\u003C\/h3\u003E\u003Cp\u003ENo one knows for certain how Ebola virus is transmitted from one person to the next. The virus has been found in the saliva, stool, breast milk, semen, and blood of infected persons.\u003Csup\u003E8,9\u003C\/sup\u003E Studies of transmission in Ebola virus outbreaks have identified activities like caring for an infected person, sharing a bed, funeral activities, and contact with blood or other body fluids to be key risk factors for transmission.\u003Csup\u003E10-12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EOn the basis of epidemiologic evidence, it has been presumed that Ebola viruses are transmitted by contaminated hands in contact with the mouth or eyes or broken skin or by splashes or sprays of body fluids into these areas. Ebola viruses appear to be capable of initiating infection in a variety of human cell types,\u003Csup\u003E13,14\u003C\/sup\u003E but the primary portal or portals of entry into susceptible hosts have not been identified.\u003C\/p\u003E\u003Cp\u003ESome pathogens are limited in the cell type and location they infect. Influenza, for example, is generally restricted to respiratory epithelial cells, which explains why flu is primarily a respiratory infection and is most likely aerosol transmissible. HIV infects T-helper cells in the lymphoid tissues and is primarily a bloodborne pathogen with low probability for transmission via aerosols.\u003C\/p\u003E\u003Cp\u003EEbola virus, on the other hand, is a broader-acting and more non-specific pathogen that can impede the proper functioning of macrophages and dendritic cells\u2014immune response cells located throughout the epithelium.\u003Csup\u003E15,16\u003C\/sup\u003E Epithelial tissues are found throughout the body, including in the respiratory tract. Ebola prevents these cells from carrying out their antiviral functions but does not interfere with the initial inflammatory response, which attracts additional cells to the infection site. The latter contribute to further dissemination of the virus and similar adverse consequences far beyond the initial infection site.\u003C\/p\u003E\u003Cp\u003EThe potential for transmission via inhalation of aerosols, therefore, cannot be ruled out by the observed risk factors or our knowledge of the infection process. Many body fluids, such as vomit, diarrhea, blood, and saliva, are capable of creating inhalable aerosol particles in the immediate vicinity of an infected person. Cough was identified among some cases in a 1995 outbreak in Kikwit, Democratic Republic of the Congo,\u003Csup\u003E11\u003C\/sup\u003E and coughs are known to emit viruses in respirable particles.\u003Csup\u003E17\u003C\/sup\u003E The act of vomiting produces an aerosol and has been implicated in airborne transmission of gastrointestinal viruses.\u003Csup\u003E18,19\u003C\/sup\u003E Regarding diarrhea, even when contained by toilets, toilet flushing emits a pathogen-laden aerosol that disperses in the air.\u003Csup\u003E20-22\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EExperimental work has shown that Marburg and Ebola viruses can be isolated from sera and tissue culture medium at room temperature for up to 46 days, but at room temperature no virus was recovered from glass, metal, or plastic surfaces.\u003Csup\u003E23\u003C\/sup\u003E Aerosolized (1-3 mcm) Marburg, Ebola, and Reston viruses, at 50% to 55% relative humidity and 72\u00b0F, had biological decay rates of 3.04%, 3.06%. and 1.55% per minute, respectively. These rates indicate that 99% loss in aerosol infectivity would occur in 93, 104, and 162 minutes, respectively.\u003Csup\u003E23\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EIn still air, 3-mcm particles can take up to an hour to settle. With air currents, these and smaller particles can be transported considerable distances before they are deposited on a surface.\u003C\/p\u003E\u003Cp\u003EThere is also some experimental evidence that Ebola and other filoviruses can be transmitted by the aerosol route. Jaax et al\u003Csup\u003E24\u003C\/sup\u003E reported the unexpected death of two rhesus monkeys housed approximately 3 meters from monkeys infected with Ebola virus, concluding that respiratory or eye exposure to aerosols was the only possible explanation.\u003C\/p\u003E\u003Cp\u003EZaire Ebola viruses have also been transmitted in the absence of direct contact among pigs\u003Csup\u003E25\u003C\/sup\u003E and from pigs to non-human primates,\u003Csup\u003E26\u003C\/sup\u003E which experienced lung involvement in infection. Persons with no known direct contact with Ebola virus disease patients or their bodily fluids have become infected.\u003Csup\u003E12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EDirect injection and exposure via a skin break or mucous membranes are the most efficient ways for Ebola to transmit. It may be that inhalation is a less efficient route of transmission for Ebola and other filoviruses, as lung involvement has not been reported in all non-human primate studies of Ebola aerosol infectivity.\u003Csup\u003E27\u003C\/sup\u003E However, the respiratory and gastrointestinal systems are not complete barriers to Ebola virus. Experimental studies have demonstrated that it is possible to infect non-human primates and other mammals with filovirus aerosols.\u003Csup\u003E25-27\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAltogether, these epidemiologic and experimental data offer enough evidence to suggest that Ebola and other filoviruses may be opportunistic with respect to aerosol transmission.\u003Csup\u003E28\u003C\/sup\u003E That is, other routes of entry may be more important and probable, but, given the right conditions, it is possible that transmission could also occur via aerosols.\u003C\/p\u003E\u003Cp\u003EGuidance from the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003ECDC\u003C\/a\u003E and \u003Ca href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EWHO\u003C\/a\u003E recommends the use of facemasks for healthcare workers providing routine care to patients with Ebola virus disease and respirators when aerosol-generating procedures are performed. (Interestingly, the 1998 WHO and CDC infection-control guidance for viral hemorrhagic fevers in Africa, still available on the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/abroad\/pdf\/african-healthcare-setting-vhf.pdf\u0022\u003ECDC Web site\u003C\/a\u003E, recommends the use of respirators.)\u003C\/p\u003E\u003Cp\u003EFacemasks, however, do not offer protection against inhalation of small infectious aerosols, because they lack adequate filters and do not fit tightly against the face.\u003Csup\u003E1\u003C\/sup\u003E Therefore, a higher level of protection is necessary.\u003C\/p\u003E\u003Ch3\u003EWhich respirator to wear?\u003C\/h3\u003E\u003Cp\u003EAs described in our earlier \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003ECIDRAP commentary\u003C\/a\u003E, we can use a Canadian control-banding approach to select the most appropriate respirator for exposures to Ebola in healthcare settings.\u003Csup\u003E29\u003C\/sup\u003E (See \u003Ca href=\u0022http:\/\/www.isrp.com\/americas\/docs\/st_paul_2011\/mehes_use_care_standard.pdf\u0022\u003Ethis document\u003C\/a\u003E for a detailed description of the Canadian control banding approach and the data used to select respirators in our examples below.)\u003C\/p\u003E\u003Cp\u003EThe control banding method involves the following steps:\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the organism\u0027s risk group (1 to 4).\u003C\/em\u003E\u003C\/strong\u003E Risk group reflects the toxicity of an organism, including the degree and type of disease and whether treatments are available. Ebola is in risk group 4, the most toxic organisms, because it can cause serious human or animal disease, is easily transmitted, directly or indirectly, and currently has no effective treatments or preventive measures.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the generation rate.\u003C\/em\u003E\u003C\/strong\u003E The rate of aerosol generation reflects the number of particles created per time (eg, particles per second). Some processes, such as coughing, create more aerosols than others, like normal breathing. Some processes, like intubation and toilet flushing, can rapidly generate very large quantities of aerosols. The control banding approach assigns a qualitative rank ranging from low (1) to high (4) (eg, normal breathing without coughing has a rank of 1).\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the level of control.\u003C\/em\u003E\u003C\/strong\u003E Removing contaminated air and replacing it with clean air, as accomplished with a ventilation system, is effective for lowering the overall concentration of infectious aerosol particles in a space, although it may not be effective at lowering concentration in the immediate vicinity of a source. The number of air changes per hour (ACH) reflects the rate of air removal and replacement. This is a useful variable, because it is relatively easy to measure and, for hospitals, reflects building code requirements for different types of rooms. Again, a qualitative ranking is used to reflect low (1) versus high (4) ACH. Even if the true ventilation rate is not known, the examples can be used to select an appropriate air exchange rate.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the respirator assigned protection factor.\u003C\/em\u003E\u003C\/strong\u003E Respirators are designated by their \u0022class,\u0022 each of which has an assigned protection factor (APF) that reflects the degree of protection. The APF represents the outside, environmental concentration divided by the inside, facepiece concentration. An APF of 10 means that the outside concentration of a particular contaminant will be 10 times greater than that inside the respirator. If the concentration outside the respirator is very high, an assigned protection factor of 10 may not prevent the wearer from inhaling an infective dose of a highly toxic organism.\u003C\/li\u003E\u003C\/ol\u003E\u003Ch3\u003EPractical examples\u003C\/h3\u003E\u003Cp\u003ETwo examples follow. These assume that infectious aerosols are generated only during vomiting, diarrhea, coughing, sneezing, or similar high-energy emissions such as some medical procedures. It is possible that Ebola virus may be shed as an aerosol in other manners not considered.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the early stages of disease (no bleeding, vomiting, diarrhea, coughing, sneezing, etc).\u003C\/em\u003E\u003C\/strong\u003E In this case, the generation rate is 1. For any level of control (less than 3 to more than 12 ACH), the control banding wheel indicates a respirator protection level of 1 (APF of 10), which corresponds to an air purifying (negative pressure) half-facepiece respirator such as an N95 filtering facepiece respirator. This type of respirator requires fit testing.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the later stages of disease (bleeding, vomiting, diarrhea, etc).\u003C\/em\u003E \u003C\/strong\u003EIf we assume the highest generation rate (4) and a standard patient room (control level = 2, 3-6 ACH), a respirator with an APF of at least 50 is needed. In the United States, this would be equivalent to either a full-facepiece air-purifying (negative-pressure) respirator or a half-facepiece PAPR (positive pressure), but standards differ in other countries. Fit testing is required for these types of respirators.\u003C\/p\u003E\u003Cp\u003EThe control level (room ventilation) can have a big effect on respirator selection. For the same patient housed in a negative-pressure airborne infection isolation room (6-12 ACH), a respirator with an assigned protection factor of 25 is required. This would correspond in the United States to a PAPR with a loose-fitting facepiece or with a helmet or hood. This type of respirator does not need fit testing.\u003C\/p\u003E\u003Ch3\u003EImplications for protecting health workers in Africa\u003C\/h3\u003E\u003Cp\u003EHealthcare workers have experienced very high rates of morbidity and mortality in the past and current Ebola virus outbreaks. A facemask, or surgical mask, offers no or very minimal protection from infectious aerosol particles. As our examples illustrate, for a risk group 4 organism like Ebola, the minimum level of protection should be an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003EThis type of respirator, however, would only be appropriate only when the likelihood of aerosol exposure is very low. For healthcare workers caring for many patients in an epidemic situation, this type of respirator may not provide an adequate level of protection.\u003C\/p\u003E\u003Cp\u003EFor a risk group 4 organism, any activity that has the potential for aerosolizing liquid body fluids, such as medical or disinfection procedures, should be avoided, if possible. Our risk assessment indicates that a PAPR with a full facepiece (APF = 50) or a hood or helmet (APF = 25) would be a better choice for patient care during epidemic conditions.\u003C\/p\u003E\u003Cp\u003EWe recognize that PAPRs present some logistical and infection-control problems. Batteries require frequent charging (which requires a reliable source of electricity), and the entire ensemble requires careful handling and disinfection between uses. A PAPR is also more expensive to buy and maintain than other types of respirators.\u003C\/p\u003E\u003Cp\u003EOn the other hand, a PAPR with a loose-fitting facepiece (hood or helmet) does not require fit testing. Wearing this type of respirator minimizes the need for other types of PPE, such as head coverings and goggles. And, most important, it is much more comfortable to wear than a negative-pressure respirator like an N95, especially in hot environments.\u003C\/p\u003E\u003Cp\u003EA recent report from a Medecins Sans Frontieres healthcare worker in Sierra Leone\u003Csup\u003E30\u003C\/sup\u003E notes that healthcare workers cannot tolerate the required PPE for more than 40 minutes. Exiting the workplace every 40 minutes requires removal and disinfection or disposal (burning) of all PPE. A PAPR would allow much longer work periods, use less PPE, require fewer doffing episodes, generate less infectious waste, and be more protective. In the long run, we suspect this type of protection could also be less expensive.\u003C\/p\u003E\u003Ch3\u003EAdequate protection is essential\u003C\/h3\u003E\u003Cp\u003ETo summarize, for the following reasons we believe that Ebola could be an opportunistic aerosol-transmissible disease requiring adequate respiratory protection:\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003EPatients and procedures generate aerosols, and Ebola virus remains viable in aerosols for up to 90 minutes.\u003C\/li\u003E\u003Cli\u003EAll sizes of aerosol particles are easily inhaled both near to and far from the patient.\u003C\/li\u003E\u003Cli\u003ECrowding, limited air exchange, and close interactions with patients all contribute to the probability that healthcare workers will be exposed to high concentrations of very toxic infectious aerosols.\u003C\/li\u003E\u003Cli\u003EEbola targets immune response cells found in all epithelial tissues, including in the respiratory and gastrointestinal system.\u003C\/li\u003E\u003Cli\u003EExperimental data support aerosols as a mode of disease transmission in non-human primates.\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003ERisk level and working conditions suggest that a PAPR will be more protective, cost-effective, and comfortable than an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAcknowledgements\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EWe thank Kathleen Harriman, PhD, MPH, RN, Chief, Vaccine Preventable Diseases Epidemiology Section, Immunization Branch, California Department of Public Health, and Nicole Vars McCullough, PhD, CIH, Manager, Global Technical Services, Personal Safety Division, 3M Company, for their input and review.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EReferences\u003C\/strong\u003E\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003EOberg L, Brosseau LM.\u003C\/strong\u003E Surgical mask filter and fit performance. Am J Infect Control 2008 May;36(4):276-82 [\u003Ca href=\u0022http:\/\/www.ajicjournal.org\/article\/S0196-6553(07)00774-2\/abstract\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECDC.\u003C\/strong\u003E Ebola hemorrhagic fever: transmission. 2014 Aug 13 [\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/index.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EECDC.\u003C\/strong\u003E Outbreak of Ebola virus disease in West Africa: third update, 1 August 2014. Stockholm: ECDC 2014 Aug 1 [\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-outbreak-west-africa-1-august-2014.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMartin-Moreno JM, Llinas G, Hernandez JM.\u003C\/strong\u003E Is respiratory protection appropriate in the Ebola response? Lancet 2014 Sep 6;384(9946):856 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(14)61343-X\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPapineni RS, Rosenthal FS.\u003C\/strong\u003E The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997;10(2):105-16 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10168531\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChao CYH, Wan MP, Morawska L, et al.\u003C\/strong\u003E Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci 2009 Feb;40(2):122-33 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0021850208001882\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ENicas M, Nazaroff WW, Hubbard A.\u003C\/strong\u003E Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg 2005 Mar;2(3):143-54 [\u003Ca href=\u0022http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/15459620590918466?url_ver=Z39.88-2003\u0026amp;rfr_id=ori:rid:crossref.org\u0026amp;rfr_dat=cr_pub%3dpubmed#.VBnXrS5dUZ4\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBauchsch DG, Towner JS, Dowell SF, et al.\u003C\/strong\u003E Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196:S142-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/196\/Supplement_2\/S142.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFormenty P, Leroy EM, Epelboin A, et al.\u003C\/strong\u003E Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006 Jun;42(11):1521-6 [\u003Ca href=\u0022http:\/\/cid.oxfordjournals.org\/content\/42\/11\/1521.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFrancesconi P, Yoti Z, Declich S, et al.\u003C\/strong\u003E Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 2003 Nov;9(11):1430-7 [\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/9\/11\/pdfs\/03-0339.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EDowell SF, Mukunu R, Ksiazek TG, et al.\u003C\/strong\u003E Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of Congo, 1995. J Infect Dis 1999 Feb;179:S87-91 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S87.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoels TH, Bloom AS, Buffington J, et al.\u003C\/strong\u003E Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999 Feb;179:S92-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S92.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKuhl A, Hoffmann M, Muller MA, et al.\u003C\/strong\u003E Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J Infect Dis 2011 Nov;204:S840-9 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/suppl_3\/S840.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EHunt CL, Lennemann NJ, Maury W.\u003C\/strong\u003E Filovirus entry: a novelty in the viral fusion world. Viruses 2012 Feb;4(2):258-75 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3315215\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBray M, Geisbert TW.\u003C\/strong\u003E Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005 Aug;37(8):1560-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s1357272505000725\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMohamadzadeh M, Chen L, Schmaljohn AL.\u003C\/strong\u003E How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 2007 Jul;7(7):556-67 [\u003Ca href=\u0022http:\/\/www.nature.com\/nri\/journal\/v7\/n7\/full\/nri2098.html\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ELindsley WG, Blachere FM, Thewlis RE, et al.\u003C\/strong\u003E Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One 2010 Nov 30;5(11):e15100 [\u003Ca href=\u0022http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0015100\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECaul EO.\u003C\/strong\u003E Small round structured viruses: airborne transmission and hospital control. Lancet 1994 May 21;343(8908):1240-2 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)92146-6\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChadwick PR, Walker M, Rees AE.\u003C\/strong\u003E Airborne transmission of a small round structured virus. Lancet 1994 Jan 15;343(8890):171 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)90959-8\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBest EL, Snadoe JA, Wilcox MH.\u003C\/strong\u003E Potential for aerosolization of \u003Cem\u003EClostridium difficile\u003C\/em\u003E after flushing toilets: the role of toilet lids in reducing environmental contamination. J Hosp Infect 2012 Jan;80(1):1-5 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s0195670111003392\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EGerba CP, Wallis C, Melnick JL.\u003C\/strong\u003E Microbiological hazards of household toilets: droplet production and the fate of residual organisms. Appl Microbiol 1975 Aug;30(2):229-37 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC187159\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBarker J, Jones MV.\u003C\/strong\u003E The potential spread of infection caused by aerosol contamination of surfaces after flushing a domestic toilet. J Appl Microbiol 2005;99(2):339-47 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2005.02610.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPiercy TJ, Smither SJ, Steward JA, et al.\u003C\/strong\u003E The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 2010 Nov;109(5):1531-9 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2010.04778.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EJaax N, Jahrling P, Geisbert T, et al.\u003C\/strong\u003E Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995 Dec 23-30;346(8991-2):1669-71 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8551825\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKobinger GP, Leung A, Neufeld J, et al.\u003C\/strong\u003E Replication, pathogenicity, shedding and transmission of Zaire ebolavirus in pigs. J Infect Dis 2011 Jul 15;204(2):200-8 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/2\/200.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWeingartl HM, Embury-Hyatt C, Nfon C, et al.\u003C\/strong\u003E Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2012;2:811 [\u003Ca href=\u0022http:\/\/www.nature.com\/srep\/2012\/121115\/srep00811\/full\/srep00811.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EReed DS, Lackemeyer MG, Garza NL, et al.\u003C\/strong\u003E Aerosol exposure to Zaire Ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microb Infect 2011 Oct;13(11):930-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1286457911001225\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoy CJ, Milton DK.\u003C\/strong\u003E Airborne transmission of communicable infection\u2014the elusive pathway. N Engl J Med 2004 Apr;350(17):1710-2 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp048051\u0022\u003EPreview\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECanadian Standards Association.\u003C\/strong\u003E Selection, use and care of respirators. CAN\/CSA Z94.4-11\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWolz A.\u003C\/strong\u003E Face to face with Ebola\u2014an emergency care center in Sierra Leone. (Perspective) N Engl J Med 2014 Aug 27 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmp1410179\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003C\/ol\u003E","format":"full_html","safe_value":"\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note \u003Cstrong\u003E\u003Cem\u003E(Oct 16)\u003C\/em\u003E\u003C\/strong\u003E:\u00a0 \u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003ESee the \u003C\/em\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/response-statements-falsely-attributed-cidrap-regarding-ebola-transmission\u0022 target=\u0022_blank\u0022\u003E statement\u003C\/a\u003E released today by CIDRAP related to this commentary.\u003C\/em\u003E\u003Cstrong\u003E\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note (Sep 17):\u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003E Today\u0027s commentary was submitted to CIDRAP by the authors, who are national experts on respiratory protection and infectious disease transmission. In May they published a \u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003E\u003Cem\u003Esimilar commentary on MERS-CoV\u003C\/em\u003E\u003C\/a\u003E\u003Cem\u003E. Dr Brosseau is a Professor and Dr Jones an Assistant Professor in the School of Public Health, Division of Environmental and Occupational Health Sciences, at the University of Illinois at Chicago.\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003E\u003Cstrong\u003EAuthors\u0027 disclaimer:\u003C\/strong\u003E\u003C\/em\u003E\u003Cem\u003E This commentary reflects the personal opinions of the authors. It does not represent the opinion of the University of Illinois at Chicago or any other organization. The authors have not received any compensation for the preparation of this commentary or any associated public statements. The authors do not endorse any specific manufacturer or brand of personal protective equipment (PPE) and have no direct or indirect financial interest in the use of a specific brand of PPE. In the past one or both of the authors have received research funding from numerous government agencies and organizations, including 3M.\u003C\/em\u003E\u003C\/p\u003E\u003Chr \/\u003E\u003Cp\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cdiv\u003EHealthcare workers play a very important role in the successful containment of outbreaks of infectious diseases like Ebola. The correct type and level of personal protective equipment (PPE) ensures that healthcare workers remain healthy throughout an outbreak\u2014and with the current rapidly expanding Ebola outbreak in West Africa, it\u0027s imperative to favor more conservative measures.\u003C\/div\u003E\u003Cdiv\u003E\u00a0\u003C\/div\u003E\u003Cdiv\u003EThe precautionary principle\u2014that any action designed to reduce risk should not await scientific certainty\u2014compels the use of respiratory protection for a pathogen like Ebola virus that has:\u003C\/div\u003E\u003Cdiv\u003E\u00a0\u003C\/div\u003E\u003Cul\u003E\u003Cli\u003ENo proven pre- or post-exposure treatment modalities\u003C\/li\u003E\u003Cli\u003EA high case-fatality rate\u003C\/li\u003E\u003Cli\u003EUnclear modes of transmission\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003EWe believe there is scientific and epidemiologic evidence that Ebola virus has the potential to be transmitted via infectious aerosol particles both near and at a distance from infected patients, which means that healthcare workers should be wearing respirators, not facemasks.\u003Csup\u003E1\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EThe minimum level of protection in high-risk settings should be a respirator with an assigned protection factor greater than 10. A powered air-purifying respirator (PAPR) with a hood or helmet offers many advantages over an N95 filtering facepiece or similar respirator, being more protective, comfortable, and cost-effective in the long run.\u003C\/p\u003E\u003Cp\u003EWe strongly urge the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to seek funds for the purchase and transport of PAPRs to all healthcare workers currently fighting the battle against Ebola throughout Africa\u2014and beyond.\u003C\/p\u003E\u003Cp\u003EThere has been a lot of on-line and published controversy about whether Ebola virus can be transmitted via aerosols. Most scientific and medical personnel, along with public health organizations, have been unequivocal in their statements that Ebola can be transmitted only by direct contact with virus-laden fluids\u003Csup\u003E2,3\u003C\/sup\u003E and that the only modes of transmission we should be concerned with are those termed \u0022droplet\u0022 and \u0022contact.\u0022\u003C\/p\u003E\u003Cp\u003EThese statements are based on two lines of reasoning. The first is that no one located at a distance from an infected individual has contracted the disease, or the converse, every person infected has had (or must have had) \u0022direct\u0022 contact with the body fluids of an infected person.\u003C\/p\u003E\u003Cp\u003EThis reflects an incorrect and outmoded understanding of infectious aerosols, which has been institutionalized in policies, language, culture, and approaches to infection control. We will address this below. Briefly, however, the important points are that virus-laden bodily fluids may be aerosolized and inhaled while a person is in proximity to an infectious person and that a wide range of particle sizes can be inhaled and deposited throughout the respiratory tract.\u003C\/p\u003E\u003Cp\u003EThe second line of reasoning is that respirators or other control measures for infectious aerosols cannot be recommended in developing countries because the resources, time, and\/or understanding for such measures are lacking.\u003Csup\u003E4\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAlthough there are some important barriers to the use of respirators, especially PAPRs, in developing countries, healthcare workers everywhere deserve and should be afforded the same best-practice types of protection, regardless of costs and resources. Every healthcare worker is a precious commodity whose well-being ensures everyone is protected.\u003C\/p\u003E\u003Cp\u003EIf we are willing to offer infected US healthcare workers expensive treatments and experimental drugs free of charge when most of the world has no access to them, we wonder why we are unwilling to find the resources to provide appropriate levels of comparatively less expensive respiratory protection to every healthcare worker around the world.\u003C\/p\u003E\u003Ch3\u003EHow are infectious diseases transmitted via aerosols?\u003C\/h3\u003E\u003Cp\u003EMedical and infection control professionals have relied for years on a paradigm for aerosol transmission of infectious diseases based on very outmoded research and an overly simplistic interpretation of the data. In the 1940s and 50s, William F. Wells and other \u0022aerobiologists\u0022 employed now significantly out-of-date sampling methods (eg, settling plates) and very blunt analytic approaches (eg, cell culturing) to understand the movement of bacterial aerosols in healthcare and other settings. Their work, though groundbreaking at the time, provides a very incomplete picture.\u003C\/p\u003E\u003Cp\u003EEarly aerobiologists were not able to measure small particles near an infectious person and thus assumed such particles existed only far from the source. They concluded that organisms capable of aerosol transmission (termed \u0022airborne\u0022) can only do so at around 3 feet or more from the source. Because they thought that only larger particles would be present near the source, they believed people would be exposed only via large \u0022droplets\u0022 on their face, eyes, or nose.\u003C\/p\u003E\u003Cp\u003EModern research, using more sensitive instruments and analytic methods, has shown that aerosols emitted from the respiratory tract contain a wide distribution of particle sizes\u2014including many that are small enough to be inhaled.\u003Csup\u003E5,6\u003C\/sup\u003E Thus, both small and large particles will be present near an infectious person.\u003C\/p\u003E\u003Cp\u003EThe chance of large droplets reaching the facial mucous membranes is quite small, as the nasal openings are small and shielded by their external and internal structure. Although close contact may permit large-droplet exposure, it also maximizes the possibility of aerosol inhalation.\u003C\/p\u003E\u003Cp\u003EAs noted by early aerobiologists, liquid in a spray aerosol, such as that generated during coughing or sneezing, will quickly evaporate,\u003Csup\u003E7\u003C\/sup\u003E which increases the concentration of small particles in the aerosol. Because evaporation occurs in milliseconds, many of these particles are likely to be found near the infectious person.\u003C\/p\u003E\u003Cp\u003EThe current paradigm also assumes that only \u0022small\u0022 particles (less than 5 micrometers [mcm]) can be inhaled and deposited in the respiratory tract. This is not true. Particles as large as 100 mcm (and perhaps even larger) can be inhaled into the mouth and nose. Larger particles are deposited in the nasal passages, pharynx, and upper regions of the lungs, while smaller particles are more likely to deposit in the lower, alveolar regions. And for many pathogens, infection is possible regardless of the particle size or deposition site.\u003C\/p\u003E\u003Cp\u003EIt\u0027s time to abandon the old paradigm of three mutually exclusive transmission routes for a new one that considers the full range of particle sizes both near and far from a source. In addition, we need to factor in other important features of infectivity, such as the ability of a pathogen to remain viable in air at room temperature and humidity and the likelihood that systemic disease can result from deposition of infectious particles in the respiratory system or their transfer to the gastrointestinal tract.\u003C\/p\u003E\u003Cp\u003EWe recommend using \u0022aerosol transmissible\u0022 rather than the outmoded terms \u0022droplet\u0022 or \u0022airborne\u0022 to describe pathogens that can transmit disease via infectious particles suspended in air.\u003C\/p\u003E\u003Ch3\u003EIs Ebola an aerosol-transmissible disease?\u003C\/h3\u003E\u003Cp\u003EWe recently published a \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003Ecommentary\u003C\/a\u003E on the CIDRAP site discussing whether Middle East respiratory syndrome (MERS) could be an aerosol-transmissible disease, especially in healthcare settings. We drew comparisons with a similar and more well-studied disease, severe acute respiratory syndrome (SARS).\u003C\/p\u003E\u003Cp\u003EFor Ebola and other filoviruses, however, there is much less information and research on disease transmission and survival, especially in healthcare settings.\u003C\/p\u003E\u003Cp\u003EBeing at first skeptical that Ebola virus could be an aerosol-transmissible disease, we are now persuaded by a review of experimental and epidemiologic data that this might be an important feature of disease transmission, particularly in healthcare settings.\u003C\/p\u003E\u003Ch3\u003EWhat do we know about Ebola transmission?\u003C\/h3\u003E\u003Cp\u003ENo one knows for certain how Ebola virus is transmitted from one person to the next. The virus has been found in the saliva, stool, breast milk, semen, and blood of infected persons.\u003Csup\u003E8,9\u003C\/sup\u003E Studies of transmission in Ebola virus outbreaks have identified activities like caring for an infected person, sharing a bed, funeral activities, and contact with blood or other body fluids to be key risk factors for transmission.\u003Csup\u003E10-12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EOn the basis of epidemiologic evidence, it has been presumed that Ebola viruses are transmitted by contaminated hands in contact with the mouth or eyes or broken skin or by splashes or sprays of body fluids into these areas. Ebola viruses appear to be capable of initiating infection in a variety of human cell types,\u003Csup\u003E13,14\u003C\/sup\u003E but the primary portal or portals of entry into susceptible hosts have not been identified.\u003C\/p\u003E\u003Cp\u003ESome pathogens are limited in the cell type and location they infect. Influenza, for example, is generally restricted to respiratory epithelial cells, which explains why flu is primarily a respiratory infection and is most likely aerosol transmissible. HIV infects T-helper cells in the lymphoid tissues and is primarily a bloodborne pathogen with low probability for transmission via aerosols.\u003C\/p\u003E\u003Cp\u003EEbola virus, on the other hand, is a broader-acting and more non-specific pathogen that can impede the proper functioning of macrophages and dendritic cells\u2014immune response cells located throughout the epithelium.\u003Csup\u003E15,16\u003C\/sup\u003E Epithelial tissues are found throughout the body, including in the respiratory tract. Ebola prevents these cells from carrying out their antiviral functions but does not interfere with the initial inflammatory response, which attracts additional cells to the infection site. The latter contribute to further dissemination of the virus and similar adverse consequences far beyond the initial infection site.\u003C\/p\u003E\u003Cp\u003EThe potential for transmission via inhalation of aerosols, therefore, cannot be ruled out by the observed risk factors or our knowledge of the infection process. Many body fluids, such as vomit, diarrhea, blood, and saliva, are capable of creating inhalable aerosol particles in the immediate vicinity of an infected person. Cough was identified among some cases in a 1995 outbreak in Kikwit, Democratic Republic of the Congo,\u003Csup\u003E11\u003C\/sup\u003E and coughs are known to emit viruses in respirable particles.\u003Csup\u003E17\u003C\/sup\u003E The act of vomiting produces an aerosol and has been implicated in airborne transmission of gastrointestinal viruses.\u003Csup\u003E18,19\u003C\/sup\u003E Regarding diarrhea, even when contained by toilets, toilet flushing emits a pathogen-laden aerosol that disperses in the air.\u003Csup\u003E20-22\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EExperimental work has shown that Marburg and Ebola viruses can be isolated from sera and tissue culture medium at room temperature for up to 46 days, but at room temperature no virus was recovered from glass, metal, or plastic surfaces.\u003Csup\u003E23\u003C\/sup\u003E Aerosolized (1-3 mcm) Marburg, Ebola, and Reston viruses, at 50% to 55% relative humidity and 72\u00b0F, had biological decay rates of 3.04%, 3.06%. and 1.55% per minute, respectively. These rates indicate that 99% loss in aerosol infectivity would occur in 93, 104, and 162 minutes, respectively.\u003Csup\u003E23\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EIn still air, 3-mcm particles can take up to an hour to settle. With air currents, these and smaller particles can be transported considerable distances before they are deposited on a surface.\u003C\/p\u003E\u003Cp\u003EThere is also some experimental evidence that Ebola and other filoviruses can be transmitted by the aerosol route. Jaax et al\u003Csup\u003E24\u003C\/sup\u003E reported the unexpected death of two rhesus monkeys housed approximately 3 meters from monkeys infected with Ebola virus, concluding that respiratory or eye exposure to aerosols was the only possible explanation.\u003C\/p\u003E\u003Cp\u003EZaire Ebola viruses have also been transmitted in the absence of direct contact among pigs\u003Csup\u003E25\u003C\/sup\u003E and from pigs to non-human primates,\u003Csup\u003E26\u003C\/sup\u003E which experienced lung involvement in infection. Persons with no known direct contact with Ebola virus disease patients or their bodily fluids have become infected.\u003Csup\u003E12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EDirect injection and exposure via a skin break or mucous membranes are the most efficient ways for Ebola to transmit. It may be that inhalation is a less efficient route of transmission for Ebola and other filoviruses, as lung involvement has not been reported in all non-human primate studies of Ebola aerosol infectivity.\u003Csup\u003E27\u003C\/sup\u003E However, the respiratory and gastrointestinal systems are not complete barriers to Ebola virus. Experimental studies have demonstrated that it is possible to infect non-human primates and other mammals with filovirus aerosols.\u003Csup\u003E25-27\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAltogether, these epidemiologic and experimental data offer enough evidence to suggest that Ebola and other filoviruses may be opportunistic with respect to aerosol transmission.\u003Csup\u003E28\u003C\/sup\u003E That is, other routes of entry may be more important and probable, but, given the right conditions, it is possible that transmission could also occur via aerosols.\u003C\/p\u003E\u003Cp\u003EGuidance from the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003ECDC\u003C\/a\u003E and \u003Ca href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EWHO\u003C\/a\u003E recommends the use of facemasks for healthcare workers providing routine care to patients with Ebola virus disease and respirators when aerosol-generating procedures are performed. (Interestingly, the 1998 WHO and CDC infection-control guidance for viral hemorrhagic fevers in Africa, still available on the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/abroad\/pdf\/african-healthcare-setting-vhf.pdf\u0022\u003ECDC Web site\u003C\/a\u003E, recommends the use of respirators.)\u003C\/p\u003E\u003Cp\u003EFacemasks, however, do not offer protection against inhalation of small infectious aerosols, because they lack adequate filters and do not fit tightly against the face.\u003Csup\u003E1\u003C\/sup\u003E Therefore, a higher level of protection is necessary.\u003C\/p\u003E\u003Ch3\u003EWhich respirator to wear?\u003C\/h3\u003E\u003Cp\u003EAs described in our earlier \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003ECIDRAP commentary\u003C\/a\u003E, we can use a Canadian control-banding approach to select the most appropriate respirator for exposures to Ebola in healthcare settings.\u003Csup\u003E29\u003C\/sup\u003E (See \u003Ca href=\u0022http:\/\/www.isrp.com\/americas\/docs\/st_paul_2011\/mehes_use_care_standard.pdf\u0022\u003Ethis document\u003C\/a\u003E for a detailed description of the Canadian control banding approach and the data used to select respirators in our examples below.)\u003C\/p\u003E\u003Cp\u003EThe control banding method involves the following steps:\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the organism\u0027s risk group (1 to 4).\u003C\/em\u003E\u003C\/strong\u003E Risk group reflects the toxicity of an organism, including the degree and type of disease and whether treatments are available. Ebola is in risk group 4, the most toxic organisms, because it can cause serious human or animal disease, is easily transmitted, directly or indirectly, and currently has no effective treatments or preventive measures.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the generation rate.\u003C\/em\u003E\u003C\/strong\u003E The rate of aerosol generation reflects the number of particles created per time (eg, particles per second). Some processes, such as coughing, create more aerosols than others, like normal breathing. Some processes, like intubation and toilet flushing, can rapidly generate very large quantities of aerosols. The control banding approach assigns a qualitative rank ranging from low (1) to high (4) (eg, normal breathing without coughing has a rank of 1).\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the level of control.\u003C\/em\u003E\u003C\/strong\u003E Removing contaminated air and replacing it with clean air, as accomplished with a ventilation system, is effective for lowering the overall concentration of infectious aerosol particles in a space, although it may not be effective at lowering concentration in the immediate vicinity of a source. The number of air changes per hour (ACH) reflects the rate of air removal and replacement. This is a useful variable, because it is relatively easy to measure and, for hospitals, reflects building code requirements for different types of rooms. Again, a qualitative ranking is used to reflect low (1) versus high (4) ACH. Even if the true ventilation rate is not known, the examples can be used to select an appropriate air exchange rate.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the respirator assigned protection factor.\u003C\/em\u003E\u003C\/strong\u003E Respirators are designated by their \u0022class,\u0022 each of which has an assigned protection factor (APF) that reflects the degree of protection. The APF represents the outside, environmental concentration divided by the inside, facepiece concentration. An APF of 10 means that the outside concentration of a particular contaminant will be 10 times greater than that inside the respirator. If the concentration outside the respirator is very high, an assigned protection factor of 10 may not prevent the wearer from inhaling an infective dose of a highly toxic organism.\u003C\/li\u003E\u003C\/ol\u003E\u003Ch3\u003EPractical examples\u003C\/h3\u003E\u003Cp\u003ETwo examples follow. These assume that infectious aerosols are generated only during vomiting, diarrhea, coughing, sneezing, or similar high-energy emissions such as some medical procedures. It is possible that Ebola virus may be shed as an aerosol in other manners not considered.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the early stages of disease (no bleeding, vomiting, diarrhea, coughing, sneezing, etc).\u003C\/em\u003E\u003C\/strong\u003E In this case, the generation rate is 1. For any level of control (less than 3 to more than 12 ACH), the control banding wheel indicates a respirator protection level of 1 (APF of 10), which corresponds to an air purifying (negative pressure) half-facepiece respirator such as an N95 filtering facepiece respirator. This type of respirator requires fit testing.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the later stages of disease (bleeding, vomiting, diarrhea, etc).\u003C\/em\u003E \u003C\/strong\u003EIf we assume the highest generation rate (4) and a standard patient room (control level = 2, 3-6 ACH), a respirator with an APF of at least 50 is needed. In the United States, this would be equivalent to either a full-facepiece air-purifying (negative-pressure) respirator or a half-facepiece PAPR (positive pressure), but standards differ in other countries. Fit testing is required for these types of respirators.\u003C\/p\u003E\u003Cp\u003EThe control level (room ventilation) can have a big effect on respirator selection. For the same patient housed in a negative-pressure airborne infection isolation room (6-12 ACH), a respirator with an assigned protection factor of 25 is required. This would correspond in the United States to a PAPR with a loose-fitting facepiece or with a helmet or hood. This type of respirator does not need fit testing.\u003C\/p\u003E\u003Ch3\u003EImplications for protecting health workers in Africa\u003C\/h3\u003E\u003Cp\u003EHealthcare workers have experienced very high rates of morbidity and mortality in the past and current Ebola virus outbreaks. A facemask, or surgical mask, offers no or very minimal protection from infectious aerosol particles. As our examples illustrate, for a risk group 4 organism like Ebola, the minimum level of protection should be an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003EThis type of respirator, however, would only be appropriate only when the likelihood of aerosol exposure is very low. For healthcare workers caring for many patients in an epidemic situation, this type of respirator may not provide an adequate level of protection.\u003C\/p\u003E\u003Cp\u003EFor a risk group 4 organism, any activity that has the potential for aerosolizing liquid body fluids, such as medical or disinfection procedures, should be avoided, if possible. Our risk assessment indicates that a PAPR with a full facepiece (APF = 50) or a hood or helmet (APF = 25) would be a better choice for patient care during epidemic conditions.\u003C\/p\u003E\u003Cp\u003EWe recognize that PAPRs present some logistical and infection-control problems. Batteries require frequent charging (which requires a reliable source of electricity), and the entire ensemble requires careful handling and disinfection between uses. A PAPR is also more expensive to buy and maintain than other types of respirators.\u003C\/p\u003E\u003Cp\u003EOn the other hand, a PAPR with a loose-fitting facepiece (hood or helmet) does not require fit testing. Wearing this type of respirator minimizes the need for other types of PPE, such as head coverings and goggles. And, most important, it is much more comfortable to wear than a negative-pressure respirator like an N95, especially in hot environments.\u003C\/p\u003E\u003Cp\u003EA recent report from a Medecins Sans Frontieres healthcare worker in Sierra Leone\u003Csup\u003E30\u003C\/sup\u003E notes that healthcare workers cannot tolerate the required PPE for more than 40 minutes. Exiting the workplace every 40 minutes requires removal and disinfection or disposal (burning) of all PPE. A PAPR would allow much longer work periods, use less PPE, require fewer doffing episodes, generate less infectious waste, and be more protective. In the long run, we suspect this type of protection could also be less expensive.\u003C\/p\u003E\u003Ch3\u003EAdequate protection is essential\u003C\/h3\u003E\u003Cp\u003ETo summarize, for the following reasons we believe that Ebola could be an opportunistic aerosol-transmissible disease requiring adequate respiratory protection:\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003EPatients and procedures generate aerosols, and Ebola virus remains viable in aerosols for up to 90 minutes.\u003C\/li\u003E\u003Cli\u003EAll sizes of aerosol particles are easily inhaled both near to and far from the patient.\u003C\/li\u003E\u003Cli\u003ECrowding, limited air exchange, and close interactions with patients all contribute to the probability that healthcare workers will be exposed to high concentrations of very toxic infectious aerosols.\u003C\/li\u003E\u003Cli\u003EEbola targets immune response cells found in all epithelial tissues, including in the respiratory and gastrointestinal system.\u003C\/li\u003E\u003Cli\u003EExperimental data support aerosols as a mode of disease transmission in non-human primates.\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003ERisk level and working conditions suggest that a PAPR will be more protective, cost-effective, and comfortable than an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAcknowledgements\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EWe thank Kathleen Harriman, PhD, MPH, RN, Chief, Vaccine Preventable Diseases Epidemiology Section, Immunization Branch, California Department of Public Health, and Nicole Vars McCullough, PhD, CIH, Manager, Global Technical Services, Personal Safety Division, 3M Company, for their input and review.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EReferences\u003C\/strong\u003E\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003EOberg L, Brosseau LM.\u003C\/strong\u003E Surgical mask filter and fit performance. Am J Infect Control 2008 May;36(4):276-82 [\u003Ca href=\u0022http:\/\/www.ajicjournal.org\/article\/S0196-6553(07)00774-2\/abstract\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECDC.\u003C\/strong\u003E Ebola hemorrhagic fever: transmission. 2014 Aug 13 [\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/index.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EECDC.\u003C\/strong\u003E Outbreak of Ebola virus disease in West Africa: third update, 1 August 2014. Stockholm: ECDC 2014 Aug 1 [\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-outbreak-west-africa-1-august-2014.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMartin-Moreno JM, Llinas G, Hernandez JM.\u003C\/strong\u003E Is respiratory protection appropriate in the Ebola response? Lancet 2014 Sep 6;384(9946):856 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(14)61343-X\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPapineni RS, Rosenthal FS.\u003C\/strong\u003E The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997;10(2):105-16 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10168531\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChao CYH, Wan MP, Morawska L, et al.\u003C\/strong\u003E Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci 2009 Feb;40(2):122-33 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0021850208001882\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ENicas M, Nazaroff WW, Hubbard A.\u003C\/strong\u003E Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg 2005 Mar;2(3):143-54 [\u003Ca href=\u0022http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/15459620590918466?url_ver=Z39.88-2003\u0026amp;rfr_id=ori:rid:crossref.org\u0026amp;rfr_dat=cr_pub%3dpubmed#.VBnXrS5dUZ4\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBauchsch DG, Towner JS, Dowell SF, et al.\u003C\/strong\u003E Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196:S142-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/196\/Supplement_2\/S142.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFormenty P, Leroy EM, Epelboin A, et al.\u003C\/strong\u003E Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006 Jun;42(11):1521-6 [\u003Ca href=\u0022http:\/\/cid.oxfordjournals.org\/content\/42\/11\/1521.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFrancesconi P, Yoti Z, Declich S, et al.\u003C\/strong\u003E Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 2003 Nov;9(11):1430-7 [\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/9\/11\/pdfs\/03-0339.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EDowell SF, Mukunu R, Ksiazek TG, et al.\u003C\/strong\u003E Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of Congo, 1995. J Infect Dis 1999 Feb;179:S87-91 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S87.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoels TH, Bloom AS, Buffington J, et al.\u003C\/strong\u003E Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999 Feb;179:S92-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S92.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKuhl A, Hoffmann M, Muller MA, et al.\u003C\/strong\u003E Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J Infect Dis 2011 Nov;204:S840-9 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/suppl_3\/S840.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EHunt CL, Lennemann NJ, Maury W.\u003C\/strong\u003E Filovirus entry: a novelty in the viral fusion world. Viruses 2012 Feb;4(2):258-75 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3315215\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBray M, Geisbert TW.\u003C\/strong\u003E Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005 Aug;37(8):1560-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s1357272505000725\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMohamadzadeh M, Chen L, Schmaljohn AL.\u003C\/strong\u003E How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 2007 Jul;7(7):556-67 [\u003Ca href=\u0022http:\/\/www.nature.com\/nri\/journal\/v7\/n7\/full\/nri2098.html\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ELindsley WG, Blachere FM, Thewlis RE, et al.\u003C\/strong\u003E Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One 2010 Nov 30;5(11):e15100 [\u003Ca href=\u0022http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0015100\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECaul EO.\u003C\/strong\u003E Small round structured viruses: airborne transmission and hospital control. Lancet 1994 May 21;343(8908):1240-2 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)92146-6\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChadwick PR, Walker M, Rees AE.\u003C\/strong\u003E Airborne transmission of a small round structured virus. Lancet 1994 Jan 15;343(8890):171 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)90959-8\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBest EL, Snadoe JA, Wilcox MH.\u003C\/strong\u003E Potential for aerosolization of \u003Cem\u003EClostridium difficile\u003C\/em\u003E after flushing toilets: the role of toilet lids in reducing environmental contamination. J Hosp Infect 2012 Jan;80(1):1-5 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s0195670111003392\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EGerba CP, Wallis C, Melnick JL.\u003C\/strong\u003E Microbiological hazards of household toilets: droplet production and the fate of residual organisms. Appl Microbiol 1975 Aug;30(2):229-37 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC187159\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBarker J, Jones MV.\u003C\/strong\u003E The potential spread of infection caused by aerosol contamination of surfaces after flushing a domestic toilet. J Appl Microbiol 2005;99(2):339-47 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2005.02610.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPiercy TJ, Smither SJ, Steward JA, et al.\u003C\/strong\u003E The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 2010 Nov;109(5):1531-9 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2010.04778.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EJaax N, Jahrling P, Geisbert T, et al.\u003C\/strong\u003E Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995 Dec 23-30;346(8991-2):1669-71 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8551825\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKobinger GP, Leung A, Neufeld J, et al.\u003C\/strong\u003E Replication, pathogenicity, shedding and transmission of Zaire ebolavirus in pigs. J Infect Dis 2011 Jul 15;204(2):200-8 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/2\/200.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWeingartl HM, Embury-Hyatt C, Nfon C, et al.\u003C\/strong\u003E Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2012;2:811 [\u003Ca href=\u0022http:\/\/www.nature.com\/srep\/2012\/121115\/srep00811\/full\/srep00811.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EReed DS, Lackemeyer MG, Garza NL, et al.\u003C\/strong\u003E Aerosol exposure to Zaire Ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microb Infect 2011 Oct;13(11):930-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1286457911001225\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoy CJ, Milton DK.\u003C\/strong\u003E Airborne transmission of communicable infection\u2014the elusive pathway. N Engl J Med 2004 Apr;350(17):1710-2 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp048051\u0022\u003EPreview\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECanadian Standards Association.\u003C\/strong\u003E Selection, use and care of respirators. CAN\/CSA Z94.4-11\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWolz A.\u003C\/strong\u003E Face to face with Ebola\u2014an emergency care center in Sierra Leone. (Perspective) N Engl J Med 2014 Aug 27 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmp1410179\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003C\/ol\u003E"}]},"field_image_thumbnail":{"und":[{"fid":"20346","uid":"801","filename":"papr-crop.jpg","uri":"public:\/\/images\/news\/papr-crop_1.jpg","filemime":"image\/jpeg","filesize":"17601","status":"1","timestamp":"1420487195","type":"image","uuid":"186f4ebb-4f53-47e8-8736-7470b2c0fdbb","field_file_image_alt_text":{"und":[{"value":"PAPR - powered air-purifying respirator","format":null,"safe_value":"PAPR - powered air-purifying respirator"}]},"field_file_image_title_text":[],"field_credit":[],"rdf_mapping":[],"metadata":[],"alt":"PAPR - powered air-purifying respirator","title":"","width":"440","height":"398"}]},"field_post":[],"field_teaser":{"und":[{"value":"\u003Cp\u003EWe believe there is scientific and epidemiologic evidence to recommend respirators for all patient care, and a PAPR would be the best option.\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003EWe believe there is scientific and epidemiologic evidence to recommend respirators for all patient care, and a PAPR would be the best option.\u003C\/p\u003E"}]},"field_related_topics":{"und":[{"nid":"64","access":true,"node":{"vid":"300206","uid":"1","title":"Ebola","log":"","status":"1","comment":"1","promote":"0","sticky":"0","vuuid":"f0d62dbd-9604-4f12-ae2e-ca0f89893066","nid":"64","type":"topics","language":"und","created":"1362431979","changed":"1537298807","tnid":"0","translate":"0","uuid":"c4cf9110-8082-4f36-bafd-1b24cedafd8a","revision_timestamp":"1537298807","revision_uid":"71411","field_tab_collection":[],"field_body":[],"field_overview":[],"field_show_topic":{"und":[{"value":"1"}]},"field_related_topics":{"und":[{"nid":"102"},{"nid":"77"}]},"field_ss_media_file":[],"field_last_updated":[],"field_file_attachments":[],"field_synonyms":[],"field_call_action":[],"field_related_links":[],"field_teaser":{"und":[{"value":"\u003Cdiv class=\u0022view-content\u0022\u003E\u003Cdiv class=\u0022views-set\u0022\u003E\u003Cdiv class=\u0022views-rows\u0022\u003E\u003Cdiv class=\u0022views-row views-row-4 views-row-even views-row-last\u0022\u003E\u003Cdiv id=\u0022node-65601\u0022 class=\u0022node node-ss-link node-not-full node-type-ss-link-not-full node-hp-small clearfix\u0022\u003E\u003Cdiv class=\u0022node-inner\u0022\u003E\u003Cdiv class=\u0022content fieldlayout-contents\u0022\u003E\u003Cdiv class=\u0022fieldlayout-body clearfix  fieldlayout-body-has-region-soft-left \u0022\u003E\u003Cdiv class=\u0022 fieldlayout-region-body fieldlayout-region-body-hp-small\u0022\u003E\u003Cdiv class=\u0022field field-name-field-teaser field-type-text-long field-label-hidden\u0022\u003E\u003Cdiv class=\u0022field-items\u0022\u003E\u003Cdiv class=\u0022field-item even\u0022\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E","format":"full_html","safe_value":"\u003Cdiv class=\u0022view-content\u0022\u003E\u003Cdiv class=\u0022views-set\u0022\u003E\u003Cdiv class=\u0022views-rows\u0022\u003E\u003Cdiv class=\u0022views-row views-row-4 views-row-even views-row-last\u0022\u003E\u003Cdiv id=\u0022node-65601\u0022 class=\u0022node node-ss-link node-not-full node-type-ss-link-not-full node-hp-small clearfix\u0022\u003E\u003Cdiv class=\u0022node-inner\u0022\u003E\u003Cdiv class=\u0022content fieldlayout-contents\u0022\u003E\u003Cdiv class=\u0022fieldlayout-body clearfix  fieldlayout-body-has-region-soft-left \u0022\u003E\u003Cdiv class=\u0022 fieldlayout-region-body fieldlayout-region-body-hp-small\u0022\u003E\u003Cdiv class=\u0022field field-name-field-teaser field-type-text-long field-label-hidden\u0022\u003E\u003Cdiv class=\u0022field-items\u0022\u003E\u003Cdiv class=\u0022field-item even\u0022\u003E\u003Cp\u003E\u00a0\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E"}]},"field_roundup_type":{"und":[{"value":"1"}]},"field_subtitle":{"und":[{"value":"\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/infectious-disease-topics\/vhf\u0022\u003ERelated: VHF Overview\u003C\/a\u003E\u003C\/p\u003E\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/ongoing-programs\/ebola-vaccine-team-b\u0022\u003ERelated: Ebola Team B\u0026nbsp;\u003C\/a\u003E\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/infectious-disease-topics\/vhf\u0022\u003ERelated: VHF Overview\u003C\/a\u003E\u003C\/p\u003E\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/ongoing-programs\/ebola-vaccine-team-b\u0022\u003ERelated: Ebola Team B\u00a0\u003C\/a\u003E\u003C\/p\u003E"}]},"field_super_title":{"und":[{"value":"Updated May  29","format":null,"safe_value":"Updated May  29"}]},"field_resources":{"und":[{"value":"\u003Ch4 class=\u0022button float-right\u0022\u003E\u003Ca href=\u0022#lit\u0022\u003EJump to Recent Literature\u003C\/a\u003E\u003C\/h4\u003E\u003Ch4 class=\u0022button\u0022\u003E\u0026nbsp;\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003ELast updated May 29, 2015\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em; font-family: Arial, \u0027Helvetica Neue\u0027, Helvetica, Geneva, sans-serif; font-weight: bold;\u0022\u003ELatest Cases and General Information \u003Cbr \/\u003E\u003Cimg style=\u0022float: right;\u0022 src=\u0022\/sites\/default\/files\/public\/large_ebola.jpg\u0022 alt=\u0022Ebola virus\u0022 width=\u0022283\u0022 height=\u0022283\u0022 \/\u003E\u003C\/span\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150529?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (WHO) (May 29, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/case-counts.html\u0022 target=\u0022_blank\u0022\u003EUpdated case counts\u003C\/a\u003E (CDC) (May 29, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (CDC) (May 1, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E\u0026nbsp; (MSF) (Mar 23, 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm64e0303a2.htm\u0022 target=\u0022_blank\u0022\u003ESystems for rapidly detecting and treating persons with Ebola\u2014US\u003C\/a\u003E (CDC) (Mar 3, 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/screening-travelers.pdf\u0022 target=\u0022_blank\u0022\u003EPreventing Ebola by screening travelers\u003C\/a\u003E (Feb 5 , 2015)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (WHO) (Jan 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/how-talk-children-about-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EHow to talk with your children about Ebola\u003C\/a\u003E (CDC) (Nov 20\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/qas-monitoring-and-movement-guidance.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A on monitoring and movement\u003C\/a\u003E (CDC) (Dec 16\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/infections-spread-by-air-or-droplets.pdf\u0022 target=\u0022_blank\u0022\u003EHow Ebola is Spread\u003C\/a\u003E (\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003ECDC\u003C\/span\u003E) (Nov 1\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/index.html\u0022\u003EWest Africa outbreak page\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E from CDC\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/maimunamajumder.wordpress.com\/tag\/ebola\/\u0022\u003EEbola visualizations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E by Maimuna Majumder, MPH\u003Cbr \/\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebola-virus-disease-evd-2014-west.html\u0022\u003EEbola disease page\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebolavirus-disease-evd-cases-clusters.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EEbola maps\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/healthmap.org\/ebola\/\u0022\u003EEbola outbreak map\u003C\/a\u003E from HealthMap\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/qas-pets.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola and pets\u003C\/a\u003E from CDC (Nov 12, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources for Healthcare Volunteers\u003C\/h4\u003E\u003Cp\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/advice-humanitarian-aid-organizations-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid organizations\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/humanitarian-workers-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid workers\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ENIOSH: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/buddy-system.pdf\u0022 target=\u0022_blank\u0022\u003EThe buddy system\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014) \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137410\/1\/WHO_EVD_Guidance_PPE_14.1_eng.pdf\u0022 target=\u0022_blank\u0022\u003ERapid advice guideline on PPE\u003C\/a\u003E (Oct 2014)\u003Cbr \/\u003EMSF: \u003Ca href=\u0022http:\/\/www.doctorswithoutborders.org\/article\/msf-protocols-staff-returning-ebola-affected-countries\u0022 target=\u0022_blank\u0022\u003EProtocols for staff returning from Ebola-affected countries\u003C\/a\u003E (Oct 23, 2014)\u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/index.html\u0022\u003ESafety training course for healthcare workers in West Africa\u003C\/a\u003E\u0026nbsp;(Oct 6, 2014)\u003Cbr \/\u003ETravel grants for health workers attending CDC training\u0026nbsp; \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/maternal_perinatal\/ebola\/en\/\u0022 target=\u0022_blank\u0022\u003ESafe delivery services for mothers and newborns in Ebola outbreak areas\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003Cem\u003ESee more below under CDC\u003C\/em\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EHealth Agency Documents\u003C\/h4\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWorld Health Organization (WHO)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150511?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (May 11, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/gb\/ebwha\/pdf_files\/WHA68\/A68_25-en.pdf\u0022 target=\u0022_blank\u0022\u003EEbola Interim Assessment Panel: Report by the Secretariat\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (Jan 2015) \u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/statements\/2014\/ebola-travel\/en\/\u0022 target=\u0022_blank\u0022\u003EStatement from Travel and Transport Task Force\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/factsheets\/fs103\/en\/\u0022 target=\u0022_blank\u0022\u003EFact sheet\u003C\/a\u003E \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/en\/\u0022\u003EEbola page \u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/faq-ebola\/en\/\u0022\u003EFrequently asked questions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/evd-guidance-summary\/en\/\u0022\u003EInfection prevention and control guidance summary\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/travel-guidance\/en\/\u0022\u003ETravel and transport risk assessment\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u0026nbsp;\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EClinical management of patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/protective-measures-staff\/en\/\u0022\u003EProtective measures for medical staff\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/event-management-poe\/en\/\u0022\u003EInterim guidance on event management at points of entry\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/ebola-case-definition-contact-en.pdf?ua=1\u0022\u003ECase definition recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 9, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/note-ebola-food-safety\/en\/\u0022\u003EEbola and food safety\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/ebola\/01-october-2014\/en\/\u0022\u003EExperimental vaccines\u003C\/a\u003E (Oct 1, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137096\/1\/WHO_EVD_Preparedness_14_eng.pdf?ua=1\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Checklist\u003C\/a\u003E (Oct 30, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EEbola virus in semen of men recovered from Ebola\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUnited Nations\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/liberia\/liberia-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Liberia\u003C\/a\u003E (Nov 17, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/sierra-leone\/sierra-leone-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Sierra Leone\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/guinea\/guinea-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Guinea\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=ATaQMNYpKoM\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EWorld Food Programme video: Keeping the Ebola crisis from becoming a food crisis\u003C\/a\u003E (Oct 29, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/ebolaresponse.un.org\/un-mission-ebola-emergency-response-unmeer\u0022\u003EUN Mission for Ebola Emergency Response (UNMEER)\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/UNICEF_Ebola_Waste_Management_Guidance_Note_26_09_2014.pdf\u0022\u003EUNICEF waste management guidance\u003C\/a\u003E (Sep 26, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/fao-in-action\/stories\/stories-detail\/en\/c\/251862\/\u0022 target=\u0022_blank\u0022\u003EFAO (Food and Agriculture Organization of the UN) Ebola page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/resources\/documents\/resources-detail\/en\/c\/253869\/\u0022 target=\u0022_blank\u0022\u003EFAO response summary\u003C\/a\u003E (Oct 2014)\u0026nbsp; \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUS Centers for Disease Control and Prevention (CDC)\u003C\/h5\u003E\u003Cp\u003E\u003Cem\u003EGeneral resources \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-liberians-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Liberians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-guineans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Guineans living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-sierra-leoneans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Sierra Leonians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003EGetting to zero (video) (Apr 6, 2015) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022https:\/\/www2c.cdc.gov\/podcasts\/media\/pdf\/3-19-15_EbolaUpdate_Pets.pdf\u0022 target=\u0022_blank\u0022\u003ECDC podcast on risk to pets: transcript\u003C\/a\u003E (Mar 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/families\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for families and loved ones of responders\u003C\/a\u003E (Mar 13, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-safe-school-messages2015.pdf\u0022 target=\u0022_blank\u0022\u003EKey messages for safe school operations in countries with outbreaks of Ebola\u003C\/a\u003E (Feb 25, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/qa-business-travelers.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola for US businesses, employers, and business travelers\u003C\/a\u003E (Feb 23, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/transporting-pediatric-patients.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A re transport of pediatric patients with suspected or confirmed Ebola\u003C\/a\u003E (Feb 2, 2105)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/phlp\/docs\/interim-ebolascreening.pdf\u0022 target=\u0022_blank\u0022\u003EInterim table of state Ebola screening and monitoring policies\u003C\/a\u003E (Jan 8, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm63e1216a1.htm\u0022 target=\u0022_blank\u0022\u003ELatest\u003Cem\u003E MMWR\u003C\/em\u003E update\u003C\/a\u003E (CDC) (Dec 19, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-response-team.pdf\u0022 target=\u0022_blank\u0022\u003EEbola response team fact sheet\u003C\/a\u003E (Dec 2, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/mutations.pdf\u0022 target=\u0022_blank\u0022\u003EWhy Ebola is not likely to become airborne\u003C\/a\u003E (Dec 1, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/\u0022\u003EEbola page\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/qa.html\u0022\u003EQuestions and answers\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 8, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/case-definition.html\u0022\u003ECase definitions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 4, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/index.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWest Africa outbreak page\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003EDemocratic Republic of the Congo outbreak page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/human-transmission.html\u0022 target=\u0022_blank\u0022\u003ESummary of human-to-human transmission\u003C\/a\u003E (Oct 17, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-and-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInformation on cleaning and decontamination\u003C\/a\u003E (Nov 10, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/communication-resources\/index.html\u0022 target=\u0022_blank\u0022\u003ECommunication resources for West African communities\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/information-for-west-africans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EEbola fact sheet for West Africans living in the US\u003C\/a\u003E (Nov 17) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/survivability-ebola-medical-waste.html\u0022 target=\u0022_blank\u0022\u003ESurvivability of Ebola virus in medical waste\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cem\u003EGuidance documents \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EInterim advice on the sexual transmission of Ebola\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E (Apr 8, 2015) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/laboratories\/safe-specimen-management.html\u0022 target=\u0022_blank\u0022\u003E\u003Cbr \/\u003EGuidance for US labs for managing and testing clinical specimens when there is concern about Ebola\u003C\/a\u003E (Feb 3, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/flu.html\u0022 target=\u0022_blank\u0022\u003EInterim recommendations for flu vaccination and post-exposure chemoprophylaxis in people being monitored for potential Ebola virus exposure\u003C\/a\u003E (Jan 26, 2015)\u003Cspan\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/business-travelers.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US businesses, employers, and business travelers to prevent Ebola exposure\u003C\/a\u003E (Jan 23, 2015) \u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/bury-body-safely.pdf\u0022 target=\u0022_blank\u0022\u003EEbola must go: bury all dead bodies safely\u003C\/a\u003E (Dec 23, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/ebola-associated-waste.html\u0022 target=\u0022_blank\u0022\u003EProcedures for safe handling and management of Ebola-associated waste\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for handling untreated sewage from Ebola patients in the US\u003C\/a\u003E (Nov 20\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022\u003EFAQs on interim guidance for managers and workers handling untreated sewage from suspected or confirmed individuals with Ebola in the US\u003C\/a\u003E (Dec 16, 2014) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-emergency-medical-services-systems-911-public-safety-answering-points-management-patients-known-suspected-united-states.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for EMS and 911 systems\u003C\/a\u003E (Dec 2, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-maternal-health.html\u0022 target=\u0022_blank\u0022\u003EScreening and caring for pregnant Ebola patients\u003C\/a\u003E (Nov 12\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/residental-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for residence decontamination and removal of contaminated waste\u003C\/a\u003E (Nov 3, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/monitoring-and-movement-of-persons-with-exposure.html\u0022 target=\u0022_blank\u0022\u003ERevised interim guidance for monitoring and movement of people with potential Ebola exposure\u003C\/a\u003E (Oct 27, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1027-monitoring-symptoms-controlling-movement.html\u0022 target=\u0022_blank\u0022\u003EMonitoring symptoms and controlling movement to stop the spread of Ebola\u003C\/a\u003E (Oct 27)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procedures-for-ppe.html\u0022 target=\u0022_blank\u0022\u003EGuidance for donning and doffing PPE\u003C\/a\u003E (Oct 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/limiting-heat-burden.html\u0022 target=\u0022_self\u0022\u003EInterim guidance for limiting heat burden when wearing PPE\u003C\/a\u003E (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-specimen-collection-submission-patients-suspected-infection-ebola.html\u0022\u003EInterim guidance for specimen collection\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/select-agent-regulations.html\u0022\u003EInterim guidance on compliance with select agent regulations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-safe-handling-human-remains-ebola-patients-us-hospitals-mortuaries.html\u0022\u003EGuidance for safe handling of human remains of Ebola patients\u003C\/a\u003E\u003Cspan\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/environmental-infection-control-in-hospitals.html\u0022\u003EInterim guidance for environmental infection control in hospitals\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003C\/span\u003E \u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003EResources for healthcare workers \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/training-toolkit.html\u0022 target=\u0022_blank\u0022\u003EPreparing healthcare workers to work in Ebola treatment units in Africa: Training toolkit announcement\u003C\/a\u003E (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/emergency-department-training.html\u0022 target=\u0022_blank\u0022\u003EEbola preparedness: Emergency Department training modules\u003C\/a\u003E (Feb 17, 2015)\u003Cbr \/\u003ENon-CDC lab resources for Ebola (Jan 30, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/ppe\/supplies.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for US healthcare facilities to ensure adequate supplies of PPE for Ebola preparedness\u003C\/a\u003E (Dec 31, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/preparing-frontline-healthcare-facilities.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for frontline US healthcare facilities for potential Ebola patients\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/us-hospital-preparedness.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US hospitals for potential Ebola patients: a tiered approach\u003C\/a\u003E (Dec 2, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/hand-hygiene.html\u0022 target=\u0022_blank\u0022\u003EHand hygiene in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/mixing-chlorine-solutions.html\u0022 target=\u0022_blank\u0022\u003EMixing and using chlorine solutions in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.youtube.com\/watch?v=8y19h1hecgY\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003ERespiratory protection video\u003C\/a\u003E (Nov 10, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/qa-infection-control-general-healthcare-widespread-ebola-transmission.html\u0022 target=\u0022_blank\u0022\u003EInfection control in countries with widespread Ebola\u003C\/a\u003E (Nov 3) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ambulatory-care-evaluation-of-patients-with-possible-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EAlgorithm for ambulatory care evaluation of patients with possible Ebola\u003C\/a\u003E (Oct 31, 2014)\u0026nbsp;\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/considerations-discharging-pui.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for discharging persons under investigation for Ebola\u003C\/a\u003E (Oct 30) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/ed-management-patients-possible-ebola.html\u0022 target=\u0022_blank\u0022\u003EAlgorithm for emergency department management of patients with suspected Ebola\u003C\/a\u003E (Oct 27, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1014-ebola-investigation-fact-sheet.html\u0022 target=\u0022_blank\u0022\u003EFact sheet on hospital preparedness\u003C\/a\u003E (Oct 14, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/caring-for-ebola-suspects.html\u0022 target=\u0022_blank\u0022\u003ECaring for patients under investigation for Ebola\u003C\/a\u003E (Oct 20, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/clinician-information-us-healthcare-settings.html\u0022\u003EDisease information for clinicians\u003C\/a\u003E\u003Cspan\u003E (Oct 4, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-facility-checklist-for-ebola.pdf\u0022\u003EHealthcare facility preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-provider-checklist-for-ebola.pdf\u0022\u003EHealthcare provider preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ems-checklist-ebola-preparedness.pdf\u0022\u003EEMS checklist for Ebola preparedness\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/coalition-checklist-ebola-preparedness.pdf\u0022\u003EChecklist for healthcare coalitions for Ebola preparedness\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/index.html\u0022\u003EInformation for healthcare workers\u003C\/a\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00371.asp\u0022\u003EHealth Alert Network (HAN) advisory for healthcare workers\u003C\/a\u003E (Oct 2, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.phe.gov\/Preparedness\/responders\/Pages\/ebola-healthcare-webinar.aspx\u0022\u003EEbola preparedness for US healthcare system (webinar with ASPR)\u003C\/a\u003E (Sep 29, 2014)\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003EInfection prevention and control recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ppe-poster.pdf\u0022\u003ESequence for removing personal protective equipment\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/s0914-ebola-surge.html\u0022\u003EFact sheet on surge\u003C\/a\u003E (Sep 16, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003ETravel\/flight information \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 8, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Feb 19, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-commercial-passenger-aircraft.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cleaning, disinfection, and waste disposal in commercial passenger aircraft \u003C\/a\u003E(Dec 18, 2014)\u0026nbsp;\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/airlines\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for airlines\u003C\/a\u003E (Dec 9, 2014)\u003Cem\u003E\u0026nbsp; \u003C\/em\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00372.asp\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening and monitoring for people entering US from Mali\u003C\/a\u003E (Nov 24)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Nov 16) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/p1116-travelers-from-mali.html\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening to begin for travelers to the US from Mali\u003C\/a\u003E (Nov 16)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/travelers\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for Travelers\u003C\/a\u003E (Nov 3, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003ECheck and Report Ebola (CARE) kit for travelers arriving in US from West Africa\u0026nbsp; \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/diseases\/ebola\u0022\u003EEbola Traveler\u0027s Health\u003C\/a\u003E\u0026nbsp;(Oct 7, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/pilots.html\u0022\u003ECDC death and disease reporting tool for pilots\u003C\/a\u003E (Aug 25, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/managing-sick-travelers\/ebola-guidance-airlines.html\u0022\u003EInterim guidance for airline crews, cleaning personnel, and cargo personnel\u003C\/a\u003E (Oct 2, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-air-medical-transport-patients.html\u0022\u003EGuidance on air medical transport for Ebola patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/guidance-reporting-onboard-deaths-illnesses.html\u0022\u003EGuidance for airlines on reporting onboard deaths or illnesses\u003C\/a\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/cabin-crew.html\u0022\u003ECDC death and disease reporting tool for cabin crew\u003C\/a\u003E (Aug 25, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUS Government \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.google.com\/url?sa=t\u0026amp;rct=j\u0026amp;q=\u0026amp;esrc=s\u0026amp;source=web\u0026amp;cd=2\u0026amp;cad=rja\u0026amp;uact=8\u0026amp;ved=0CCUQFjAB\u0026amp;url=http%3A%2F%2Fwww.fas.org%2Fsgp%2Fcrs%2Fmisc%2FR43809.pdf\u0026amp;ei=QB6KVLblMsmlyATqtYHwAg\u0026amp;usg=AFQjCNE2dHIgc_qruQur8MBr-U49sMQhDQ\u0026amp;bvm=bv.81456516,d.aWw\u0022 target=\u0022_blank\u0022\u003EPreventing the introduction and spread of Ebola in the United States: FAQs\u003C\/a\u003E (Dec 5, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/blogs.fda.gov\/fdavoice\/index.php\/2014\/10\/fda-as-part-of-a-coordinated-global-response-on-ebola\/\u0022 target=\u0022_blank\u0022\u003EFDA Commissioner\u0027s statement on agency\u0027s involvement with Ebola response\u003C\/a\u003E (Oct 28)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.hhs.gov\/news\/press\/2014pres\/09\/20140916b.html\u0022\u003EHHS statement on deployment of US Public Health Service Commissioned Corps\u003C\/a\u003E (Sep 16, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/sis.nlm.nih.gov\/dimrc\/ebola_2014.html\u0022\u003ENLM Disaster Information Management Research Center resource list\u003C\/a\u003E (Oct 8, 2014)\u0026nbsp;\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EInstitute of Medicine (IOM)\u0026nbsp; \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.nap.edu\/read\/19004\/chapter\/1\u0022 target=\u0022_blank\u0022\u003EResearch priorities to inform public health and medical practice for Ebola virus disease\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nationalacademies.org\/hmd\/Reports\/2014\/Enabling-Rapid-Sustainable-Public-Health-Research-During-Disasters.aspx\u0022 target=\u0022_blank\u0022\u003EEnabling rapid and sustainable public health research during disasters\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/nationalacademies.org\/hmd\/Global\/Topics\/Ebola.aspx\u0022 target=\u0022_blank\u0022\u003EVideo from IOM workshop on research priorities for Ebola\u003C\/a\u003E (Nov 4) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EAmerican Veterinary Medical Association (AVMA) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/pets-of-ebola-contacts.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for public health officials on pets of Ebola contacts\u003C\/a\u003E (Nov 10, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/dog-cat-quarantine.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for dog or cat quarantine after exposure to a human with confirmed Ebola\u003C\/a\u003E (Nov 10) \u003Cbr \/\u003E\u003Cem\u003ENote:\u003C\/em\u003E The following resources require AVMA membership or site registration: \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071962:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EChecklist for vets when presented with patient or client with possible Ebola exposure\u003C\/a\u003E \u003Cbr \/\u003E \u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071963:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EHandout on Ebola for pet owners\u003C\/a\u003E\u0026nbsp; \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EEuropean Centre for Disease Prevention and Control (ECDC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/safe-use-of-ppe.pdf\u0022 target=\u0022_blank\u0022\u003ESafe use of PPE in the treatment of infectious diseases with high consequence\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-public-health-contact-management-update-10-November.pdf\u0022 target=\u0022_blank\u0022\u003EGuidance for managing persons who have been exposed\u003C\/a\u003E (Nov 7, 2014, update) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/management-healthcare-workers-returning-Ebola-affected-areas.pdf\u0022 target=\u0022_blank\u0022\u003EPublic health management of healthcare workers returning from affected areas\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1094\u0022 target=\u0022_blank\u0022\u003EGuide to medical air evacuation\u003C\/a\u003E (Oct 23, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1084\u0022 target=\u0022_blank\u0022\u003ERapid risk assessment\u003C\/a\u003E (Oct 15, 2014)\u0026nbsp; \u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/healthtopics\/ebola_marburg_fevers\/EVDcasedefinition\/Pages\/default.aspx\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1076\u0022\u003EEpidemiological update - West Africa\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1064\u0022\u003EEpidemiological update - Democratic Republic of the Congo\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/_layouts\/forms\/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90\u0026amp;ID=1178\u0022\u003ERisk of Ebola transmission via donated blood and other substances of human origin\u003C\/a\u003E (Oct 6, 2014) \u003Cbr \/\u003E \u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1082\u0022 target=\u0022_blank\u0022\u003EEntry and exit screening messages\u003C\/a\u003E (Oct 13, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUnited Kingdom agencies\u003C\/h5\u003E\u003Cp\u003EPublic Health England (PHE): \u003Ca href=\u0022https:\/\/www.gov.uk\/government\/collections\/ebola-virus-disease-clinical-management-and-guidance\u0022 target=\u0022_blank\u0022\u003EClinical management and guidance for healthcare professionals\u003C\/a\u003E \u003Cbr \/\u003ENational Health Service (NHS): \u003Ca href=\u0022http:\/\/www.nhs.uk\/conditions\/ebola-virus\/Pages\/Ebola-virus.aspx\u0022 target=\u0022_blank\u0022\u003EEbola resource page for consumers \u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EPublic Health Agency of Canada (PHAC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/national-case-definition-nationale-cas-eng.php\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 23, 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr style=\u0022line-height: 1.35em;\u0022 \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-ipc-pci-eng.php\u0022\u003EInterim guidance for infection prevention and control\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-biosafety-biosecurite-eng.php\u0022\u003EInterim biosafety guidelines for laboratory specimen handling\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 22, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/evd_crf-mvd_fdc-eng.php\u0022\u003ECase report form\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EFederal Ministry of Health (Nigeria)\u003C\/h5\u003E\u003Cp\u003EEbola Virus Information Unit website\u003Cbr \/\u003E \u003Ca href=\u0022http:\/\/www.health.gov.ng\/index.php\/news-media\/press-releases\u0022\u003ERecent press releases\u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EMedecins sans Frontieres (MSF; Doctors Without Borders)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E (Mar 23, 2015)\u003C\/p\u003E\u003Ch5\u003EMinistry of Health and Sanitation (Sierra Leone)\u003C\/h5\u003E\u003Cp\u003ECase updates\u003Cbr \/\u003E Situation reports\u003Cbr \/\u003E Frequently asked questions\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EMinistry of Health (Liberia)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/moh.gov.lr\/\u0022\u003EMain page\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003Ch4\u003EProfessional Organizations\u003C\/h4\u003E\u003Ch5\u003E\u003Cstrong\u003EAmerican College of Chest Physicians (Nov 5, 2014) \u003C\/strong\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=GQgpul5czUY\u0022 target=\u0022_blank\u0022\u003EPreparing for Ebola\u003C\/a\u003E (1-hr video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=E_K-fYvHsO0\u0022 target=\u0022_blank\u0022\u003ECritical care of Persons with Ebola in Sierra Leone and at Emory University\u003C\/a\u003E ( 1-hr 15-minute video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=QPYwuwnYF4M\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EOpportunities, Lessons Learned, and Future Action Items\u003C\/a\u003E (48-minute video)\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003Ch4\u003EAcademic Institutions\u003C\/h4\u003E\u003Cp\u003EIDS (Institute of Development Studies) in conjunction with UK universities: \u003Ca href=\u0022http:\/\/www.ebola-anthropology.net\/\u0022 target=\u0022_blank\u0022\u003EEbola Response Anthropology Platform \u003C\/a\u003E\u003Cbr \/\u003EGeorge Washington University: \u003Ca href=\u0022http:\/\/publichealthonline.gwu.edu\/ebola-public-health-crisis\/\u0022 target=\u0022_blank\u0022\u003EInfographic on ripple effects of Ebola outbreak\u003C\/a\u003E (Nov 12) \u003Cbr \/\u003EEmory University: \u003Ca href=\u0022http:\/\/www.emoryhealthcare.org\/ebola-protocol\/resources.html\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Protocols\u003C\/a\u003E (requires registration)\u003Cbr \/\u003EUniversity of Nebraska Biocontainment Unit: \u003Ca href=\u0022http:\/\/www.nebraskamed.com\/biocontainment-unit\u0022 target=\u0022_blank\u0022\u003EPatient care links\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u0026nbsp;\u003C\/h4\u003E\u003Ch4\u003ETools\/Posters\u003C\/h4\u003E\u003Cp\u003ECDC Flipbook: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (May 1, 2015)\u003Cbr \/\u003ECDC children\u0027s activity book: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-activity-book-general.pdf\u0022 target=\u0022_blank\u0022\u003EHelping people in West Africa\u003C\/a\u003E (CDC)(Apr 22, 2015) \u003Cbr \/\u003ECDC brochure: \u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (Apr 21, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-liberia.pdf\u0022 target=\u0022_blank\u0022\u003ELiberians in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EGuineans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003ESierra Leoneans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Guinea)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-liberia.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Liberia)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ors-instructions.pdf\u0022 target=\u0022_blank\u0022\u003EHow to safely give oral rehydration solution\u003C\/a\u003E (Dec 9, 2014) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/21-day-investigation-guinea.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts in Guinea\u003C\/a\u003E (Dec 4, 2014)\u003Cbr \/\u003ECDC slides and video: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/ppt\/what-you-really-need-know-ebola.pptx\u0022 target=\u0022_blank\u0022\u003EWhat you REALLY need to know about Ebola\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/sierra-leone-21-day-investigation.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts\u2014Sierra Leone\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/top-10-things.pdf\u0022 target=\u0022_blank\u0022\u003ETop 10 things you really need to know about Ebola\u003C\/a\u003E (Nov 19, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003EMEDBOX:\u0026nbsp;\u003Ca href=\u0022http:\/\/www.medbox.org\/ebola-toolbox\/listing\u0022 target=\u0022_blank\u0022\u003EEbola Toolbox\u003C\/a\u003E \u003Cbr \/\u003EUniversity of Nebraska: \u003Ca href=\u0022https:\/\/www.nebraskamed.com\/sites\/default\/files\/documents\/biocontainment\/ebolappechecklist.pdf\u0022 target=\u0022_blank\u0022\u003EDonning \u0026amp; Doffing PPE\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EWorld Bank\u003C\/h4\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.worldbank.org\/en\/topic\/health\/brief\/world-bank-group-ebola-fact-sheet\u0022 target=\u0022_blank\u0022\u003EEbola Fact Sheet\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/documents.worldbank.org\/curated\/en\/2014\/10\/20270083\/\u0022 target=\u0022_blank\u0022\u003EEconomic impact statement\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources from Journals\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/21\/5\/14-2016_article\u0022 target=\u0022_blank\u0022\u003EUsing lessons learned from previous Ebola outbreaks to inform current risk management\u003C\/a\u003E (May 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.springer.com\/biomed\/virology\/spotlight+on+ebola?SGWID=0-1771314-0-0-0\u0022 target=\u0022_blank\u0022\u003EBioMed Central \u0026amp; Springer Ebola Resource Center\u003C\/a\u003E (open-access articles) (launched Dec 5, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003EDisaster Medicine and Public Health Preparedness \u003C\/a\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003Especial edition on Ebola\u003C\/a\u003E \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displayFulltext?type=6\u0026amp;fid=9388028\u0026amp;jid=DMP\u0026amp;volumeId=-1\u0026amp;issueId=-1\u0026amp;aid=9388027\u0026amp;fulltextType=BT\u0026amp;fileId=S1935789314001153\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EDisaster Medicine and Public Health Preparedness: A primer on Ebola for clinicians\u003C\/em\u003E\u003C\/a\u003E\u0026nbsp; (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/page\/ebola-spotlight\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nature.com\/news\/ebola-by-the-numbers-the-size-spread-and-cost-of-an-outbreak-1.16144\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003ENature:\u003C\/em\u003E Ebola by the numbers\u003C\/a\u003E\u0026nbsp; \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.nejm.org\/page\/ebola-outbreak\u0022\u003EN Engl J Med\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/ebola.thelancet.com\/\u0022\u003EThe Lancet\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/www.sciencemag.org\/site\/extra\/ebola\/\u0022\u003E\u003Cem\u003EScience\u003C\/em\u003E\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/blogs.plos.org\/speakingofmedicine\/2014\/09\/05\/plos-resources-ebola\/\u0022\u003EPLoS journals\u003C\/a\u003E \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/jama.jamanetwork.com\/article.aspx?articleid=1905875\u0022\u003EJAMA\u003C\/a\u003E\u003C\/em\u003E\u0026nbsp;\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003ETwitter\u003C\/h4\u003E\u003Cp\u003ECIDRAP (\u003Ca href=\u0022https:\/\/twitter.com\/cidrap\u0022 target=\u0022_blank\u0022\u003E@CIDRAP\u003C\/a\u003E)\u003Cbr \/\u003E Helen Branswell (\u003Ca href=\u0022https:\/\/twitter.com\/HelenBranswell\u0022 target=\u0022_blank\u0022\u003E@HelenBranswell\u003C\/a\u003E)\u003Cbr \/\u003E Michael Coston (\u003Ca href=\u0022https:\/\/twitter.com\/Fla_Medic\u0022 target=\u0022_blank\u0022\u003E@Fla_Medic\u003C\/a\u003E)\u003Cbr \/\u003E ECDC Outbreaks (\u003Ca href=\u0022https:\/\/twitter.com\/ECDC_Outbreaks\u0022 target=\u0022_blank\u0022\u003E@ECDC_Outbreaks\u003C\/a\u003E)\u003Cbr \/\u003E Martin Enserink (\u003Ca href=\u0022https:\/\/twitter.com\/martinenserink\u0022 target=\u0022_blank\u0022\u003E@martinenserink\u003C\/a\u003E) \u003Cbr \/\u003E Jason Gale (\u003Ca href=\u0022https:\/\/twitter.com\/jwgale\u0022 target=\u0022_blank\u0022\u003E@jwgale\u003C\/a\u003E) \u003Cbr \/\u003E HealthMap.org (\u003Ca href=\u0022https:\/\/twitter.com\/healthmap\u0022 target=\u0022_blank\u0022\u003E@healthmap\u003C\/a\u003E)\u003Cbr \/\u003E Crawford Kilian (\u003Ca href=\u0022https:\/\/twitter.com\/Crof\u0022 target=\u0022_blank\u0022\u003E@crof\u003C\/a\u003E)\u003Cbr \/\u003E Ian M Mackay, PhD (\u003Ca href=\u0022https:\/\/twitter.com\/MackayIM\u0022 target=\u0022_blank\u0022\u003E@MackayIM\u003C\/a\u003E)\u003Cbr \/\u003E Maia Majumder, MPH (\u003Ca href=\u0022https:\/\/twitter.com\/maiamajumder\u0022\u003E@maiamajumder\u003C\/a\u003E)\u003C\/p\u003E\u003Cp\u003E\u003Ca name=\u0022lit\u0022\u003E\u003C\/a\u003E\u003C\/p\u003E","format":"full_html","safe_value":"\u003Ch4 class=\u0022button float-right\u0022\u003E\u003Ca href=\u0022#lit\u0022\u003EJump to Recent Literature\u003C\/a\u003E\u003C\/h4\u003E\u003Ch4 class=\u0022button\u0022\u003E\u00a0\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003ELast updated May 29, 2015\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em; font-family: Arial, \u0027Helvetica Neue\u0027, Helvetica, Geneva, sans-serif; font-weight: bold;\u0022\u003ELatest Cases and General Information \u003Cbr \/\u003E\u003Cimg style=\u0022float: right;\u0022 src=\u0022\/sites\/default\/files\/public\/large_ebola.jpg\u0022 alt=\u0022Ebola virus\u0022 width=\u0022283\u0022 height=\u0022283\u0022 \/\u003E\u003C\/span\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150529?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (WHO) (May 29, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/case-counts.html\u0022 target=\u0022_blank\u0022\u003EUpdated case counts\u003C\/a\u003E (CDC) (May 29, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (CDC) (May 1, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E\u00a0 (MSF) (Mar 23, 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm64e0303a2.htm\u0022 target=\u0022_blank\u0022\u003ESystems for rapidly detecting and treating persons with Ebola\u2014US\u003C\/a\u003E (CDC) (Mar 3, 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/screening-travelers.pdf\u0022 target=\u0022_blank\u0022\u003EPreventing Ebola by screening travelers\u003C\/a\u003E (Feb 5 , 2015)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (WHO) (Jan 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/how-talk-children-about-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EHow to talk with your children about Ebola\u003C\/a\u003E (CDC) (Nov 20\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/qas-monitoring-and-movement-guidance.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A on monitoring and movement\u003C\/a\u003E (CDC) (Dec 16\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/infections-spread-by-air-or-droplets.pdf\u0022 target=\u0022_blank\u0022\u003EHow Ebola is Spread\u003C\/a\u003E (\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003ECDC\u003C\/span\u003E) (Nov 1\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/index.html\u0022\u003EWest Africa outbreak page\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E from CDC\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/maimunamajumder.wordpress.com\/tag\/ebola\/\u0022\u003EEbola visualizations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E by Maimuna Majumder, MPH\u003Cbr \/\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebola-virus-disease-evd-2014-west.html\u0022\u003EEbola disease page\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebolavirus-disease-evd-cases-clusters.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EEbola maps\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/healthmap.org\/ebola\/\u0022\u003EEbola outbreak map\u003C\/a\u003E from HealthMap\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/qas-pets.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola and pets\u003C\/a\u003E from CDC (Nov 12, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources for Healthcare Volunteers\u003C\/h4\u003E\u003Cp\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/advice-humanitarian-aid-organizations-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid organizations\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/humanitarian-workers-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid workers\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ENIOSH: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/buddy-system.pdf\u0022 target=\u0022_blank\u0022\u003EThe buddy system\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014) \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137410\/1\/WHO_EVD_Guidance_PPE_14.1_eng.pdf\u0022 target=\u0022_blank\u0022\u003ERapid advice guideline on PPE\u003C\/a\u003E (Oct 2014)\u003Cbr \/\u003EMSF: \u003Ca href=\u0022http:\/\/www.doctorswithoutborders.org\/article\/msf-protocols-staff-returning-ebola-affected-countries\u0022 target=\u0022_blank\u0022\u003EProtocols for staff returning from Ebola-affected countries\u003C\/a\u003E (Oct 23, 2014)\u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/index.html\u0022\u003ESafety training course for healthcare workers in West Africa\u003C\/a\u003E\u00a0(Oct 6, 2014)\u003Cbr \/\u003ETravel grants for health workers attending CDC training\u00a0 \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/maternal_perinatal\/ebola\/en\/\u0022 target=\u0022_blank\u0022\u003ESafe delivery services for mothers and newborns in Ebola outbreak areas\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003Cem\u003ESee more below under CDC\u003C\/em\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EHealth Agency Documents\u003C\/h4\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWorld Health Organization (WHO)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150511?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (May 11, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/gb\/ebwha\/pdf_files\/WHA68\/A68_25-en.pdf\u0022 target=\u0022_blank\u0022\u003EEbola Interim Assessment Panel: Report by the Secretariat\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (Jan 2015) \u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/statements\/2014\/ebola-travel\/en\/\u0022 target=\u0022_blank\u0022\u003EStatement from Travel and Transport Task Force\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/factsheets\/fs103\/en\/\u0022 target=\u0022_blank\u0022\u003EFact sheet\u003C\/a\u003E \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/en\/\u0022\u003EEbola page \u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/faq-ebola\/en\/\u0022\u003EFrequently asked questions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/evd-guidance-summary\/en\/\u0022\u003EInfection prevention and control guidance summary\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/travel-guidance\/en\/\u0022\u003ETravel and transport risk assessment\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u00a0\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EClinical management of patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/protective-measures-staff\/en\/\u0022\u003EProtective measures for medical staff\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/event-management-poe\/en\/\u0022\u003EInterim guidance on event management at points of entry\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/ebola-case-definition-contact-en.pdf?ua=1\u0022\u003ECase definition recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 9, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/note-ebola-food-safety\/en\/\u0022\u003EEbola and food safety\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/ebola\/01-october-2014\/en\/\u0022\u003EExperimental vaccines\u003C\/a\u003E (Oct 1, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137096\/1\/WHO_EVD_Preparedness_14_eng.pdf?ua=1\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Checklist\u003C\/a\u003E (Oct 30, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EEbola virus in semen of men recovered from Ebola\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUnited Nations\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/liberia\/liberia-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Liberia\u003C\/a\u003E (Nov 17, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/sierra-leone\/sierra-leone-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Sierra Leone\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/guinea\/guinea-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Guinea\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=ATaQMNYpKoM\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EWorld Food Programme video: Keeping the Ebola crisis from becoming a food crisis\u003C\/a\u003E (Oct 29, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/ebolaresponse.un.org\/un-mission-ebola-emergency-response-unmeer\u0022\u003EUN Mission for Ebola Emergency Response (UNMEER)\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/UNICEF_Ebola_Waste_Management_Guidance_Note_26_09_2014.pdf\u0022\u003EUNICEF waste management guidance\u003C\/a\u003E (Sep 26, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/fao-in-action\/stories\/stories-detail\/en\/c\/251862\/\u0022 target=\u0022_blank\u0022\u003EFAO (Food and Agriculture Organization of the UN) Ebola page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/resources\/documents\/resources-detail\/en\/c\/253869\/\u0022 target=\u0022_blank\u0022\u003EFAO response summary\u003C\/a\u003E (Oct 2014)\u00a0 \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUS Centers for Disease Control and Prevention (CDC)\u003C\/h5\u003E\u003Cp\u003E\u003Cem\u003EGeneral resources \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-liberians-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Liberians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-guineans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Guineans living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-sierra-leoneans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Sierra Leonians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003EGetting to zero (video) (Apr 6, 2015) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022https:\/\/www2c.cdc.gov\/podcasts\/media\/pdf\/3-19-15_EbolaUpdate_Pets.pdf\u0022 target=\u0022_blank\u0022\u003ECDC podcast on risk to pets: transcript\u003C\/a\u003E (Mar 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/families\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for families and loved ones of responders\u003C\/a\u003E (Mar 13, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-safe-school-messages2015.pdf\u0022 target=\u0022_blank\u0022\u003EKey messages for safe school operations in countries with outbreaks of Ebola\u003C\/a\u003E (Feb 25, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/qa-business-travelers.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola for US businesses, employers, and business travelers\u003C\/a\u003E (Feb 23, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/transporting-pediatric-patients.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A re transport of pediatric patients with suspected or confirmed Ebola\u003C\/a\u003E (Feb 2, 2105)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/phlp\/docs\/interim-ebolascreening.pdf\u0022 target=\u0022_blank\u0022\u003EInterim table of state Ebola screening and monitoring policies\u003C\/a\u003E (Jan 8, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm63e1216a1.htm\u0022 target=\u0022_blank\u0022\u003ELatest\u003Cem\u003E MMWR\u003C\/em\u003E update\u003C\/a\u003E (CDC) (Dec 19, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-response-team.pdf\u0022 target=\u0022_blank\u0022\u003EEbola response team fact sheet\u003C\/a\u003E (Dec 2, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/mutations.pdf\u0022 target=\u0022_blank\u0022\u003EWhy Ebola is not likely to become airborne\u003C\/a\u003E (Dec 1, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/\u0022\u003EEbola page\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/qa.html\u0022\u003EQuestions and answers\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 8, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/case-definition.html\u0022\u003ECase definitions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 4, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/index.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWest Africa outbreak page\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003EDemocratic Republic of the Congo outbreak page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/human-transmission.html\u0022 target=\u0022_blank\u0022\u003ESummary of human-to-human transmission\u003C\/a\u003E (Oct 17, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-and-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInformation on cleaning and decontamination\u003C\/a\u003E (Nov 10, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/communication-resources\/index.html\u0022 target=\u0022_blank\u0022\u003ECommunication resources for West African communities\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/information-for-west-africans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EEbola fact sheet for West Africans living in the US\u003C\/a\u003E (Nov 17) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/survivability-ebola-medical-waste.html\u0022 target=\u0022_blank\u0022\u003ESurvivability of Ebola virus in medical waste\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cem\u003EGuidance documents \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EInterim advice on the sexual transmission of Ebola\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E (Apr 8, 2015) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/laboratories\/safe-specimen-management.html\u0022 target=\u0022_blank\u0022\u003E\u003Cbr \/\u003EGuidance for US labs for managing and testing clinical specimens when there is concern about Ebola\u003C\/a\u003E (Feb 3, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/flu.html\u0022 target=\u0022_blank\u0022\u003EInterim recommendations for flu vaccination and post-exposure chemoprophylaxis in people being monitored for potential Ebola virus exposure\u003C\/a\u003E (Jan 26, 2015)\u003Cspan\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/business-travelers.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US businesses, employers, and business travelers to prevent Ebola exposure\u003C\/a\u003E (Jan 23, 2015) \u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/bury-body-safely.pdf\u0022 target=\u0022_blank\u0022\u003EEbola must go: bury all dead bodies safely\u003C\/a\u003E (Dec 23, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/ebola-associated-waste.html\u0022 target=\u0022_blank\u0022\u003EProcedures for safe handling and management of Ebola-associated waste\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for handling untreated sewage from Ebola patients in the US\u003C\/a\u003E (Nov 20\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022\u003EFAQs on interim guidance for managers and workers handling untreated sewage from suspected or confirmed individuals with Ebola in the US\u003C\/a\u003E (Dec 16, 2014) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-emergency-medical-services-systems-911-public-safety-answering-points-management-patients-known-suspected-united-states.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for EMS and 911 systems\u003C\/a\u003E (Dec 2, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-maternal-health.html\u0022 target=\u0022_blank\u0022\u003EScreening and caring for pregnant Ebola patients\u003C\/a\u003E (Nov 12\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/residental-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for residence decontamination and removal of contaminated waste\u003C\/a\u003E (Nov 3, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/monitoring-and-movement-of-persons-with-exposure.html\u0022 target=\u0022_blank\u0022\u003ERevised interim guidance for monitoring and movement of people with potential Ebola exposure\u003C\/a\u003E (Oct 27, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1027-monitoring-symptoms-controlling-movement.html\u0022 target=\u0022_blank\u0022\u003EMonitoring symptoms and controlling movement to stop the spread of Ebola\u003C\/a\u003E (Oct 27)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procedures-for-ppe.html\u0022 target=\u0022_blank\u0022\u003EGuidance for donning and doffing PPE\u003C\/a\u003E (Oct 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/limiting-heat-burden.html\u0022 target=\u0022_self\u0022\u003EInterim guidance for limiting heat burden when wearing PPE\u003C\/a\u003E (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-specimen-collection-submission-patients-suspected-infection-ebola.html\u0022\u003EInterim guidance for specimen collection\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/select-agent-regulations.html\u0022\u003EInterim guidance on compliance with select agent regulations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-safe-handling-human-remains-ebola-patients-us-hospitals-mortuaries.html\u0022\u003EGuidance for safe handling of human remains of Ebola patients\u003C\/a\u003E\u003Cspan\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/environmental-infection-control-in-hospitals.html\u0022\u003EInterim guidance for environmental infection control in hospitals\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003C\/span\u003E \u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003EResources for healthcare workers \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/training-toolkit.html\u0022 target=\u0022_blank\u0022\u003EPreparing healthcare workers to work in Ebola treatment units in Africa: Training toolkit announcement\u003C\/a\u003E (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/emergency-department-training.html\u0022 target=\u0022_blank\u0022\u003EEbola preparedness: Emergency Department training modules\u003C\/a\u003E (Feb 17, 2015)\u003Cbr \/\u003ENon-CDC lab resources for Ebola (Jan 30, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/ppe\/supplies.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for US healthcare facilities to ensure adequate supplies of PPE for Ebola preparedness\u003C\/a\u003E (Dec 31, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/preparing-frontline-healthcare-facilities.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for frontline US healthcare facilities for potential Ebola patients\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/us-hospital-preparedness.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US hospitals for potential Ebola patients: a tiered approach\u003C\/a\u003E (Dec 2, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/hand-hygiene.html\u0022 target=\u0022_blank\u0022\u003EHand hygiene in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/mixing-chlorine-solutions.html\u0022 target=\u0022_blank\u0022\u003EMixing and using chlorine solutions in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.youtube.com\/watch?v=8y19h1hecgY\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003ERespiratory protection video\u003C\/a\u003E (Nov 10, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/qa-infection-control-general-healthcare-widespread-ebola-transmission.html\u0022 target=\u0022_blank\u0022\u003EInfection control in countries with widespread Ebola\u003C\/a\u003E (Nov 3) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ambulatory-care-evaluation-of-patients-with-possible-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EAlgorithm for ambulatory care evaluation of patients with possible Ebola\u003C\/a\u003E (Oct 31, 2014)\u00a0\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/considerations-discharging-pui.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for discharging persons under investigation for Ebola\u003C\/a\u003E (Oct 30) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/ed-management-patients-possible-ebola.html\u0022 target=\u0022_blank\u0022\u003EAlgorithm for emergency department management of patients with suspected Ebola\u003C\/a\u003E (Oct 27, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1014-ebola-investigation-fact-sheet.html\u0022 target=\u0022_blank\u0022\u003EFact sheet on hospital preparedness\u003C\/a\u003E (Oct 14, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/caring-for-ebola-suspects.html\u0022 target=\u0022_blank\u0022\u003ECaring for patients under investigation for Ebola\u003C\/a\u003E (Oct 20, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/clinician-information-us-healthcare-settings.html\u0022\u003EDisease information for clinicians\u003C\/a\u003E\u003Cspan\u003E (Oct 4, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-facility-checklist-for-ebola.pdf\u0022\u003EHealthcare facility preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-provider-checklist-for-ebola.pdf\u0022\u003EHealthcare provider preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ems-checklist-ebola-preparedness.pdf\u0022\u003EEMS checklist for Ebola preparedness\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/coalition-checklist-ebola-preparedness.pdf\u0022\u003EChecklist for healthcare coalitions for Ebola preparedness\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/index.html\u0022\u003EInformation for healthcare workers\u003C\/a\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00371.asp\u0022\u003EHealth Alert Network (HAN) advisory for healthcare workers\u003C\/a\u003E (Oct 2, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.phe.gov\/Preparedness\/responders\/Pages\/ebola-healthcare-webinar.aspx\u0022\u003EEbola preparedness for US healthcare system (webinar with ASPR)\u003C\/a\u003E (Sep 29, 2014)\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003EInfection prevention and control recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ppe-poster.pdf\u0022\u003ESequence for removing personal protective equipment\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/s0914-ebola-surge.html\u0022\u003EFact sheet on surge\u003C\/a\u003E (Sep 16, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003ETravel\/flight information \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 8, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Feb 19, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-commercial-passenger-aircraft.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cleaning, disinfection, and waste disposal in commercial passenger aircraft \u003C\/a\u003E(Dec 18, 2014)\u00a0\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/airlines\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for airlines\u003C\/a\u003E (Dec 9, 2014)\u003Cem\u003E\u00a0 \u003C\/em\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00372.asp\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening and monitoring for people entering US from Mali\u003C\/a\u003E (Nov 24)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Nov 16) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/p1116-travelers-from-mali.html\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening to begin for travelers to the US from Mali\u003C\/a\u003E (Nov 16)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/travelers\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for Travelers\u003C\/a\u003E (Nov 3, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003ECheck and Report Ebola (CARE) kit for travelers arriving in US from West Africa\u00a0 \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/diseases\/ebola\u0022\u003EEbola Traveler\u0027s Health\u003C\/a\u003E\u00a0(Oct 7, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/pilots.html\u0022\u003ECDC death and disease reporting tool for pilots\u003C\/a\u003E (Aug 25, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/managing-sick-travelers\/ebola-guidance-airlines.html\u0022\u003EInterim guidance for airline crews, cleaning personnel, and cargo personnel\u003C\/a\u003E (Oct 2, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-air-medical-transport-patients.html\u0022\u003EGuidance on air medical transport for Ebola patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/guidance-reporting-onboard-deaths-illnesses.html\u0022\u003EGuidance for airlines on reporting onboard deaths or illnesses\u003C\/a\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/cabin-crew.html\u0022\u003ECDC death and disease reporting tool for cabin crew\u003C\/a\u003E (Aug 25, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUS Government \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.google.com\/url?sa=t\u0026amp;rct=j\u0026amp;q=\u0026amp;esrc=s\u0026amp;source=web\u0026amp;cd=2\u0026amp;cad=rja\u0026amp;uact=8\u0026amp;ved=0CCUQFjAB\u0026amp;url=http%3A%2F%2Fwww.fas.org%2Fsgp%2Fcrs%2Fmisc%2FR43809.pdf\u0026amp;ei=QB6KVLblMsmlyATqtYHwAg\u0026amp;usg=AFQjCNE2dHIgc_qruQur8MBr-U49sMQhDQ\u0026amp;bvm=bv.81456516,d.aWw\u0022 target=\u0022_blank\u0022\u003EPreventing the introduction and spread of Ebola in the United States: FAQs\u003C\/a\u003E (Dec 5, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/blogs.fda.gov\/fdavoice\/index.php\/2014\/10\/fda-as-part-of-a-coordinated-global-response-on-ebola\/\u0022 target=\u0022_blank\u0022\u003EFDA Commissioner\u0027s statement on agency\u0027s involvement with Ebola response\u003C\/a\u003E (Oct 28)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.hhs.gov\/news\/press\/2014pres\/09\/20140916b.html\u0022\u003EHHS statement on deployment of US Public Health Service Commissioned Corps\u003C\/a\u003E (Sep 16, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/sis.nlm.nih.gov\/dimrc\/ebola_2014.html\u0022\u003ENLM Disaster Information Management Research Center resource list\u003C\/a\u003E (Oct 8, 2014)\u00a0\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EInstitute of Medicine (IOM)\u00a0 \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.nap.edu\/read\/19004\/chapter\/1\u0022 target=\u0022_blank\u0022\u003EResearch priorities to inform public health and medical practice for Ebola virus disease\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nationalacademies.org\/hmd\/Reports\/2014\/Enabling-Rapid-Sustainable-Public-Health-Research-During-Disasters.aspx\u0022 target=\u0022_blank\u0022\u003EEnabling rapid and sustainable public health research during disasters\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/nationalacademies.org\/hmd\/Global\/Topics\/Ebola.aspx\u0022 target=\u0022_blank\u0022\u003EVideo from IOM workshop on research priorities for Ebola\u003C\/a\u003E (Nov 4) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EAmerican Veterinary Medical Association (AVMA) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/pets-of-ebola-contacts.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for public health officials on pets of Ebola contacts\u003C\/a\u003E (Nov 10, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/dog-cat-quarantine.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for dog or cat quarantine after exposure to a human with confirmed Ebola\u003C\/a\u003E (Nov 10) \u003Cbr \/\u003E\u003Cem\u003ENote:\u003C\/em\u003E The following resources require AVMA membership or site registration: \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071962:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EChecklist for vets when presented with patient or client with possible Ebola exposure\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071963:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EHandout on Ebola for pet owners\u003C\/a\u003E\u00a0 \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EEuropean Centre for Disease Prevention and Control (ECDC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/safe-use-of-ppe.pdf\u0022 target=\u0022_blank\u0022\u003ESafe use of PPE in the treatment of infectious diseases with high consequence\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-public-health-contact-management-update-10-November.pdf\u0022 target=\u0022_blank\u0022\u003EGuidance for managing persons who have been exposed\u003C\/a\u003E (Nov 7, 2014, update) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/management-healthcare-workers-returning-Ebola-affected-areas.pdf\u0022 target=\u0022_blank\u0022\u003EPublic health management of healthcare workers returning from affected areas\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1094\u0022 target=\u0022_blank\u0022\u003EGuide to medical air evacuation\u003C\/a\u003E (Oct 23, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1084\u0022 target=\u0022_blank\u0022\u003ERapid risk assessment\u003C\/a\u003E (Oct 15, 2014)\u00a0 \u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/healthtopics\/ebola_marburg_fevers\/EVDcasedefinition\/Pages\/default.aspx\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1076\u0022\u003EEpidemiological update - West Africa\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1064\u0022\u003EEpidemiological update - Democratic Republic of the Congo\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/_layouts\/forms\/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90\u0026amp;ID=1178\u0022\u003ERisk of Ebola transmission via donated blood and other substances of human origin\u003C\/a\u003E (Oct 6, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1082\u0022 target=\u0022_blank\u0022\u003EEntry and exit screening messages\u003C\/a\u003E (Oct 13, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUnited Kingdom agencies\u003C\/h5\u003E\u003Cp\u003EPublic Health England (PHE): \u003Ca href=\u0022https:\/\/www.gov.uk\/government\/collections\/ebola-virus-disease-clinical-management-and-guidance\u0022 target=\u0022_blank\u0022\u003EClinical management and guidance for healthcare professionals\u003C\/a\u003E \u003Cbr \/\u003ENational Health Service (NHS): \u003Ca href=\u0022http:\/\/www.nhs.uk\/conditions\/ebola-virus\/Pages\/Ebola-virus.aspx\u0022 target=\u0022_blank\u0022\u003EEbola resource page for consumers \u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EPublic Health Agency of Canada (PHAC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/national-case-definition-nationale-cas-eng.php\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 23, 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr style=\u0022line-height: 1.35em;\u0022 \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-ipc-pci-eng.php\u0022\u003EInterim guidance for infection prevention and control\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-biosafety-biosecurite-eng.php\u0022\u003EInterim biosafety guidelines for laboratory specimen handling\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 22, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/evd_crf-mvd_fdc-eng.php\u0022\u003ECase report form\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EFederal Ministry of Health (Nigeria)\u003C\/h5\u003E\u003Cp\u003EEbola Virus Information Unit website\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.health.gov.ng\/index.php\/news-media\/press-releases\u0022\u003ERecent press releases\u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EMedecins sans Frontieres (MSF; Doctors Without Borders)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E (Mar 23, 2015)\u003C\/p\u003E\u003Ch5\u003EMinistry of Health and Sanitation (Sierra Leone)\u003C\/h5\u003E\u003Cp\u003ECase updates\u003Cbr \/\u003E Situation reports\u003Cbr \/\u003E Frequently asked questions\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EMinistry of Health (Liberia)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/moh.gov.lr\/\u0022\u003EMain page\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u00a0\u003C\/p\u003E\u003Ch4\u003EProfessional Organizations\u003C\/h4\u003E\u003Ch5\u003E\u003Cstrong\u003EAmerican College of Chest Physicians (Nov 5, 2014) \u003C\/strong\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=GQgpul5czUY\u0022 target=\u0022_blank\u0022\u003EPreparing for Ebola\u003C\/a\u003E (1-hr video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=E_K-fYvHsO0\u0022 target=\u0022_blank\u0022\u003ECritical care of Persons with Ebola in Sierra Leone and at Emory University\u003C\/a\u003E ( 1-hr 15-minute video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=QPYwuwnYF4M\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EOpportunities, Lessons Learned, and Future Action Items\u003C\/a\u003E (48-minute video)\u003C\/p\u003E\u003Cp\u003E\u00a0\u003C\/p\u003E\u003Ch4\u003EAcademic Institutions\u003C\/h4\u003E\u003Cp\u003EIDS (Institute of Development Studies) in conjunction with UK universities: \u003Ca href=\u0022http:\/\/www.ebola-anthropology.net\/\u0022 target=\u0022_blank\u0022\u003EEbola Response Anthropology Platform \u003C\/a\u003E\u003Cbr \/\u003EGeorge Washington University: \u003Ca href=\u0022http:\/\/publichealthonline.gwu.edu\/ebola-public-health-crisis\/\u0022 target=\u0022_blank\u0022\u003EInfographic on ripple effects of Ebola outbreak\u003C\/a\u003E (Nov 12) \u003Cbr \/\u003EEmory University: \u003Ca href=\u0022http:\/\/www.emoryhealthcare.org\/ebola-protocol\/resources.html\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Protocols\u003C\/a\u003E (requires registration)\u003Cbr \/\u003EUniversity of Nebraska Biocontainment Unit: \u003Ca href=\u0022http:\/\/www.nebraskamed.com\/biocontainment-unit\u0022 target=\u0022_blank\u0022\u003EPatient care links\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u00a0\u003C\/h4\u003E\u003Ch4\u003ETools\/Posters\u003C\/h4\u003E\u003Cp\u003ECDC Flipbook: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (May 1, 2015)\u003Cbr \/\u003ECDC children\u0027s activity book: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-activity-book-general.pdf\u0022 target=\u0022_blank\u0022\u003EHelping people in West Africa\u003C\/a\u003E (CDC)(Apr 22, 2015) \u003Cbr \/\u003ECDC brochure: \u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (Apr 21, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-liberia.pdf\u0022 target=\u0022_blank\u0022\u003ELiberians in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EGuineans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003ESierra Leoneans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Guinea)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-liberia.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Liberia)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ors-instructions.pdf\u0022 target=\u0022_blank\u0022\u003EHow to safely give oral rehydration solution\u003C\/a\u003E (Dec 9, 2014) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/21-day-investigation-guinea.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts in Guinea\u003C\/a\u003E (Dec 4, 2014)\u003Cbr \/\u003ECDC slides and video: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/ppt\/what-you-really-need-know-ebola.pptx\u0022 target=\u0022_blank\u0022\u003EWhat you REALLY need to know about Ebola\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/sierra-leone-21-day-investigation.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts\u2014Sierra Leone\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/top-10-things.pdf\u0022 target=\u0022_blank\u0022\u003ETop 10 things you really need to know about Ebola\u003C\/a\u003E (Nov 19, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003EMEDBOX:\u00a0\u003Ca href=\u0022http:\/\/www.medbox.org\/ebola-toolbox\/listing\u0022 target=\u0022_blank\u0022\u003EEbola Toolbox\u003C\/a\u003E \u003Cbr \/\u003EUniversity of Nebraska: \u003Ca href=\u0022https:\/\/www.nebraskamed.com\/sites\/default\/files\/documents\/biocontainment\/ebolappechecklist.pdf\u0022 target=\u0022_blank\u0022\u003EDonning \u0026amp; Doffing PPE\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EWorld Bank\u003C\/h4\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.worldbank.org\/en\/topic\/health\/brief\/world-bank-group-ebola-fact-sheet\u0022 target=\u0022_blank\u0022\u003EEbola Fact Sheet\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/documents.worldbank.org\/curated\/en\/2014\/10\/20270083\/\u0022 target=\u0022_blank\u0022\u003EEconomic impact statement\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources from Journals\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/21\/5\/14-2016_article\u0022 target=\u0022_blank\u0022\u003EUsing lessons learned from previous Ebola outbreaks to inform current risk management\u003C\/a\u003E (May 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.springer.com\/biomed\/virology\/spotlight+on+ebola?SGWID=0-1771314-0-0-0\u0022 target=\u0022_blank\u0022\u003EBioMed Central \u0026amp; Springer Ebola Resource Center\u003C\/a\u003E (open-access articles) (launched Dec 5, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003EDisaster Medicine and Public Health Preparedness \u003C\/a\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003Especial edition on Ebola\u003C\/a\u003E \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displayFulltext?type=6\u0026amp;fid=9388028\u0026amp;jid=DMP\u0026amp;volumeId=-1\u0026amp;issueId=-1\u0026amp;aid=9388027\u0026amp;fulltextType=BT\u0026amp;fileId=S1935789314001153\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EDisaster Medicine and Public Health Preparedness: A primer on Ebola for clinicians\u003C\/em\u003E\u003C\/a\u003E\u00a0 (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/page\/ebola-spotlight\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nature.com\/news\/ebola-by-the-numbers-the-size-spread-and-cost-of-an-outbreak-1.16144\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003ENature:\u003C\/em\u003E Ebola by the numbers\u003C\/a\u003E\u00a0 \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.nejm.org\/page\/ebola-outbreak\u0022\u003EN Engl J Med\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/ebola.thelancet.com\/\u0022\u003EThe Lancet\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/www.sciencemag.org\/site\/extra\/ebola\/\u0022\u003E\u003Cem\u003EScience\u003C\/em\u003E\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/blogs.plos.org\/speakingofmedicine\/2014\/09\/05\/plos-resources-ebola\/\u0022\u003EPLoS journals\u003C\/a\u003E \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/jama.jamanetwork.com\/article.aspx?articleid=1905875\u0022\u003EJAMA\u003C\/a\u003E\u003C\/em\u003E\u00a0\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003ETwitter\u003C\/h4\u003E\u003Cp\u003ECIDRAP (\u003Ca href=\u0022https:\/\/twitter.com\/cidrap\u0022 target=\u0022_blank\u0022\u003E@CIDRAP\u003C\/a\u003E)\u003Cbr \/\u003E Helen Branswell (\u003Ca href=\u0022https:\/\/twitter.com\/HelenBranswell\u0022 target=\u0022_blank\u0022\u003E@HelenBranswell\u003C\/a\u003E)\u003Cbr \/\u003E Michael Coston (\u003Ca href=\u0022https:\/\/twitter.com\/Fla_Medic\u0022 target=\u0022_blank\u0022\u003E@Fla_Medic\u003C\/a\u003E)\u003Cbr \/\u003E ECDC Outbreaks (\u003Ca href=\u0022https:\/\/twitter.com\/ECDC_Outbreaks\u0022 target=\u0022_blank\u0022\u003E@ECDC_Outbreaks\u003C\/a\u003E)\u003Cbr \/\u003E Martin Enserink (\u003Ca href=\u0022https:\/\/twitter.com\/martinenserink\u0022 target=\u0022_blank\u0022\u003E@martinenserink\u003C\/a\u003E) \u003Cbr \/\u003E Jason Gale (\u003Ca href=\u0022https:\/\/twitter.com\/jwgale\u0022 target=\u0022_blank\u0022\u003E@jwgale\u003C\/a\u003E) \u003Cbr \/\u003E HealthMap.org (\u003Ca href=\u0022https:\/\/twitter.com\/healthmap\u0022 target=\u0022_blank\u0022\u003E@healthmap\u003C\/a\u003E)\u003Cbr \/\u003E Crawford Kilian (\u003Ca href=\u0022https:\/\/twitter.com\/Crof\u0022 target=\u0022_blank\u0022\u003E@crof\u003C\/a\u003E)\u003Cbr \/\u003E Ian M Mackay, PhD (\u003Ca href=\u0022https:\/\/twitter.com\/MackayIM\u0022 target=\u0022_blank\u0022\u003E@MackayIM\u003C\/a\u003E)\u003Cbr \/\u003E Maia Majumder, MPH (\u003Ca href=\u0022https:\/\/twitter.com\/maiamajumder\u0022\u003E@maiamajumder\u003C\/a\u003E)\u003C\/p\u003E\u003Cp\u003E\u003Ca name=\u0022lit\u0022 id=\u0022lit\u0022\u003E\u003C\/a\u003E\u003C\/p\u003E"}]},"field_hp_size":{"und":[{"mode":"hp_large"}]},"field_bibliography":[],"field_body_biblio":[],"field_field_collection_biblio":[],"rdf_mapping":{"rdftype":["sioc:Item","foaf:Document"],"title":{"predicates":["dc:title"]},"created":{"predicates":["dc:date","dc:created"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"changed":{"predicates":["dc:modified"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"body":{"predicates":["content:encoded"]},"uid":{"predicates":["sioc:has_creator"],"type":"rel"},"name":{"predicates":["foaf:name"]},"comment_count":{"predicates":["sioc:num_replies"],"datatype":"xsd:integer"},"last_activity":{"predicates":["sioc:last_activity_date"],"datatype":"xsd:dateTime","callback":"date_iso8601"}},"path":{"pathauto":"1"},"cid":"0","last_comment_timestamp":"1362431979","last_comment_name":null,"last_comment_uid":"1","comment_count":"0","nodehierarchy_menu_links":[],"name":"admin","picture":"0","data":"a:8:{s:19:\u0022biblio_show_profile\u0022;i:0;s:19:\u0022biblio_my_pubs_menu\u0022;i:0;s:21:\u0022biblio_contributor_id\u0022;s:1:\u00220\u0022;s:22:\u0022biblio_id_change_count\u0022;s:1:\u00220\u0022;s:17:\u0022biblio_user_style\u0022;s:6:\u0022system\u0022;s:18:\u0022biblio_baseopenurl\u0022;s:0:\u0022\u0022;s:18:\u0022biblio_openurl_sid\u0022;s:0:\u0022\u0022;s:19:\u0022biblio_crossref_pid\u0022;s:0:\u0022\u0022;}","print_html_display":1,"print_html_display_comment":0,"print_html_display_urllist":1}},{"nid":"102","access":true,"node":{"vid":"260556","uid":"1","title":"VHF","log":"","status":"1","comment":"1","promote":"0","sticky":"0","vuuid":"be4d865e-8914-4d80-9ab3-26056a6009fc","nid":"102","type":"topics","language":"und","created":"1362432020","changed":"1496768999","tnid":"0","translate":"0","uuid":"0f616411-1ec2-4f74-98a8-bd0c6f438699","revision_timestamp":"1496768999","revision_uid":"61146","field_tab_collection":{"und":[{"value":"341","revision_id":"41541"},{"value":"346","revision_id":"41546"},{"value":"351","revision_id":"41551"},{"value":"356","revision_id":"41556"},{"value":"361","revision_id":"41561"},{"value":"366","revision_id":"41566"},{"value":"371","revision_id":"41571"},{"value":"376","revision_id":"41576"}]},"field_body":[],"field_overview":{"und":[{"value":"\u003Cp\u003E\u003Cem\u003ELast updated Jun 21, 2012\u003C\/em\u003E\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003E\u003Cem\u003ELast updated Jun 21, 2012\u003C\/em\u003E\u003C\/p\u003E"}]},"field_show_topic":{"und":[{"value":"1"}]},"field_related_topics":{"und":[{"nid":"64"},{"nid":"77"},{"nid":"104"}]},"field_ss_media_file":[],"field_last_updated":[],"field_file_attachments":[],"field_synonyms":{"und":[{"value":"Viral Hemorrhagic Fever","format":null,"safe_value":"Viral Hemorrhagic Fever"}]},"field_call_action":[],"field_related_links":[],"field_teaser":{"und":[{"value":"\u003Cp\u003ECIDRAP-authored overview\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003ECIDRAP-authored overview\u003C\/p\u003E"}]},"field_roundup_type":{"und":[{"value":"1"}]},"field_subtitle":{"und":[{"value":"\u003Cp\u003EViral hemorrhagic fever\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003EViral hemorrhagic fever\u003C\/p\u003E"}]},"field_super_title":[],"field_resources":[],"field_hp_size":[],"field_bibliography":[],"field_body_biblio":[],"field_field_collection_biblio":[],"rdf_mapping":{"rdftype":["sioc:Item","foaf:Document"],"title":{"predicates":["dc:title"]},"created":{"predicates":["dc:date","dc:created"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"changed":{"predicates":["dc:modified"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"body":{"predicates":["content:encoded"]},"uid":{"predicates":["sioc:has_creator"],"type":"rel"},"name":{"predicates":["foaf:name"]},"comment_count":{"predicates":["sioc:num_replies"],"datatype":"xsd:integer"},"last_activity":{"predicates":["sioc:last_activity_date"],"datatype":"xsd:dateTime","callback":"date_iso8601"}},"path":{"pathauto":"1"},"cid":"0","last_comment_timestamp":"1362432020","last_comment_name":null,"last_comment_uid":"1","comment_count":"0","nodehierarchy_menu_links":[],"name":"admin","picture":"0","data":"a:8:{s:19:\u0022biblio_show_profile\u0022;i:0;s:19:\u0022biblio_my_pubs_menu\u0022;i:0;s:21:\u0022biblio_contributor_id\u0022;s:1:\u00220\u0022;s:22:\u0022biblio_id_change_count\u0022;s:1:\u00220\u0022;s:17:\u0022biblio_user_style\u0022;s:6:\u0022system\u0022;s:18:\u0022biblio_baseopenurl\u0022;s:0:\u0022\u0022;s:18:\u0022biblio_openurl_sid\u0022;s:0:\u0022\u0022;s:19:\u0022biblio_crossref_pid\u0022;s:0:\u0022\u0022;}","print_html_display":1,"print_html_display_comment":0,"print_html_display_urllist":1}}]},"field_file_attachments":[],"field_tags":[],"field_country":[],"field_organization":{"und":[{"tid":"221"},{"tid":"268"}]},"field_ss_media_file":{"und":[{"fid":"20351","uid":"801","filename":"papr.jpg","uri":"public:\/\/media\/article\/papr_0.jpg","filemime":"image\/jpeg","filesize":"52939","status":"1","timestamp":"1411044209","type":"image","uuid":"2858d463-8f51-4409-99b6-72777b4492a3","field_file_image_alt_text":{"und":[{"value":"PAPR - powered air-purifying respirator","format":null,"safe_value":"PAPR - powered air-purifying respirator"}]},"field_file_image_title_text":{"und":[{"value":"A powered air-purifying respirator (PAPR).","format":null,"safe_value":"A powered air-purifying respirator (PAPR)."}]},"field_credit":{"und":[{"value":"Courtesy of 3M Company","format":null,"safe_value":"Courtesy of 3M Company"}]},"rdf_mapping":[],"metadata":[],"alt":"PAPR - powered air-purifying respirator","title":"A powered air-purifying respirator (PAPR).","display":"1","description":null}]},"field_related_articles":[],"field_related_literature":[],"field_related_news":{"und":[{"vname":"news|entity_view_1","vargs":""}]},"field_byline":{"und":[{"tid":"881","taxonomy_term":{"tid":"881","vid":"21","name":"Lisa M Brosseau, ScD, and Rachael Jones, PhD","description":"","format":"full_html","weight":"19","uuid":"d7f5f545-e776-4984-90b9-5f48481d6f9f","vocabulary_machine_name":"bylines","rdf_mapping":{"rdftype":["skos:Concept"],"name":{"predicates":["rdfs:label","skos:prefLabel"]},"description":{"predicates":["skos:definition"]},"vid":{"predicates":["skos:inScheme"],"type":"rel"},"parent":{"predicates":["skos:broader"],"type":"rel"}}}}]},"field_super_title":[],"field_hp_size":{"und":[{"mode":"hp_large"}]},"field_th_asp_topic":[],"rdf_mapping":{"rdftype":["sioc:Item","foaf:Document"],"title":{"predicates":["dc:title"]},"created":{"predicates":["dc:date","dc:created"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"changed":{"predicates":["dc:modified"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"body":{"predicates":["content:encoded"]},"uid":{"predicates":["sioc:has_creator"],"type":"rel"},"name":{"predicates":["foaf:name"]},"comment_count":{"predicates":["sioc:num_replies"],"datatype":"xsd:integer"},"last_activity":{"predicates":["sioc:last_activity_date"],"datatype":"xsd:dateTime","callback":"date_iso8601"}},"cid":0,"last_comment_timestamp":"1410995616","last_comment_name":"","last_comment_uid":"801","comment_count":0,"nodehierarchy_menu_links":[],"name":"Jim Wappes","picture":"0","data":"b:0;","print_html_display":1,"print_html_display_comment":0,"print_html_display_urllist":1,"entity_view_prepared":true,"service_links":{"service-links-facebook":{"title":"Share","href":"http:\/\/www.facebook.com\/sharer.php","query":{"u":"http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola","t":"COMMENTARY: Health workers need optimal respiratory protection for Ebola"},"attributes":{"title":"Share on Facebook","class":["service-links-facebook"],"rel":"nofollow"}},"service-links-twitter":{"title":"Tweet","href":"http:\/\/twitter.com\/share","query":{"url":"http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola","text":"COMMENTARY: Health workers need optimal respiratory protection for Ebola"},"attributes":{"title":"Share this on Twitter","class":["service-links-twitter"],"rel":"nofollow"}},"service-links-linkedin":{"title":"LinkedIn","href":"http:\/\/www.linkedin.com\/shareArticle","query":{"mini":"true","url":"http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola","title":"COMMENTARY: Health workers need optimal respiratory protection for Ebola","summary":"","source":"CIDRAP"},"attributes":{"title":"Publish this post to LinkedIn","class":["service-links-linkedin"],"rel":"nofollow"}},"service-links-forward":{"title":"Email","href":"http:\/\/www.cidrap.umn.edu\/forward","query":{"path":"node\/84276"},"attributes":{"title":"Send to a friend","class":["service-links-forward"],"rel":"nofollow"}},"service-links-printfriendly":{"title":"Print \u0026 PDF","href":"http:\/\/www.printfriendly.com","query":null,"attributes":{"class":["printfriendly","service-links-printfriendly"],"onclick":"window.print();return false;","title":"Print and PDF versions","rel":"nofollow"}}},"service_links_rendered":"\u003Cdiv class=\u0022service-links\u0022\u003E\u003Cdiv class=\u0022service-label\u0022\u003EShare this page: \u003C\/div\u003E\u003Cul class=\u0022links\u0022\u003E\u003Cli class=\u0022service-links-facebook link-share link-http--wwwfacebookcom-sharerphp link-idx-0 link-idx--4 first\u0022\u003E\u003Ca href=\u0022http:\/\/www.facebook.com\/sharer.php?u=http%3A\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola\u0026amp;t=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola\u0022 title=\u0022Share on Facebook\u0022 class=\u0022service-links-facebook\u0022 rel=\u0022nofollow\u0022\u003EShare\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-twitter link-tweet link-http--twittercom-share link-idx-1 link-idx--3\u0022\u003E\u003Ca href=\u0022http:\/\/twitter.com\/share?url=http%3A\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola\u0026amp;text=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola\u0022 title=\u0022Share this on Twitter\u0022 class=\u0022service-links-twitter\u0022 rel=\u0022nofollow\u0022\u003ETweet\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-linkedin link-linkedin link-http--wwwlinkedincom-sharearticle link-idx-2 link-idx--2\u0022\u003E\u003Ca href=\u0022http:\/\/www.linkedin.com\/shareArticle?mini=true\u0026amp;url=http%3A\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola\u0026amp;title=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola\u0026amp;summary=\u0026amp;source=CIDRAP\u0022 title=\u0022Publish this post to LinkedIn\u0022 class=\u0022service-links-linkedin\u0022 rel=\u0022nofollow\u0022\u003ELinkedIn\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-forward link-email link-http--wwwcidrapumnedu-forward link-idx-3 link-idx--1\u0022\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/forward?path=node\/84276\u0022 title=\u0022Send to a friend\u0022 class=\u0022service-links-forward\u0022 rel=\u0022nofollow\u0022\u003EEmail\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-printfriendly link-print--pdf link-http--wwwprintfriendlycom link-idx-4 link-idx--0 last\u0022\u003E\u003Ca href=\u0022http:\/\/www.printfriendly.com\u0022 class=\u0022printfriendly service-links-printfriendly\u0022 onclick=\u0022window.print();return false;\u0022 title=\u0022Print and PDF versions\u0022 rel=\u0022nofollow\u0022\u003EPrint \u0026amp; PDF\u003C\/a\u003E\u003C\/li\u003E\n\u003C\/ul\u003E\u003C\/div\u003E","fieldlayout_cache":[]},"referencing_entity_type":"node","referencing_field":"field_ss_media_file","entity_view_prepared":true},"#items":[{"value":"A powered air-purifying respirator (PAPR).","format":null,"safe_value":"A powered air-purifying respirator (PAPR)."}],"#formatter":"text_default","0":{"#markup":"A powered air-purifying respirator (PAPR)."}},"field_credit":{"#theme":"field","#weight":"1","#title":"Credit","#access":true,"#label_display":"hidden","#view_mode":"full","#language":"und","#field_name":"field_credit","#field_type":"text","#field_translatable":"0","#entity_type":"file","#bundle":"image","#object":{"fid":"20351","uid":"801","filename":"papr.jpg","uri":"public:\/\/media\/article\/papr_0.jpg","filemime":"image\/jpeg","filesize":"52939","status":"1","timestamp":"1411044209","type":"image","uuid":"2858d463-8f51-4409-99b6-72777b4492a3","field_file_image_alt_text":{"und":[{"value":"PAPR - powered air-purifying respirator","format":null,"safe_value":"PAPR - powered air-purifying respirator"}]},"field_file_image_title_text":{"und":[{"value":"A powered air-purifying respirator (PAPR).","format":null,"safe_value":"A powered air-purifying respirator (PAPR)."}]},"field_credit":{"und":[{"value":"Courtesy of 3M Company","format":null,"safe_value":"Courtesy of 3M Company"}]},"rdf_mapping":[],"metadata":{"width":null,"height":null},"alt":"PAPR - powered air-purifying respirator","title":"A powered air-purifying respirator (PAPR).","display":"1","referencing_entity":{"vid":"197071","uid":"801","title":"COMMENTARY: Health workers need optimal respiratory protection for Ebola","log":"","status":"1","comment":"0","promote":"0","sticky":"1","vuuid":"a32af743-a649-4c4c-afd1-8e1ae959c714","nid":"84276","type":"ss_news","language":"und","created":"1410995616","changed":"1420487195","tnid":"0","translate":"0","uuid":"c815f393-5cac-4094-8891-027c1ae7eec3","revision_timestamp":"1420487195","revision_uid":"30796","field_date":{"und":[{"value":"2014-09-17 00:00:00","timezone":"America\/Chicago","timezone_db":"America\/Chicago","date_type":"datetime"}]},"field_body":{"und":[{"value":"\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note \u003Cstrong\u003E\u003Cem\u003E(Oct 16)\u003C\/em\u003E\u003C\/strong\u003E:\u0026nbsp; \u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003ESee the \u003C\/em\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/response-statements-falsely-attributed-cidrap-regarding-ebola-transmission\u0022 target=\u0022_blank\u0022\u003E statement\u003C\/a\u003E released today by CIDRAP related to this commentary.\u003C\/em\u003E\u003Cstrong\u003E\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note (Sep 17):\u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003E Today\u0027s commentary was submitted to CIDRAP by the authors, who are national experts on respiratory protection and infectious disease transmission. In May they published a \u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003E\u003Cem\u003Esimilar commentary on MERS-CoV\u003C\/em\u003E\u003C\/a\u003E\u003Cem\u003E. Dr Brosseau is a Professor and Dr Jones an Assistant Professor in the School of Public Health, Division of Environmental and Occupational Health Sciences, at the University of Illinois at Chicago.\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003E\u003Cstrong\u003EAuthors\u0027 disclaimer:\u003C\/strong\u003E\u003C\/em\u003E\u003Cem\u003E This commentary reflects the personal opinions of the authors. It does not represent the opinion of the University of Illinois at Chicago or any other organization. The authors have not received any compensation for the preparation of this commentary or any associated public statements. The authors do not endorse any specific manufacturer or brand of personal protective equipment (PPE) and have no direct or indirect financial interest in the use of a specific brand of PPE. In the past one or both of the authors have received research funding from numerous government agencies and organizations, including 3M.\u003C\/em\u003E\u003C\/p\u003E\u003Chr \/\u003E\u003Cp\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cdiv\u003EHealthcare workers play a very important role in the successful containment of outbreaks of infectious diseases like Ebola. The correct type and level of personal protective equipment (PPE) ensures that healthcare workers remain healthy throughout an outbreak\u2014and with the current rapidly expanding Ebola outbreak in West Africa, it\u0027s imperative to favor more conservative measures.\u003C\/div\u003E\u003Cdiv\u003E\u0026nbsp;\u003C\/div\u003E\u003Cdiv\u003EThe precautionary principle\u2014that any action designed to reduce risk should not await scientific certainty\u2014compels the use of respiratory protection for a pathogen like Ebola virus that has:\u003C\/div\u003E\u003Cdiv\u003E\u0026nbsp;\u003C\/div\u003E\u003Cul\u003E\u003Cli\u003ENo proven pre- or post-exposure treatment modalities\u003C\/li\u003E\u003Cli\u003EA high case-fatality rate\u003C\/li\u003E\u003Cli\u003EUnclear modes of transmission\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003EWe believe there is scientific and epidemiologic evidence that Ebola virus has the potential to be transmitted via infectious aerosol particles both near and at a distance from infected patients, which means that healthcare workers should be wearing respirators, not facemasks.\u003Csup\u003E1\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EThe minimum level of protection in high-risk settings should be a respirator with an assigned protection factor greater than 10. A powered air-purifying respirator (PAPR) with a hood or helmet offers many advantages over an N95 filtering facepiece or similar respirator, being more protective, comfortable, and cost-effective in the long run.\u003C\/p\u003E\u003Cp\u003EWe strongly urge the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to seek funds for the purchase and transport of PAPRs to all healthcare workers currently fighting the battle against Ebola throughout Africa\u2014and beyond.\u003C\/p\u003E\u003Cp\u003EThere has been a lot of on-line and published controversy about whether Ebola virus can be transmitted via aerosols. Most scientific and medical personnel, along with public health organizations, have been unequivocal in their statements that Ebola can be transmitted only by direct contact with virus-laden fluids\u003Csup\u003E2,3\u003C\/sup\u003E and that the only modes of transmission we should be concerned with are those termed \u0022droplet\u0022 and \u0022contact.\u0022\u003C\/p\u003E\u003Cp\u003EThese statements are based on two lines of reasoning. The first is that no one located at a distance from an infected individual has contracted the disease, or the converse, every person infected has had (or must have had) \u0022direct\u0022 contact with the body fluids of an infected person.\u003C\/p\u003E\u003Cp\u003EThis reflects an incorrect and outmoded understanding of infectious aerosols, which has been institutionalized in policies, language, culture, and approaches to infection control. We will address this below. Briefly, however, the important points are that virus-laden bodily fluids may be aerosolized and inhaled while a person is in proximity to an infectious person and that a wide range of particle sizes can be inhaled and deposited throughout the respiratory tract.\u003C\/p\u003E\u003Cp\u003EThe second line of reasoning is that respirators or other control measures for infectious aerosols cannot be recommended in developing countries because the resources, time, and\/or understanding for such measures are lacking.\u003Csup\u003E4\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAlthough there are some important barriers to the use of respirators, especially PAPRs, in developing countries, healthcare workers everywhere deserve and should be afforded the same best-practice types of protection, regardless of costs and resources. Every healthcare worker is a precious commodity whose well-being ensures everyone is protected.\u003C\/p\u003E\u003Cp\u003EIf we are willing to offer infected US healthcare workers expensive treatments and experimental drugs free of charge when most of the world has no access to them, we wonder why we are unwilling to find the resources to provide appropriate levels of comparatively less expensive respiratory protection to every healthcare worker around the world.\u003C\/p\u003E\u003Ch3\u003EHow are infectious diseases transmitted via aerosols?\u003C\/h3\u003E\u003Cp\u003EMedical and infection control professionals have relied for years on a paradigm for aerosol transmission of infectious diseases based on very outmoded research and an overly simplistic interpretation of the data. In the 1940s and 50s, William F. Wells and other \u0022aerobiologists\u0022 employed now significantly out-of-date sampling methods (eg, settling plates) and very blunt analytic approaches (eg, cell culturing) to understand the movement of bacterial aerosols in healthcare and other settings. Their work, though groundbreaking at the time, provides a very incomplete picture.\u003C\/p\u003E\u003Cp\u003EEarly aerobiologists were not able to measure small particles near an infectious person and thus assumed such particles existed only far from the source. They concluded that organisms capable of aerosol transmission (termed \u0022airborne\u0022) can only do so at around 3 feet or more from the source. Because they thought that only larger particles would be present near the source, they believed people would be exposed only via large \u0022droplets\u0022 on their face, eyes, or nose.\u003C\/p\u003E\u003Cp\u003EModern research, using more sensitive instruments and analytic methods, has shown that aerosols emitted from the respiratory tract contain a wide distribution of particle sizes\u2014including many that are small enough to be inhaled.\u003Csup\u003E5,6\u003C\/sup\u003E Thus, both small and large particles will be present near an infectious person.\u003C\/p\u003E\u003Cp\u003EThe chance of large droplets reaching the facial mucous membranes is quite small, as the nasal openings are small and shielded by their external and internal structure. Although close contact may permit large-droplet exposure, it also maximizes the possibility of aerosol inhalation.\u003C\/p\u003E\u003Cp\u003EAs noted by early aerobiologists, liquid in a spray aerosol, such as that generated during coughing or sneezing, will quickly evaporate,\u003Csup\u003E7\u003C\/sup\u003E which increases the concentration of small particles in the aerosol. Because evaporation occurs in milliseconds, many of these particles are likely to be found near the infectious person.\u003C\/p\u003E\u003Cp\u003EThe current paradigm also assumes that only \u0022small\u0022 particles (less than 5 micrometers [mcm]) can be inhaled and deposited in the respiratory tract. This is not true. Particles as large as 100 mcm (and perhaps even larger) can be inhaled into the mouth and nose. Larger particles are deposited in the nasal passages, pharynx, and upper regions of the lungs, while smaller particles are more likely to deposit in the lower, alveolar regions. And for many pathogens, infection is possible regardless of the particle size or deposition site.\u003C\/p\u003E\u003Cp\u003EIt\u0027s time to abandon the old paradigm of three mutually exclusive transmission routes for a new one that considers the full range of particle sizes both near and far from a source. In addition, we need to factor in other important features of infectivity, such as the ability of a pathogen to remain viable in air at room temperature and humidity and the likelihood that systemic disease can result from deposition of infectious particles in the respiratory system or their transfer to the gastrointestinal tract.\u003C\/p\u003E\u003Cp\u003EWe recommend using \u0022aerosol transmissible\u0022 rather than the outmoded terms \u0022droplet\u0022 or \u0022airborne\u0022 to describe pathogens that can transmit disease via infectious particles suspended in air.\u003C\/p\u003E\u003Ch3\u003EIs Ebola an aerosol-transmissible disease?\u003C\/h3\u003E\u003Cp\u003EWe recently published a \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003Ecommentary\u003C\/a\u003E on the CIDRAP site discussing whether Middle East respiratory syndrome (MERS) could be an aerosol-transmissible disease, especially in healthcare settings. We drew comparisons with a similar and more well-studied disease, severe acute respiratory syndrome (SARS).\u003C\/p\u003E\u003Cp\u003EFor Ebola and other filoviruses, however, there is much less information and research on disease transmission and survival, especially in healthcare settings.\u003C\/p\u003E\u003Cp\u003EBeing at first skeptical that Ebola virus could be an aerosol-transmissible disease, we are now persuaded by a review of experimental and epidemiologic data that this might be an important feature of disease transmission, particularly in healthcare settings.\u003C\/p\u003E\u003Ch3\u003EWhat do we know about Ebola transmission?\u003C\/h3\u003E\u003Cp\u003ENo one knows for certain how Ebola virus is transmitted from one person to the next. The virus has been found in the saliva, stool, breast milk, semen, and blood of infected persons.\u003Csup\u003E8,9\u003C\/sup\u003E Studies of transmission in Ebola virus outbreaks have identified activities like caring for an infected person, sharing a bed, funeral activities, and contact with blood or other body fluids to be key risk factors for transmission.\u003Csup\u003E10-12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EOn the basis of epidemiologic evidence, it has been presumed that Ebola viruses are transmitted by contaminated hands in contact with the mouth or eyes or broken skin or by splashes or sprays of body fluids into these areas. Ebola viruses appear to be capable of initiating infection in a variety of human cell types,\u003Csup\u003E13,14\u003C\/sup\u003E but the primary portal or portals of entry into susceptible hosts have not been identified.\u003C\/p\u003E\u003Cp\u003ESome pathogens are limited in the cell type and location they infect. Influenza, for example, is generally restricted to respiratory epithelial cells, which explains why flu is primarily a respiratory infection and is most likely aerosol transmissible. HIV infects T-helper cells in the lymphoid tissues and is primarily a bloodborne pathogen with low probability for transmission via aerosols.\u003C\/p\u003E\u003Cp\u003EEbola virus, on the other hand, is a broader-acting and more non-specific pathogen that can impede the proper functioning of macrophages and dendritic cells\u2014immune response cells located throughout the epithelium.\u003Csup\u003E15,16\u003C\/sup\u003E Epithelial tissues are found throughout the body, including in the respiratory tract. Ebola prevents these cells from carrying out their antiviral functions but does not interfere with the initial inflammatory response, which attracts additional cells to the infection site. The latter contribute to further dissemination of the virus and similar adverse consequences far beyond the initial infection site.\u003C\/p\u003E\u003Cp\u003EThe potential for transmission via inhalation of aerosols, therefore, cannot be ruled out by the observed risk factors or our knowledge of the infection process. Many body fluids, such as vomit, diarrhea, blood, and saliva, are capable of creating inhalable aerosol particles in the immediate vicinity of an infected person. Cough was identified among some cases in a 1995 outbreak in Kikwit, Democratic Republic of the Congo,\u003Csup\u003E11\u003C\/sup\u003E and coughs are known to emit viruses in respirable particles.\u003Csup\u003E17\u003C\/sup\u003E The act of vomiting produces an aerosol and has been implicated in airborne transmission of gastrointestinal viruses.\u003Csup\u003E18,19\u003C\/sup\u003E Regarding diarrhea, even when contained by toilets, toilet flushing emits a pathogen-laden aerosol that disperses in the air.\u003Csup\u003E20-22\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EExperimental work has shown that Marburg and Ebola viruses can be isolated from sera and tissue culture medium at room temperature for up to 46 days, but at room temperature no virus was recovered from glass, metal, or plastic surfaces.\u003Csup\u003E23\u003C\/sup\u003E Aerosolized (1-3 mcm) Marburg, Ebola, and Reston viruses, at 50% to 55% relative humidity and 72\u00b0F, had biological decay rates of 3.04%, 3.06%. and 1.55% per minute, respectively. These rates indicate that 99% loss in aerosol infectivity would occur in 93, 104, and 162 minutes, respectively.\u003Csup\u003E23\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EIn still air, 3-mcm particles can take up to an hour to settle. With air currents, these and smaller particles can be transported considerable distances before they are deposited on a surface.\u003C\/p\u003E\u003Cp\u003EThere is also some experimental evidence that Ebola and other filoviruses can be transmitted by the aerosol route. Jaax et al\u003Csup\u003E24\u003C\/sup\u003E reported the unexpected death of two rhesus monkeys housed approximately 3 meters from monkeys infected with Ebola virus, concluding that respiratory or eye exposure to aerosols was the only possible explanation.\u003C\/p\u003E\u003Cp\u003EZaire Ebola viruses have also been transmitted in the absence of direct contact among pigs\u003Csup\u003E25\u003C\/sup\u003E and from pigs to non-human primates,\u003Csup\u003E26\u003C\/sup\u003E which experienced lung involvement in infection. Persons with no known direct contact with Ebola virus disease patients or their bodily fluids have become infected.\u003Csup\u003E12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EDirect injection and exposure via a skin break or mucous membranes are the most efficient ways for Ebola to transmit. It may be that inhalation is a less efficient route of transmission for Ebola and other filoviruses, as lung involvement has not been reported in all non-human primate studies of Ebola aerosol infectivity.\u003Csup\u003E27\u003C\/sup\u003E However, the respiratory and gastrointestinal systems are not complete barriers to Ebola virus. Experimental studies have demonstrated that it is possible to infect non-human primates and other mammals with filovirus aerosols.\u003Csup\u003E25-27\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAltogether, these epidemiologic and experimental data offer enough evidence to suggest that Ebola and other filoviruses may be opportunistic with respect to aerosol transmission.\u003Csup\u003E28\u003C\/sup\u003E That is, other routes of entry may be more important and probable, but, given the right conditions, it is possible that transmission could also occur via aerosols.\u003C\/p\u003E\u003Cp\u003EGuidance from the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003ECDC\u003C\/a\u003E and \u003Ca href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EWHO\u003C\/a\u003E recommends the use of facemasks for healthcare workers providing routine care to patients with Ebola virus disease and respirators when aerosol-generating procedures are performed. (Interestingly, the 1998 WHO and CDC infection-control guidance for viral hemorrhagic fevers in Africa, still available on the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/abroad\/pdf\/african-healthcare-setting-vhf.pdf\u0022\u003ECDC Web site\u003C\/a\u003E, recommends the use of respirators.)\u003C\/p\u003E\u003Cp\u003EFacemasks, however, do not offer protection against inhalation of small infectious aerosols, because they lack adequate filters and do not fit tightly against the face.\u003Csup\u003E1\u003C\/sup\u003E Therefore, a higher level of protection is necessary.\u003C\/p\u003E\u003Ch3\u003EWhich respirator to wear?\u003C\/h3\u003E\u003Cp\u003EAs described in our earlier \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003ECIDRAP commentary\u003C\/a\u003E, we can use a Canadian control-banding approach to select the most appropriate respirator for exposures to Ebola in healthcare settings.\u003Csup\u003E29\u003C\/sup\u003E (See \u003Ca href=\u0022http:\/\/www.isrp.com\/americas\/docs\/st_paul_2011\/mehes_use_care_standard.pdf\u0022\u003Ethis document\u003C\/a\u003E for a detailed description of the Canadian control banding approach and the data used to select respirators in our examples below.)\u003C\/p\u003E\u003Cp\u003EThe control banding method involves the following steps:\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the organism\u0027s risk group (1 to 4).\u003C\/em\u003E\u003C\/strong\u003E Risk group reflects the toxicity of an organism, including the degree and type of disease and whether treatments are available. Ebola is in risk group 4, the most toxic organisms, because it can cause serious human or animal disease, is easily transmitted, directly or indirectly, and currently has no effective treatments or preventive measures.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the generation rate.\u003C\/em\u003E\u003C\/strong\u003E The rate of aerosol generation reflects the number of particles created per time (eg, particles per second). Some processes, such as coughing, create more aerosols than others, like normal breathing. Some processes, like intubation and toilet flushing, can rapidly generate very large quantities of aerosols. The control banding approach assigns a qualitative rank ranging from low (1) to high (4) (eg, normal breathing without coughing has a rank of 1).\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the level of control.\u003C\/em\u003E\u003C\/strong\u003E Removing contaminated air and replacing it with clean air, as accomplished with a ventilation system, is effective for lowering the overall concentration of infectious aerosol particles in a space, although it may not be effective at lowering concentration in the immediate vicinity of a source. The number of air changes per hour (ACH) reflects the rate of air removal and replacement. This is a useful variable, because it is relatively easy to measure and, for hospitals, reflects building code requirements for different types of rooms. Again, a qualitative ranking is used to reflect low (1) versus high (4) ACH. Even if the true ventilation rate is not known, the examples can be used to select an appropriate air exchange rate.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the respirator assigned protection factor.\u003C\/em\u003E\u003C\/strong\u003E Respirators are designated by their \u0022class,\u0022 each of which has an assigned protection factor (APF) that reflects the degree of protection. The APF represents the outside, environmental concentration divided by the inside, facepiece concentration. An APF of 10 means that the outside concentration of a particular contaminant will be 10 times greater than that inside the respirator. If the concentration outside the respirator is very high, an assigned protection factor of 10 may not prevent the wearer from inhaling an infective dose of a highly toxic organism.\u003C\/li\u003E\u003C\/ol\u003E\u003Ch3\u003EPractical examples\u003C\/h3\u003E\u003Cp\u003ETwo examples follow. These assume that infectious aerosols are generated only during vomiting, diarrhea, coughing, sneezing, or similar high-energy emissions such as some medical procedures. It is possible that Ebola virus may be shed as an aerosol in other manners not considered.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the early stages of disease (no bleeding, vomiting, diarrhea, coughing, sneezing, etc).\u003C\/em\u003E\u003C\/strong\u003E In this case, the generation rate is 1. For any level of control (less than 3 to more than 12 ACH), the control banding wheel indicates a respirator protection level of 1 (APF of 10), which corresponds to an air purifying (negative pressure) half-facepiece respirator such as an N95 filtering facepiece respirator. This type of respirator requires fit testing.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the later stages of disease (bleeding, vomiting, diarrhea, etc).\u003C\/em\u003E \u003C\/strong\u003EIf we assume the highest generation rate (4) and a standard patient room (control level = 2, 3-6 ACH), a respirator with an APF of at least 50 is needed. In the United States, this would be equivalent to either a full-facepiece air-purifying (negative-pressure) respirator or a half-facepiece PAPR (positive pressure), but standards differ in other countries. Fit testing is required for these types of respirators.\u003C\/p\u003E\u003Cp\u003EThe control level (room ventilation) can have a big effect on respirator selection. For the same patient housed in a negative-pressure airborne infection isolation room (6-12 ACH), a respirator with an assigned protection factor of 25 is required. This would correspond in the United States to a PAPR with a loose-fitting facepiece or with a helmet or hood. This type of respirator does not need fit testing.\u003C\/p\u003E\u003Ch3\u003EImplications for protecting health workers in Africa\u003C\/h3\u003E\u003Cp\u003EHealthcare workers have experienced very high rates of morbidity and mortality in the past and current Ebola virus outbreaks. A facemask, or surgical mask, offers no or very minimal protection from infectious aerosol particles. As our examples illustrate, for a risk group 4 organism like Ebola, the minimum level of protection should be an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003EThis type of respirator, however, would only be appropriate only when the likelihood of aerosol exposure is very low. For healthcare workers caring for many patients in an epidemic situation, this type of respirator may not provide an adequate level of protection.\u003C\/p\u003E\u003Cp\u003EFor a risk group 4 organism, any activity that has the potential for aerosolizing liquid body fluids, such as medical or disinfection procedures, should be avoided, if possible. Our risk assessment indicates that a PAPR with a full facepiece (APF = 50) or a hood or helmet (APF = 25) would be a better choice for patient care during epidemic conditions.\u003C\/p\u003E\u003Cp\u003EWe recognize that PAPRs present some logistical and infection-control problems. Batteries require frequent charging (which requires a reliable source of electricity), and the entire ensemble requires careful handling and disinfection between uses. A PAPR is also more expensive to buy and maintain than other types of respirators.\u003C\/p\u003E\u003Cp\u003EOn the other hand, a PAPR with a loose-fitting facepiece (hood or helmet) does not require fit testing. Wearing this type of respirator minimizes the need for other types of PPE, such as head coverings and goggles. And, most important, it is much more comfortable to wear than a negative-pressure respirator like an N95, especially in hot environments.\u003C\/p\u003E\u003Cp\u003EA recent report from a Medecins Sans Frontieres healthcare worker in Sierra Leone\u003Csup\u003E30\u003C\/sup\u003E notes that healthcare workers cannot tolerate the required PPE for more than 40 minutes. Exiting the workplace every 40 minutes requires removal and disinfection or disposal (burning) of all PPE. A PAPR would allow much longer work periods, use less PPE, require fewer doffing episodes, generate less infectious waste, and be more protective. In the long run, we suspect this type of protection could also be less expensive.\u003C\/p\u003E\u003Ch3\u003EAdequate protection is essential\u003C\/h3\u003E\u003Cp\u003ETo summarize, for the following reasons we believe that Ebola could be an opportunistic aerosol-transmissible disease requiring adequate respiratory protection:\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003EPatients and procedures generate aerosols, and Ebola virus remains viable in aerosols for up to 90 minutes.\u003C\/li\u003E\u003Cli\u003EAll sizes of aerosol particles are easily inhaled both near to and far from the patient.\u003C\/li\u003E\u003Cli\u003ECrowding, limited air exchange, and close interactions with patients all contribute to the probability that healthcare workers will be exposed to high concentrations of very toxic infectious aerosols.\u003C\/li\u003E\u003Cli\u003EEbola targets immune response cells found in all epithelial tissues, including in the respiratory and gastrointestinal system.\u003C\/li\u003E\u003Cli\u003EExperimental data support aerosols as a mode of disease transmission in non-human primates.\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003ERisk level and working conditions suggest that a PAPR will be more protective, cost-effective, and comfortable than an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAcknowledgements\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EWe thank Kathleen Harriman, PhD, MPH, RN, Chief, Vaccine Preventable Diseases Epidemiology Section, Immunization Branch, California Department of Public Health, and Nicole Vars McCullough, PhD, CIH, Manager, Global Technical Services, Personal Safety Division, 3M Company, for their input and review.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EReferences\u003C\/strong\u003E\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003EOberg L, Brosseau LM.\u003C\/strong\u003E Surgical mask filter and fit performance. Am J Infect Control 2008 May;36(4):276-82 [\u003Ca href=\u0022http:\/\/www.ajicjournal.org\/article\/S0196-6553(07)00774-2\/abstract\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECDC.\u003C\/strong\u003E Ebola hemorrhagic fever: transmission. 2014 Aug 13 [\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/index.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EECDC.\u003C\/strong\u003E Outbreak of Ebola virus disease in West Africa: third update, 1 August 2014. Stockholm: ECDC 2014 Aug 1 [\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-outbreak-west-africa-1-august-2014.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMartin-Moreno JM, Llinas G, Hernandez JM.\u003C\/strong\u003E Is respiratory protection appropriate in the Ebola response? Lancet 2014 Sep 6;384(9946):856 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(14)61343-X\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPapineni RS, Rosenthal FS.\u003C\/strong\u003E The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997;10(2):105-16 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10168531\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChao CYH, Wan MP, Morawska L, et al.\u003C\/strong\u003E Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci 2009 Feb;40(2):122-33 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0021850208001882\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ENicas M, Nazaroff WW, Hubbard A.\u003C\/strong\u003E Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg 2005 Mar;2(3):143-54 [\u003Ca href=\u0022http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/15459620590918466?url_ver=Z39.88-2003\u0026amp;rfr_id=ori:rid:crossref.org\u0026amp;rfr_dat=cr_pub%3dpubmed#.VBnXrS5dUZ4\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBauchsch DG, Towner JS, Dowell SF, et al.\u003C\/strong\u003E Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196:S142-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/196\/Supplement_2\/S142.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFormenty P, Leroy EM, Epelboin A, et al.\u003C\/strong\u003E Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006 Jun;42(11):1521-6 [\u003Ca href=\u0022http:\/\/cid.oxfordjournals.org\/content\/42\/11\/1521.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFrancesconi P, Yoti Z, Declich S, et al.\u003C\/strong\u003E Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 2003 Nov;9(11):1430-7 [\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/9\/11\/pdfs\/03-0339.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EDowell SF, Mukunu R, Ksiazek TG, et al.\u003C\/strong\u003E Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of Congo, 1995. J Infect Dis 1999 Feb;179:S87-91 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S87.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoels TH, Bloom AS, Buffington J, et al.\u003C\/strong\u003E Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999 Feb;179:S92-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S92.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKuhl A, Hoffmann M, Muller MA, et al.\u003C\/strong\u003E Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J Infect Dis 2011 Nov;204:S840-9 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/suppl_3\/S840.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EHunt CL, Lennemann NJ, Maury W.\u003C\/strong\u003E Filovirus entry: a novelty in the viral fusion world. Viruses 2012 Feb;4(2):258-75 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3315215\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBray M, Geisbert TW.\u003C\/strong\u003E Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005 Aug;37(8):1560-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s1357272505000725\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMohamadzadeh M, Chen L, Schmaljohn AL.\u003C\/strong\u003E How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 2007 Jul;7(7):556-67 [\u003Ca href=\u0022http:\/\/www.nature.com\/nri\/journal\/v7\/n7\/full\/nri2098.html\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ELindsley WG, Blachere FM, Thewlis RE, et al.\u003C\/strong\u003E Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One 2010 Nov 30;5(11):e15100 [\u003Ca href=\u0022http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0015100\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECaul EO.\u003C\/strong\u003E Small round structured viruses: airborne transmission and hospital control. Lancet 1994 May 21;343(8908):1240-2 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)92146-6\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChadwick PR, Walker M, Rees AE.\u003C\/strong\u003E Airborne transmission of a small round structured virus. Lancet 1994 Jan 15;343(8890):171 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)90959-8\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBest EL, Snadoe JA, Wilcox MH.\u003C\/strong\u003E Potential for aerosolization of \u003Cem\u003EClostridium difficile\u003C\/em\u003E after flushing toilets: the role of toilet lids in reducing environmental contamination. J Hosp Infect 2012 Jan;80(1):1-5 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s0195670111003392\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EGerba CP, Wallis C, Melnick JL.\u003C\/strong\u003E Microbiological hazards of household toilets: droplet production and the fate of residual organisms. Appl Microbiol 1975 Aug;30(2):229-37 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC187159\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBarker J, Jones MV.\u003C\/strong\u003E The potential spread of infection caused by aerosol contamination of surfaces after flushing a domestic toilet. J Appl Microbiol 2005;99(2):339-47 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2005.02610.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPiercy TJ, Smither SJ, Steward JA, et al.\u003C\/strong\u003E The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 2010 Nov;109(5):1531-9 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2010.04778.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EJaax N, Jahrling P, Geisbert T, et al.\u003C\/strong\u003E Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995 Dec 23-30;346(8991-2):1669-71 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8551825\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKobinger GP, Leung A, Neufeld J, et al.\u003C\/strong\u003E Replication, pathogenicity, shedding and transmission of Zaire ebolavirus in pigs. J Infect Dis 2011 Jul 15;204(2):200-8 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/2\/200.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWeingartl HM, Embury-Hyatt C, Nfon C, et al.\u003C\/strong\u003E Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2012;2:811 [\u003Ca href=\u0022http:\/\/www.nature.com\/srep\/2012\/121115\/srep00811\/full\/srep00811.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EReed DS, Lackemeyer MG, Garza NL, et al.\u003C\/strong\u003E Aerosol exposure to Zaire Ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microb Infect 2011 Oct;13(11):930-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1286457911001225\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoy CJ, Milton DK.\u003C\/strong\u003E Airborne transmission of communicable infection\u2014the elusive pathway. N Engl J Med 2004 Apr;350(17):1710-2 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp048051\u0022\u003EPreview\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECanadian Standards Association.\u003C\/strong\u003E Selection, use and care of respirators. CAN\/CSA Z94.4-11\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWolz A.\u003C\/strong\u003E Face to face with Ebola\u2014an emergency care center in Sierra Leone. (Perspective) N Engl J Med 2014 Aug 27 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmp1410179\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003C\/ol\u003E","format":"full_html","safe_value":"\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note \u003Cstrong\u003E\u003Cem\u003E(Oct 16)\u003C\/em\u003E\u003C\/strong\u003E:\u00a0 \u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003ESee the \u003C\/em\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/response-statements-falsely-attributed-cidrap-regarding-ebola-transmission\u0022 target=\u0022_blank\u0022\u003E statement\u003C\/a\u003E released today by CIDRAP related to this commentary.\u003C\/em\u003E\u003Cstrong\u003E\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note (Sep 17):\u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003E Today\u0027s commentary was submitted to CIDRAP by the authors, who are national experts on respiratory protection and infectious disease transmission. In May they published a \u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003E\u003Cem\u003Esimilar commentary on MERS-CoV\u003C\/em\u003E\u003C\/a\u003E\u003Cem\u003E. Dr Brosseau is a Professor and Dr Jones an Assistant Professor in the School of Public Health, Division of Environmental and Occupational Health Sciences, at the University of Illinois at Chicago.\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003E\u003Cstrong\u003EAuthors\u0027 disclaimer:\u003C\/strong\u003E\u003C\/em\u003E\u003Cem\u003E This commentary reflects the personal opinions of the authors. It does not represent the opinion of the University of Illinois at Chicago or any other organization. The authors have not received any compensation for the preparation of this commentary or any associated public statements. The authors do not endorse any specific manufacturer or brand of personal protective equipment (PPE) and have no direct or indirect financial interest in the use of a specific brand of PPE. In the past one or both of the authors have received research funding from numerous government agencies and organizations, including 3M.\u003C\/em\u003E\u003C\/p\u003E\u003Chr \/\u003E\u003Cp\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cdiv\u003EHealthcare workers play a very important role in the successful containment of outbreaks of infectious diseases like Ebola. The correct type and level of personal protective equipment (PPE) ensures that healthcare workers remain healthy throughout an outbreak\u2014and with the current rapidly expanding Ebola outbreak in West Africa, it\u0027s imperative to favor more conservative measures.\u003C\/div\u003E\u003Cdiv\u003E\u00a0\u003C\/div\u003E\u003Cdiv\u003EThe precautionary principle\u2014that any action designed to reduce risk should not await scientific certainty\u2014compels the use of respiratory protection for a pathogen like Ebola virus that has:\u003C\/div\u003E\u003Cdiv\u003E\u00a0\u003C\/div\u003E\u003Cul\u003E\u003Cli\u003ENo proven pre- or post-exposure treatment modalities\u003C\/li\u003E\u003Cli\u003EA high case-fatality rate\u003C\/li\u003E\u003Cli\u003EUnclear modes of transmission\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003EWe believe there is scientific and epidemiologic evidence that Ebola virus has the potential to be transmitted via infectious aerosol particles both near and at a distance from infected patients, which means that healthcare workers should be wearing respirators, not facemasks.\u003Csup\u003E1\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EThe minimum level of protection in high-risk settings should be a respirator with an assigned protection factor greater than 10. A powered air-purifying respirator (PAPR) with a hood or helmet offers many advantages over an N95 filtering facepiece or similar respirator, being more protective, comfortable, and cost-effective in the long run.\u003C\/p\u003E\u003Cp\u003EWe strongly urge the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to seek funds for the purchase and transport of PAPRs to all healthcare workers currently fighting the battle against Ebola throughout Africa\u2014and beyond.\u003C\/p\u003E\u003Cp\u003EThere has been a lot of on-line and published controversy about whether Ebola virus can be transmitted via aerosols. Most scientific and medical personnel, along with public health organizations, have been unequivocal in their statements that Ebola can be transmitted only by direct contact with virus-laden fluids\u003Csup\u003E2,3\u003C\/sup\u003E and that the only modes of transmission we should be concerned with are those termed \u0022droplet\u0022 and \u0022contact.\u0022\u003C\/p\u003E\u003Cp\u003EThese statements are based on two lines of reasoning. The first is that no one located at a distance from an infected individual has contracted the disease, or the converse, every person infected has had (or must have had) \u0022direct\u0022 contact with the body fluids of an infected person.\u003C\/p\u003E\u003Cp\u003EThis reflects an incorrect and outmoded understanding of infectious aerosols, which has been institutionalized in policies, language, culture, and approaches to infection control. We will address this below. Briefly, however, the important points are that virus-laden bodily fluids may be aerosolized and inhaled while a person is in proximity to an infectious person and that a wide range of particle sizes can be inhaled and deposited throughout the respiratory tract.\u003C\/p\u003E\u003Cp\u003EThe second line of reasoning is that respirators or other control measures for infectious aerosols cannot be recommended in developing countries because the resources, time, and\/or understanding for such measures are lacking.\u003Csup\u003E4\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAlthough there are some important barriers to the use of respirators, especially PAPRs, in developing countries, healthcare workers everywhere deserve and should be afforded the same best-practice types of protection, regardless of costs and resources. Every healthcare worker is a precious commodity whose well-being ensures everyone is protected.\u003C\/p\u003E\u003Cp\u003EIf we are willing to offer infected US healthcare workers expensive treatments and experimental drugs free of charge when most of the world has no access to them, we wonder why we are unwilling to find the resources to provide appropriate levels of comparatively less expensive respiratory protection to every healthcare worker around the world.\u003C\/p\u003E\u003Ch3\u003EHow are infectious diseases transmitted via aerosols?\u003C\/h3\u003E\u003Cp\u003EMedical and infection control professionals have relied for years on a paradigm for aerosol transmission of infectious diseases based on very outmoded research and an overly simplistic interpretation of the data. In the 1940s and 50s, William F. Wells and other \u0022aerobiologists\u0022 employed now significantly out-of-date sampling methods (eg, settling plates) and very blunt analytic approaches (eg, cell culturing) to understand the movement of bacterial aerosols in healthcare and other settings. Their work, though groundbreaking at the time, provides a very incomplete picture.\u003C\/p\u003E\u003Cp\u003EEarly aerobiologists were not able to measure small particles near an infectious person and thus assumed such particles existed only far from the source. They concluded that organisms capable of aerosol transmission (termed \u0022airborne\u0022) can only do so at around 3 feet or more from the source. Because they thought that only larger particles would be present near the source, they believed people would be exposed only via large \u0022droplets\u0022 on their face, eyes, or nose.\u003C\/p\u003E\u003Cp\u003EModern research, using more sensitive instruments and analytic methods, has shown that aerosols emitted from the respiratory tract contain a wide distribution of particle sizes\u2014including many that are small enough to be inhaled.\u003Csup\u003E5,6\u003C\/sup\u003E Thus, both small and large particles will be present near an infectious person.\u003C\/p\u003E\u003Cp\u003EThe chance of large droplets reaching the facial mucous membranes is quite small, as the nasal openings are small and shielded by their external and internal structure. Although close contact may permit large-droplet exposure, it also maximizes the possibility of aerosol inhalation.\u003C\/p\u003E\u003Cp\u003EAs noted by early aerobiologists, liquid in a spray aerosol, such as that generated during coughing or sneezing, will quickly evaporate,\u003Csup\u003E7\u003C\/sup\u003E which increases the concentration of small particles in the aerosol. Because evaporation occurs in milliseconds, many of these particles are likely to be found near the infectious person.\u003C\/p\u003E\u003Cp\u003EThe current paradigm also assumes that only \u0022small\u0022 particles (less than 5 micrometers [mcm]) can be inhaled and deposited in the respiratory tract. This is not true. Particles as large as 100 mcm (and perhaps even larger) can be inhaled into the mouth and nose. Larger particles are deposited in the nasal passages, pharynx, and upper regions of the lungs, while smaller particles are more likely to deposit in the lower, alveolar regions. And for many pathogens, infection is possible regardless of the particle size or deposition site.\u003C\/p\u003E\u003Cp\u003EIt\u0027s time to abandon the old paradigm of three mutually exclusive transmission routes for a new one that considers the full range of particle sizes both near and far from a source. In addition, we need to factor in other important features of infectivity, such as the ability of a pathogen to remain viable in air at room temperature and humidity and the likelihood that systemic disease can result from deposition of infectious particles in the respiratory system or their transfer to the gastrointestinal tract.\u003C\/p\u003E\u003Cp\u003EWe recommend using \u0022aerosol transmissible\u0022 rather than the outmoded terms \u0022droplet\u0022 or \u0022airborne\u0022 to describe pathogens that can transmit disease via infectious particles suspended in air.\u003C\/p\u003E\u003Ch3\u003EIs Ebola an aerosol-transmissible disease?\u003C\/h3\u003E\u003Cp\u003EWe recently published a \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003Ecommentary\u003C\/a\u003E on the CIDRAP site discussing whether Middle East respiratory syndrome (MERS) could be an aerosol-transmissible disease, especially in healthcare settings. We drew comparisons with a similar and more well-studied disease, severe acute respiratory syndrome (SARS).\u003C\/p\u003E\u003Cp\u003EFor Ebola and other filoviruses, however, there is much less information and research on disease transmission and survival, especially in healthcare settings.\u003C\/p\u003E\u003Cp\u003EBeing at first skeptical that Ebola virus could be an aerosol-transmissible disease, we are now persuaded by a review of experimental and epidemiologic data that this might be an important feature of disease transmission, particularly in healthcare settings.\u003C\/p\u003E\u003Ch3\u003EWhat do we know about Ebola transmission?\u003C\/h3\u003E\u003Cp\u003ENo one knows for certain how Ebola virus is transmitted from one person to the next. The virus has been found in the saliva, stool, breast milk, semen, and blood of infected persons.\u003Csup\u003E8,9\u003C\/sup\u003E Studies of transmission in Ebola virus outbreaks have identified activities like caring for an infected person, sharing a bed, funeral activities, and contact with blood or other body fluids to be key risk factors for transmission.\u003Csup\u003E10-12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EOn the basis of epidemiologic evidence, it has been presumed that Ebola viruses are transmitted by contaminated hands in contact with the mouth or eyes or broken skin or by splashes or sprays of body fluids into these areas. Ebola viruses appear to be capable of initiating infection in a variety of human cell types,\u003Csup\u003E13,14\u003C\/sup\u003E but the primary portal or portals of entry into susceptible hosts have not been identified.\u003C\/p\u003E\u003Cp\u003ESome pathogens are limited in the cell type and location they infect. Influenza, for example, is generally restricted to respiratory epithelial cells, which explains why flu is primarily a respiratory infection and is most likely aerosol transmissible. HIV infects T-helper cells in the lymphoid tissues and is primarily a bloodborne pathogen with low probability for transmission via aerosols.\u003C\/p\u003E\u003Cp\u003EEbola virus, on the other hand, is a broader-acting and more non-specific pathogen that can impede the proper functioning of macrophages and dendritic cells\u2014immune response cells located throughout the epithelium.\u003Csup\u003E15,16\u003C\/sup\u003E Epithelial tissues are found throughout the body, including in the respiratory tract. Ebola prevents these cells from carrying out their antiviral functions but does not interfere with the initial inflammatory response, which attracts additional cells to the infection site. The latter contribute to further dissemination of the virus and similar adverse consequences far beyond the initial infection site.\u003C\/p\u003E\u003Cp\u003EThe potential for transmission via inhalation of aerosols, therefore, cannot be ruled out by the observed risk factors or our knowledge of the infection process. Many body fluids, such as vomit, diarrhea, blood, and saliva, are capable of creating inhalable aerosol particles in the immediate vicinity of an infected person. Cough was identified among some cases in a 1995 outbreak in Kikwit, Democratic Republic of the Congo,\u003Csup\u003E11\u003C\/sup\u003E and coughs are known to emit viruses in respirable particles.\u003Csup\u003E17\u003C\/sup\u003E The act of vomiting produces an aerosol and has been implicated in airborne transmission of gastrointestinal viruses.\u003Csup\u003E18,19\u003C\/sup\u003E Regarding diarrhea, even when contained by toilets, toilet flushing emits a pathogen-laden aerosol that disperses in the air.\u003Csup\u003E20-22\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EExperimental work has shown that Marburg and Ebola viruses can be isolated from sera and tissue culture medium at room temperature for up to 46 days, but at room temperature no virus was recovered from glass, metal, or plastic surfaces.\u003Csup\u003E23\u003C\/sup\u003E Aerosolized (1-3 mcm) Marburg, Ebola, and Reston viruses, at 50% to 55% relative humidity and 72\u00b0F, had biological decay rates of 3.04%, 3.06%. and 1.55% per minute, respectively. These rates indicate that 99% loss in aerosol infectivity would occur in 93, 104, and 162 minutes, respectively.\u003Csup\u003E23\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EIn still air, 3-mcm particles can take up to an hour to settle. With air currents, these and smaller particles can be transported considerable distances before they are deposited on a surface.\u003C\/p\u003E\u003Cp\u003EThere is also some experimental evidence that Ebola and other filoviruses can be transmitted by the aerosol route. Jaax et al\u003Csup\u003E24\u003C\/sup\u003E reported the unexpected death of two rhesus monkeys housed approximately 3 meters from monkeys infected with Ebola virus, concluding that respiratory or eye exposure to aerosols was the only possible explanation.\u003C\/p\u003E\u003Cp\u003EZaire Ebola viruses have also been transmitted in the absence of direct contact among pigs\u003Csup\u003E25\u003C\/sup\u003E and from pigs to non-human primates,\u003Csup\u003E26\u003C\/sup\u003E which experienced lung involvement in infection. Persons with no known direct contact with Ebola virus disease patients or their bodily fluids have become infected.\u003Csup\u003E12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EDirect injection and exposure via a skin break or mucous membranes are the most efficient ways for Ebola to transmit. It may be that inhalation is a less efficient route of transmission for Ebola and other filoviruses, as lung involvement has not been reported in all non-human primate studies of Ebola aerosol infectivity.\u003Csup\u003E27\u003C\/sup\u003E However, the respiratory and gastrointestinal systems are not complete barriers to Ebola virus. Experimental studies have demonstrated that it is possible to infect non-human primates and other mammals with filovirus aerosols.\u003Csup\u003E25-27\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAltogether, these epidemiologic and experimental data offer enough evidence to suggest that Ebola and other filoviruses may be opportunistic with respect to aerosol transmission.\u003Csup\u003E28\u003C\/sup\u003E That is, other routes of entry may be more important and probable, but, given the right conditions, it is possible that transmission could also occur via aerosols.\u003C\/p\u003E\u003Cp\u003EGuidance from the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003ECDC\u003C\/a\u003E and \u003Ca href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EWHO\u003C\/a\u003E recommends the use of facemasks for healthcare workers providing routine care to patients with Ebola virus disease and respirators when aerosol-generating procedures are performed. (Interestingly, the 1998 WHO and CDC infection-control guidance for viral hemorrhagic fevers in Africa, still available on the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/abroad\/pdf\/african-healthcare-setting-vhf.pdf\u0022\u003ECDC Web site\u003C\/a\u003E, recommends the use of respirators.)\u003C\/p\u003E\u003Cp\u003EFacemasks, however, do not offer protection against inhalation of small infectious aerosols, because they lack adequate filters and do not fit tightly against the face.\u003Csup\u003E1\u003C\/sup\u003E Therefore, a higher level of protection is necessary.\u003C\/p\u003E\u003Ch3\u003EWhich respirator to wear?\u003C\/h3\u003E\u003Cp\u003EAs described in our earlier \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003ECIDRAP commentary\u003C\/a\u003E, we can use a Canadian control-banding approach to select the most appropriate respirator for exposures to Ebola in healthcare settings.\u003Csup\u003E29\u003C\/sup\u003E (See \u003Ca href=\u0022http:\/\/www.isrp.com\/americas\/docs\/st_paul_2011\/mehes_use_care_standard.pdf\u0022\u003Ethis document\u003C\/a\u003E for a detailed description of the Canadian control banding approach and the data used to select respirators in our examples below.)\u003C\/p\u003E\u003Cp\u003EThe control banding method involves the following steps:\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the organism\u0027s risk group (1 to 4).\u003C\/em\u003E\u003C\/strong\u003E Risk group reflects the toxicity of an organism, including the degree and type of disease and whether treatments are available. Ebola is in risk group 4, the most toxic organisms, because it can cause serious human or animal disease, is easily transmitted, directly or indirectly, and currently has no effective treatments or preventive measures.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the generation rate.\u003C\/em\u003E\u003C\/strong\u003E The rate of aerosol generation reflects the number of particles created per time (eg, particles per second). Some processes, such as coughing, create more aerosols than others, like normal breathing. Some processes, like intubation and toilet flushing, can rapidly generate very large quantities of aerosols. The control banding approach assigns a qualitative rank ranging from low (1) to high (4) (eg, normal breathing without coughing has a rank of 1).\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the level of control.\u003C\/em\u003E\u003C\/strong\u003E Removing contaminated air and replacing it with clean air, as accomplished with a ventilation system, is effective for lowering the overall concentration of infectious aerosol particles in a space, although it may not be effective at lowering concentration in the immediate vicinity of a source. The number of air changes per hour (ACH) reflects the rate of air removal and replacement. This is a useful variable, because it is relatively easy to measure and, for hospitals, reflects building code requirements for different types of rooms. Again, a qualitative ranking is used to reflect low (1) versus high (4) ACH. Even if the true ventilation rate is not known, the examples can be used to select an appropriate air exchange rate.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the respirator assigned protection factor.\u003C\/em\u003E\u003C\/strong\u003E Respirators are designated by their \u0022class,\u0022 each of which has an assigned protection factor (APF) that reflects the degree of protection. The APF represents the outside, environmental concentration divided by the inside, facepiece concentration. An APF of 10 means that the outside concentration of a particular contaminant will be 10 times greater than that inside the respirator. If the concentration outside the respirator is very high, an assigned protection factor of 10 may not prevent the wearer from inhaling an infective dose of a highly toxic organism.\u003C\/li\u003E\u003C\/ol\u003E\u003Ch3\u003EPractical examples\u003C\/h3\u003E\u003Cp\u003ETwo examples follow. These assume that infectious aerosols are generated only during vomiting, diarrhea, coughing, sneezing, or similar high-energy emissions such as some medical procedures. It is possible that Ebola virus may be shed as an aerosol in other manners not considered.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the early stages of disease (no bleeding, vomiting, diarrhea, coughing, sneezing, etc).\u003C\/em\u003E\u003C\/strong\u003E In this case, the generation rate is 1. For any level of control (less than 3 to more than 12 ACH), the control banding wheel indicates a respirator protection level of 1 (APF of 10), which corresponds to an air purifying (negative pressure) half-facepiece respirator such as an N95 filtering facepiece respirator. This type of respirator requires fit testing.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the later stages of disease (bleeding, vomiting, diarrhea, etc).\u003C\/em\u003E \u003C\/strong\u003EIf we assume the highest generation rate (4) and a standard patient room (control level = 2, 3-6 ACH), a respirator with an APF of at least 50 is needed. In the United States, this would be equivalent to either a full-facepiece air-purifying (negative-pressure) respirator or a half-facepiece PAPR (positive pressure), but standards differ in other countries. Fit testing is required for these types of respirators.\u003C\/p\u003E\u003Cp\u003EThe control level (room ventilation) can have a big effect on respirator selection. For the same patient housed in a negative-pressure airborne infection isolation room (6-12 ACH), a respirator with an assigned protection factor of 25 is required. This would correspond in the United States to a PAPR with a loose-fitting facepiece or with a helmet or hood. This type of respirator does not need fit testing.\u003C\/p\u003E\u003Ch3\u003EImplications for protecting health workers in Africa\u003C\/h3\u003E\u003Cp\u003EHealthcare workers have experienced very high rates of morbidity and mortality in the past and current Ebola virus outbreaks. A facemask, or surgical mask, offers no or very minimal protection from infectious aerosol particles. As our examples illustrate, for a risk group 4 organism like Ebola, the minimum level of protection should be an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003EThis type of respirator, however, would only be appropriate only when the likelihood of aerosol exposure is very low. For healthcare workers caring for many patients in an epidemic situation, this type of respirator may not provide an adequate level of protection.\u003C\/p\u003E\u003Cp\u003EFor a risk group 4 organism, any activity that has the potential for aerosolizing liquid body fluids, such as medical or disinfection procedures, should be avoided, if possible. Our risk assessment indicates that a PAPR with a full facepiece (APF = 50) or a hood or helmet (APF = 25) would be a better choice for patient care during epidemic conditions.\u003C\/p\u003E\u003Cp\u003EWe recognize that PAPRs present some logistical and infection-control problems. Batteries require frequent charging (which requires a reliable source of electricity), and the entire ensemble requires careful handling and disinfection between uses. A PAPR is also more expensive to buy and maintain than other types of respirators.\u003C\/p\u003E\u003Cp\u003EOn the other hand, a PAPR with a loose-fitting facepiece (hood or helmet) does not require fit testing. Wearing this type of respirator minimizes the need for other types of PPE, such as head coverings and goggles. And, most important, it is much more comfortable to wear than a negative-pressure respirator like an N95, especially in hot environments.\u003C\/p\u003E\u003Cp\u003EA recent report from a Medecins Sans Frontieres healthcare worker in Sierra Leone\u003Csup\u003E30\u003C\/sup\u003E notes that healthcare workers cannot tolerate the required PPE for more than 40 minutes. Exiting the workplace every 40 minutes requires removal and disinfection or disposal (burning) of all PPE. A PAPR would allow much longer work periods, use less PPE, require fewer doffing episodes, generate less infectious waste, and be more protective. In the long run, we suspect this type of protection could also be less expensive.\u003C\/p\u003E\u003Ch3\u003EAdequate protection is essential\u003C\/h3\u003E\u003Cp\u003ETo summarize, for the following reasons we believe that Ebola could be an opportunistic aerosol-transmissible disease requiring adequate respiratory protection:\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003EPatients and procedures generate aerosols, and Ebola virus remains viable in aerosols for up to 90 minutes.\u003C\/li\u003E\u003Cli\u003EAll sizes of aerosol particles are easily inhaled both near to and far from the patient.\u003C\/li\u003E\u003Cli\u003ECrowding, limited air exchange, and close interactions with patients all contribute to the probability that healthcare workers will be exposed to high concentrations of very toxic infectious aerosols.\u003C\/li\u003E\u003Cli\u003EEbola targets immune response cells found in all epithelial tissues, including in the respiratory and gastrointestinal system.\u003C\/li\u003E\u003Cli\u003EExperimental data support aerosols as a mode of disease transmission in non-human primates.\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003ERisk level and working conditions suggest that a PAPR will be more protective, cost-effective, and comfortable than an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAcknowledgements\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EWe thank Kathleen Harriman, PhD, MPH, RN, Chief, Vaccine Preventable Diseases Epidemiology Section, Immunization Branch, California Department of Public Health, and Nicole Vars McCullough, PhD, CIH, Manager, Global Technical Services, Personal Safety Division, 3M Company, for their input and review.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EReferences\u003C\/strong\u003E\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003EOberg L, Brosseau LM.\u003C\/strong\u003E Surgical mask filter and fit performance. Am J Infect Control 2008 May;36(4):276-82 [\u003Ca href=\u0022http:\/\/www.ajicjournal.org\/article\/S0196-6553(07)00774-2\/abstract\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECDC.\u003C\/strong\u003E Ebola hemorrhagic fever: transmission. 2014 Aug 13 [\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/index.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EECDC.\u003C\/strong\u003E Outbreak of Ebola virus disease in West Africa: third update, 1 August 2014. Stockholm: ECDC 2014 Aug 1 [\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-outbreak-west-africa-1-august-2014.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMartin-Moreno JM, Llinas G, Hernandez JM.\u003C\/strong\u003E Is respiratory protection appropriate in the Ebola response? Lancet 2014 Sep 6;384(9946):856 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(14)61343-X\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPapineni RS, Rosenthal FS.\u003C\/strong\u003E The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997;10(2):105-16 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10168531\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChao CYH, Wan MP, Morawska L, et al.\u003C\/strong\u003E Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci 2009 Feb;40(2):122-33 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0021850208001882\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ENicas M, Nazaroff WW, Hubbard A.\u003C\/strong\u003E Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg 2005 Mar;2(3):143-54 [\u003Ca href=\u0022http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/15459620590918466?url_ver=Z39.88-2003\u0026amp;rfr_id=ori:rid:crossref.org\u0026amp;rfr_dat=cr_pub%3dpubmed#.VBnXrS5dUZ4\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBauchsch DG, Towner JS, Dowell SF, et al.\u003C\/strong\u003E Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196:S142-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/196\/Supplement_2\/S142.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFormenty P, Leroy EM, Epelboin A, et al.\u003C\/strong\u003E Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006 Jun;42(11):1521-6 [\u003Ca href=\u0022http:\/\/cid.oxfordjournals.org\/content\/42\/11\/1521.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFrancesconi P, Yoti Z, Declich S, et al.\u003C\/strong\u003E Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 2003 Nov;9(11):1430-7 [\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/9\/11\/pdfs\/03-0339.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EDowell SF, Mukunu R, Ksiazek TG, et al.\u003C\/strong\u003E Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of Congo, 1995. J Infect Dis 1999 Feb;179:S87-91 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S87.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoels TH, Bloom AS, Buffington J, et al.\u003C\/strong\u003E Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999 Feb;179:S92-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S92.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKuhl A, Hoffmann M, Muller MA, et al.\u003C\/strong\u003E Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J Infect Dis 2011 Nov;204:S840-9 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/suppl_3\/S840.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EHunt CL, Lennemann NJ, Maury W.\u003C\/strong\u003E Filovirus entry: a novelty in the viral fusion world. Viruses 2012 Feb;4(2):258-75 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3315215\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBray M, Geisbert TW.\u003C\/strong\u003E Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005 Aug;37(8):1560-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s1357272505000725\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMohamadzadeh M, Chen L, Schmaljohn AL.\u003C\/strong\u003E How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 2007 Jul;7(7):556-67 [\u003Ca href=\u0022http:\/\/www.nature.com\/nri\/journal\/v7\/n7\/full\/nri2098.html\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ELindsley WG, Blachere FM, Thewlis RE, et al.\u003C\/strong\u003E Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One 2010 Nov 30;5(11):e15100 [\u003Ca href=\u0022http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0015100\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECaul EO.\u003C\/strong\u003E Small round structured viruses: airborne transmission and hospital control. Lancet 1994 May 21;343(8908):1240-2 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)92146-6\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChadwick PR, Walker M, Rees AE.\u003C\/strong\u003E Airborne transmission of a small round structured virus. Lancet 1994 Jan 15;343(8890):171 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)90959-8\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBest EL, Snadoe JA, Wilcox MH.\u003C\/strong\u003E Potential for aerosolization of \u003Cem\u003EClostridium difficile\u003C\/em\u003E after flushing toilets: the role of toilet lids in reducing environmental contamination. J Hosp Infect 2012 Jan;80(1):1-5 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s0195670111003392\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EGerba CP, Wallis C, Melnick JL.\u003C\/strong\u003E Microbiological hazards of household toilets: droplet production and the fate of residual organisms. Appl Microbiol 1975 Aug;30(2):229-37 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC187159\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBarker J, Jones MV.\u003C\/strong\u003E The potential spread of infection caused by aerosol contamination of surfaces after flushing a domestic toilet. J Appl Microbiol 2005;99(2):339-47 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2005.02610.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPiercy TJ, Smither SJ, Steward JA, et al.\u003C\/strong\u003E The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 2010 Nov;109(5):1531-9 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2010.04778.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EJaax N, Jahrling P, Geisbert T, et al.\u003C\/strong\u003E Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995 Dec 23-30;346(8991-2):1669-71 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8551825\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKobinger GP, Leung A, Neufeld J, et al.\u003C\/strong\u003E Replication, pathogenicity, shedding and transmission of Zaire ebolavirus in pigs. J Infect Dis 2011 Jul 15;204(2):200-8 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/2\/200.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWeingartl HM, Embury-Hyatt C, Nfon C, et al.\u003C\/strong\u003E Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2012;2:811 [\u003Ca href=\u0022http:\/\/www.nature.com\/srep\/2012\/121115\/srep00811\/full\/srep00811.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EReed DS, Lackemeyer MG, Garza NL, et al.\u003C\/strong\u003E Aerosol exposure to Zaire Ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microb Infect 2011 Oct;13(11):930-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1286457911001225\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoy CJ, Milton DK.\u003C\/strong\u003E Airborne transmission of communicable infection\u2014the elusive pathway. N Engl J Med 2004 Apr;350(17):1710-2 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp048051\u0022\u003EPreview\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECanadian Standards Association.\u003C\/strong\u003E Selection, use and care of respirators. CAN\/CSA Z94.4-11\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWolz A.\u003C\/strong\u003E Face to face with Ebola\u2014an emergency care center in Sierra Leone. (Perspective) N Engl J Med 2014 Aug 27 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmp1410179\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003C\/ol\u003E"}]},"field_image_thumbnail":{"und":[{"fid":"20346","uid":"801","filename":"papr-crop.jpg","uri":"public:\/\/images\/news\/papr-crop_1.jpg","filemime":"image\/jpeg","filesize":"17601","status":"1","timestamp":"1420487195","type":"image","uuid":"186f4ebb-4f53-47e8-8736-7470b2c0fdbb","field_file_image_alt_text":{"und":[{"value":"PAPR - powered air-purifying respirator","format":null,"safe_value":"PAPR - powered air-purifying respirator"}]},"field_file_image_title_text":[],"field_credit":[],"rdf_mapping":[],"metadata":[],"alt":"PAPR - powered air-purifying respirator","title":"","width":"440","height":"398"}]},"field_post":[],"field_teaser":{"und":[{"value":"\u003Cp\u003EWe believe there is scientific and epidemiologic evidence to recommend respirators for all patient care, and a PAPR would be the best option.\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003EWe believe there is scientific and epidemiologic evidence to recommend respirators for all patient care, and a PAPR would be the best option.\u003C\/p\u003E"}]},"field_related_topics":{"und":[{"nid":"64","access":true,"node":{"vid":"300206","uid":"1","title":"Ebola","log":"","status":"1","comment":"1","promote":"0","sticky":"0","vuuid":"f0d62dbd-9604-4f12-ae2e-ca0f89893066","nid":"64","type":"topics","language":"und","created":"1362431979","changed":"1537298807","tnid":"0","translate":"0","uuid":"c4cf9110-8082-4f36-bafd-1b24cedafd8a","revision_timestamp":"1537298807","revision_uid":"71411","field_tab_collection":[],"field_body":[],"field_overview":[],"field_show_topic":{"und":[{"value":"1"}]},"field_related_topics":{"und":[{"nid":"102"},{"nid":"77"}]},"field_ss_media_file":[],"field_last_updated":[],"field_file_attachments":[],"field_synonyms":[],"field_call_action":[],"field_related_links":[],"field_teaser":{"und":[{"value":"\u003Cdiv class=\u0022view-content\u0022\u003E\u003Cdiv class=\u0022views-set\u0022\u003E\u003Cdiv class=\u0022views-rows\u0022\u003E\u003Cdiv class=\u0022views-row views-row-4 views-row-even views-row-last\u0022\u003E\u003Cdiv id=\u0022node-65601\u0022 class=\u0022node node-ss-link node-not-full node-type-ss-link-not-full node-hp-small clearfix\u0022\u003E\u003Cdiv class=\u0022node-inner\u0022\u003E\u003Cdiv class=\u0022content fieldlayout-contents\u0022\u003E\u003Cdiv class=\u0022fieldlayout-body clearfix  fieldlayout-body-has-region-soft-left \u0022\u003E\u003Cdiv class=\u0022 fieldlayout-region-body fieldlayout-region-body-hp-small\u0022\u003E\u003Cdiv class=\u0022field field-name-field-teaser field-type-text-long field-label-hidden\u0022\u003E\u003Cdiv class=\u0022field-items\u0022\u003E\u003Cdiv class=\u0022field-item even\u0022\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E","format":"full_html","safe_value":"\u003Cdiv class=\u0022view-content\u0022\u003E\u003Cdiv class=\u0022views-set\u0022\u003E\u003Cdiv class=\u0022views-rows\u0022\u003E\u003Cdiv class=\u0022views-row views-row-4 views-row-even views-row-last\u0022\u003E\u003Cdiv id=\u0022node-65601\u0022 class=\u0022node node-ss-link node-not-full node-type-ss-link-not-full node-hp-small clearfix\u0022\u003E\u003Cdiv class=\u0022node-inner\u0022\u003E\u003Cdiv class=\u0022content fieldlayout-contents\u0022\u003E\u003Cdiv class=\u0022fieldlayout-body clearfix  fieldlayout-body-has-region-soft-left \u0022\u003E\u003Cdiv class=\u0022 fieldlayout-region-body fieldlayout-region-body-hp-small\u0022\u003E\u003Cdiv class=\u0022field field-name-field-teaser field-type-text-long field-label-hidden\u0022\u003E\u003Cdiv class=\u0022field-items\u0022\u003E\u003Cdiv class=\u0022field-item even\u0022\u003E\u003Cp\u003E\u00a0\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E"}]},"field_roundup_type":{"und":[{"value":"1"}]},"field_subtitle":{"und":[{"value":"\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/infectious-disease-topics\/vhf\u0022\u003ERelated: VHF Overview\u003C\/a\u003E\u003C\/p\u003E\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/ongoing-programs\/ebola-vaccine-team-b\u0022\u003ERelated: Ebola Team B\u0026nbsp;\u003C\/a\u003E\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/infectious-disease-topics\/vhf\u0022\u003ERelated: VHF Overview\u003C\/a\u003E\u003C\/p\u003E\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/ongoing-programs\/ebola-vaccine-team-b\u0022\u003ERelated: Ebola Team B\u00a0\u003C\/a\u003E\u003C\/p\u003E"}]},"field_super_title":{"und":[{"value":"Updated May  29","format":null,"safe_value":"Updated May  29"}]},"field_resources":{"und":[{"value":"\u003Ch4 class=\u0022button float-right\u0022\u003E\u003Ca href=\u0022#lit\u0022\u003EJump to Recent Literature\u003C\/a\u003E\u003C\/h4\u003E\u003Ch4 class=\u0022button\u0022\u003E\u0026nbsp;\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003ELast updated May 29, 2015\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em; font-family: Arial, \u0027Helvetica Neue\u0027, Helvetica, Geneva, sans-serif; font-weight: bold;\u0022\u003ELatest Cases and General Information \u003Cbr \/\u003E\u003Cimg style=\u0022float: right;\u0022 src=\u0022\/sites\/default\/files\/public\/large_ebola.jpg\u0022 alt=\u0022Ebola virus\u0022 width=\u0022283\u0022 height=\u0022283\u0022 \/\u003E\u003C\/span\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150529?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (WHO) (May 29, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/case-counts.html\u0022 target=\u0022_blank\u0022\u003EUpdated case counts\u003C\/a\u003E (CDC) (May 29, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (CDC) (May 1, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E\u0026nbsp; (MSF) (Mar 23, 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm64e0303a2.htm\u0022 target=\u0022_blank\u0022\u003ESystems for rapidly detecting and treating persons with Ebola\u2014US\u003C\/a\u003E (CDC) (Mar 3, 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/screening-travelers.pdf\u0022 target=\u0022_blank\u0022\u003EPreventing Ebola by screening travelers\u003C\/a\u003E (Feb 5 , 2015)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (WHO) (Jan 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/how-talk-children-about-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EHow to talk with your children about Ebola\u003C\/a\u003E (CDC) (Nov 20\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/qas-monitoring-and-movement-guidance.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A on monitoring and movement\u003C\/a\u003E (CDC) (Dec 16\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/infections-spread-by-air-or-droplets.pdf\u0022 target=\u0022_blank\u0022\u003EHow Ebola is Spread\u003C\/a\u003E (\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003ECDC\u003C\/span\u003E) (Nov 1\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/index.html\u0022\u003EWest Africa outbreak page\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E from CDC\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/maimunamajumder.wordpress.com\/tag\/ebola\/\u0022\u003EEbola visualizations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E by Maimuna Majumder, MPH\u003Cbr \/\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebola-virus-disease-evd-2014-west.html\u0022\u003EEbola disease page\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebolavirus-disease-evd-cases-clusters.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EEbola maps\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/healthmap.org\/ebola\/\u0022\u003EEbola outbreak map\u003C\/a\u003E from HealthMap\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/qas-pets.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola and pets\u003C\/a\u003E from CDC (Nov 12, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources for Healthcare Volunteers\u003C\/h4\u003E\u003Cp\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/advice-humanitarian-aid-organizations-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid organizations\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/humanitarian-workers-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid workers\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ENIOSH: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/buddy-system.pdf\u0022 target=\u0022_blank\u0022\u003EThe buddy system\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014) \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137410\/1\/WHO_EVD_Guidance_PPE_14.1_eng.pdf\u0022 target=\u0022_blank\u0022\u003ERapid advice guideline on PPE\u003C\/a\u003E (Oct 2014)\u003Cbr \/\u003EMSF: \u003Ca href=\u0022http:\/\/www.doctorswithoutborders.org\/article\/msf-protocols-staff-returning-ebola-affected-countries\u0022 target=\u0022_blank\u0022\u003EProtocols for staff returning from Ebola-affected countries\u003C\/a\u003E (Oct 23, 2014)\u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/index.html\u0022\u003ESafety training course for healthcare workers in West Africa\u003C\/a\u003E\u0026nbsp;(Oct 6, 2014)\u003Cbr \/\u003ETravel grants for health workers attending CDC training\u0026nbsp; \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/maternal_perinatal\/ebola\/en\/\u0022 target=\u0022_blank\u0022\u003ESafe delivery services for mothers and newborns in Ebola outbreak areas\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003Cem\u003ESee more below under CDC\u003C\/em\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EHealth Agency Documents\u003C\/h4\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWorld Health Organization (WHO)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150511?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (May 11, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/gb\/ebwha\/pdf_files\/WHA68\/A68_25-en.pdf\u0022 target=\u0022_blank\u0022\u003EEbola Interim Assessment Panel: Report by the Secretariat\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (Jan 2015) \u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/statements\/2014\/ebola-travel\/en\/\u0022 target=\u0022_blank\u0022\u003EStatement from Travel and Transport Task Force\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/factsheets\/fs103\/en\/\u0022 target=\u0022_blank\u0022\u003EFact sheet\u003C\/a\u003E \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/en\/\u0022\u003EEbola page \u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/faq-ebola\/en\/\u0022\u003EFrequently asked questions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/evd-guidance-summary\/en\/\u0022\u003EInfection prevention and control guidance summary\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/travel-guidance\/en\/\u0022\u003ETravel and transport risk assessment\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u0026nbsp;\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EClinical management of patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/protective-measures-staff\/en\/\u0022\u003EProtective measures for medical staff\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/event-management-poe\/en\/\u0022\u003EInterim guidance on event management at points of entry\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/ebola-case-definition-contact-en.pdf?ua=1\u0022\u003ECase definition recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 9, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/note-ebola-food-safety\/en\/\u0022\u003EEbola and food safety\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/ebola\/01-october-2014\/en\/\u0022\u003EExperimental vaccines\u003C\/a\u003E (Oct 1, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137096\/1\/WHO_EVD_Preparedness_14_eng.pdf?ua=1\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Checklist\u003C\/a\u003E (Oct 30, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EEbola virus in semen of men recovered from Ebola\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUnited Nations\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/liberia\/liberia-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Liberia\u003C\/a\u003E (Nov 17, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/sierra-leone\/sierra-leone-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Sierra Leone\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/guinea\/guinea-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Guinea\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=ATaQMNYpKoM\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EWorld Food Programme video: Keeping the Ebola crisis from becoming a food crisis\u003C\/a\u003E (Oct 29, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/ebolaresponse.un.org\/un-mission-ebola-emergency-response-unmeer\u0022\u003EUN Mission for Ebola Emergency Response (UNMEER)\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/UNICEF_Ebola_Waste_Management_Guidance_Note_26_09_2014.pdf\u0022\u003EUNICEF waste management guidance\u003C\/a\u003E (Sep 26, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/fao-in-action\/stories\/stories-detail\/en\/c\/251862\/\u0022 target=\u0022_blank\u0022\u003EFAO (Food and Agriculture Organization of the UN) Ebola page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/resources\/documents\/resources-detail\/en\/c\/253869\/\u0022 target=\u0022_blank\u0022\u003EFAO response summary\u003C\/a\u003E (Oct 2014)\u0026nbsp; \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUS Centers for Disease Control and Prevention (CDC)\u003C\/h5\u003E\u003Cp\u003E\u003Cem\u003EGeneral resources \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-liberians-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Liberians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-guineans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Guineans living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-sierra-leoneans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Sierra Leonians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003EGetting to zero (video) (Apr 6, 2015) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022https:\/\/www2c.cdc.gov\/podcasts\/media\/pdf\/3-19-15_EbolaUpdate_Pets.pdf\u0022 target=\u0022_blank\u0022\u003ECDC podcast on risk to pets: transcript\u003C\/a\u003E (Mar 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/families\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for families and loved ones of responders\u003C\/a\u003E (Mar 13, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-safe-school-messages2015.pdf\u0022 target=\u0022_blank\u0022\u003EKey messages for safe school operations in countries with outbreaks of Ebola\u003C\/a\u003E (Feb 25, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/qa-business-travelers.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola for US businesses, employers, and business travelers\u003C\/a\u003E (Feb 23, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/transporting-pediatric-patients.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A re transport of pediatric patients with suspected or confirmed Ebola\u003C\/a\u003E (Feb 2, 2105)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/phlp\/docs\/interim-ebolascreening.pdf\u0022 target=\u0022_blank\u0022\u003EInterim table of state Ebola screening and monitoring policies\u003C\/a\u003E (Jan 8, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm63e1216a1.htm\u0022 target=\u0022_blank\u0022\u003ELatest\u003Cem\u003E MMWR\u003C\/em\u003E update\u003C\/a\u003E (CDC) (Dec 19, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-response-team.pdf\u0022 target=\u0022_blank\u0022\u003EEbola response team fact sheet\u003C\/a\u003E (Dec 2, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/mutations.pdf\u0022 target=\u0022_blank\u0022\u003EWhy Ebola is not likely to become airborne\u003C\/a\u003E (Dec 1, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/\u0022\u003EEbola page\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/qa.html\u0022\u003EQuestions and answers\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 8, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/case-definition.html\u0022\u003ECase definitions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 4, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/index.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWest Africa outbreak page\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003EDemocratic Republic of the Congo outbreak page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/human-transmission.html\u0022 target=\u0022_blank\u0022\u003ESummary of human-to-human transmission\u003C\/a\u003E (Oct 17, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-and-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInformation on cleaning and decontamination\u003C\/a\u003E (Nov 10, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/communication-resources\/index.html\u0022 target=\u0022_blank\u0022\u003ECommunication resources for West African communities\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/information-for-west-africans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EEbola fact sheet for West Africans living in the US\u003C\/a\u003E (Nov 17) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/survivability-ebola-medical-waste.html\u0022 target=\u0022_blank\u0022\u003ESurvivability of Ebola virus in medical waste\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cem\u003EGuidance documents \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EInterim advice on the sexual transmission of Ebola\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E (Apr 8, 2015) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/laboratories\/safe-specimen-management.html\u0022 target=\u0022_blank\u0022\u003E\u003Cbr \/\u003EGuidance for US labs for managing and testing clinical specimens when there is concern about Ebola\u003C\/a\u003E (Feb 3, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/flu.html\u0022 target=\u0022_blank\u0022\u003EInterim recommendations for flu vaccination and post-exposure chemoprophylaxis in people being monitored for potential Ebola virus exposure\u003C\/a\u003E (Jan 26, 2015)\u003Cspan\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/business-travelers.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US businesses, employers, and business travelers to prevent Ebola exposure\u003C\/a\u003E (Jan 23, 2015) \u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/bury-body-safely.pdf\u0022 target=\u0022_blank\u0022\u003EEbola must go: bury all dead bodies safely\u003C\/a\u003E (Dec 23, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/ebola-associated-waste.html\u0022 target=\u0022_blank\u0022\u003EProcedures for safe handling and management of Ebola-associated waste\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for handling untreated sewage from Ebola patients in the US\u003C\/a\u003E (Nov 20\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022\u003EFAQs on interim guidance for managers and workers handling untreated sewage from suspected or confirmed individuals with Ebola in the US\u003C\/a\u003E (Dec 16, 2014) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-emergency-medical-services-systems-911-public-safety-answering-points-management-patients-known-suspected-united-states.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for EMS and 911 systems\u003C\/a\u003E (Dec 2, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-maternal-health.html\u0022 target=\u0022_blank\u0022\u003EScreening and caring for pregnant Ebola patients\u003C\/a\u003E (Nov 12\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/residental-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for residence decontamination and removal of contaminated waste\u003C\/a\u003E (Nov 3, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/monitoring-and-movement-of-persons-with-exposure.html\u0022 target=\u0022_blank\u0022\u003ERevised interim guidance for monitoring and movement of people with potential Ebola exposure\u003C\/a\u003E (Oct 27, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1027-monitoring-symptoms-controlling-movement.html\u0022 target=\u0022_blank\u0022\u003EMonitoring symptoms and controlling movement to stop the spread of Ebola\u003C\/a\u003E (Oct 27)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procedures-for-ppe.html\u0022 target=\u0022_blank\u0022\u003EGuidance for donning and doffing PPE\u003C\/a\u003E (Oct 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/limiting-heat-burden.html\u0022 target=\u0022_self\u0022\u003EInterim guidance for limiting heat burden when wearing PPE\u003C\/a\u003E (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-specimen-collection-submission-patients-suspected-infection-ebola.html\u0022\u003EInterim guidance for specimen collection\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/select-agent-regulations.html\u0022\u003EInterim guidance on compliance with select agent regulations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-safe-handling-human-remains-ebola-patients-us-hospitals-mortuaries.html\u0022\u003EGuidance for safe handling of human remains of Ebola patients\u003C\/a\u003E\u003Cspan\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/environmental-infection-control-in-hospitals.html\u0022\u003EInterim guidance for environmental infection control in hospitals\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003C\/span\u003E \u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003EResources for healthcare workers \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/training-toolkit.html\u0022 target=\u0022_blank\u0022\u003EPreparing healthcare workers to work in Ebola treatment units in Africa: Training toolkit announcement\u003C\/a\u003E (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/emergency-department-training.html\u0022 target=\u0022_blank\u0022\u003EEbola preparedness: Emergency Department training modules\u003C\/a\u003E (Feb 17, 2015)\u003Cbr \/\u003ENon-CDC lab resources for Ebola (Jan 30, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/ppe\/supplies.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for US healthcare facilities to ensure adequate supplies of PPE for Ebola preparedness\u003C\/a\u003E (Dec 31, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/preparing-frontline-healthcare-facilities.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for frontline US healthcare facilities for potential Ebola patients\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/us-hospital-preparedness.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US hospitals for potential Ebola patients: a tiered approach\u003C\/a\u003E (Dec 2, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/hand-hygiene.html\u0022 target=\u0022_blank\u0022\u003EHand hygiene in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/mixing-chlorine-solutions.html\u0022 target=\u0022_blank\u0022\u003EMixing and using chlorine solutions in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.youtube.com\/watch?v=8y19h1hecgY\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003ERespiratory protection video\u003C\/a\u003E (Nov 10, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/qa-infection-control-general-healthcare-widespread-ebola-transmission.html\u0022 target=\u0022_blank\u0022\u003EInfection control in countries with widespread Ebola\u003C\/a\u003E (Nov 3) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ambulatory-care-evaluation-of-patients-with-possible-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EAlgorithm for ambulatory care evaluation of patients with possible Ebola\u003C\/a\u003E (Oct 31, 2014)\u0026nbsp;\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/considerations-discharging-pui.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for discharging persons under investigation for Ebola\u003C\/a\u003E (Oct 30) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/ed-management-patients-possible-ebola.html\u0022 target=\u0022_blank\u0022\u003EAlgorithm for emergency department management of patients with suspected Ebola\u003C\/a\u003E (Oct 27, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1014-ebola-investigation-fact-sheet.html\u0022 target=\u0022_blank\u0022\u003EFact sheet on hospital preparedness\u003C\/a\u003E (Oct 14, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/caring-for-ebola-suspects.html\u0022 target=\u0022_blank\u0022\u003ECaring for patients under investigation for Ebola\u003C\/a\u003E (Oct 20, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/clinician-information-us-healthcare-settings.html\u0022\u003EDisease information for clinicians\u003C\/a\u003E\u003Cspan\u003E (Oct 4, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-facility-checklist-for-ebola.pdf\u0022\u003EHealthcare facility preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-provider-checklist-for-ebola.pdf\u0022\u003EHealthcare provider preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ems-checklist-ebola-preparedness.pdf\u0022\u003EEMS checklist for Ebola preparedness\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/coalition-checklist-ebola-preparedness.pdf\u0022\u003EChecklist for healthcare coalitions for Ebola preparedness\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/index.html\u0022\u003EInformation for healthcare workers\u003C\/a\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00371.asp\u0022\u003EHealth Alert Network (HAN) advisory for healthcare workers\u003C\/a\u003E (Oct 2, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.phe.gov\/Preparedness\/responders\/Pages\/ebola-healthcare-webinar.aspx\u0022\u003EEbola preparedness for US healthcare system (webinar with ASPR)\u003C\/a\u003E (Sep 29, 2014)\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003EInfection prevention and control recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ppe-poster.pdf\u0022\u003ESequence for removing personal protective equipment\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/s0914-ebola-surge.html\u0022\u003EFact sheet on surge\u003C\/a\u003E (Sep 16, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003ETravel\/flight information \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 8, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Feb 19, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-commercial-passenger-aircraft.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cleaning, disinfection, and waste disposal in commercial passenger aircraft \u003C\/a\u003E(Dec 18, 2014)\u0026nbsp;\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/airlines\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for airlines\u003C\/a\u003E (Dec 9, 2014)\u003Cem\u003E\u0026nbsp; \u003C\/em\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00372.asp\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening and monitoring for people entering US from Mali\u003C\/a\u003E (Nov 24)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Nov 16) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/p1116-travelers-from-mali.html\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening to begin for travelers to the US from Mali\u003C\/a\u003E (Nov 16)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/travelers\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for Travelers\u003C\/a\u003E (Nov 3, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003ECheck and Report Ebola (CARE) kit for travelers arriving in US from West Africa\u0026nbsp; \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/diseases\/ebola\u0022\u003EEbola Traveler\u0027s Health\u003C\/a\u003E\u0026nbsp;(Oct 7, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/pilots.html\u0022\u003ECDC death and disease reporting tool for pilots\u003C\/a\u003E (Aug 25, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/managing-sick-travelers\/ebola-guidance-airlines.html\u0022\u003EInterim guidance for airline crews, cleaning personnel, and cargo personnel\u003C\/a\u003E (Oct 2, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-air-medical-transport-patients.html\u0022\u003EGuidance on air medical transport for Ebola patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/guidance-reporting-onboard-deaths-illnesses.html\u0022\u003EGuidance for airlines on reporting onboard deaths or illnesses\u003C\/a\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/cabin-crew.html\u0022\u003ECDC death and disease reporting tool for cabin crew\u003C\/a\u003E (Aug 25, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUS Government \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.google.com\/url?sa=t\u0026amp;rct=j\u0026amp;q=\u0026amp;esrc=s\u0026amp;source=web\u0026amp;cd=2\u0026amp;cad=rja\u0026amp;uact=8\u0026amp;ved=0CCUQFjAB\u0026amp;url=http%3A%2F%2Fwww.fas.org%2Fsgp%2Fcrs%2Fmisc%2FR43809.pdf\u0026amp;ei=QB6KVLblMsmlyATqtYHwAg\u0026amp;usg=AFQjCNE2dHIgc_qruQur8MBr-U49sMQhDQ\u0026amp;bvm=bv.81456516,d.aWw\u0022 target=\u0022_blank\u0022\u003EPreventing the introduction and spread of Ebola in the United States: FAQs\u003C\/a\u003E (Dec 5, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/blogs.fda.gov\/fdavoice\/index.php\/2014\/10\/fda-as-part-of-a-coordinated-global-response-on-ebola\/\u0022 target=\u0022_blank\u0022\u003EFDA Commissioner\u0027s statement on agency\u0027s involvement with Ebola response\u003C\/a\u003E (Oct 28)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.hhs.gov\/news\/press\/2014pres\/09\/20140916b.html\u0022\u003EHHS statement on deployment of US Public Health Service Commissioned Corps\u003C\/a\u003E (Sep 16, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/sis.nlm.nih.gov\/dimrc\/ebola_2014.html\u0022\u003ENLM Disaster Information Management Research Center resource list\u003C\/a\u003E (Oct 8, 2014)\u0026nbsp;\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EInstitute of Medicine (IOM)\u0026nbsp; \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.nap.edu\/read\/19004\/chapter\/1\u0022 target=\u0022_blank\u0022\u003EResearch priorities to inform public health and medical practice for Ebola virus disease\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nationalacademies.org\/hmd\/Reports\/2014\/Enabling-Rapid-Sustainable-Public-Health-Research-During-Disasters.aspx\u0022 target=\u0022_blank\u0022\u003EEnabling rapid and sustainable public health research during disasters\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/nationalacademies.org\/hmd\/Global\/Topics\/Ebola.aspx\u0022 target=\u0022_blank\u0022\u003EVideo from IOM workshop on research priorities for Ebola\u003C\/a\u003E (Nov 4) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EAmerican Veterinary Medical Association (AVMA) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/pets-of-ebola-contacts.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for public health officials on pets of Ebola contacts\u003C\/a\u003E (Nov 10, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/dog-cat-quarantine.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for dog or cat quarantine after exposure to a human with confirmed Ebola\u003C\/a\u003E (Nov 10) \u003Cbr \/\u003E\u003Cem\u003ENote:\u003C\/em\u003E The following resources require AVMA membership or site registration: \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071962:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EChecklist for vets when presented with patient or client with possible Ebola exposure\u003C\/a\u003E \u003Cbr \/\u003E \u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071963:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EHandout on Ebola for pet owners\u003C\/a\u003E\u0026nbsp; \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EEuropean Centre for Disease Prevention and Control (ECDC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/safe-use-of-ppe.pdf\u0022 target=\u0022_blank\u0022\u003ESafe use of PPE in the treatment of infectious diseases with high consequence\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-public-health-contact-management-update-10-November.pdf\u0022 target=\u0022_blank\u0022\u003EGuidance for managing persons who have been exposed\u003C\/a\u003E (Nov 7, 2014, update) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/management-healthcare-workers-returning-Ebola-affected-areas.pdf\u0022 target=\u0022_blank\u0022\u003EPublic health management of healthcare workers returning from affected areas\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1094\u0022 target=\u0022_blank\u0022\u003EGuide to medical air evacuation\u003C\/a\u003E (Oct 23, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1084\u0022 target=\u0022_blank\u0022\u003ERapid risk assessment\u003C\/a\u003E (Oct 15, 2014)\u0026nbsp; \u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/healthtopics\/ebola_marburg_fevers\/EVDcasedefinition\/Pages\/default.aspx\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1076\u0022\u003EEpidemiological update - West Africa\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1064\u0022\u003EEpidemiological update - Democratic Republic of the Congo\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/_layouts\/forms\/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90\u0026amp;ID=1178\u0022\u003ERisk of Ebola transmission via donated blood and other substances of human origin\u003C\/a\u003E (Oct 6, 2014) \u003Cbr \/\u003E \u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1082\u0022 target=\u0022_blank\u0022\u003EEntry and exit screening messages\u003C\/a\u003E (Oct 13, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUnited Kingdom agencies\u003C\/h5\u003E\u003Cp\u003EPublic Health England (PHE): \u003Ca href=\u0022https:\/\/www.gov.uk\/government\/collections\/ebola-virus-disease-clinical-management-and-guidance\u0022 target=\u0022_blank\u0022\u003EClinical management and guidance for healthcare professionals\u003C\/a\u003E \u003Cbr \/\u003ENational Health Service (NHS): \u003Ca href=\u0022http:\/\/www.nhs.uk\/conditions\/ebola-virus\/Pages\/Ebola-virus.aspx\u0022 target=\u0022_blank\u0022\u003EEbola resource page for consumers \u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EPublic Health Agency of Canada (PHAC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/national-case-definition-nationale-cas-eng.php\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 23, 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr style=\u0022line-height: 1.35em;\u0022 \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-ipc-pci-eng.php\u0022\u003EInterim guidance for infection prevention and control\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-biosafety-biosecurite-eng.php\u0022\u003EInterim biosafety guidelines for laboratory specimen handling\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 22, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/evd_crf-mvd_fdc-eng.php\u0022\u003ECase report form\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EFederal Ministry of Health (Nigeria)\u003C\/h5\u003E\u003Cp\u003EEbola Virus Information Unit website\u003Cbr \/\u003E \u003Ca href=\u0022http:\/\/www.health.gov.ng\/index.php\/news-media\/press-releases\u0022\u003ERecent press releases\u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EMedecins sans Frontieres (MSF; Doctors Without Borders)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E (Mar 23, 2015)\u003C\/p\u003E\u003Ch5\u003EMinistry of Health and Sanitation (Sierra Leone)\u003C\/h5\u003E\u003Cp\u003ECase updates\u003Cbr \/\u003E Situation reports\u003Cbr \/\u003E Frequently asked questions\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EMinistry of Health (Liberia)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/moh.gov.lr\/\u0022\u003EMain page\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003Ch4\u003EProfessional Organizations\u003C\/h4\u003E\u003Ch5\u003E\u003Cstrong\u003EAmerican College of Chest Physicians (Nov 5, 2014) \u003C\/strong\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=GQgpul5czUY\u0022 target=\u0022_blank\u0022\u003EPreparing for Ebola\u003C\/a\u003E (1-hr video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=E_K-fYvHsO0\u0022 target=\u0022_blank\u0022\u003ECritical care of Persons with Ebola in Sierra Leone and at Emory University\u003C\/a\u003E ( 1-hr 15-minute video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=QPYwuwnYF4M\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EOpportunities, Lessons Learned, and Future Action Items\u003C\/a\u003E (48-minute video)\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003Ch4\u003EAcademic Institutions\u003C\/h4\u003E\u003Cp\u003EIDS (Institute of Development Studies) in conjunction with UK universities: \u003Ca href=\u0022http:\/\/www.ebola-anthropology.net\/\u0022 target=\u0022_blank\u0022\u003EEbola Response Anthropology Platform \u003C\/a\u003E\u003Cbr \/\u003EGeorge Washington University: \u003Ca href=\u0022http:\/\/publichealthonline.gwu.edu\/ebola-public-health-crisis\/\u0022 target=\u0022_blank\u0022\u003EInfographic on ripple effects of Ebola outbreak\u003C\/a\u003E (Nov 12) \u003Cbr \/\u003EEmory University: \u003Ca href=\u0022http:\/\/www.emoryhealthcare.org\/ebola-protocol\/resources.html\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Protocols\u003C\/a\u003E (requires registration)\u003Cbr \/\u003EUniversity of Nebraska Biocontainment Unit: \u003Ca href=\u0022http:\/\/www.nebraskamed.com\/biocontainment-unit\u0022 target=\u0022_blank\u0022\u003EPatient care links\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u0026nbsp;\u003C\/h4\u003E\u003Ch4\u003ETools\/Posters\u003C\/h4\u003E\u003Cp\u003ECDC Flipbook: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (May 1, 2015)\u003Cbr \/\u003ECDC children\u0027s activity book: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-activity-book-general.pdf\u0022 target=\u0022_blank\u0022\u003EHelping people in West Africa\u003C\/a\u003E (CDC)(Apr 22, 2015) \u003Cbr \/\u003ECDC brochure: \u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (Apr 21, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-liberia.pdf\u0022 target=\u0022_blank\u0022\u003ELiberians in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EGuineans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003ESierra Leoneans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Guinea)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-liberia.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Liberia)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ors-instructions.pdf\u0022 target=\u0022_blank\u0022\u003EHow to safely give oral rehydration solution\u003C\/a\u003E (Dec 9, 2014) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/21-day-investigation-guinea.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts in Guinea\u003C\/a\u003E (Dec 4, 2014)\u003Cbr \/\u003ECDC slides and video: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/ppt\/what-you-really-need-know-ebola.pptx\u0022 target=\u0022_blank\u0022\u003EWhat you REALLY need to know about Ebola\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/sierra-leone-21-day-investigation.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts\u2014Sierra Leone\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/top-10-things.pdf\u0022 target=\u0022_blank\u0022\u003ETop 10 things you really need to know about Ebola\u003C\/a\u003E (Nov 19, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003EMEDBOX:\u0026nbsp;\u003Ca href=\u0022http:\/\/www.medbox.org\/ebola-toolbox\/listing\u0022 target=\u0022_blank\u0022\u003EEbola Toolbox\u003C\/a\u003E \u003Cbr \/\u003EUniversity of Nebraska: \u003Ca href=\u0022https:\/\/www.nebraskamed.com\/sites\/default\/files\/documents\/biocontainment\/ebolappechecklist.pdf\u0022 target=\u0022_blank\u0022\u003EDonning \u0026amp; Doffing PPE\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EWorld Bank\u003C\/h4\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.worldbank.org\/en\/topic\/health\/brief\/world-bank-group-ebola-fact-sheet\u0022 target=\u0022_blank\u0022\u003EEbola Fact Sheet\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/documents.worldbank.org\/curated\/en\/2014\/10\/20270083\/\u0022 target=\u0022_blank\u0022\u003EEconomic impact statement\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources from Journals\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/21\/5\/14-2016_article\u0022 target=\u0022_blank\u0022\u003EUsing lessons learned from previous Ebola outbreaks to inform current risk management\u003C\/a\u003E (May 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.springer.com\/biomed\/virology\/spotlight+on+ebola?SGWID=0-1771314-0-0-0\u0022 target=\u0022_blank\u0022\u003EBioMed Central \u0026amp; Springer Ebola Resource Center\u003C\/a\u003E (open-access articles) (launched Dec 5, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003EDisaster Medicine and Public Health Preparedness \u003C\/a\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003Especial edition on Ebola\u003C\/a\u003E \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displayFulltext?type=6\u0026amp;fid=9388028\u0026amp;jid=DMP\u0026amp;volumeId=-1\u0026amp;issueId=-1\u0026amp;aid=9388027\u0026amp;fulltextType=BT\u0026amp;fileId=S1935789314001153\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EDisaster Medicine and Public Health Preparedness: A primer on Ebola for clinicians\u003C\/em\u003E\u003C\/a\u003E\u0026nbsp; (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/page\/ebola-spotlight\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nature.com\/news\/ebola-by-the-numbers-the-size-spread-and-cost-of-an-outbreak-1.16144\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003ENature:\u003C\/em\u003E Ebola by the numbers\u003C\/a\u003E\u0026nbsp; \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.nejm.org\/page\/ebola-outbreak\u0022\u003EN Engl J Med\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/ebola.thelancet.com\/\u0022\u003EThe Lancet\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/www.sciencemag.org\/site\/extra\/ebola\/\u0022\u003E\u003Cem\u003EScience\u003C\/em\u003E\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/blogs.plos.org\/speakingofmedicine\/2014\/09\/05\/plos-resources-ebola\/\u0022\u003EPLoS journals\u003C\/a\u003E \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/jama.jamanetwork.com\/article.aspx?articleid=1905875\u0022\u003EJAMA\u003C\/a\u003E\u003C\/em\u003E\u0026nbsp;\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003ETwitter\u003C\/h4\u003E\u003Cp\u003ECIDRAP (\u003Ca href=\u0022https:\/\/twitter.com\/cidrap\u0022 target=\u0022_blank\u0022\u003E@CIDRAP\u003C\/a\u003E)\u003Cbr \/\u003E Helen Branswell (\u003Ca href=\u0022https:\/\/twitter.com\/HelenBranswell\u0022 target=\u0022_blank\u0022\u003E@HelenBranswell\u003C\/a\u003E)\u003Cbr \/\u003E Michael Coston (\u003Ca href=\u0022https:\/\/twitter.com\/Fla_Medic\u0022 target=\u0022_blank\u0022\u003E@Fla_Medic\u003C\/a\u003E)\u003Cbr \/\u003E ECDC Outbreaks (\u003Ca href=\u0022https:\/\/twitter.com\/ECDC_Outbreaks\u0022 target=\u0022_blank\u0022\u003E@ECDC_Outbreaks\u003C\/a\u003E)\u003Cbr \/\u003E Martin Enserink (\u003Ca href=\u0022https:\/\/twitter.com\/martinenserink\u0022 target=\u0022_blank\u0022\u003E@martinenserink\u003C\/a\u003E) \u003Cbr \/\u003E Jason Gale (\u003Ca href=\u0022https:\/\/twitter.com\/jwgale\u0022 target=\u0022_blank\u0022\u003E@jwgale\u003C\/a\u003E) \u003Cbr \/\u003E HealthMap.org (\u003Ca href=\u0022https:\/\/twitter.com\/healthmap\u0022 target=\u0022_blank\u0022\u003E@healthmap\u003C\/a\u003E)\u003Cbr \/\u003E Crawford Kilian (\u003Ca href=\u0022https:\/\/twitter.com\/Crof\u0022 target=\u0022_blank\u0022\u003E@crof\u003C\/a\u003E)\u003Cbr \/\u003E Ian M Mackay, PhD (\u003Ca href=\u0022https:\/\/twitter.com\/MackayIM\u0022 target=\u0022_blank\u0022\u003E@MackayIM\u003C\/a\u003E)\u003Cbr \/\u003E Maia Majumder, MPH (\u003Ca href=\u0022https:\/\/twitter.com\/maiamajumder\u0022\u003E@maiamajumder\u003C\/a\u003E)\u003C\/p\u003E\u003Cp\u003E\u003Ca name=\u0022lit\u0022\u003E\u003C\/a\u003E\u003C\/p\u003E","format":"full_html","safe_value":"\u003Ch4 class=\u0022button float-right\u0022\u003E\u003Ca href=\u0022#lit\u0022\u003EJump to Recent Literature\u003C\/a\u003E\u003C\/h4\u003E\u003Ch4 class=\u0022button\u0022\u003E\u00a0\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003ELast updated May 29, 2015\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em; font-family: Arial, \u0027Helvetica Neue\u0027, Helvetica, Geneva, sans-serif; font-weight: bold;\u0022\u003ELatest Cases and General Information \u003Cbr \/\u003E\u003Cimg style=\u0022float: right;\u0022 src=\u0022\/sites\/default\/files\/public\/large_ebola.jpg\u0022 alt=\u0022Ebola virus\u0022 width=\u0022283\u0022 height=\u0022283\u0022 \/\u003E\u003C\/span\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150529?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (WHO) (May 29, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/case-counts.html\u0022 target=\u0022_blank\u0022\u003EUpdated case counts\u003C\/a\u003E (CDC) (May 29, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (CDC) (May 1, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E\u00a0 (MSF) (Mar 23, 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm64e0303a2.htm\u0022 target=\u0022_blank\u0022\u003ESystems for rapidly detecting and treating persons with Ebola\u2014US\u003C\/a\u003E (CDC) (Mar 3, 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/screening-travelers.pdf\u0022 target=\u0022_blank\u0022\u003EPreventing Ebola by screening travelers\u003C\/a\u003E (Feb 5 , 2015)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (WHO) (Jan 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/how-talk-children-about-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EHow to talk with your children about Ebola\u003C\/a\u003E (CDC) (Nov 20\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/qas-monitoring-and-movement-guidance.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A on monitoring and movement\u003C\/a\u003E (CDC) (Dec 16\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/infections-spread-by-air-or-droplets.pdf\u0022 target=\u0022_blank\u0022\u003EHow Ebola is Spread\u003C\/a\u003E (\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003ECDC\u003C\/span\u003E) (Nov 1\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/index.html\u0022\u003EWest Africa outbreak page\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E from CDC\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/maimunamajumder.wordpress.com\/tag\/ebola\/\u0022\u003EEbola visualizations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E by Maimuna Majumder, MPH\u003Cbr \/\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebola-virus-disease-evd-2014-west.html\u0022\u003EEbola disease page\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebolavirus-disease-evd-cases-clusters.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EEbola maps\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/healthmap.org\/ebola\/\u0022\u003EEbola outbreak map\u003C\/a\u003E from HealthMap\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/qas-pets.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola and pets\u003C\/a\u003E from CDC (Nov 12, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources for Healthcare Volunteers\u003C\/h4\u003E\u003Cp\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/advice-humanitarian-aid-organizations-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid organizations\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/humanitarian-workers-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid workers\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ENIOSH: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/buddy-system.pdf\u0022 target=\u0022_blank\u0022\u003EThe buddy system\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014) \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137410\/1\/WHO_EVD_Guidance_PPE_14.1_eng.pdf\u0022 target=\u0022_blank\u0022\u003ERapid advice guideline on PPE\u003C\/a\u003E (Oct 2014)\u003Cbr \/\u003EMSF: \u003Ca href=\u0022http:\/\/www.doctorswithoutborders.org\/article\/msf-protocols-staff-returning-ebola-affected-countries\u0022 target=\u0022_blank\u0022\u003EProtocols for staff returning from Ebola-affected countries\u003C\/a\u003E (Oct 23, 2014)\u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/index.html\u0022\u003ESafety training course for healthcare workers in West Africa\u003C\/a\u003E\u00a0(Oct 6, 2014)\u003Cbr \/\u003ETravel grants for health workers attending CDC training\u00a0 \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/maternal_perinatal\/ebola\/en\/\u0022 target=\u0022_blank\u0022\u003ESafe delivery services for mothers and newborns in Ebola outbreak areas\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003Cem\u003ESee more below under CDC\u003C\/em\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EHealth Agency Documents\u003C\/h4\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWorld Health Organization (WHO)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150511?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (May 11, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/gb\/ebwha\/pdf_files\/WHA68\/A68_25-en.pdf\u0022 target=\u0022_blank\u0022\u003EEbola Interim Assessment Panel: Report by the Secretariat\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (Jan 2015) \u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/statements\/2014\/ebola-travel\/en\/\u0022 target=\u0022_blank\u0022\u003EStatement from Travel and Transport Task Force\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/factsheets\/fs103\/en\/\u0022 target=\u0022_blank\u0022\u003EFact sheet\u003C\/a\u003E \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/en\/\u0022\u003EEbola page \u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/faq-ebola\/en\/\u0022\u003EFrequently asked questions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/evd-guidance-summary\/en\/\u0022\u003EInfection prevention and control guidance summary\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/travel-guidance\/en\/\u0022\u003ETravel and transport risk assessment\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u00a0\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EClinical management of patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/protective-measures-staff\/en\/\u0022\u003EProtective measures for medical staff\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/event-management-poe\/en\/\u0022\u003EInterim guidance on event management at points of entry\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/ebola-case-definition-contact-en.pdf?ua=1\u0022\u003ECase definition recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 9, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/note-ebola-food-safety\/en\/\u0022\u003EEbola and food safety\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/ebola\/01-october-2014\/en\/\u0022\u003EExperimental vaccines\u003C\/a\u003E (Oct 1, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137096\/1\/WHO_EVD_Preparedness_14_eng.pdf?ua=1\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Checklist\u003C\/a\u003E (Oct 30, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EEbola virus in semen of men recovered from Ebola\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUnited Nations\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/liberia\/liberia-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Liberia\u003C\/a\u003E (Nov 17, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/sierra-leone\/sierra-leone-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Sierra Leone\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/guinea\/guinea-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Guinea\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=ATaQMNYpKoM\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EWorld Food Programme video: Keeping the Ebola crisis from becoming a food crisis\u003C\/a\u003E (Oct 29, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/ebolaresponse.un.org\/un-mission-ebola-emergency-response-unmeer\u0022\u003EUN Mission for Ebola Emergency Response (UNMEER)\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/UNICEF_Ebola_Waste_Management_Guidance_Note_26_09_2014.pdf\u0022\u003EUNICEF waste management guidance\u003C\/a\u003E (Sep 26, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/fao-in-action\/stories\/stories-detail\/en\/c\/251862\/\u0022 target=\u0022_blank\u0022\u003EFAO (Food and Agriculture Organization of the UN) Ebola page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/resources\/documents\/resources-detail\/en\/c\/253869\/\u0022 target=\u0022_blank\u0022\u003EFAO response summary\u003C\/a\u003E (Oct 2014)\u00a0 \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUS Centers for Disease Control and Prevention (CDC)\u003C\/h5\u003E\u003Cp\u003E\u003Cem\u003EGeneral resources \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-liberians-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Liberians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-guineans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Guineans living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-sierra-leoneans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Sierra Leonians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003EGetting to zero (video) (Apr 6, 2015) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022https:\/\/www2c.cdc.gov\/podcasts\/media\/pdf\/3-19-15_EbolaUpdate_Pets.pdf\u0022 target=\u0022_blank\u0022\u003ECDC podcast on risk to pets: transcript\u003C\/a\u003E (Mar 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/families\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for families and loved ones of responders\u003C\/a\u003E (Mar 13, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-safe-school-messages2015.pdf\u0022 target=\u0022_blank\u0022\u003EKey messages for safe school operations in countries with outbreaks of Ebola\u003C\/a\u003E (Feb 25, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/qa-business-travelers.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola for US businesses, employers, and business travelers\u003C\/a\u003E (Feb 23, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/transporting-pediatric-patients.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A re transport of pediatric patients with suspected or confirmed Ebola\u003C\/a\u003E (Feb 2, 2105)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/phlp\/docs\/interim-ebolascreening.pdf\u0022 target=\u0022_blank\u0022\u003EInterim table of state Ebola screening and monitoring policies\u003C\/a\u003E (Jan 8, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm63e1216a1.htm\u0022 target=\u0022_blank\u0022\u003ELatest\u003Cem\u003E MMWR\u003C\/em\u003E update\u003C\/a\u003E (CDC) (Dec 19, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-response-team.pdf\u0022 target=\u0022_blank\u0022\u003EEbola response team fact sheet\u003C\/a\u003E (Dec 2, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/mutations.pdf\u0022 target=\u0022_blank\u0022\u003EWhy Ebola is not likely to become airborne\u003C\/a\u003E (Dec 1, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/\u0022\u003EEbola page\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/qa.html\u0022\u003EQuestions and answers\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 8, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/case-definition.html\u0022\u003ECase definitions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 4, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/index.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWest Africa outbreak page\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003EDemocratic Republic of the Congo outbreak page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/human-transmission.html\u0022 target=\u0022_blank\u0022\u003ESummary of human-to-human transmission\u003C\/a\u003E (Oct 17, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-and-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInformation on cleaning and decontamination\u003C\/a\u003E (Nov 10, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/communication-resources\/index.html\u0022 target=\u0022_blank\u0022\u003ECommunication resources for West African communities\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/information-for-west-africans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EEbola fact sheet for West Africans living in the US\u003C\/a\u003E (Nov 17) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/survivability-ebola-medical-waste.html\u0022 target=\u0022_blank\u0022\u003ESurvivability of Ebola virus in medical waste\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cem\u003EGuidance documents \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EInterim advice on the sexual transmission of Ebola\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E (Apr 8, 2015) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/laboratories\/safe-specimen-management.html\u0022 target=\u0022_blank\u0022\u003E\u003Cbr \/\u003EGuidance for US labs for managing and testing clinical specimens when there is concern about Ebola\u003C\/a\u003E (Feb 3, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/flu.html\u0022 target=\u0022_blank\u0022\u003EInterim recommendations for flu vaccination and post-exposure chemoprophylaxis in people being monitored for potential Ebola virus exposure\u003C\/a\u003E (Jan 26, 2015)\u003Cspan\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/business-travelers.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US businesses, employers, and business travelers to prevent Ebola exposure\u003C\/a\u003E (Jan 23, 2015) \u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/bury-body-safely.pdf\u0022 target=\u0022_blank\u0022\u003EEbola must go: bury all dead bodies safely\u003C\/a\u003E (Dec 23, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/ebola-associated-waste.html\u0022 target=\u0022_blank\u0022\u003EProcedures for safe handling and management of Ebola-associated waste\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for handling untreated sewage from Ebola patients in the US\u003C\/a\u003E (Nov 20\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022\u003EFAQs on interim guidance for managers and workers handling untreated sewage from suspected or confirmed individuals with Ebola in the US\u003C\/a\u003E (Dec 16, 2014) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-emergency-medical-services-systems-911-public-safety-answering-points-management-patients-known-suspected-united-states.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for EMS and 911 systems\u003C\/a\u003E (Dec 2, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-maternal-health.html\u0022 target=\u0022_blank\u0022\u003EScreening and caring for pregnant Ebola patients\u003C\/a\u003E (Nov 12\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/residental-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for residence decontamination and removal of contaminated waste\u003C\/a\u003E (Nov 3, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/monitoring-and-movement-of-persons-with-exposure.html\u0022 target=\u0022_blank\u0022\u003ERevised interim guidance for monitoring and movement of people with potential Ebola exposure\u003C\/a\u003E (Oct 27, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1027-monitoring-symptoms-controlling-movement.html\u0022 target=\u0022_blank\u0022\u003EMonitoring symptoms and controlling movement to stop the spread of Ebola\u003C\/a\u003E (Oct 27)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procedures-for-ppe.html\u0022 target=\u0022_blank\u0022\u003EGuidance for donning and doffing PPE\u003C\/a\u003E (Oct 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/limiting-heat-burden.html\u0022 target=\u0022_self\u0022\u003EInterim guidance for limiting heat burden when wearing PPE\u003C\/a\u003E (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-specimen-collection-submission-patients-suspected-infection-ebola.html\u0022\u003EInterim guidance for specimen collection\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/select-agent-regulations.html\u0022\u003EInterim guidance on compliance with select agent regulations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-safe-handling-human-remains-ebola-patients-us-hospitals-mortuaries.html\u0022\u003EGuidance for safe handling of human remains of Ebola patients\u003C\/a\u003E\u003Cspan\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/environmental-infection-control-in-hospitals.html\u0022\u003EInterim guidance for environmental infection control in hospitals\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003C\/span\u003E \u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003EResources for healthcare workers \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/training-toolkit.html\u0022 target=\u0022_blank\u0022\u003EPreparing healthcare workers to work in Ebola treatment units in Africa: Training toolkit announcement\u003C\/a\u003E (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/emergency-department-training.html\u0022 target=\u0022_blank\u0022\u003EEbola preparedness: Emergency Department training modules\u003C\/a\u003E (Feb 17, 2015)\u003Cbr \/\u003ENon-CDC lab resources for Ebola (Jan 30, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/ppe\/supplies.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for US healthcare facilities to ensure adequate supplies of PPE for Ebola preparedness\u003C\/a\u003E (Dec 31, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/preparing-frontline-healthcare-facilities.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for frontline US healthcare facilities for potential Ebola patients\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/us-hospital-preparedness.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US hospitals for potential Ebola patients: a tiered approach\u003C\/a\u003E (Dec 2, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/hand-hygiene.html\u0022 target=\u0022_blank\u0022\u003EHand hygiene in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/mixing-chlorine-solutions.html\u0022 target=\u0022_blank\u0022\u003EMixing and using chlorine solutions in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.youtube.com\/watch?v=8y19h1hecgY\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003ERespiratory protection video\u003C\/a\u003E (Nov 10, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/qa-infection-control-general-healthcare-widespread-ebola-transmission.html\u0022 target=\u0022_blank\u0022\u003EInfection control in countries with widespread Ebola\u003C\/a\u003E (Nov 3) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ambulatory-care-evaluation-of-patients-with-possible-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EAlgorithm for ambulatory care evaluation of patients with possible Ebola\u003C\/a\u003E (Oct 31, 2014)\u00a0\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/considerations-discharging-pui.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for discharging persons under investigation for Ebola\u003C\/a\u003E (Oct 30) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/ed-management-patients-possible-ebola.html\u0022 target=\u0022_blank\u0022\u003EAlgorithm for emergency department management of patients with suspected Ebola\u003C\/a\u003E (Oct 27, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1014-ebola-investigation-fact-sheet.html\u0022 target=\u0022_blank\u0022\u003EFact sheet on hospital preparedness\u003C\/a\u003E (Oct 14, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/caring-for-ebola-suspects.html\u0022 target=\u0022_blank\u0022\u003ECaring for patients under investigation for Ebola\u003C\/a\u003E (Oct 20, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/clinician-information-us-healthcare-settings.html\u0022\u003EDisease information for clinicians\u003C\/a\u003E\u003Cspan\u003E (Oct 4, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-facility-checklist-for-ebola.pdf\u0022\u003EHealthcare facility preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-provider-checklist-for-ebola.pdf\u0022\u003EHealthcare provider preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ems-checklist-ebola-preparedness.pdf\u0022\u003EEMS checklist for Ebola preparedness\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/coalition-checklist-ebola-preparedness.pdf\u0022\u003EChecklist for healthcare coalitions for Ebola preparedness\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/index.html\u0022\u003EInformation for healthcare workers\u003C\/a\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00371.asp\u0022\u003EHealth Alert Network (HAN) advisory for healthcare workers\u003C\/a\u003E (Oct 2, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.phe.gov\/Preparedness\/responders\/Pages\/ebola-healthcare-webinar.aspx\u0022\u003EEbola preparedness for US healthcare system (webinar with ASPR)\u003C\/a\u003E (Sep 29, 2014)\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003EInfection prevention and control recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ppe-poster.pdf\u0022\u003ESequence for removing personal protective equipment\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/s0914-ebola-surge.html\u0022\u003EFact sheet on surge\u003C\/a\u003E (Sep 16, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003ETravel\/flight information \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 8, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Feb 19, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-commercial-passenger-aircraft.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cleaning, disinfection, and waste disposal in commercial passenger aircraft \u003C\/a\u003E(Dec 18, 2014)\u00a0\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/airlines\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for airlines\u003C\/a\u003E (Dec 9, 2014)\u003Cem\u003E\u00a0 \u003C\/em\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00372.asp\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening and monitoring for people entering US from Mali\u003C\/a\u003E (Nov 24)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Nov 16) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/p1116-travelers-from-mali.html\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening to begin for travelers to the US from Mali\u003C\/a\u003E (Nov 16)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/travelers\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for Travelers\u003C\/a\u003E (Nov 3, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003ECheck and Report Ebola (CARE) kit for travelers arriving in US from West Africa\u00a0 \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/diseases\/ebola\u0022\u003EEbola Traveler\u0027s Health\u003C\/a\u003E\u00a0(Oct 7, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/pilots.html\u0022\u003ECDC death and disease reporting tool for pilots\u003C\/a\u003E (Aug 25, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/managing-sick-travelers\/ebola-guidance-airlines.html\u0022\u003EInterim guidance for airline crews, cleaning personnel, and cargo personnel\u003C\/a\u003E (Oct 2, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-air-medical-transport-patients.html\u0022\u003EGuidance on air medical transport for Ebola patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/guidance-reporting-onboard-deaths-illnesses.html\u0022\u003EGuidance for airlines on reporting onboard deaths or illnesses\u003C\/a\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/cabin-crew.html\u0022\u003ECDC death and disease reporting tool for cabin crew\u003C\/a\u003E (Aug 25, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUS Government \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.google.com\/url?sa=t\u0026amp;rct=j\u0026amp;q=\u0026amp;esrc=s\u0026amp;source=web\u0026amp;cd=2\u0026amp;cad=rja\u0026amp;uact=8\u0026amp;ved=0CCUQFjAB\u0026amp;url=http%3A%2F%2Fwww.fas.org%2Fsgp%2Fcrs%2Fmisc%2FR43809.pdf\u0026amp;ei=QB6KVLblMsmlyATqtYHwAg\u0026amp;usg=AFQjCNE2dHIgc_qruQur8MBr-U49sMQhDQ\u0026amp;bvm=bv.81456516,d.aWw\u0022 target=\u0022_blank\u0022\u003EPreventing the introduction and spread of Ebola in the United States: FAQs\u003C\/a\u003E (Dec 5, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/blogs.fda.gov\/fdavoice\/index.php\/2014\/10\/fda-as-part-of-a-coordinated-global-response-on-ebola\/\u0022 target=\u0022_blank\u0022\u003EFDA Commissioner\u0027s statement on agency\u0027s involvement with Ebola response\u003C\/a\u003E (Oct 28)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.hhs.gov\/news\/press\/2014pres\/09\/20140916b.html\u0022\u003EHHS statement on deployment of US Public Health Service Commissioned Corps\u003C\/a\u003E (Sep 16, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/sis.nlm.nih.gov\/dimrc\/ebola_2014.html\u0022\u003ENLM Disaster Information Management Research Center resource list\u003C\/a\u003E (Oct 8, 2014)\u00a0\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EInstitute of Medicine (IOM)\u00a0 \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.nap.edu\/read\/19004\/chapter\/1\u0022 target=\u0022_blank\u0022\u003EResearch priorities to inform public health and medical practice for Ebola virus disease\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nationalacademies.org\/hmd\/Reports\/2014\/Enabling-Rapid-Sustainable-Public-Health-Research-During-Disasters.aspx\u0022 target=\u0022_blank\u0022\u003EEnabling rapid and sustainable public health research during disasters\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/nationalacademies.org\/hmd\/Global\/Topics\/Ebola.aspx\u0022 target=\u0022_blank\u0022\u003EVideo from IOM workshop on research priorities for Ebola\u003C\/a\u003E (Nov 4) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EAmerican Veterinary Medical Association (AVMA) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/pets-of-ebola-contacts.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for public health officials on pets of Ebola contacts\u003C\/a\u003E (Nov 10, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/dog-cat-quarantine.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for dog or cat quarantine after exposure to a human with confirmed Ebola\u003C\/a\u003E (Nov 10) \u003Cbr \/\u003E\u003Cem\u003ENote:\u003C\/em\u003E The following resources require AVMA membership or site registration: \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071962:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EChecklist for vets when presented with patient or client with possible Ebola exposure\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071963:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EHandout on Ebola for pet owners\u003C\/a\u003E\u00a0 \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EEuropean Centre for Disease Prevention and Control (ECDC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/safe-use-of-ppe.pdf\u0022 target=\u0022_blank\u0022\u003ESafe use of PPE in the treatment of infectious diseases with high consequence\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-public-health-contact-management-update-10-November.pdf\u0022 target=\u0022_blank\u0022\u003EGuidance for managing persons who have been exposed\u003C\/a\u003E (Nov 7, 2014, update) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/management-healthcare-workers-returning-Ebola-affected-areas.pdf\u0022 target=\u0022_blank\u0022\u003EPublic health management of healthcare workers returning from affected areas\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1094\u0022 target=\u0022_blank\u0022\u003EGuide to medical air evacuation\u003C\/a\u003E (Oct 23, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1084\u0022 target=\u0022_blank\u0022\u003ERapid risk assessment\u003C\/a\u003E (Oct 15, 2014)\u00a0 \u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/healthtopics\/ebola_marburg_fevers\/EVDcasedefinition\/Pages\/default.aspx\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1076\u0022\u003EEpidemiological update - West Africa\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1064\u0022\u003EEpidemiological update - Democratic Republic of the Congo\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/_layouts\/forms\/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90\u0026amp;ID=1178\u0022\u003ERisk of Ebola transmission via donated blood and other substances of human origin\u003C\/a\u003E (Oct 6, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1082\u0022 target=\u0022_blank\u0022\u003EEntry and exit screening messages\u003C\/a\u003E (Oct 13, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUnited Kingdom agencies\u003C\/h5\u003E\u003Cp\u003EPublic Health England (PHE): \u003Ca href=\u0022https:\/\/www.gov.uk\/government\/collections\/ebola-virus-disease-clinical-management-and-guidance\u0022 target=\u0022_blank\u0022\u003EClinical management and guidance for healthcare professionals\u003C\/a\u003E \u003Cbr \/\u003ENational Health Service (NHS): \u003Ca href=\u0022http:\/\/www.nhs.uk\/conditions\/ebola-virus\/Pages\/Ebola-virus.aspx\u0022 target=\u0022_blank\u0022\u003EEbola resource page for consumers \u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EPublic Health Agency of Canada (PHAC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/national-case-definition-nationale-cas-eng.php\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 23, 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr style=\u0022line-height: 1.35em;\u0022 \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-ipc-pci-eng.php\u0022\u003EInterim guidance for infection prevention and control\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-biosafety-biosecurite-eng.php\u0022\u003EInterim biosafety guidelines for laboratory specimen handling\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 22, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/evd_crf-mvd_fdc-eng.php\u0022\u003ECase report form\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EFederal Ministry of Health (Nigeria)\u003C\/h5\u003E\u003Cp\u003EEbola Virus Information Unit website\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.health.gov.ng\/index.php\/news-media\/press-releases\u0022\u003ERecent press releases\u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EMedecins sans Frontieres (MSF; Doctors Without Borders)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E (Mar 23, 2015)\u003C\/p\u003E\u003Ch5\u003EMinistry of Health and Sanitation (Sierra Leone)\u003C\/h5\u003E\u003Cp\u003ECase updates\u003Cbr \/\u003E Situation reports\u003Cbr \/\u003E Frequently asked questions\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EMinistry of Health (Liberia)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/moh.gov.lr\/\u0022\u003EMain page\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u00a0\u003C\/p\u003E\u003Ch4\u003EProfessional Organizations\u003C\/h4\u003E\u003Ch5\u003E\u003Cstrong\u003EAmerican College of Chest Physicians (Nov 5, 2014) \u003C\/strong\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=GQgpul5czUY\u0022 target=\u0022_blank\u0022\u003EPreparing for Ebola\u003C\/a\u003E (1-hr video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=E_K-fYvHsO0\u0022 target=\u0022_blank\u0022\u003ECritical care of Persons with Ebola in Sierra Leone and at Emory University\u003C\/a\u003E ( 1-hr 15-minute video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=QPYwuwnYF4M\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EOpportunities, Lessons Learned, and Future Action Items\u003C\/a\u003E (48-minute video)\u003C\/p\u003E\u003Cp\u003E\u00a0\u003C\/p\u003E\u003Ch4\u003EAcademic Institutions\u003C\/h4\u003E\u003Cp\u003EIDS (Institute of Development Studies) in conjunction with UK universities: \u003Ca href=\u0022http:\/\/www.ebola-anthropology.net\/\u0022 target=\u0022_blank\u0022\u003EEbola Response Anthropology Platform \u003C\/a\u003E\u003Cbr \/\u003EGeorge Washington University: \u003Ca href=\u0022http:\/\/publichealthonline.gwu.edu\/ebola-public-health-crisis\/\u0022 target=\u0022_blank\u0022\u003EInfographic on ripple effects of Ebola outbreak\u003C\/a\u003E (Nov 12) \u003Cbr \/\u003EEmory University: \u003Ca href=\u0022http:\/\/www.emoryhealthcare.org\/ebola-protocol\/resources.html\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Protocols\u003C\/a\u003E (requires registration)\u003Cbr \/\u003EUniversity of Nebraska Biocontainment Unit: \u003Ca href=\u0022http:\/\/www.nebraskamed.com\/biocontainment-unit\u0022 target=\u0022_blank\u0022\u003EPatient care links\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u00a0\u003C\/h4\u003E\u003Ch4\u003ETools\/Posters\u003C\/h4\u003E\u003Cp\u003ECDC Flipbook: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (May 1, 2015)\u003Cbr \/\u003ECDC children\u0027s activity book: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-activity-book-general.pdf\u0022 target=\u0022_blank\u0022\u003EHelping people in West Africa\u003C\/a\u003E (CDC)(Apr 22, 2015) \u003Cbr \/\u003ECDC brochure: \u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (Apr 21, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-liberia.pdf\u0022 target=\u0022_blank\u0022\u003ELiberians in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EGuineans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003ESierra Leoneans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Guinea)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-liberia.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Liberia)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ors-instructions.pdf\u0022 target=\u0022_blank\u0022\u003EHow to safely give oral rehydration solution\u003C\/a\u003E (Dec 9, 2014) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/21-day-investigation-guinea.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts in Guinea\u003C\/a\u003E (Dec 4, 2014)\u003Cbr \/\u003ECDC slides and video: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/ppt\/what-you-really-need-know-ebola.pptx\u0022 target=\u0022_blank\u0022\u003EWhat you REALLY need to know about Ebola\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/sierra-leone-21-day-investigation.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts\u2014Sierra Leone\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/top-10-things.pdf\u0022 target=\u0022_blank\u0022\u003ETop 10 things you really need to know about Ebola\u003C\/a\u003E (Nov 19, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003EMEDBOX:\u00a0\u003Ca href=\u0022http:\/\/www.medbox.org\/ebola-toolbox\/listing\u0022 target=\u0022_blank\u0022\u003EEbola Toolbox\u003C\/a\u003E \u003Cbr \/\u003EUniversity of Nebraska: \u003Ca href=\u0022https:\/\/www.nebraskamed.com\/sites\/default\/files\/documents\/biocontainment\/ebolappechecklist.pdf\u0022 target=\u0022_blank\u0022\u003EDonning \u0026amp; Doffing PPE\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EWorld Bank\u003C\/h4\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.worldbank.org\/en\/topic\/health\/brief\/world-bank-group-ebola-fact-sheet\u0022 target=\u0022_blank\u0022\u003EEbola Fact Sheet\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/documents.worldbank.org\/curated\/en\/2014\/10\/20270083\/\u0022 target=\u0022_blank\u0022\u003EEconomic impact statement\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources from Journals\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/21\/5\/14-2016_article\u0022 target=\u0022_blank\u0022\u003EUsing lessons learned from previous Ebola outbreaks to inform current risk management\u003C\/a\u003E (May 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.springer.com\/biomed\/virology\/spotlight+on+ebola?SGWID=0-1771314-0-0-0\u0022 target=\u0022_blank\u0022\u003EBioMed Central \u0026amp; Springer Ebola Resource Center\u003C\/a\u003E (open-access articles) (launched Dec 5, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003EDisaster Medicine and Public Health Preparedness \u003C\/a\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003Especial edition on Ebola\u003C\/a\u003E \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displayFulltext?type=6\u0026amp;fid=9388028\u0026amp;jid=DMP\u0026amp;volumeId=-1\u0026amp;issueId=-1\u0026amp;aid=9388027\u0026amp;fulltextType=BT\u0026amp;fileId=S1935789314001153\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EDisaster Medicine and Public Health Preparedness: A primer on Ebola for clinicians\u003C\/em\u003E\u003C\/a\u003E\u00a0 (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/page\/ebola-spotlight\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nature.com\/news\/ebola-by-the-numbers-the-size-spread-and-cost-of-an-outbreak-1.16144\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003ENature:\u003C\/em\u003E Ebola by the numbers\u003C\/a\u003E\u00a0 \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.nejm.org\/page\/ebola-outbreak\u0022\u003EN Engl J Med\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/ebola.thelancet.com\/\u0022\u003EThe Lancet\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/www.sciencemag.org\/site\/extra\/ebola\/\u0022\u003E\u003Cem\u003EScience\u003C\/em\u003E\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/blogs.plos.org\/speakingofmedicine\/2014\/09\/05\/plos-resources-ebola\/\u0022\u003EPLoS journals\u003C\/a\u003E \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/jama.jamanetwork.com\/article.aspx?articleid=1905875\u0022\u003EJAMA\u003C\/a\u003E\u003C\/em\u003E\u00a0\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003ETwitter\u003C\/h4\u003E\u003Cp\u003ECIDRAP (\u003Ca href=\u0022https:\/\/twitter.com\/cidrap\u0022 target=\u0022_blank\u0022\u003E@CIDRAP\u003C\/a\u003E)\u003Cbr \/\u003E Helen Branswell (\u003Ca href=\u0022https:\/\/twitter.com\/HelenBranswell\u0022 target=\u0022_blank\u0022\u003E@HelenBranswell\u003C\/a\u003E)\u003Cbr \/\u003E Michael Coston (\u003Ca href=\u0022https:\/\/twitter.com\/Fla_Medic\u0022 target=\u0022_blank\u0022\u003E@Fla_Medic\u003C\/a\u003E)\u003Cbr \/\u003E ECDC Outbreaks (\u003Ca href=\u0022https:\/\/twitter.com\/ECDC_Outbreaks\u0022 target=\u0022_blank\u0022\u003E@ECDC_Outbreaks\u003C\/a\u003E)\u003Cbr \/\u003E Martin Enserink (\u003Ca href=\u0022https:\/\/twitter.com\/martinenserink\u0022 target=\u0022_blank\u0022\u003E@martinenserink\u003C\/a\u003E) \u003Cbr \/\u003E Jason Gale (\u003Ca href=\u0022https:\/\/twitter.com\/jwgale\u0022 target=\u0022_blank\u0022\u003E@jwgale\u003C\/a\u003E) \u003Cbr \/\u003E HealthMap.org (\u003Ca href=\u0022https:\/\/twitter.com\/healthmap\u0022 target=\u0022_blank\u0022\u003E@healthmap\u003C\/a\u003E)\u003Cbr \/\u003E Crawford Kilian (\u003Ca href=\u0022https:\/\/twitter.com\/Crof\u0022 target=\u0022_blank\u0022\u003E@crof\u003C\/a\u003E)\u003Cbr \/\u003E Ian M Mackay, PhD (\u003Ca href=\u0022https:\/\/twitter.com\/MackayIM\u0022 target=\u0022_blank\u0022\u003E@MackayIM\u003C\/a\u003E)\u003Cbr \/\u003E Maia Majumder, MPH (\u003Ca href=\u0022https:\/\/twitter.com\/maiamajumder\u0022\u003E@maiamajumder\u003C\/a\u003E)\u003C\/p\u003E\u003Cp\u003E\u003Ca name=\u0022lit\u0022 id=\u0022lit\u0022\u003E\u003C\/a\u003E\u003C\/p\u003E"}]},"field_hp_size":{"und":[{"mode":"hp_large"}]},"field_bibliography":[],"field_body_biblio":[],"field_field_collection_biblio":[],"rdf_mapping":{"rdftype":["sioc:Item","foaf:Document"],"title":{"predicates":["dc:title"]},"created":{"predicates":["dc:date","dc:created"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"changed":{"predicates":["dc:modified"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"body":{"predicates":["content:encoded"]},"uid":{"predicates":["sioc:has_creator"],"type":"rel"},"name":{"predicates":["foaf:name"]},"comment_count":{"predicates":["sioc:num_replies"],"datatype":"xsd:integer"},"last_activity":{"predicates":["sioc:last_activity_date"],"datatype":"xsd:dateTime","callback":"date_iso8601"}},"path":{"pathauto":"1"},"cid":"0","last_comment_timestamp":"1362431979","last_comment_name":null,"last_comment_uid":"1","comment_count":"0","nodehierarchy_menu_links":[],"name":"admin","picture":"0","data":"a:8:{s:19:\u0022biblio_show_profile\u0022;i:0;s:19:\u0022biblio_my_pubs_menu\u0022;i:0;s:21:\u0022biblio_contributor_id\u0022;s:1:\u00220\u0022;s:22:\u0022biblio_id_change_count\u0022;s:1:\u00220\u0022;s:17:\u0022biblio_user_style\u0022;s:6:\u0022system\u0022;s:18:\u0022biblio_baseopenurl\u0022;s:0:\u0022\u0022;s:18:\u0022biblio_openurl_sid\u0022;s:0:\u0022\u0022;s:19:\u0022biblio_crossref_pid\u0022;s:0:\u0022\u0022;}","print_html_display":1,"print_html_display_comment":0,"print_html_display_urllist":1}},{"nid":"102","access":true,"node":{"vid":"260556","uid":"1","title":"VHF","log":"","status":"1","comment":"1","promote":"0","sticky":"0","vuuid":"be4d865e-8914-4d80-9ab3-26056a6009fc","nid":"102","type":"topics","language":"und","created":"1362432020","changed":"1496768999","tnid":"0","translate":"0","uuid":"0f616411-1ec2-4f74-98a8-bd0c6f438699","revision_timestamp":"1496768999","revision_uid":"61146","field_tab_collection":{"und":[{"value":"341","revision_id":"41541"},{"value":"346","revision_id":"41546"},{"value":"351","revision_id":"41551"},{"value":"356","revision_id":"41556"},{"value":"361","revision_id":"41561"},{"value":"366","revision_id":"41566"},{"value":"371","revision_id":"41571"},{"value":"376","revision_id":"41576"}]},"field_body":[],"field_overview":{"und":[{"value":"\u003Cp\u003E\u003Cem\u003ELast updated Jun 21, 2012\u003C\/em\u003E\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003E\u003Cem\u003ELast updated Jun 21, 2012\u003C\/em\u003E\u003C\/p\u003E"}]},"field_show_topic":{"und":[{"value":"1"}]},"field_related_topics":{"und":[{"nid":"64"},{"nid":"77"},{"nid":"104"}]},"field_ss_media_file":[],"field_last_updated":[],"field_file_attachments":[],"field_synonyms":{"und":[{"value":"Viral Hemorrhagic Fever","format":null,"safe_value":"Viral Hemorrhagic Fever"}]},"field_call_action":[],"field_related_links":[],"field_teaser":{"und":[{"value":"\u003Cp\u003ECIDRAP-authored overview\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003ECIDRAP-authored overview\u003C\/p\u003E"}]},"field_roundup_type":{"und":[{"value":"1"}]},"field_subtitle":{"und":[{"value":"\u003Cp\u003EViral hemorrhagic fever\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003EViral hemorrhagic fever\u003C\/p\u003E"}]},"field_super_title":[],"field_resources":[],"field_hp_size":[],"field_bibliography":[],"field_body_biblio":[],"field_field_collection_biblio":[],"rdf_mapping":{"rdftype":["sioc:Item","foaf:Document"],"title":{"predicates":["dc:title"]},"created":{"predicates":["dc:date","dc:created"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"changed":{"predicates":["dc:modified"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"body":{"predicates":["content:encoded"]},"uid":{"predicates":["sioc:has_creator"],"type":"rel"},"name":{"predicates":["foaf:name"]},"comment_count":{"predicates":["sioc:num_replies"],"datatype":"xsd:integer"},"last_activity":{"predicates":["sioc:last_activity_date"],"datatype":"xsd:dateTime","callback":"date_iso8601"}},"path":{"pathauto":"1"},"cid":"0","last_comment_timestamp":"1362432020","last_comment_name":null,"last_comment_uid":"1","comment_count":"0","nodehierarchy_menu_links":[],"name":"admin","picture":"0","data":"a:8:{s:19:\u0022biblio_show_profile\u0022;i:0;s:19:\u0022biblio_my_pubs_menu\u0022;i:0;s:21:\u0022biblio_contributor_id\u0022;s:1:\u00220\u0022;s:22:\u0022biblio_id_change_count\u0022;s:1:\u00220\u0022;s:17:\u0022biblio_user_style\u0022;s:6:\u0022system\u0022;s:18:\u0022biblio_baseopenurl\u0022;s:0:\u0022\u0022;s:18:\u0022biblio_openurl_sid\u0022;s:0:\u0022\u0022;s:19:\u0022biblio_crossref_pid\u0022;s:0:\u0022\u0022;}","print_html_display":1,"print_html_display_comment":0,"print_html_display_urllist":1}}]},"field_file_attachments":[],"field_tags":[],"field_country":[],"field_organization":{"und":[{"tid":"221"},{"tid":"268"}]},"field_ss_media_file":{"und":[{"fid":"20351","uid":"801","filename":"papr.jpg","uri":"public:\/\/media\/article\/papr_0.jpg","filemime":"image\/jpeg","filesize":"52939","status":"1","timestamp":"1411044209","type":"image","uuid":"2858d463-8f51-4409-99b6-72777b4492a3","field_file_image_alt_text":{"und":[{"value":"PAPR - powered air-purifying respirator","format":null,"safe_value":"PAPR - powered air-purifying respirator"}]},"field_file_image_title_text":{"und":[{"value":"A powered air-purifying respirator (PAPR).","format":null,"safe_value":"A powered air-purifying respirator (PAPR)."}]},"field_credit":{"und":[{"value":"Courtesy of 3M Company","format":null,"safe_value":"Courtesy of 3M Company"}]},"rdf_mapping":[],"metadata":[],"alt":"PAPR - powered air-purifying respirator","title":"A powered air-purifying respirator (PAPR).","display":"1","description":null}]},"field_related_articles":[],"field_related_literature":[],"field_related_news":{"und":[{"vname":"news|entity_view_1","vargs":""}]},"field_byline":{"und":[{"tid":"881","taxonomy_term":{"tid":"881","vid":"21","name":"Lisa M Brosseau, ScD, and Rachael Jones, PhD","description":"","format":"full_html","weight":"19","uuid":"d7f5f545-e776-4984-90b9-5f48481d6f9f","vocabulary_machine_name":"bylines","rdf_mapping":{"rdftype":["skos:Concept"],"name":{"predicates":["rdfs:label","skos:prefLabel"]},"description":{"predicates":["skos:definition"]},"vid":{"predicates":["skos:inScheme"],"type":"rel"},"parent":{"predicates":["skos:broader"],"type":"rel"}}}}]},"field_super_title":[],"field_hp_size":{"und":[{"mode":"hp_large"}]},"field_th_asp_topic":[],"rdf_mapping":{"rdftype":["sioc:Item","foaf:Document"],"title":{"predicates":["dc:title"]},"created":{"predicates":["dc:date","dc:created"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"changed":{"predicates":["dc:modified"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"body":{"predicates":["content:encoded"]},"uid":{"predicates":["sioc:has_creator"],"type":"rel"},"name":{"predicates":["foaf:name"]},"comment_count":{"predicates":["sioc:num_replies"],"datatype":"xsd:integer"},"last_activity":{"predicates":["sioc:last_activity_date"],"datatype":"xsd:dateTime","callback":"date_iso8601"}},"cid":0,"last_comment_timestamp":"1410995616","last_comment_name":"","last_comment_uid":"801","comment_count":0,"nodehierarchy_menu_links":[],"name":"Jim Wappes","picture":"0","data":"b:0;","print_html_display":1,"print_html_display_comment":0,"print_html_display_urllist":1,"entity_view_prepared":true,"service_links":{"service-links-facebook":{"title":"Share","href":"http:\/\/www.facebook.com\/sharer.php","query":{"u":"http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola","t":"COMMENTARY: Health workers need optimal respiratory protection for Ebola"},"attributes":{"title":"Share on Facebook","class":["service-links-facebook"],"rel":"nofollow"}},"service-links-twitter":{"title":"Tweet","href":"http:\/\/twitter.com\/share","query":{"url":"http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola","text":"COMMENTARY: Health workers need optimal respiratory protection for Ebola"},"attributes":{"title":"Share this on Twitter","class":["service-links-twitter"],"rel":"nofollow"}},"service-links-linkedin":{"title":"LinkedIn","href":"http:\/\/www.linkedin.com\/shareArticle","query":{"mini":"true","url":"http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola","title":"COMMENTARY: Health workers need optimal respiratory protection for Ebola","summary":"","source":"CIDRAP"},"attributes":{"title":"Publish this post to LinkedIn","class":["service-links-linkedin"],"rel":"nofollow"}},"service-links-forward":{"title":"Email","href":"http:\/\/www.cidrap.umn.edu\/forward","query":{"path":"node\/84276"},"attributes":{"title":"Send to a friend","class":["service-links-forward"],"rel":"nofollow"}},"service-links-printfriendly":{"title":"Print \u0026 PDF","href":"http:\/\/www.printfriendly.com","query":null,"attributes":{"class":["printfriendly","service-links-printfriendly"],"onclick":"window.print();return false;","title":"Print and PDF versions","rel":"nofollow"}}},"service_links_rendered":"\u003Cdiv class=\u0022service-links\u0022\u003E\u003Cdiv class=\u0022service-label\u0022\u003EShare this page: \u003C\/div\u003E\u003Cul class=\u0022links\u0022\u003E\u003Cli class=\u0022service-links-facebook link-share link-http--wwwfacebookcom-sharerphp link-idx-0 link-idx--4 first\u0022\u003E\u003Ca href=\u0022http:\/\/www.facebook.com\/sharer.php?u=http%3A\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola\u0026amp;t=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola\u0022 title=\u0022Share on Facebook\u0022 class=\u0022service-links-facebook\u0022 rel=\u0022nofollow\u0022\u003EShare\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-twitter link-tweet link-http--twittercom-share link-idx-1 link-idx--3\u0022\u003E\u003Ca href=\u0022http:\/\/twitter.com\/share?url=http%3A\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola\u0026amp;text=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola\u0022 title=\u0022Share this on Twitter\u0022 class=\u0022service-links-twitter\u0022 rel=\u0022nofollow\u0022\u003ETweet\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-linkedin link-linkedin link-http--wwwlinkedincom-sharearticle link-idx-2 link-idx--2\u0022\u003E\u003Ca href=\u0022http:\/\/www.linkedin.com\/shareArticle?mini=true\u0026amp;url=http%3A\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola\u0026amp;title=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola\u0026amp;summary=\u0026amp;source=CIDRAP\u0022 title=\u0022Publish this post to LinkedIn\u0022 class=\u0022service-links-linkedin\u0022 rel=\u0022nofollow\u0022\u003ELinkedIn\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-forward link-email link-http--wwwcidrapumnedu-forward link-idx-3 link-idx--1\u0022\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/forward?path=node\/84276\u0022 title=\u0022Send to a friend\u0022 class=\u0022service-links-forward\u0022 rel=\u0022nofollow\u0022\u003EEmail\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-printfriendly link-print--pdf link-http--wwwprintfriendlycom link-idx-4 link-idx--0 last\u0022\u003E\u003Ca href=\u0022http:\/\/www.printfriendly.com\u0022 class=\u0022printfriendly service-links-printfriendly\u0022 onclick=\u0022window.print();return false;\u0022 title=\u0022Print and PDF versions\u0022 rel=\u0022nofollow\u0022\u003EPrint \u0026amp; PDF\u003C\/a\u003E\u003C\/li\u003E\n\u003C\/ul\u003E\u003C\/div\u003E","fieldlayout_cache":[]},"referencing_entity_type":"node","referencing_field":"field_ss_media_file","entity_view_prepared":true},"#items":[{"value":"Courtesy of 3M Company","format":null,"safe_value":"Courtesy of 3M Company"}],"#formatter":"text_default","0":{"#markup":"Courtesy of 3M Company"}},"#pre_render":["_field_extra_fields_pre_render"],"#entity_type":"file","#bundle":"image","#groups":[],"#fieldgroups":[],"#group_children":[],"links":{"#theme":"links__file","#pre_render":["drupal_pre_render_links"],"#attributes":{"class":["links","inline"]},"file":{"#theme":"links__file__file","#links":[],"#attributes":{"class":["links","inline"]}}},"#entity_view_mode":{"entity_type":"file","id":"20351","bundle":"image","view_mode":"full","langcode":"en","has_bundles":true},"#theme":"file_entity","#file":{"fid":"20351","uid":"801","filename":"papr.jpg","uri":"public:\/\/media\/article\/papr_0.jpg","filemime":"image\/jpeg","filesize":"52939","status":"1","timestamp":"1411044209","type":"image","uuid":"2858d463-8f51-4409-99b6-72777b4492a3","field_file_image_alt_text":{"und":[{"value":"PAPR - powered air-purifying respirator","format":null,"safe_value":"PAPR - powered air-purifying respirator"}]},"field_file_image_title_text":{"und":[{"value":"A powered air-purifying respirator (PAPR).","format":null,"safe_value":"A powered air-purifying respirator (PAPR)."}]},"field_credit":{"und":[{"value":"Courtesy of 3M Company","format":null,"safe_value":"Courtesy of 3M Company"}]},"rdf_mapping":[],"metadata":{"width":null,"height":null},"alt":"PAPR - powered air-purifying respirator","title":"A powered air-purifying respirator (PAPR).","display":"1","referencing_entity":{"vid":"197071","uid":"801","title":"COMMENTARY: Health workers need optimal respiratory protection for Ebola","log":"","status":"1","comment":"0","promote":"0","sticky":"1","vuuid":"a32af743-a649-4c4c-afd1-8e1ae959c714","nid":"84276","type":"ss_news","language":"und","created":"1410995616","changed":"1420487195","tnid":"0","translate":"0","uuid":"c815f393-5cac-4094-8891-027c1ae7eec3","revision_timestamp":"1420487195","revision_uid":"30796","field_date":{"und":[{"value":"2014-09-17 00:00:00","timezone":"America\/Chicago","timezone_db":"America\/Chicago","date_type":"datetime"}]},"field_body":{"und":[{"value":"\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note \u003Cstrong\u003E\u003Cem\u003E(Oct 16)\u003C\/em\u003E\u003C\/strong\u003E:\u0026nbsp; \u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003ESee the \u003C\/em\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/response-statements-falsely-attributed-cidrap-regarding-ebola-transmission\u0022 target=\u0022_blank\u0022\u003E statement\u003C\/a\u003E released today by CIDRAP related to this commentary.\u003C\/em\u003E\u003Cstrong\u003E\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note (Sep 17):\u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003E Today\u0027s commentary was submitted to CIDRAP by the authors, who are national experts on respiratory protection and infectious disease transmission. In May they published a \u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003E\u003Cem\u003Esimilar commentary on MERS-CoV\u003C\/em\u003E\u003C\/a\u003E\u003Cem\u003E. Dr Brosseau is a Professor and Dr Jones an Assistant Professor in the School of Public Health, Division of Environmental and Occupational Health Sciences, at the University of Illinois at Chicago.\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003E\u003Cstrong\u003EAuthors\u0027 disclaimer:\u003C\/strong\u003E\u003C\/em\u003E\u003Cem\u003E This commentary reflects the personal opinions of the authors. It does not represent the opinion of the University of Illinois at Chicago or any other organization. The authors have not received any compensation for the preparation of this commentary or any associated public statements. The authors do not endorse any specific manufacturer or brand of personal protective equipment (PPE) and have no direct or indirect financial interest in the use of a specific brand of PPE. In the past one or both of the authors have received research funding from numerous government agencies and organizations, including 3M.\u003C\/em\u003E\u003C\/p\u003E\u003Chr \/\u003E\u003Cp\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cdiv\u003EHealthcare workers play a very important role in the successful containment of outbreaks of infectious diseases like Ebola. The correct type and level of personal protective equipment (PPE) ensures that healthcare workers remain healthy throughout an outbreak\u2014and with the current rapidly expanding Ebola outbreak in West Africa, it\u0027s imperative to favor more conservative measures.\u003C\/div\u003E\u003Cdiv\u003E\u0026nbsp;\u003C\/div\u003E\u003Cdiv\u003EThe precautionary principle\u2014that any action designed to reduce risk should not await scientific certainty\u2014compels the use of respiratory protection for a pathogen like Ebola virus that has:\u003C\/div\u003E\u003Cdiv\u003E\u0026nbsp;\u003C\/div\u003E\u003Cul\u003E\u003Cli\u003ENo proven pre- or post-exposure treatment modalities\u003C\/li\u003E\u003Cli\u003EA high case-fatality rate\u003C\/li\u003E\u003Cli\u003EUnclear modes of transmission\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003EWe believe there is scientific and epidemiologic evidence that Ebola virus has the potential to be transmitted via infectious aerosol particles both near and at a distance from infected patients, which means that healthcare workers should be wearing respirators, not facemasks.\u003Csup\u003E1\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EThe minimum level of protection in high-risk settings should be a respirator with an assigned protection factor greater than 10. A powered air-purifying respirator (PAPR) with a hood or helmet offers many advantages over an N95 filtering facepiece or similar respirator, being more protective, comfortable, and cost-effective in the long run.\u003C\/p\u003E\u003Cp\u003EWe strongly urge the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to seek funds for the purchase and transport of PAPRs to all healthcare workers currently fighting the battle against Ebola throughout Africa\u2014and beyond.\u003C\/p\u003E\u003Cp\u003EThere has been a lot of on-line and published controversy about whether Ebola virus can be transmitted via aerosols. Most scientific and medical personnel, along with public health organizations, have been unequivocal in their statements that Ebola can be transmitted only by direct contact with virus-laden fluids\u003Csup\u003E2,3\u003C\/sup\u003E and that the only modes of transmission we should be concerned with are those termed \u0022droplet\u0022 and \u0022contact.\u0022\u003C\/p\u003E\u003Cp\u003EThese statements are based on two lines of reasoning. The first is that no one located at a distance from an infected individual has contracted the disease, or the converse, every person infected has had (or must have had) \u0022direct\u0022 contact with the body fluids of an infected person.\u003C\/p\u003E\u003Cp\u003EThis reflects an incorrect and outmoded understanding of infectious aerosols, which has been institutionalized in policies, language, culture, and approaches to infection control. We will address this below. Briefly, however, the important points are that virus-laden bodily fluids may be aerosolized and inhaled while a person is in proximity to an infectious person and that a wide range of particle sizes can be inhaled and deposited throughout the respiratory tract.\u003C\/p\u003E\u003Cp\u003EThe second line of reasoning is that respirators or other control measures for infectious aerosols cannot be recommended in developing countries because the resources, time, and\/or understanding for such measures are lacking.\u003Csup\u003E4\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAlthough there are some important barriers to the use of respirators, especially PAPRs, in developing countries, healthcare workers everywhere deserve and should be afforded the same best-practice types of protection, regardless of costs and resources. Every healthcare worker is a precious commodity whose well-being ensures everyone is protected.\u003C\/p\u003E\u003Cp\u003EIf we are willing to offer infected US healthcare workers expensive treatments and experimental drugs free of charge when most of the world has no access to them, we wonder why we are unwilling to find the resources to provide appropriate levels of comparatively less expensive respiratory protection to every healthcare worker around the world.\u003C\/p\u003E\u003Ch3\u003EHow are infectious diseases transmitted via aerosols?\u003C\/h3\u003E\u003Cp\u003EMedical and infection control professionals have relied for years on a paradigm for aerosol transmission of infectious diseases based on very outmoded research and an overly simplistic interpretation of the data. In the 1940s and 50s, William F. Wells and other \u0022aerobiologists\u0022 employed now significantly out-of-date sampling methods (eg, settling plates) and very blunt analytic approaches (eg, cell culturing) to understand the movement of bacterial aerosols in healthcare and other settings. Their work, though groundbreaking at the time, provides a very incomplete picture.\u003C\/p\u003E\u003Cp\u003EEarly aerobiologists were not able to measure small particles near an infectious person and thus assumed such particles existed only far from the source. They concluded that organisms capable of aerosol transmission (termed \u0022airborne\u0022) can only do so at around 3 feet or more from the source. Because they thought that only larger particles would be present near the source, they believed people would be exposed only via large \u0022droplets\u0022 on their face, eyes, or nose.\u003C\/p\u003E\u003Cp\u003EModern research, using more sensitive instruments and analytic methods, has shown that aerosols emitted from the respiratory tract contain a wide distribution of particle sizes\u2014including many that are small enough to be inhaled.\u003Csup\u003E5,6\u003C\/sup\u003E Thus, both small and large particles will be present near an infectious person.\u003C\/p\u003E\u003Cp\u003EThe chance of large droplets reaching the facial mucous membranes is quite small, as the nasal openings are small and shielded by their external and internal structure. Although close contact may permit large-droplet exposure, it also maximizes the possibility of aerosol inhalation.\u003C\/p\u003E\u003Cp\u003EAs noted by early aerobiologists, liquid in a spray aerosol, such as that generated during coughing or sneezing, will quickly evaporate,\u003Csup\u003E7\u003C\/sup\u003E which increases the concentration of small particles in the aerosol. Because evaporation occurs in milliseconds, many of these particles are likely to be found near the infectious person.\u003C\/p\u003E\u003Cp\u003EThe current paradigm also assumes that only \u0022small\u0022 particles (less than 5 micrometers [mcm]) can be inhaled and deposited in the respiratory tract. This is not true. Particles as large as 100 mcm (and perhaps even larger) can be inhaled into the mouth and nose. Larger particles are deposited in the nasal passages, pharynx, and upper regions of the lungs, while smaller particles are more likely to deposit in the lower, alveolar regions. And for many pathogens, infection is possible regardless of the particle size or deposition site.\u003C\/p\u003E\u003Cp\u003EIt\u0027s time to abandon the old paradigm of three mutually exclusive transmission routes for a new one that considers the full range of particle sizes both near and far from a source. In addition, we need to factor in other important features of infectivity, such as the ability of a pathogen to remain viable in air at room temperature and humidity and the likelihood that systemic disease can result from deposition of infectious particles in the respiratory system or their transfer to the gastrointestinal tract.\u003C\/p\u003E\u003Cp\u003EWe recommend using \u0022aerosol transmissible\u0022 rather than the outmoded terms \u0022droplet\u0022 or \u0022airborne\u0022 to describe pathogens that can transmit disease via infectious particles suspended in air.\u003C\/p\u003E\u003Ch3\u003EIs Ebola an aerosol-transmissible disease?\u003C\/h3\u003E\u003Cp\u003EWe recently published a \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003Ecommentary\u003C\/a\u003E on the CIDRAP site discussing whether Middle East respiratory syndrome (MERS) could be an aerosol-transmissible disease, especially in healthcare settings. We drew comparisons with a similar and more well-studied disease, severe acute respiratory syndrome (SARS).\u003C\/p\u003E\u003Cp\u003EFor Ebola and other filoviruses, however, there is much less information and research on disease transmission and survival, especially in healthcare settings.\u003C\/p\u003E\u003Cp\u003EBeing at first skeptical that Ebola virus could be an aerosol-transmissible disease, we are now persuaded by a review of experimental and epidemiologic data that this might be an important feature of disease transmission, particularly in healthcare settings.\u003C\/p\u003E\u003Ch3\u003EWhat do we know about Ebola transmission?\u003C\/h3\u003E\u003Cp\u003ENo one knows for certain how Ebola virus is transmitted from one person to the next. The virus has been found in the saliva, stool, breast milk, semen, and blood of infected persons.\u003Csup\u003E8,9\u003C\/sup\u003E Studies of transmission in Ebola virus outbreaks have identified activities like caring for an infected person, sharing a bed, funeral activities, and contact with blood or other body fluids to be key risk factors for transmission.\u003Csup\u003E10-12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EOn the basis of epidemiologic evidence, it has been presumed that Ebola viruses are transmitted by contaminated hands in contact with the mouth or eyes or broken skin or by splashes or sprays of body fluids into these areas. Ebola viruses appear to be capable of initiating infection in a variety of human cell types,\u003Csup\u003E13,14\u003C\/sup\u003E but the primary portal or portals of entry into susceptible hosts have not been identified.\u003C\/p\u003E\u003Cp\u003ESome pathogens are limited in the cell type and location they infect. Influenza, for example, is generally restricted to respiratory epithelial cells, which explains why flu is primarily a respiratory infection and is most likely aerosol transmissible. HIV infects T-helper cells in the lymphoid tissues and is primarily a bloodborne pathogen with low probability for transmission via aerosols.\u003C\/p\u003E\u003Cp\u003EEbola virus, on the other hand, is a broader-acting and more non-specific pathogen that can impede the proper functioning of macrophages and dendritic cells\u2014immune response cells located throughout the epithelium.\u003Csup\u003E15,16\u003C\/sup\u003E Epithelial tissues are found throughout the body, including in the respiratory tract. Ebola prevents these cells from carrying out their antiviral functions but does not interfere with the initial inflammatory response, which attracts additional cells to the infection site. The latter contribute to further dissemination of the virus and similar adverse consequences far beyond the initial infection site.\u003C\/p\u003E\u003Cp\u003EThe potential for transmission via inhalation of aerosols, therefore, cannot be ruled out by the observed risk factors or our knowledge of the infection process. Many body fluids, such as vomit, diarrhea, blood, and saliva, are capable of creating inhalable aerosol particles in the immediate vicinity of an infected person. Cough was identified among some cases in a 1995 outbreak in Kikwit, Democratic Republic of the Congo,\u003Csup\u003E11\u003C\/sup\u003E and coughs are known to emit viruses in respirable particles.\u003Csup\u003E17\u003C\/sup\u003E The act of vomiting produces an aerosol and has been implicated in airborne transmission of gastrointestinal viruses.\u003Csup\u003E18,19\u003C\/sup\u003E Regarding diarrhea, even when contained by toilets, toilet flushing emits a pathogen-laden aerosol that disperses in the air.\u003Csup\u003E20-22\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EExperimental work has shown that Marburg and Ebola viruses can be isolated from sera and tissue culture medium at room temperature for up to 46 days, but at room temperature no virus was recovered from glass, metal, or plastic surfaces.\u003Csup\u003E23\u003C\/sup\u003E Aerosolized (1-3 mcm) Marburg, Ebola, and Reston viruses, at 50% to 55% relative humidity and 72\u00b0F, had biological decay rates of 3.04%, 3.06%. and 1.55% per minute, respectively. These rates indicate that 99% loss in aerosol infectivity would occur in 93, 104, and 162 minutes, respectively.\u003Csup\u003E23\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EIn still air, 3-mcm particles can take up to an hour to settle. With air currents, these and smaller particles can be transported considerable distances before they are deposited on a surface.\u003C\/p\u003E\u003Cp\u003EThere is also some experimental evidence that Ebola and other filoviruses can be transmitted by the aerosol route. Jaax et al\u003Csup\u003E24\u003C\/sup\u003E reported the unexpected death of two rhesus monkeys housed approximately 3 meters from monkeys infected with Ebola virus, concluding that respiratory or eye exposure to aerosols was the only possible explanation.\u003C\/p\u003E\u003Cp\u003EZaire Ebola viruses have also been transmitted in the absence of direct contact among pigs\u003Csup\u003E25\u003C\/sup\u003E and from pigs to non-human primates,\u003Csup\u003E26\u003C\/sup\u003E which experienced lung involvement in infection. Persons with no known direct contact with Ebola virus disease patients or their bodily fluids have become infected.\u003Csup\u003E12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EDirect injection and exposure via a skin break or mucous membranes are the most efficient ways for Ebola to transmit. It may be that inhalation is a less efficient route of transmission for Ebola and other filoviruses, as lung involvement has not been reported in all non-human primate studies of Ebola aerosol infectivity.\u003Csup\u003E27\u003C\/sup\u003E However, the respiratory and gastrointestinal systems are not complete barriers to Ebola virus. Experimental studies have demonstrated that it is possible to infect non-human primates and other mammals with filovirus aerosols.\u003Csup\u003E25-27\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAltogether, these epidemiologic and experimental data offer enough evidence to suggest that Ebola and other filoviruses may be opportunistic with respect to aerosol transmission.\u003Csup\u003E28\u003C\/sup\u003E That is, other routes of entry may be more important and probable, but, given the right conditions, it is possible that transmission could also occur via aerosols.\u003C\/p\u003E\u003Cp\u003EGuidance from the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003ECDC\u003C\/a\u003E and \u003Ca href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EWHO\u003C\/a\u003E recommends the use of facemasks for healthcare workers providing routine care to patients with Ebola virus disease and respirators when aerosol-generating procedures are performed. (Interestingly, the 1998 WHO and CDC infection-control guidance for viral hemorrhagic fevers in Africa, still available on the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/abroad\/pdf\/african-healthcare-setting-vhf.pdf\u0022\u003ECDC Web site\u003C\/a\u003E, recommends the use of respirators.)\u003C\/p\u003E\u003Cp\u003EFacemasks, however, do not offer protection against inhalation of small infectious aerosols, because they lack adequate filters and do not fit tightly against the face.\u003Csup\u003E1\u003C\/sup\u003E Therefore, a higher level of protection is necessary.\u003C\/p\u003E\u003Ch3\u003EWhich respirator to wear?\u003C\/h3\u003E\u003Cp\u003EAs described in our earlier \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003ECIDRAP commentary\u003C\/a\u003E, we can use a Canadian control-banding approach to select the most appropriate respirator for exposures to Ebola in healthcare settings.\u003Csup\u003E29\u003C\/sup\u003E (See \u003Ca href=\u0022http:\/\/www.isrp.com\/americas\/docs\/st_paul_2011\/mehes_use_care_standard.pdf\u0022\u003Ethis document\u003C\/a\u003E for a detailed description of the Canadian control banding approach and the data used to select respirators in our examples below.)\u003C\/p\u003E\u003Cp\u003EThe control banding method involves the following steps:\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the organism\u0027s risk group (1 to 4).\u003C\/em\u003E\u003C\/strong\u003E Risk group reflects the toxicity of an organism, including the degree and type of disease and whether treatments are available. Ebola is in risk group 4, the most toxic organisms, because it can cause serious human or animal disease, is easily transmitted, directly or indirectly, and currently has no effective treatments or preventive measures.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the generation rate.\u003C\/em\u003E\u003C\/strong\u003E The rate of aerosol generation reflects the number of particles created per time (eg, particles per second). Some processes, such as coughing, create more aerosols than others, like normal breathing. Some processes, like intubation and toilet flushing, can rapidly generate very large quantities of aerosols. The control banding approach assigns a qualitative rank ranging from low (1) to high (4) (eg, normal breathing without coughing has a rank of 1).\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the level of control.\u003C\/em\u003E\u003C\/strong\u003E Removing contaminated air and replacing it with clean air, as accomplished with a ventilation system, is effective for lowering the overall concentration of infectious aerosol particles in a space, although it may not be effective at lowering concentration in the immediate vicinity of a source. The number of air changes per hour (ACH) reflects the rate of air removal and replacement. This is a useful variable, because it is relatively easy to measure and, for hospitals, reflects building code requirements for different types of rooms. Again, a qualitative ranking is used to reflect low (1) versus high (4) ACH. Even if the true ventilation rate is not known, the examples can be used to select an appropriate air exchange rate.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the respirator assigned protection factor.\u003C\/em\u003E\u003C\/strong\u003E Respirators are designated by their \u0022class,\u0022 each of which has an assigned protection factor (APF) that reflects the degree of protection. The APF represents the outside, environmental concentration divided by the inside, facepiece concentration. An APF of 10 means that the outside concentration of a particular contaminant will be 10 times greater than that inside the respirator. If the concentration outside the respirator is very high, an assigned protection factor of 10 may not prevent the wearer from inhaling an infective dose of a highly toxic organism.\u003C\/li\u003E\u003C\/ol\u003E\u003Ch3\u003EPractical examples\u003C\/h3\u003E\u003Cp\u003ETwo examples follow. These assume that infectious aerosols are generated only during vomiting, diarrhea, coughing, sneezing, or similar high-energy emissions such as some medical procedures. It is possible that Ebola virus may be shed as an aerosol in other manners not considered.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the early stages of disease (no bleeding, vomiting, diarrhea, coughing, sneezing, etc).\u003C\/em\u003E\u003C\/strong\u003E In this case, the generation rate is 1. For any level of control (less than 3 to more than 12 ACH), the control banding wheel indicates a respirator protection level of 1 (APF of 10), which corresponds to an air purifying (negative pressure) half-facepiece respirator such as an N95 filtering facepiece respirator. This type of respirator requires fit testing.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the later stages of disease (bleeding, vomiting, diarrhea, etc).\u003C\/em\u003E \u003C\/strong\u003EIf we assume the highest generation rate (4) and a standard patient room (control level = 2, 3-6 ACH), a respirator with an APF of at least 50 is needed. In the United States, this would be equivalent to either a full-facepiece air-purifying (negative-pressure) respirator or a half-facepiece PAPR (positive pressure), but standards differ in other countries. Fit testing is required for these types of respirators.\u003C\/p\u003E\u003Cp\u003EThe control level (room ventilation) can have a big effect on respirator selection. For the same patient housed in a negative-pressure airborne infection isolation room (6-12 ACH), a respirator with an assigned protection factor of 25 is required. This would correspond in the United States to a PAPR with a loose-fitting facepiece or with a helmet or hood. This type of respirator does not need fit testing.\u003C\/p\u003E\u003Ch3\u003EImplications for protecting health workers in Africa\u003C\/h3\u003E\u003Cp\u003EHealthcare workers have experienced very high rates of morbidity and mortality in the past and current Ebola virus outbreaks. A facemask, or surgical mask, offers no or very minimal protection from infectious aerosol particles. As our examples illustrate, for a risk group 4 organism like Ebola, the minimum level of protection should be an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003EThis type of respirator, however, would only be appropriate only when the likelihood of aerosol exposure is very low. For healthcare workers caring for many patients in an epidemic situation, this type of respirator may not provide an adequate level of protection.\u003C\/p\u003E\u003Cp\u003EFor a risk group 4 organism, any activity that has the potential for aerosolizing liquid body fluids, such as medical or disinfection procedures, should be avoided, if possible. Our risk assessment indicates that a PAPR with a full facepiece (APF = 50) or a hood or helmet (APF = 25) would be a better choice for patient care during epidemic conditions.\u003C\/p\u003E\u003Cp\u003EWe recognize that PAPRs present some logistical and infection-control problems. Batteries require frequent charging (which requires a reliable source of electricity), and the entire ensemble requires careful handling and disinfection between uses. A PAPR is also more expensive to buy and maintain than other types of respirators.\u003C\/p\u003E\u003Cp\u003EOn the other hand, a PAPR with a loose-fitting facepiece (hood or helmet) does not require fit testing. Wearing this type of respirator minimizes the need for other types of PPE, such as head coverings and goggles. And, most important, it is much more comfortable to wear than a negative-pressure respirator like an N95, especially in hot environments.\u003C\/p\u003E\u003Cp\u003EA recent report from a Medecins Sans Frontieres healthcare worker in Sierra Leone\u003Csup\u003E30\u003C\/sup\u003E notes that healthcare workers cannot tolerate the required PPE for more than 40 minutes. Exiting the workplace every 40 minutes requires removal and disinfection or disposal (burning) of all PPE. A PAPR would allow much longer work periods, use less PPE, require fewer doffing episodes, generate less infectious waste, and be more protective. In the long run, we suspect this type of protection could also be less expensive.\u003C\/p\u003E\u003Ch3\u003EAdequate protection is essential\u003C\/h3\u003E\u003Cp\u003ETo summarize, for the following reasons we believe that Ebola could be an opportunistic aerosol-transmissible disease requiring adequate respiratory protection:\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003EPatients and procedures generate aerosols, and Ebola virus remains viable in aerosols for up to 90 minutes.\u003C\/li\u003E\u003Cli\u003EAll sizes of aerosol particles are easily inhaled both near to and far from the patient.\u003C\/li\u003E\u003Cli\u003ECrowding, limited air exchange, and close interactions with patients all contribute to the probability that healthcare workers will be exposed to high concentrations of very toxic infectious aerosols.\u003C\/li\u003E\u003Cli\u003EEbola targets immune response cells found in all epithelial tissues, including in the respiratory and gastrointestinal system.\u003C\/li\u003E\u003Cli\u003EExperimental data support aerosols as a mode of disease transmission in non-human primates.\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003ERisk level and working conditions suggest that a PAPR will be more protective, cost-effective, and comfortable than an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAcknowledgements\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EWe thank Kathleen Harriman, PhD, MPH, RN, Chief, Vaccine Preventable Diseases Epidemiology Section, Immunization Branch, California Department of Public Health, and Nicole Vars McCullough, PhD, CIH, Manager, Global Technical Services, Personal Safety Division, 3M Company, for their input and review.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EReferences\u003C\/strong\u003E\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003EOberg L, Brosseau LM.\u003C\/strong\u003E Surgical mask filter and fit performance. Am J Infect Control 2008 May;36(4):276-82 [\u003Ca href=\u0022http:\/\/www.ajicjournal.org\/article\/S0196-6553(07)00774-2\/abstract\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECDC.\u003C\/strong\u003E Ebola hemorrhagic fever: transmission. 2014 Aug 13 [\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/index.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EECDC.\u003C\/strong\u003E Outbreak of Ebola virus disease in West Africa: third update, 1 August 2014. Stockholm: ECDC 2014 Aug 1 [\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-outbreak-west-africa-1-august-2014.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMartin-Moreno JM, Llinas G, Hernandez JM.\u003C\/strong\u003E Is respiratory protection appropriate in the Ebola response? Lancet 2014 Sep 6;384(9946):856 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(14)61343-X\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPapineni RS, Rosenthal FS.\u003C\/strong\u003E The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997;10(2):105-16 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10168531\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChao CYH, Wan MP, Morawska L, et al.\u003C\/strong\u003E Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci 2009 Feb;40(2):122-33 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0021850208001882\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ENicas M, Nazaroff WW, Hubbard A.\u003C\/strong\u003E Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg 2005 Mar;2(3):143-54 [\u003Ca href=\u0022http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/15459620590918466?url_ver=Z39.88-2003\u0026amp;rfr_id=ori:rid:crossref.org\u0026amp;rfr_dat=cr_pub%3dpubmed#.VBnXrS5dUZ4\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBauchsch DG, Towner JS, Dowell SF, et al.\u003C\/strong\u003E Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196:S142-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/196\/Supplement_2\/S142.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFormenty P, Leroy EM, Epelboin A, et al.\u003C\/strong\u003E Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006 Jun;42(11):1521-6 [\u003Ca href=\u0022http:\/\/cid.oxfordjournals.org\/content\/42\/11\/1521.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFrancesconi P, Yoti Z, Declich S, et al.\u003C\/strong\u003E Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 2003 Nov;9(11):1430-7 [\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/9\/11\/pdfs\/03-0339.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EDowell SF, Mukunu R, Ksiazek TG, et al.\u003C\/strong\u003E Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of Congo, 1995. J Infect Dis 1999 Feb;179:S87-91 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S87.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoels TH, Bloom AS, Buffington J, et al.\u003C\/strong\u003E Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999 Feb;179:S92-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S92.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKuhl A, Hoffmann M, Muller MA, et al.\u003C\/strong\u003E Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J Infect Dis 2011 Nov;204:S840-9 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/suppl_3\/S840.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EHunt CL, Lennemann NJ, Maury W.\u003C\/strong\u003E Filovirus entry: a novelty in the viral fusion world. Viruses 2012 Feb;4(2):258-75 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3315215\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBray M, Geisbert TW.\u003C\/strong\u003E Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005 Aug;37(8):1560-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s1357272505000725\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMohamadzadeh M, Chen L, Schmaljohn AL.\u003C\/strong\u003E How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 2007 Jul;7(7):556-67 [\u003Ca href=\u0022http:\/\/www.nature.com\/nri\/journal\/v7\/n7\/full\/nri2098.html\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ELindsley WG, Blachere FM, Thewlis RE, et al.\u003C\/strong\u003E Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One 2010 Nov 30;5(11):e15100 [\u003Ca href=\u0022http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0015100\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECaul EO.\u003C\/strong\u003E Small round structured viruses: airborne transmission and hospital control. Lancet 1994 May 21;343(8908):1240-2 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)92146-6\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChadwick PR, Walker M, Rees AE.\u003C\/strong\u003E Airborne transmission of a small round structured virus. Lancet 1994 Jan 15;343(8890):171 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)90959-8\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBest EL, Snadoe JA, Wilcox MH.\u003C\/strong\u003E Potential for aerosolization of \u003Cem\u003EClostridium difficile\u003C\/em\u003E after flushing toilets: the role of toilet lids in reducing environmental contamination. J Hosp Infect 2012 Jan;80(1):1-5 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s0195670111003392\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EGerba CP, Wallis C, Melnick JL.\u003C\/strong\u003E Microbiological hazards of household toilets: droplet production and the fate of residual organisms. Appl Microbiol 1975 Aug;30(2):229-37 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC187159\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBarker J, Jones MV.\u003C\/strong\u003E The potential spread of infection caused by aerosol contamination of surfaces after flushing a domestic toilet. J Appl Microbiol 2005;99(2):339-47 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2005.02610.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPiercy TJ, Smither SJ, Steward JA, et al.\u003C\/strong\u003E The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 2010 Nov;109(5):1531-9 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2010.04778.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EJaax N, Jahrling P, Geisbert T, et al.\u003C\/strong\u003E Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995 Dec 23-30;346(8991-2):1669-71 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8551825\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKobinger GP, Leung A, Neufeld J, et al.\u003C\/strong\u003E Replication, pathogenicity, shedding and transmission of Zaire ebolavirus in pigs. J Infect Dis 2011 Jul 15;204(2):200-8 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/2\/200.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWeingartl HM, Embury-Hyatt C, Nfon C, et al.\u003C\/strong\u003E Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2012;2:811 [\u003Ca href=\u0022http:\/\/www.nature.com\/srep\/2012\/121115\/srep00811\/full\/srep00811.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EReed DS, Lackemeyer MG, Garza NL, et al.\u003C\/strong\u003E Aerosol exposure to Zaire Ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microb Infect 2011 Oct;13(11):930-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1286457911001225\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoy CJ, Milton DK.\u003C\/strong\u003E Airborne transmission of communicable infection\u2014the elusive pathway. N Engl J Med 2004 Apr;350(17):1710-2 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp048051\u0022\u003EPreview\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECanadian Standards Association.\u003C\/strong\u003E Selection, use and care of respirators. CAN\/CSA Z94.4-11\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWolz A.\u003C\/strong\u003E Face to face with Ebola\u2014an emergency care center in Sierra Leone. (Perspective) N Engl J Med 2014 Aug 27 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmp1410179\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003C\/ol\u003E","format":"full_html","safe_value":"\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note \u003Cstrong\u003E\u003Cem\u003E(Oct 16)\u003C\/em\u003E\u003C\/strong\u003E:\u00a0 \u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003ESee the \u003C\/em\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/response-statements-falsely-attributed-cidrap-regarding-ebola-transmission\u0022 target=\u0022_blank\u0022\u003E statement\u003C\/a\u003E released today by CIDRAP related to this commentary.\u003C\/em\u003E\u003Cstrong\u003E\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003EEditor\u0027s Note (Sep 17):\u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003E Today\u0027s commentary was submitted to CIDRAP by the authors, who are national experts on respiratory protection and infectious disease transmission. In May they published a \u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003E\u003Cem\u003Esimilar commentary on MERS-CoV\u003C\/em\u003E\u003C\/a\u003E\u003Cem\u003E. Dr Brosseau is a Professor and Dr Jones an Assistant Professor in the School of Public Health, Division of Environmental and Occupational Health Sciences, at the University of Illinois at Chicago.\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cem\u003E\u003Cstrong\u003EAuthors\u0027 disclaimer:\u003C\/strong\u003E\u003C\/em\u003E\u003Cem\u003E This commentary reflects the personal opinions of the authors. It does not represent the opinion of the University of Illinois at Chicago or any other organization. The authors have not received any compensation for the preparation of this commentary or any associated public statements. The authors do not endorse any specific manufacturer or brand of personal protective equipment (PPE) and have no direct or indirect financial interest in the use of a specific brand of PPE. In the past one or both of the authors have received research funding from numerous government agencies and organizations, including 3M.\u003C\/em\u003E\u003C\/p\u003E\u003Chr \/\u003E\u003Cp\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cdiv\u003EHealthcare workers play a very important role in the successful containment of outbreaks of infectious diseases like Ebola. The correct type and level of personal protective equipment (PPE) ensures that healthcare workers remain healthy throughout an outbreak\u2014and with the current rapidly expanding Ebola outbreak in West Africa, it\u0027s imperative to favor more conservative measures.\u003C\/div\u003E\u003Cdiv\u003E\u00a0\u003C\/div\u003E\u003Cdiv\u003EThe precautionary principle\u2014that any action designed to reduce risk should not await scientific certainty\u2014compels the use of respiratory protection for a pathogen like Ebola virus that has:\u003C\/div\u003E\u003Cdiv\u003E\u00a0\u003C\/div\u003E\u003Cul\u003E\u003Cli\u003ENo proven pre- or post-exposure treatment modalities\u003C\/li\u003E\u003Cli\u003EA high case-fatality rate\u003C\/li\u003E\u003Cli\u003EUnclear modes of transmission\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003EWe believe there is scientific and epidemiologic evidence that Ebola virus has the potential to be transmitted via infectious aerosol particles both near and at a distance from infected patients, which means that healthcare workers should be wearing respirators, not facemasks.\u003Csup\u003E1\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EThe minimum level of protection in high-risk settings should be a respirator with an assigned protection factor greater than 10. A powered air-purifying respirator (PAPR) with a hood or helmet offers many advantages over an N95 filtering facepiece or similar respirator, being more protective, comfortable, and cost-effective in the long run.\u003C\/p\u003E\u003Cp\u003EWe strongly urge the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to seek funds for the purchase and transport of PAPRs to all healthcare workers currently fighting the battle against Ebola throughout Africa\u2014and beyond.\u003C\/p\u003E\u003Cp\u003EThere has been a lot of on-line and published controversy about whether Ebola virus can be transmitted via aerosols. Most scientific and medical personnel, along with public health organizations, have been unequivocal in their statements that Ebola can be transmitted only by direct contact with virus-laden fluids\u003Csup\u003E2,3\u003C\/sup\u003E and that the only modes of transmission we should be concerned with are those termed \u0022droplet\u0022 and \u0022contact.\u0022\u003C\/p\u003E\u003Cp\u003EThese statements are based on two lines of reasoning. The first is that no one located at a distance from an infected individual has contracted the disease, or the converse, every person infected has had (or must have had) \u0022direct\u0022 contact with the body fluids of an infected person.\u003C\/p\u003E\u003Cp\u003EThis reflects an incorrect and outmoded understanding of infectious aerosols, which has been institutionalized in policies, language, culture, and approaches to infection control. We will address this below. Briefly, however, the important points are that virus-laden bodily fluids may be aerosolized and inhaled while a person is in proximity to an infectious person and that a wide range of particle sizes can be inhaled and deposited throughout the respiratory tract.\u003C\/p\u003E\u003Cp\u003EThe second line of reasoning is that respirators or other control measures for infectious aerosols cannot be recommended in developing countries because the resources, time, and\/or understanding for such measures are lacking.\u003Csup\u003E4\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAlthough there are some important barriers to the use of respirators, especially PAPRs, in developing countries, healthcare workers everywhere deserve and should be afforded the same best-practice types of protection, regardless of costs and resources. Every healthcare worker is a precious commodity whose well-being ensures everyone is protected.\u003C\/p\u003E\u003Cp\u003EIf we are willing to offer infected US healthcare workers expensive treatments and experimental drugs free of charge when most of the world has no access to them, we wonder why we are unwilling to find the resources to provide appropriate levels of comparatively less expensive respiratory protection to every healthcare worker around the world.\u003C\/p\u003E\u003Ch3\u003EHow are infectious diseases transmitted via aerosols?\u003C\/h3\u003E\u003Cp\u003EMedical and infection control professionals have relied for years on a paradigm for aerosol transmission of infectious diseases based on very outmoded research and an overly simplistic interpretation of the data. In the 1940s and 50s, William F. Wells and other \u0022aerobiologists\u0022 employed now significantly out-of-date sampling methods (eg, settling plates) and very blunt analytic approaches (eg, cell culturing) to understand the movement of bacterial aerosols in healthcare and other settings. Their work, though groundbreaking at the time, provides a very incomplete picture.\u003C\/p\u003E\u003Cp\u003EEarly aerobiologists were not able to measure small particles near an infectious person and thus assumed such particles existed only far from the source. They concluded that organisms capable of aerosol transmission (termed \u0022airborne\u0022) can only do so at around 3 feet or more from the source. Because they thought that only larger particles would be present near the source, they believed people would be exposed only via large \u0022droplets\u0022 on their face, eyes, or nose.\u003C\/p\u003E\u003Cp\u003EModern research, using more sensitive instruments and analytic methods, has shown that aerosols emitted from the respiratory tract contain a wide distribution of particle sizes\u2014including many that are small enough to be inhaled.\u003Csup\u003E5,6\u003C\/sup\u003E Thus, both small and large particles will be present near an infectious person.\u003C\/p\u003E\u003Cp\u003EThe chance of large droplets reaching the facial mucous membranes is quite small, as the nasal openings are small and shielded by their external and internal structure. Although close contact may permit large-droplet exposure, it also maximizes the possibility of aerosol inhalation.\u003C\/p\u003E\u003Cp\u003EAs noted by early aerobiologists, liquid in a spray aerosol, such as that generated during coughing or sneezing, will quickly evaporate,\u003Csup\u003E7\u003C\/sup\u003E which increases the concentration of small particles in the aerosol. Because evaporation occurs in milliseconds, many of these particles are likely to be found near the infectious person.\u003C\/p\u003E\u003Cp\u003EThe current paradigm also assumes that only \u0022small\u0022 particles (less than 5 micrometers [mcm]) can be inhaled and deposited in the respiratory tract. This is not true. Particles as large as 100 mcm (and perhaps even larger) can be inhaled into the mouth and nose. Larger particles are deposited in the nasal passages, pharynx, and upper regions of the lungs, while smaller particles are more likely to deposit in the lower, alveolar regions. And for many pathogens, infection is possible regardless of the particle size or deposition site.\u003C\/p\u003E\u003Cp\u003EIt\u0027s time to abandon the old paradigm of three mutually exclusive transmission routes for a new one that considers the full range of particle sizes both near and far from a source. In addition, we need to factor in other important features of infectivity, such as the ability of a pathogen to remain viable in air at room temperature and humidity and the likelihood that systemic disease can result from deposition of infectious particles in the respiratory system or their transfer to the gastrointestinal tract.\u003C\/p\u003E\u003Cp\u003EWe recommend using \u0022aerosol transmissible\u0022 rather than the outmoded terms \u0022droplet\u0022 or \u0022airborne\u0022 to describe pathogens that can transmit disease via infectious particles suspended in air.\u003C\/p\u003E\u003Ch3\u003EIs Ebola an aerosol-transmissible disease?\u003C\/h3\u003E\u003Cp\u003EWe recently published a \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003Ecommentary\u003C\/a\u003E on the CIDRAP site discussing whether Middle East respiratory syndrome (MERS) could be an aerosol-transmissible disease, especially in healthcare settings. We drew comparisons with a similar and more well-studied disease, severe acute respiratory syndrome (SARS).\u003C\/p\u003E\u003Cp\u003EFor Ebola and other filoviruses, however, there is much less information and research on disease transmission and survival, especially in healthcare settings.\u003C\/p\u003E\u003Cp\u003EBeing at first skeptical that Ebola virus could be an aerosol-transmissible disease, we are now persuaded by a review of experimental and epidemiologic data that this might be an important feature of disease transmission, particularly in healthcare settings.\u003C\/p\u003E\u003Ch3\u003EWhat do we know about Ebola transmission?\u003C\/h3\u003E\u003Cp\u003ENo one knows for certain how Ebola virus is transmitted from one person to the next. The virus has been found in the saliva, stool, breast milk, semen, and blood of infected persons.\u003Csup\u003E8,9\u003C\/sup\u003E Studies of transmission in Ebola virus outbreaks have identified activities like caring for an infected person, sharing a bed, funeral activities, and contact with blood or other body fluids to be key risk factors for transmission.\u003Csup\u003E10-12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EOn the basis of epidemiologic evidence, it has been presumed that Ebola viruses are transmitted by contaminated hands in contact with the mouth or eyes or broken skin or by splashes or sprays of body fluids into these areas. Ebola viruses appear to be capable of initiating infection in a variety of human cell types,\u003Csup\u003E13,14\u003C\/sup\u003E but the primary portal or portals of entry into susceptible hosts have not been identified.\u003C\/p\u003E\u003Cp\u003ESome pathogens are limited in the cell type and location they infect. Influenza, for example, is generally restricted to respiratory epithelial cells, which explains why flu is primarily a respiratory infection and is most likely aerosol transmissible. HIV infects T-helper cells in the lymphoid tissues and is primarily a bloodborne pathogen with low probability for transmission via aerosols.\u003C\/p\u003E\u003Cp\u003EEbola virus, on the other hand, is a broader-acting and more non-specific pathogen that can impede the proper functioning of macrophages and dendritic cells\u2014immune response cells located throughout the epithelium.\u003Csup\u003E15,16\u003C\/sup\u003E Epithelial tissues are found throughout the body, including in the respiratory tract. Ebola prevents these cells from carrying out their antiviral functions but does not interfere with the initial inflammatory response, which attracts additional cells to the infection site. The latter contribute to further dissemination of the virus and similar adverse consequences far beyond the initial infection site.\u003C\/p\u003E\u003Cp\u003EThe potential for transmission via inhalation of aerosols, therefore, cannot be ruled out by the observed risk factors or our knowledge of the infection process. Many body fluids, such as vomit, diarrhea, blood, and saliva, are capable of creating inhalable aerosol particles in the immediate vicinity of an infected person. Cough was identified among some cases in a 1995 outbreak in Kikwit, Democratic Republic of the Congo,\u003Csup\u003E11\u003C\/sup\u003E and coughs are known to emit viruses in respirable particles.\u003Csup\u003E17\u003C\/sup\u003E The act of vomiting produces an aerosol and has been implicated in airborne transmission of gastrointestinal viruses.\u003Csup\u003E18,19\u003C\/sup\u003E Regarding diarrhea, even when contained by toilets, toilet flushing emits a pathogen-laden aerosol that disperses in the air.\u003Csup\u003E20-22\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EExperimental work has shown that Marburg and Ebola viruses can be isolated from sera and tissue culture medium at room temperature for up to 46 days, but at room temperature no virus was recovered from glass, metal, or plastic surfaces.\u003Csup\u003E23\u003C\/sup\u003E Aerosolized (1-3 mcm) Marburg, Ebola, and Reston viruses, at 50% to 55% relative humidity and 72\u00b0F, had biological decay rates of 3.04%, 3.06%. and 1.55% per minute, respectively. These rates indicate that 99% loss in aerosol infectivity would occur in 93, 104, and 162 minutes, respectively.\u003Csup\u003E23\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EIn still air, 3-mcm particles can take up to an hour to settle. With air currents, these and smaller particles can be transported considerable distances before they are deposited on a surface.\u003C\/p\u003E\u003Cp\u003EThere is also some experimental evidence that Ebola and other filoviruses can be transmitted by the aerosol route. Jaax et al\u003Csup\u003E24\u003C\/sup\u003E reported the unexpected death of two rhesus monkeys housed approximately 3 meters from monkeys infected with Ebola virus, concluding that respiratory or eye exposure to aerosols was the only possible explanation.\u003C\/p\u003E\u003Cp\u003EZaire Ebola viruses have also been transmitted in the absence of direct contact among pigs\u003Csup\u003E25\u003C\/sup\u003E and from pigs to non-human primates,\u003Csup\u003E26\u003C\/sup\u003E which experienced lung involvement in infection. Persons with no known direct contact with Ebola virus disease patients or their bodily fluids have become infected.\u003Csup\u003E12\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EDirect injection and exposure via a skin break or mucous membranes are the most efficient ways for Ebola to transmit. It may be that inhalation is a less efficient route of transmission for Ebola and other filoviruses, as lung involvement has not been reported in all non-human primate studies of Ebola aerosol infectivity.\u003Csup\u003E27\u003C\/sup\u003E However, the respiratory and gastrointestinal systems are not complete barriers to Ebola virus. Experimental studies have demonstrated that it is possible to infect non-human primates and other mammals with filovirus aerosols.\u003Csup\u003E25-27\u003C\/sup\u003E\u003C\/p\u003E\u003Cp\u003EAltogether, these epidemiologic and experimental data offer enough evidence to suggest that Ebola and other filoviruses may be opportunistic with respect to aerosol transmission.\u003Csup\u003E28\u003C\/sup\u003E That is, other routes of entry may be more important and probable, but, given the right conditions, it is possible that transmission could also occur via aerosols.\u003C\/p\u003E\u003Cp\u003EGuidance from the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003ECDC\u003C\/a\u003E and \u003Ca href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EWHO\u003C\/a\u003E recommends the use of facemasks for healthcare workers providing routine care to patients with Ebola virus disease and respirators when aerosol-generating procedures are performed. (Interestingly, the 1998 WHO and CDC infection-control guidance for viral hemorrhagic fevers in Africa, still available on the \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/abroad\/pdf\/african-healthcare-setting-vhf.pdf\u0022\u003ECDC Web site\u003C\/a\u003E, recommends the use of respirators.)\u003C\/p\u003E\u003Cp\u003EFacemasks, however, do not offer protection against inhalation of small infectious aerosols, because they lack adequate filters and do not fit tightly against the face.\u003Csup\u003E1\u003C\/sup\u003E Therefore, a higher level of protection is necessary.\u003C\/p\u003E\u003Ch3\u003EWhich respirator to wear?\u003C\/h3\u003E\u003Cp\u003EAs described in our earlier \u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/05\/commentary-protecting-health-workers-airborne-mers-cov-learning-sars\u0022\u003ECIDRAP commentary\u003C\/a\u003E, we can use a Canadian control-banding approach to select the most appropriate respirator for exposures to Ebola in healthcare settings.\u003Csup\u003E29\u003C\/sup\u003E (See \u003Ca href=\u0022http:\/\/www.isrp.com\/americas\/docs\/st_paul_2011\/mehes_use_care_standard.pdf\u0022\u003Ethis document\u003C\/a\u003E for a detailed description of the Canadian control banding approach and the data used to select respirators in our examples below.)\u003C\/p\u003E\u003Cp\u003EThe control banding method involves the following steps:\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the organism\u0027s risk group (1 to 4).\u003C\/em\u003E\u003C\/strong\u003E Risk group reflects the toxicity of an organism, including the degree and type of disease and whether treatments are available. Ebola is in risk group 4, the most toxic organisms, because it can cause serious human or animal disease, is easily transmitted, directly or indirectly, and currently has no effective treatments or preventive measures.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the generation rate.\u003C\/em\u003E\u003C\/strong\u003E The rate of aerosol generation reflects the number of particles created per time (eg, particles per second). Some processes, such as coughing, create more aerosols than others, like normal breathing. Some processes, like intubation and toilet flushing, can rapidly generate very large quantities of aerosols. The control banding approach assigns a qualitative rank ranging from low (1) to high (4) (eg, normal breathing without coughing has a rank of 1).\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the level of control.\u003C\/em\u003E\u003C\/strong\u003E Removing contaminated air and replacing it with clean air, as accomplished with a ventilation system, is effective for lowering the overall concentration of infectious aerosol particles in a space, although it may not be effective at lowering concentration in the immediate vicinity of a source. The number of air changes per hour (ACH) reflects the rate of air removal and replacement. This is a useful variable, because it is relatively easy to measure and, for hospitals, reflects building code requirements for different types of rooms. Again, a qualitative ranking is used to reflect low (1) versus high (4) ACH. Even if the true ventilation rate is not known, the examples can be used to select an appropriate air exchange rate.\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003E\u003Cem\u003EIdentify the respirator assigned protection factor.\u003C\/em\u003E\u003C\/strong\u003E Respirators are designated by their \u0022class,\u0022 each of which has an assigned protection factor (APF) that reflects the degree of protection. The APF represents the outside, environmental concentration divided by the inside, facepiece concentration. An APF of 10 means that the outside concentration of a particular contaminant will be 10 times greater than that inside the respirator. If the concentration outside the respirator is very high, an assigned protection factor of 10 may not prevent the wearer from inhaling an infective dose of a highly toxic organism.\u003C\/li\u003E\u003C\/ol\u003E\u003Ch3\u003EPractical examples\u003C\/h3\u003E\u003Cp\u003ETwo examples follow. These assume that infectious aerosols are generated only during vomiting, diarrhea, coughing, sneezing, or similar high-energy emissions such as some medical procedures. It is possible that Ebola virus may be shed as an aerosol in other manners not considered.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the early stages of disease (no bleeding, vomiting, diarrhea, coughing, sneezing, etc).\u003C\/em\u003E\u003C\/strong\u003E In this case, the generation rate is 1. For any level of control (less than 3 to more than 12 ACH), the control banding wheel indicates a respirator protection level of 1 (APF of 10), which corresponds to an air purifying (negative pressure) half-facepiece respirator such as an N95 filtering facepiece respirator. This type of respirator requires fit testing.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003ECaring for a patient in the later stages of disease (bleeding, vomiting, diarrhea, etc).\u003C\/em\u003E \u003C\/strong\u003EIf we assume the highest generation rate (4) and a standard patient room (control level = 2, 3-6 ACH), a respirator with an APF of at least 50 is needed. In the United States, this would be equivalent to either a full-facepiece air-purifying (negative-pressure) respirator or a half-facepiece PAPR (positive pressure), but standards differ in other countries. Fit testing is required for these types of respirators.\u003C\/p\u003E\u003Cp\u003EThe control level (room ventilation) can have a big effect on respirator selection. For the same patient housed in a negative-pressure airborne infection isolation room (6-12 ACH), a respirator with an assigned protection factor of 25 is required. This would correspond in the United States to a PAPR with a loose-fitting facepiece or with a helmet or hood. This type of respirator does not need fit testing.\u003C\/p\u003E\u003Ch3\u003EImplications for protecting health workers in Africa\u003C\/h3\u003E\u003Cp\u003EHealthcare workers have experienced very high rates of morbidity and mortality in the past and current Ebola virus outbreaks. A facemask, or surgical mask, offers no or very minimal protection from infectious aerosol particles. As our examples illustrate, for a risk group 4 organism like Ebola, the minimum level of protection should be an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003EThis type of respirator, however, would only be appropriate only when the likelihood of aerosol exposure is very low. For healthcare workers caring for many patients in an epidemic situation, this type of respirator may not provide an adequate level of protection.\u003C\/p\u003E\u003Cp\u003EFor a risk group 4 organism, any activity that has the potential for aerosolizing liquid body fluids, such as medical or disinfection procedures, should be avoided, if possible. Our risk assessment indicates that a PAPR with a full facepiece (APF = 50) or a hood or helmet (APF = 25) would be a better choice for patient care during epidemic conditions.\u003C\/p\u003E\u003Cp\u003EWe recognize that PAPRs present some logistical and infection-control problems. Batteries require frequent charging (which requires a reliable source of electricity), and the entire ensemble requires careful handling and disinfection between uses. A PAPR is also more expensive to buy and maintain than other types of respirators.\u003C\/p\u003E\u003Cp\u003EOn the other hand, a PAPR with a loose-fitting facepiece (hood or helmet) does not require fit testing. Wearing this type of respirator minimizes the need for other types of PPE, such as head coverings and goggles. And, most important, it is much more comfortable to wear than a negative-pressure respirator like an N95, especially in hot environments.\u003C\/p\u003E\u003Cp\u003EA recent report from a Medecins Sans Frontieres healthcare worker in Sierra Leone\u003Csup\u003E30\u003C\/sup\u003E notes that healthcare workers cannot tolerate the required PPE for more than 40 minutes. Exiting the workplace every 40 minutes requires removal and disinfection or disposal (burning) of all PPE. A PAPR would allow much longer work periods, use less PPE, require fewer doffing episodes, generate less infectious waste, and be more protective. In the long run, we suspect this type of protection could also be less expensive.\u003C\/p\u003E\u003Ch3\u003EAdequate protection is essential\u003C\/h3\u003E\u003Cp\u003ETo summarize, for the following reasons we believe that Ebola could be an opportunistic aerosol-transmissible disease requiring adequate respiratory protection:\u003C\/p\u003E\u003Cul\u003E\u003Cli\u003EPatients and procedures generate aerosols, and Ebola virus remains viable in aerosols for up to 90 minutes.\u003C\/li\u003E\u003Cli\u003EAll sizes of aerosol particles are easily inhaled both near to and far from the patient.\u003C\/li\u003E\u003Cli\u003ECrowding, limited air exchange, and close interactions with patients all contribute to the probability that healthcare workers will be exposed to high concentrations of very toxic infectious aerosols.\u003C\/li\u003E\u003Cli\u003EEbola targets immune response cells found in all epithelial tissues, including in the respiratory and gastrointestinal system.\u003C\/li\u003E\u003Cli\u003EExperimental data support aerosols as a mode of disease transmission in non-human primates.\u003C\/li\u003E\u003C\/ul\u003E\u003Cp\u003ERisk level and working conditions suggest that a PAPR will be more protective, cost-effective, and comfortable than an N95 filtering facepiece respirator.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EAcknowledgements\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EWe thank Kathleen Harriman, PhD, MPH, RN, Chief, Vaccine Preventable Diseases Epidemiology Section, Immunization Branch, California Department of Public Health, and Nicole Vars McCullough, PhD, CIH, Manager, Global Technical Services, Personal Safety Division, 3M Company, for their input and review.\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EReferences\u003C\/strong\u003E\u003C\/p\u003E\u003Col\u003E\u003Cli\u003E\u003Cstrong\u003EOberg L, Brosseau LM.\u003C\/strong\u003E Surgical mask filter and fit performance. Am J Infect Control 2008 May;36(4):276-82 [\u003Ca href=\u0022http:\/\/www.ajicjournal.org\/article\/S0196-6553(07)00774-2\/abstract\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECDC.\u003C\/strong\u003E Ebola hemorrhagic fever: transmission. 2014 Aug 13 [\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/index.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EECDC.\u003C\/strong\u003E Outbreak of Ebola virus disease in West Africa: third update, 1 August 2014. Stockholm: ECDC 2014 Aug 1 [\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-outbreak-west-africa-1-august-2014.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMartin-Moreno JM, Llinas G, Hernandez JM.\u003C\/strong\u003E Is respiratory protection appropriate in the Ebola response? Lancet 2014 Sep 6;384(9946):856 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(14)61343-X\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPapineni RS, Rosenthal FS.\u003C\/strong\u003E The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997;10(2):105-16 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10168531\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChao CYH, Wan MP, Morawska L, et al.\u003C\/strong\u003E Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci 2009 Feb;40(2):122-33 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0021850208001882\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ENicas M, Nazaroff WW, Hubbard A.\u003C\/strong\u003E Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg 2005 Mar;2(3):143-54 [\u003Ca href=\u0022http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/15459620590918466?url_ver=Z39.88-2003\u0026amp;rfr_id=ori:rid:crossref.org\u0026amp;rfr_dat=cr_pub%3dpubmed#.VBnXrS5dUZ4\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBauchsch DG, Towner JS, Dowell SF, et al.\u003C\/strong\u003E Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196:S142-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/196\/Supplement_2\/S142.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFormenty P, Leroy EM, Epelboin A, et al.\u003C\/strong\u003E Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006 Jun;42(11):1521-6 [\u003Ca href=\u0022http:\/\/cid.oxfordjournals.org\/content\/42\/11\/1521.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EFrancesconi P, Yoti Z, Declich S, et al.\u003C\/strong\u003E Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 2003 Nov;9(11):1430-7 [\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/9\/11\/pdfs\/03-0339.pdf\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EDowell SF, Mukunu R, Ksiazek TG, et al.\u003C\/strong\u003E Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of Congo, 1995. J Infect Dis 1999 Feb;179:S87-91 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S87.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoels TH, Bloom AS, Buffington J, et al.\u003C\/strong\u003E Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999 Feb;179:S92-7 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/179\/Supplement_1\/S92.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKuhl A, Hoffmann M, Muller MA, et al.\u003C\/strong\u003E Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J Infect Dis 2011 Nov;204:S840-9 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/suppl_3\/S840.full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EHunt CL, Lennemann NJ, Maury W.\u003C\/strong\u003E Filovirus entry: a novelty in the viral fusion world. Viruses 2012 Feb;4(2):258-75 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3315215\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBray M, Geisbert TW.\u003C\/strong\u003E Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005 Aug;37(8):1560-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s1357272505000725\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EMohamadzadeh M, Chen L, Schmaljohn AL.\u003C\/strong\u003E How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 2007 Jul;7(7):556-67 [\u003Ca href=\u0022http:\/\/www.nature.com\/nri\/journal\/v7\/n7\/full\/nri2098.html\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ELindsley WG, Blachere FM, Thewlis RE, et al.\u003C\/strong\u003E Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One 2010 Nov 30;5(11):e15100 [\u003Ca href=\u0022http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0015100\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECaul EO.\u003C\/strong\u003E Small round structured viruses: airborne transmission and hospital control. Lancet 1994 May 21;343(8908):1240-2 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)92146-6\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EChadwick PR, Walker M, Rees AE.\u003C\/strong\u003E Airborne transmission of a small round structured virus. Lancet 1994 Jan 15;343(8890):171 [\u003Ca href=\u0022http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(94)90959-8\/fulltext\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBest EL, Snadoe JA, Wilcox MH.\u003C\/strong\u003E Potential for aerosolization of \u003Cem\u003EClostridium difficile\u003C\/em\u003E after flushing toilets: the role of toilet lids in reducing environmental contamination. J Hosp Infect 2012 Jan;80(1):1-5 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/s0195670111003392\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EGerba CP, Wallis C, Melnick JL.\u003C\/strong\u003E Microbiological hazards of household toilets: droplet production and the fate of residual organisms. Appl Microbiol 1975 Aug;30(2):229-37 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC187159\/\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EBarker J, Jones MV.\u003C\/strong\u003E The potential spread of infection caused by aerosol contamination of surfaces after flushing a domestic toilet. J Appl Microbiol 2005;99(2):339-47 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2005.02610.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EPiercy TJ, Smither SJ, Steward JA, et al.\u003C\/strong\u003E The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 2010 Nov;109(5):1531-9 [\u003Ca href=\u0022http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2672.2010.04778.x\/full\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EJaax N, Jahrling P, Geisbert T, et al.\u003C\/strong\u003E Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995 Dec 23-30;346(8991-2):1669-71 [\u003Ca href=\u0022http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8551825\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EKobinger GP, Leung A, Neufeld J, et al.\u003C\/strong\u003E Replication, pathogenicity, shedding and transmission of Zaire ebolavirus in pigs. J Infect Dis 2011 Jul 15;204(2):200-8 [\u003Ca href=\u0022http:\/\/jid.oxfordjournals.org\/content\/204\/2\/200.long\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWeingartl HM, Embury-Hyatt C, Nfon C, et al.\u003C\/strong\u003E Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2012;2:811 [\u003Ca href=\u0022http:\/\/www.nature.com\/srep\/2012\/121115\/srep00811\/full\/srep00811.html\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EReed DS, Lackemeyer MG, Garza NL, et al.\u003C\/strong\u003E Aerosol exposure to Zaire Ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microb Infect 2011 Oct;13(11):930-6 [\u003Ca href=\u0022http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1286457911001225\u0022\u003EAbstract\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ERoy CJ, Milton DK.\u003C\/strong\u003E Airborne transmission of communicable infection\u2014the elusive pathway. N Engl J Med 2004 Apr;350(17):1710-2 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMp048051\u0022\u003EPreview\u003C\/a\u003E]\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003ECanadian Standards Association.\u003C\/strong\u003E Selection, use and care of respirators. CAN\/CSA Z94.4-11\u003C\/li\u003E\u003Cli\u003E\u003Cstrong\u003EWolz A.\u003C\/strong\u003E Face to face with Ebola\u2014an emergency care center in Sierra Leone. (Perspective) N Engl J Med 2014 Aug 27 [\u003Ca href=\u0022http:\/\/www.nejm.org\/doi\/full\/10.1056\/nejmp1410179\u0022\u003EFull text\u003C\/a\u003E]\u003C\/li\u003E\u003C\/ol\u003E"}]},"field_image_thumbnail":{"und":[{"fid":"20346","uid":"801","filename":"papr-crop.jpg","uri":"public:\/\/images\/news\/papr-crop_1.jpg","filemime":"image\/jpeg","filesize":"17601","status":"1","timestamp":"1420487195","type":"image","uuid":"186f4ebb-4f53-47e8-8736-7470b2c0fdbb","field_file_image_alt_text":{"und":[{"value":"PAPR - powered air-purifying respirator","format":null,"safe_value":"PAPR - powered air-purifying respirator"}]},"field_file_image_title_text":[],"field_credit":[],"rdf_mapping":[],"metadata":[],"alt":"PAPR - powered air-purifying respirator","title":"","width":"440","height":"398"}]},"field_post":[],"field_teaser":{"und":[{"value":"\u003Cp\u003EWe believe there is scientific and epidemiologic evidence to recommend respirators for all patient care, and a PAPR would be the best option.\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003EWe believe there is scientific and epidemiologic evidence to recommend respirators for all patient care, and a PAPR would be the best option.\u003C\/p\u003E"}]},"field_related_topics":{"und":[{"nid":"64","access":true,"node":{"vid":"300206","uid":"1","title":"Ebola","log":"","status":"1","comment":"1","promote":"0","sticky":"0","vuuid":"f0d62dbd-9604-4f12-ae2e-ca0f89893066","nid":"64","type":"topics","language":"und","created":"1362431979","changed":"1537298807","tnid":"0","translate":"0","uuid":"c4cf9110-8082-4f36-bafd-1b24cedafd8a","revision_timestamp":"1537298807","revision_uid":"71411","field_tab_collection":[],"field_body":[],"field_overview":[],"field_show_topic":{"und":[{"value":"1"}]},"field_related_topics":{"und":[{"nid":"102"},{"nid":"77"}]},"field_ss_media_file":[],"field_last_updated":[],"field_file_attachments":[],"field_synonyms":[],"field_call_action":[],"field_related_links":[],"field_teaser":{"und":[{"value":"\u003Cdiv class=\u0022view-content\u0022\u003E\u003Cdiv class=\u0022views-set\u0022\u003E\u003Cdiv class=\u0022views-rows\u0022\u003E\u003Cdiv class=\u0022views-row views-row-4 views-row-even views-row-last\u0022\u003E\u003Cdiv id=\u0022node-65601\u0022 class=\u0022node node-ss-link node-not-full node-type-ss-link-not-full node-hp-small clearfix\u0022\u003E\u003Cdiv class=\u0022node-inner\u0022\u003E\u003Cdiv class=\u0022content fieldlayout-contents\u0022\u003E\u003Cdiv class=\u0022fieldlayout-body clearfix  fieldlayout-body-has-region-soft-left \u0022\u003E\u003Cdiv class=\u0022 fieldlayout-region-body fieldlayout-region-body-hp-small\u0022\u003E\u003Cdiv class=\u0022field field-name-field-teaser field-type-text-long field-label-hidden\u0022\u003E\u003Cdiv class=\u0022field-items\u0022\u003E\u003Cdiv class=\u0022field-item even\u0022\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E","format":"full_html","safe_value":"\u003Cdiv class=\u0022view-content\u0022\u003E\u003Cdiv class=\u0022views-set\u0022\u003E\u003Cdiv class=\u0022views-rows\u0022\u003E\u003Cdiv class=\u0022views-row views-row-4 views-row-even views-row-last\u0022\u003E\u003Cdiv id=\u0022node-65601\u0022 class=\u0022node node-ss-link node-not-full node-type-ss-link-not-full node-hp-small clearfix\u0022\u003E\u003Cdiv class=\u0022node-inner\u0022\u003E\u003Cdiv class=\u0022content fieldlayout-contents\u0022\u003E\u003Cdiv class=\u0022fieldlayout-body clearfix  fieldlayout-body-has-region-soft-left \u0022\u003E\u003Cdiv class=\u0022 fieldlayout-region-body fieldlayout-region-body-hp-small\u0022\u003E\u003Cdiv class=\u0022field field-name-field-teaser field-type-text-long field-label-hidden\u0022\u003E\u003Cdiv class=\u0022field-items\u0022\u003E\u003Cdiv class=\u0022field-item even\u0022\u003E\u003Cp\u003E\u00a0\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E"}]},"field_roundup_type":{"und":[{"value":"1"}]},"field_subtitle":{"und":[{"value":"\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/infectious-disease-topics\/vhf\u0022\u003ERelated: VHF Overview\u003C\/a\u003E\u003C\/p\u003E\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/ongoing-programs\/ebola-vaccine-team-b\u0022\u003ERelated: Ebola Team B\u0026nbsp;\u003C\/a\u003E\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/infectious-disease-topics\/vhf\u0022\u003ERelated: VHF Overview\u003C\/a\u003E\u003C\/p\u003E\u003Cp class=\u0022button\u0022\u003E\u003Ca href=\u0022\/ongoing-programs\/ebola-vaccine-team-b\u0022\u003ERelated: Ebola Team B\u00a0\u003C\/a\u003E\u003C\/p\u003E"}]},"field_super_title":{"und":[{"value":"Updated May  29","format":null,"safe_value":"Updated May  29"}]},"field_resources":{"und":[{"value":"\u003Ch4 class=\u0022button float-right\u0022\u003E\u003Ca href=\u0022#lit\u0022\u003EJump to Recent Literature\u003C\/a\u003E\u003C\/h4\u003E\u003Ch4 class=\u0022button\u0022\u003E\u0026nbsp;\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003ELast updated May 29, 2015\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em; font-family: Arial, \u0027Helvetica Neue\u0027, Helvetica, Geneva, sans-serif; font-weight: bold;\u0022\u003ELatest Cases and General Information \u003Cbr \/\u003E\u003Cimg style=\u0022float: right;\u0022 src=\u0022\/sites\/default\/files\/public\/large_ebola.jpg\u0022 alt=\u0022Ebola virus\u0022 width=\u0022283\u0022 height=\u0022283\u0022 \/\u003E\u003C\/span\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150529?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (WHO) (May 29, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/case-counts.html\u0022 target=\u0022_blank\u0022\u003EUpdated case counts\u003C\/a\u003E (CDC) (May 29, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (CDC) (May 1, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E\u0026nbsp; (MSF) (Mar 23, 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm64e0303a2.htm\u0022 target=\u0022_blank\u0022\u003ESystems for rapidly detecting and treating persons with Ebola\u2014US\u003C\/a\u003E (CDC) (Mar 3, 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/screening-travelers.pdf\u0022 target=\u0022_blank\u0022\u003EPreventing Ebola by screening travelers\u003C\/a\u003E (Feb 5 , 2015)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (WHO) (Jan 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/how-talk-children-about-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EHow to talk with your children about Ebola\u003C\/a\u003E (CDC) (Nov 20\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/qas-monitoring-and-movement-guidance.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A on monitoring and movement\u003C\/a\u003E (CDC) (Dec 16\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/infections-spread-by-air-or-droplets.pdf\u0022 target=\u0022_blank\u0022\u003EHow Ebola is Spread\u003C\/a\u003E (\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003ECDC\u003C\/span\u003E) (Nov 1\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/index.html\u0022\u003EWest Africa outbreak page\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E from CDC\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/maimunamajumder.wordpress.com\/tag\/ebola\/\u0022\u003EEbola visualizations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E by Maimuna Majumder, MPH\u003Cbr \/\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebola-virus-disease-evd-2014-west.html\u0022\u003EEbola disease page\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebolavirus-disease-evd-cases-clusters.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EEbola maps\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/healthmap.org\/ebola\/\u0022\u003EEbola outbreak map\u003C\/a\u003E from HealthMap\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/qas-pets.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola and pets\u003C\/a\u003E from CDC (Nov 12, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources for Healthcare Volunteers\u003C\/h4\u003E\u003Cp\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/advice-humanitarian-aid-organizations-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid organizations\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/humanitarian-workers-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid workers\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ENIOSH: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/buddy-system.pdf\u0022 target=\u0022_blank\u0022\u003EThe buddy system\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014) \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137410\/1\/WHO_EVD_Guidance_PPE_14.1_eng.pdf\u0022 target=\u0022_blank\u0022\u003ERapid advice guideline on PPE\u003C\/a\u003E (Oct 2014)\u003Cbr \/\u003EMSF: \u003Ca href=\u0022http:\/\/www.doctorswithoutborders.org\/article\/msf-protocols-staff-returning-ebola-affected-countries\u0022 target=\u0022_blank\u0022\u003EProtocols for staff returning from Ebola-affected countries\u003C\/a\u003E (Oct 23, 2014)\u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/index.html\u0022\u003ESafety training course for healthcare workers in West Africa\u003C\/a\u003E\u0026nbsp;(Oct 6, 2014)\u003Cbr \/\u003ETravel grants for health workers attending CDC training\u0026nbsp; \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/maternal_perinatal\/ebola\/en\/\u0022 target=\u0022_blank\u0022\u003ESafe delivery services for mothers and newborns in Ebola outbreak areas\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003Cem\u003ESee more below under CDC\u003C\/em\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EHealth Agency Documents\u003C\/h4\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWorld Health Organization (WHO)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150511?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (May 11, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/gb\/ebwha\/pdf_files\/WHA68\/A68_25-en.pdf\u0022 target=\u0022_blank\u0022\u003EEbola Interim Assessment Panel: Report by the Secretariat\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (Jan 2015) \u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/statements\/2014\/ebola-travel\/en\/\u0022 target=\u0022_blank\u0022\u003EStatement from Travel and Transport Task Force\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/factsheets\/fs103\/en\/\u0022 target=\u0022_blank\u0022\u003EFact sheet\u003C\/a\u003E \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/en\/\u0022\u003EEbola page \u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/faq-ebola\/en\/\u0022\u003EFrequently asked questions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/evd-guidance-summary\/en\/\u0022\u003EInfection prevention and control guidance summary\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/travel-guidance\/en\/\u0022\u003ETravel and transport risk assessment\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u0026nbsp;\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EClinical management of patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/protective-measures-staff\/en\/\u0022\u003EProtective measures for medical staff\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/event-management-poe\/en\/\u0022\u003EInterim guidance on event management at points of entry\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/ebola-case-definition-contact-en.pdf?ua=1\u0022\u003ECase definition recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 9, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/note-ebola-food-safety\/en\/\u0022\u003EEbola and food safety\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/ebola\/01-october-2014\/en\/\u0022\u003EExperimental vaccines\u003C\/a\u003E (Oct 1, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137096\/1\/WHO_EVD_Preparedness_14_eng.pdf?ua=1\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Checklist\u003C\/a\u003E (Oct 30, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EEbola virus in semen of men recovered from Ebola\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUnited Nations\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/liberia\/liberia-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Liberia\u003C\/a\u003E (Nov 17, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/sierra-leone\/sierra-leone-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Sierra Leone\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/guinea\/guinea-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Guinea\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=ATaQMNYpKoM\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EWorld Food Programme video: Keeping the Ebola crisis from becoming a food crisis\u003C\/a\u003E (Oct 29, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/ebolaresponse.un.org\/un-mission-ebola-emergency-response-unmeer\u0022\u003EUN Mission for Ebola Emergency Response (UNMEER)\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/UNICEF_Ebola_Waste_Management_Guidance_Note_26_09_2014.pdf\u0022\u003EUNICEF waste management guidance\u003C\/a\u003E (Sep 26, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/fao-in-action\/stories\/stories-detail\/en\/c\/251862\/\u0022 target=\u0022_blank\u0022\u003EFAO (Food and Agriculture Organization of the UN) Ebola page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/resources\/documents\/resources-detail\/en\/c\/253869\/\u0022 target=\u0022_blank\u0022\u003EFAO response summary\u003C\/a\u003E (Oct 2014)\u0026nbsp; \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUS Centers for Disease Control and Prevention (CDC)\u003C\/h5\u003E\u003Cp\u003E\u003Cem\u003EGeneral resources \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-liberians-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Liberians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-guineans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Guineans living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-sierra-leoneans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Sierra Leonians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003EGetting to zero (video) (Apr 6, 2015) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022https:\/\/www2c.cdc.gov\/podcasts\/media\/pdf\/3-19-15_EbolaUpdate_Pets.pdf\u0022 target=\u0022_blank\u0022\u003ECDC podcast on risk to pets: transcript\u003C\/a\u003E (Mar 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/families\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for families and loved ones of responders\u003C\/a\u003E (Mar 13, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-safe-school-messages2015.pdf\u0022 target=\u0022_blank\u0022\u003EKey messages for safe school operations in countries with outbreaks of Ebola\u003C\/a\u003E (Feb 25, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/qa-business-travelers.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola for US businesses, employers, and business travelers\u003C\/a\u003E (Feb 23, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/transporting-pediatric-patients.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A re transport of pediatric patients with suspected or confirmed Ebola\u003C\/a\u003E (Feb 2, 2105)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/phlp\/docs\/interim-ebolascreening.pdf\u0022 target=\u0022_blank\u0022\u003EInterim table of state Ebola screening and monitoring policies\u003C\/a\u003E (Jan 8, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm63e1216a1.htm\u0022 target=\u0022_blank\u0022\u003ELatest\u003Cem\u003E MMWR\u003C\/em\u003E update\u003C\/a\u003E (CDC) (Dec 19, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-response-team.pdf\u0022 target=\u0022_blank\u0022\u003EEbola response team fact sheet\u003C\/a\u003E (Dec 2, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/mutations.pdf\u0022 target=\u0022_blank\u0022\u003EWhy Ebola is not likely to become airborne\u003C\/a\u003E (Dec 1, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/\u0022\u003EEbola page\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/qa.html\u0022\u003EQuestions and answers\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 8, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/case-definition.html\u0022\u003ECase definitions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 4, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/index.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWest Africa outbreak page\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003EDemocratic Republic of the Congo outbreak page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/human-transmission.html\u0022 target=\u0022_blank\u0022\u003ESummary of human-to-human transmission\u003C\/a\u003E (Oct 17, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-and-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInformation on cleaning and decontamination\u003C\/a\u003E (Nov 10, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/communication-resources\/index.html\u0022 target=\u0022_blank\u0022\u003ECommunication resources for West African communities\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/information-for-west-africans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EEbola fact sheet for West Africans living in the US\u003C\/a\u003E (Nov 17) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/survivability-ebola-medical-waste.html\u0022 target=\u0022_blank\u0022\u003ESurvivability of Ebola virus in medical waste\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cem\u003EGuidance documents \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EInterim advice on the sexual transmission of Ebola\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E (Apr 8, 2015) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/laboratories\/safe-specimen-management.html\u0022 target=\u0022_blank\u0022\u003E\u003Cbr \/\u003EGuidance for US labs for managing and testing clinical specimens when there is concern about Ebola\u003C\/a\u003E (Feb 3, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/flu.html\u0022 target=\u0022_blank\u0022\u003EInterim recommendations for flu vaccination and post-exposure chemoprophylaxis in people being monitored for potential Ebola virus exposure\u003C\/a\u003E (Jan 26, 2015)\u003Cspan\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/business-travelers.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US businesses, employers, and business travelers to prevent Ebola exposure\u003C\/a\u003E (Jan 23, 2015) \u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/bury-body-safely.pdf\u0022 target=\u0022_blank\u0022\u003EEbola must go: bury all dead bodies safely\u003C\/a\u003E (Dec 23, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/ebola-associated-waste.html\u0022 target=\u0022_blank\u0022\u003EProcedures for safe handling and management of Ebola-associated waste\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for handling untreated sewage from Ebola patients in the US\u003C\/a\u003E (Nov 20\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022\u003EFAQs on interim guidance for managers and workers handling untreated sewage from suspected or confirmed individuals with Ebola in the US\u003C\/a\u003E (Dec 16, 2014) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-emergency-medical-services-systems-911-public-safety-answering-points-management-patients-known-suspected-united-states.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for EMS and 911 systems\u003C\/a\u003E (Dec 2, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-maternal-health.html\u0022 target=\u0022_blank\u0022\u003EScreening and caring for pregnant Ebola patients\u003C\/a\u003E (Nov 12\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/residental-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for residence decontamination and removal of contaminated waste\u003C\/a\u003E (Nov 3, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/monitoring-and-movement-of-persons-with-exposure.html\u0022 target=\u0022_blank\u0022\u003ERevised interim guidance for monitoring and movement of people with potential Ebola exposure\u003C\/a\u003E (Oct 27, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1027-monitoring-symptoms-controlling-movement.html\u0022 target=\u0022_blank\u0022\u003EMonitoring symptoms and controlling movement to stop the spread of Ebola\u003C\/a\u003E (Oct 27)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procedures-for-ppe.html\u0022 target=\u0022_blank\u0022\u003EGuidance for donning and doffing PPE\u003C\/a\u003E (Oct 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/limiting-heat-burden.html\u0022 target=\u0022_self\u0022\u003EInterim guidance for limiting heat burden when wearing PPE\u003C\/a\u003E (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-specimen-collection-submission-patients-suspected-infection-ebola.html\u0022\u003EInterim guidance for specimen collection\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/select-agent-regulations.html\u0022\u003EInterim guidance on compliance with select agent regulations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-safe-handling-human-remains-ebola-patients-us-hospitals-mortuaries.html\u0022\u003EGuidance for safe handling of human remains of Ebola patients\u003C\/a\u003E\u003Cspan\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/environmental-infection-control-in-hospitals.html\u0022\u003EInterim guidance for environmental infection control in hospitals\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003C\/span\u003E \u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003EResources for healthcare workers \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/training-toolkit.html\u0022 target=\u0022_blank\u0022\u003EPreparing healthcare workers to work in Ebola treatment units in Africa: Training toolkit announcement\u003C\/a\u003E (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/emergency-department-training.html\u0022 target=\u0022_blank\u0022\u003EEbola preparedness: Emergency Department training modules\u003C\/a\u003E (Feb 17, 2015)\u003Cbr \/\u003ENon-CDC lab resources for Ebola (Jan 30, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/ppe\/supplies.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for US healthcare facilities to ensure adequate supplies of PPE for Ebola preparedness\u003C\/a\u003E (Dec 31, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/preparing-frontline-healthcare-facilities.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for frontline US healthcare facilities for potential Ebola patients\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/us-hospital-preparedness.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US hospitals for potential Ebola patients: a tiered approach\u003C\/a\u003E (Dec 2, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/hand-hygiene.html\u0022 target=\u0022_blank\u0022\u003EHand hygiene in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/mixing-chlorine-solutions.html\u0022 target=\u0022_blank\u0022\u003EMixing and using chlorine solutions in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.youtube.com\/watch?v=8y19h1hecgY\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003ERespiratory protection video\u003C\/a\u003E (Nov 10, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/qa-infection-control-general-healthcare-widespread-ebola-transmission.html\u0022 target=\u0022_blank\u0022\u003EInfection control in countries with widespread Ebola\u003C\/a\u003E (Nov 3) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ambulatory-care-evaluation-of-patients-with-possible-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EAlgorithm for ambulatory care evaluation of patients with possible Ebola\u003C\/a\u003E (Oct 31, 2014)\u0026nbsp;\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/considerations-discharging-pui.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for discharging persons under investigation for Ebola\u003C\/a\u003E (Oct 30) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/ed-management-patients-possible-ebola.html\u0022 target=\u0022_blank\u0022\u003EAlgorithm for emergency department management of patients with suspected Ebola\u003C\/a\u003E (Oct 27, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1014-ebola-investigation-fact-sheet.html\u0022 target=\u0022_blank\u0022\u003EFact sheet on hospital preparedness\u003C\/a\u003E (Oct 14, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/caring-for-ebola-suspects.html\u0022 target=\u0022_blank\u0022\u003ECaring for patients under investigation for Ebola\u003C\/a\u003E (Oct 20, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/clinician-information-us-healthcare-settings.html\u0022\u003EDisease information for clinicians\u003C\/a\u003E\u003Cspan\u003E (Oct 4, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-facility-checklist-for-ebola.pdf\u0022\u003EHealthcare facility preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-provider-checklist-for-ebola.pdf\u0022\u003EHealthcare provider preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ems-checklist-ebola-preparedness.pdf\u0022\u003EEMS checklist for Ebola preparedness\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/coalition-checklist-ebola-preparedness.pdf\u0022\u003EChecklist for healthcare coalitions for Ebola preparedness\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/index.html\u0022\u003EInformation for healthcare workers\u003C\/a\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00371.asp\u0022\u003EHealth Alert Network (HAN) advisory for healthcare workers\u003C\/a\u003E (Oct 2, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.phe.gov\/Preparedness\/responders\/Pages\/ebola-healthcare-webinar.aspx\u0022\u003EEbola preparedness for US healthcare system (webinar with ASPR)\u003C\/a\u003E (Sep 29, 2014)\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003EInfection prevention and control recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ppe-poster.pdf\u0022\u003ESequence for removing personal protective equipment\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/s0914-ebola-surge.html\u0022\u003EFact sheet on surge\u003C\/a\u003E (Sep 16, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003ETravel\/flight information \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 8, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Feb 19, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-commercial-passenger-aircraft.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cleaning, disinfection, and waste disposal in commercial passenger aircraft \u003C\/a\u003E(Dec 18, 2014)\u0026nbsp;\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/airlines\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for airlines\u003C\/a\u003E (Dec 9, 2014)\u003Cem\u003E\u0026nbsp; \u003C\/em\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00372.asp\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening and monitoring for people entering US from Mali\u003C\/a\u003E (Nov 24)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Nov 16) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/p1116-travelers-from-mali.html\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening to begin for travelers to the US from Mali\u003C\/a\u003E (Nov 16)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/travelers\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for Travelers\u003C\/a\u003E (Nov 3, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003ECheck and Report Ebola (CARE) kit for travelers arriving in US from West Africa\u0026nbsp; \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/diseases\/ebola\u0022\u003EEbola Traveler\u0027s Health\u003C\/a\u003E\u0026nbsp;(Oct 7, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/pilots.html\u0022\u003ECDC death and disease reporting tool for pilots\u003C\/a\u003E (Aug 25, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/managing-sick-travelers\/ebola-guidance-airlines.html\u0022\u003EInterim guidance for airline crews, cleaning personnel, and cargo personnel\u003C\/a\u003E (Oct 2, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-air-medical-transport-patients.html\u0022\u003EGuidance on air medical transport for Ebola patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/guidance-reporting-onboard-deaths-illnesses.html\u0022\u003EGuidance for airlines on reporting onboard deaths or illnesses\u003C\/a\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/cabin-crew.html\u0022\u003ECDC death and disease reporting tool for cabin crew\u003C\/a\u003E (Aug 25, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUS Government \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.google.com\/url?sa=t\u0026amp;rct=j\u0026amp;q=\u0026amp;esrc=s\u0026amp;source=web\u0026amp;cd=2\u0026amp;cad=rja\u0026amp;uact=8\u0026amp;ved=0CCUQFjAB\u0026amp;url=http%3A%2F%2Fwww.fas.org%2Fsgp%2Fcrs%2Fmisc%2FR43809.pdf\u0026amp;ei=QB6KVLblMsmlyATqtYHwAg\u0026amp;usg=AFQjCNE2dHIgc_qruQur8MBr-U49sMQhDQ\u0026amp;bvm=bv.81456516,d.aWw\u0022 target=\u0022_blank\u0022\u003EPreventing the introduction and spread of Ebola in the United States: FAQs\u003C\/a\u003E (Dec 5, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/blogs.fda.gov\/fdavoice\/index.php\/2014\/10\/fda-as-part-of-a-coordinated-global-response-on-ebola\/\u0022 target=\u0022_blank\u0022\u003EFDA Commissioner\u0027s statement on agency\u0027s involvement with Ebola response\u003C\/a\u003E (Oct 28)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.hhs.gov\/news\/press\/2014pres\/09\/20140916b.html\u0022\u003EHHS statement on deployment of US Public Health Service Commissioned Corps\u003C\/a\u003E (Sep 16, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/sis.nlm.nih.gov\/dimrc\/ebola_2014.html\u0022\u003ENLM Disaster Information Management Research Center resource list\u003C\/a\u003E (Oct 8, 2014)\u0026nbsp;\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EInstitute of Medicine (IOM)\u0026nbsp; \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.nap.edu\/read\/19004\/chapter\/1\u0022 target=\u0022_blank\u0022\u003EResearch priorities to inform public health and medical practice for Ebola virus disease\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nationalacademies.org\/hmd\/Reports\/2014\/Enabling-Rapid-Sustainable-Public-Health-Research-During-Disasters.aspx\u0022 target=\u0022_blank\u0022\u003EEnabling rapid and sustainable public health research during disasters\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/nationalacademies.org\/hmd\/Global\/Topics\/Ebola.aspx\u0022 target=\u0022_blank\u0022\u003EVideo from IOM workshop on research priorities for Ebola\u003C\/a\u003E (Nov 4) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EAmerican Veterinary Medical Association (AVMA) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/pets-of-ebola-contacts.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for public health officials on pets of Ebola contacts\u003C\/a\u003E (Nov 10, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/dog-cat-quarantine.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for dog or cat quarantine after exposure to a human with confirmed Ebola\u003C\/a\u003E (Nov 10) \u003Cbr \/\u003E\u003Cem\u003ENote:\u003C\/em\u003E The following resources require AVMA membership or site registration: \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071962:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EChecklist for vets when presented with patient or client with possible Ebola exposure\u003C\/a\u003E \u003Cbr \/\u003E \u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071963:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EHandout on Ebola for pet owners\u003C\/a\u003E\u0026nbsp; \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EEuropean Centre for Disease Prevention and Control (ECDC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/safe-use-of-ppe.pdf\u0022 target=\u0022_blank\u0022\u003ESafe use of PPE in the treatment of infectious diseases with high consequence\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-public-health-contact-management-update-10-November.pdf\u0022 target=\u0022_blank\u0022\u003EGuidance for managing persons who have been exposed\u003C\/a\u003E (Nov 7, 2014, update) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/management-healthcare-workers-returning-Ebola-affected-areas.pdf\u0022 target=\u0022_blank\u0022\u003EPublic health management of healthcare workers returning from affected areas\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1094\u0022 target=\u0022_blank\u0022\u003EGuide to medical air evacuation\u003C\/a\u003E (Oct 23, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1084\u0022 target=\u0022_blank\u0022\u003ERapid risk assessment\u003C\/a\u003E (Oct 15, 2014)\u0026nbsp; \u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/healthtopics\/ebola_marburg_fevers\/EVDcasedefinition\/Pages\/default.aspx\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1076\u0022\u003EEpidemiological update - West Africa\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1064\u0022\u003EEpidemiological update - Democratic Republic of the Congo\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/_layouts\/forms\/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90\u0026amp;ID=1178\u0022\u003ERisk of Ebola transmission via donated blood and other substances of human origin\u003C\/a\u003E (Oct 6, 2014) \u003Cbr \/\u003E \u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1082\u0022 target=\u0022_blank\u0022\u003EEntry and exit screening messages\u003C\/a\u003E (Oct 13, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUnited Kingdom agencies\u003C\/h5\u003E\u003Cp\u003EPublic Health England (PHE): \u003Ca href=\u0022https:\/\/www.gov.uk\/government\/collections\/ebola-virus-disease-clinical-management-and-guidance\u0022 target=\u0022_blank\u0022\u003EClinical management and guidance for healthcare professionals\u003C\/a\u003E \u003Cbr \/\u003ENational Health Service (NHS): \u003Ca href=\u0022http:\/\/www.nhs.uk\/conditions\/ebola-virus\/Pages\/Ebola-virus.aspx\u0022 target=\u0022_blank\u0022\u003EEbola resource page for consumers \u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EPublic Health Agency of Canada (PHAC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/national-case-definition-nationale-cas-eng.php\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 23, 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr style=\u0022line-height: 1.35em;\u0022 \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-ipc-pci-eng.php\u0022\u003EInterim guidance for infection prevention and control\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-biosafety-biosecurite-eng.php\u0022\u003EInterim biosafety guidelines for laboratory specimen handling\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 22, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/evd_crf-mvd_fdc-eng.php\u0022\u003ECase report form\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EFederal Ministry of Health (Nigeria)\u003C\/h5\u003E\u003Cp\u003EEbola Virus Information Unit website\u003Cbr \/\u003E \u003Ca href=\u0022http:\/\/www.health.gov.ng\/index.php\/news-media\/press-releases\u0022\u003ERecent press releases\u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EMedecins sans Frontieres (MSF; Doctors Without Borders)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E (Mar 23, 2015)\u003C\/p\u003E\u003Ch5\u003EMinistry of Health and Sanitation (Sierra Leone)\u003C\/h5\u003E\u003Cp\u003ECase updates\u003Cbr \/\u003E Situation reports\u003Cbr \/\u003E Frequently asked questions\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EMinistry of Health (Liberia)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/moh.gov.lr\/\u0022\u003EMain page\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003Ch4\u003EProfessional Organizations\u003C\/h4\u003E\u003Ch5\u003E\u003Cstrong\u003EAmerican College of Chest Physicians (Nov 5, 2014) \u003C\/strong\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=GQgpul5czUY\u0022 target=\u0022_blank\u0022\u003EPreparing for Ebola\u003C\/a\u003E (1-hr video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=E_K-fYvHsO0\u0022 target=\u0022_blank\u0022\u003ECritical care of Persons with Ebola in Sierra Leone and at Emory University\u003C\/a\u003E ( 1-hr 15-minute video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=QPYwuwnYF4M\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EOpportunities, Lessons Learned, and Future Action Items\u003C\/a\u003E (48-minute video)\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\u003Ch4\u003EAcademic Institutions\u003C\/h4\u003E\u003Cp\u003EIDS (Institute of Development Studies) in conjunction with UK universities: \u003Ca href=\u0022http:\/\/www.ebola-anthropology.net\/\u0022 target=\u0022_blank\u0022\u003EEbola Response Anthropology Platform \u003C\/a\u003E\u003Cbr \/\u003EGeorge Washington University: \u003Ca href=\u0022http:\/\/publichealthonline.gwu.edu\/ebola-public-health-crisis\/\u0022 target=\u0022_blank\u0022\u003EInfographic on ripple effects of Ebola outbreak\u003C\/a\u003E (Nov 12) \u003Cbr \/\u003EEmory University: \u003Ca href=\u0022http:\/\/www.emoryhealthcare.org\/ebola-protocol\/resources.html\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Protocols\u003C\/a\u003E (requires registration)\u003Cbr \/\u003EUniversity of Nebraska Biocontainment Unit: \u003Ca href=\u0022http:\/\/www.nebraskamed.com\/biocontainment-unit\u0022 target=\u0022_blank\u0022\u003EPatient care links\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u0026nbsp;\u003C\/h4\u003E\u003Ch4\u003ETools\/Posters\u003C\/h4\u003E\u003Cp\u003ECDC Flipbook: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (May 1, 2015)\u003Cbr \/\u003ECDC children\u0027s activity book: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-activity-book-general.pdf\u0022 target=\u0022_blank\u0022\u003EHelping people in West Africa\u003C\/a\u003E (CDC)(Apr 22, 2015) \u003Cbr \/\u003ECDC brochure: \u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (Apr 21, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-liberia.pdf\u0022 target=\u0022_blank\u0022\u003ELiberians in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EGuineans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003ESierra Leoneans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Guinea)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-liberia.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Liberia)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ors-instructions.pdf\u0022 target=\u0022_blank\u0022\u003EHow to safely give oral rehydration solution\u003C\/a\u003E (Dec 9, 2014) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/21-day-investigation-guinea.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts in Guinea\u003C\/a\u003E (Dec 4, 2014)\u003Cbr \/\u003ECDC slides and video: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/ppt\/what-you-really-need-know-ebola.pptx\u0022 target=\u0022_blank\u0022\u003EWhat you REALLY need to know about Ebola\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/sierra-leone-21-day-investigation.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts\u2014Sierra Leone\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/top-10-things.pdf\u0022 target=\u0022_blank\u0022\u003ETop 10 things you really need to know about Ebola\u003C\/a\u003E (Nov 19, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003EMEDBOX:\u0026nbsp;\u003Ca href=\u0022http:\/\/www.medbox.org\/ebola-toolbox\/listing\u0022 target=\u0022_blank\u0022\u003EEbola Toolbox\u003C\/a\u003E \u003Cbr \/\u003EUniversity of Nebraska: \u003Ca href=\u0022https:\/\/www.nebraskamed.com\/sites\/default\/files\/documents\/biocontainment\/ebolappechecklist.pdf\u0022 target=\u0022_blank\u0022\u003EDonning \u0026amp; Doffing PPE\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EWorld Bank\u003C\/h4\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.worldbank.org\/en\/topic\/health\/brief\/world-bank-group-ebola-fact-sheet\u0022 target=\u0022_blank\u0022\u003EEbola Fact Sheet\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/documents.worldbank.org\/curated\/en\/2014\/10\/20270083\/\u0022 target=\u0022_blank\u0022\u003EEconomic impact statement\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources from Journals\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/21\/5\/14-2016_article\u0022 target=\u0022_blank\u0022\u003EUsing lessons learned from previous Ebola outbreaks to inform current risk management\u003C\/a\u003E (May 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.springer.com\/biomed\/virology\/spotlight+on+ebola?SGWID=0-1771314-0-0-0\u0022 target=\u0022_blank\u0022\u003EBioMed Central \u0026amp; Springer Ebola Resource Center\u003C\/a\u003E (open-access articles) (launched Dec 5, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003EDisaster Medicine and Public Health Preparedness \u003C\/a\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003Especial edition on Ebola\u003C\/a\u003E \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displayFulltext?type=6\u0026amp;fid=9388028\u0026amp;jid=DMP\u0026amp;volumeId=-1\u0026amp;issueId=-1\u0026amp;aid=9388027\u0026amp;fulltextType=BT\u0026amp;fileId=S1935789314001153\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EDisaster Medicine and Public Health Preparedness: A primer on Ebola for clinicians\u003C\/em\u003E\u003C\/a\u003E\u0026nbsp; (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/page\/ebola-spotlight\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nature.com\/news\/ebola-by-the-numbers-the-size-spread-and-cost-of-an-outbreak-1.16144\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003ENature:\u003C\/em\u003E Ebola by the numbers\u003C\/a\u003E\u0026nbsp; \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.nejm.org\/page\/ebola-outbreak\u0022\u003EN Engl J Med\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/ebola.thelancet.com\/\u0022\u003EThe Lancet\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/www.sciencemag.org\/site\/extra\/ebola\/\u0022\u003E\u003Cem\u003EScience\u003C\/em\u003E\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/blogs.plos.org\/speakingofmedicine\/2014\/09\/05\/plos-resources-ebola\/\u0022\u003EPLoS journals\u003C\/a\u003E \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/jama.jamanetwork.com\/article.aspx?articleid=1905875\u0022\u003EJAMA\u003C\/a\u003E\u003C\/em\u003E\u0026nbsp;\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003ETwitter\u003C\/h4\u003E\u003Cp\u003ECIDRAP (\u003Ca href=\u0022https:\/\/twitter.com\/cidrap\u0022 target=\u0022_blank\u0022\u003E@CIDRAP\u003C\/a\u003E)\u003Cbr \/\u003E Helen Branswell (\u003Ca href=\u0022https:\/\/twitter.com\/HelenBranswell\u0022 target=\u0022_blank\u0022\u003E@HelenBranswell\u003C\/a\u003E)\u003Cbr \/\u003E Michael Coston (\u003Ca href=\u0022https:\/\/twitter.com\/Fla_Medic\u0022 target=\u0022_blank\u0022\u003E@Fla_Medic\u003C\/a\u003E)\u003Cbr \/\u003E ECDC Outbreaks (\u003Ca href=\u0022https:\/\/twitter.com\/ECDC_Outbreaks\u0022 target=\u0022_blank\u0022\u003E@ECDC_Outbreaks\u003C\/a\u003E)\u003Cbr \/\u003E Martin Enserink (\u003Ca href=\u0022https:\/\/twitter.com\/martinenserink\u0022 target=\u0022_blank\u0022\u003E@martinenserink\u003C\/a\u003E) \u003Cbr \/\u003E Jason Gale (\u003Ca href=\u0022https:\/\/twitter.com\/jwgale\u0022 target=\u0022_blank\u0022\u003E@jwgale\u003C\/a\u003E) \u003Cbr \/\u003E HealthMap.org (\u003Ca href=\u0022https:\/\/twitter.com\/healthmap\u0022 target=\u0022_blank\u0022\u003E@healthmap\u003C\/a\u003E)\u003Cbr \/\u003E Crawford Kilian (\u003Ca href=\u0022https:\/\/twitter.com\/Crof\u0022 target=\u0022_blank\u0022\u003E@crof\u003C\/a\u003E)\u003Cbr \/\u003E Ian M Mackay, PhD (\u003Ca href=\u0022https:\/\/twitter.com\/MackayIM\u0022 target=\u0022_blank\u0022\u003E@MackayIM\u003C\/a\u003E)\u003Cbr \/\u003E Maia Majumder, MPH (\u003Ca href=\u0022https:\/\/twitter.com\/maiamajumder\u0022\u003E@maiamajumder\u003C\/a\u003E)\u003C\/p\u003E\u003Cp\u003E\u003Ca name=\u0022lit\u0022\u003E\u003C\/a\u003E\u003C\/p\u003E","format":"full_html","safe_value":"\u003Ch4 class=\u0022button float-right\u0022\u003E\u003Ca href=\u0022#lit\u0022\u003EJump to Recent Literature\u003C\/a\u003E\u003C\/h4\u003E\u003Ch4 class=\u0022button\u0022\u003E\u00a0\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003ELast updated May 29, 2015\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em; font-family: Arial, \u0027Helvetica Neue\u0027, Helvetica, Geneva, sans-serif; font-weight: bold;\u0022\u003ELatest Cases and General Information \u003Cbr \/\u003E\u003Cimg style=\u0022float: right;\u0022 src=\u0022\/sites\/default\/files\/public\/large_ebola.jpg\u0022 alt=\u0022Ebola virus\u0022 width=\u0022283\u0022 height=\u0022283\u0022 \/\u003E\u003C\/span\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150529?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (WHO) (May 29, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/case-counts.html\u0022 target=\u0022_blank\u0022\u003EUpdated case counts\u003C\/a\u003E (CDC) (May 29, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (CDC) (May 1, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E\u00a0 (MSF) (Mar 23, 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm64e0303a2.htm\u0022 target=\u0022_blank\u0022\u003ESystems for rapidly detecting and treating persons with Ebola\u2014US\u003C\/a\u003E (CDC) (Mar 3, 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/screening-travelers.pdf\u0022 target=\u0022_blank\u0022\u003EPreventing Ebola by screening travelers\u003C\/a\u003E (Feb 5 , 2015)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (WHO) (Jan 2015)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/how-talk-children-about-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EHow to talk with your children about Ebola\u003C\/a\u003E (CDC) (Nov 20\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/qas-monitoring-and-movement-guidance.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A on monitoring and movement\u003C\/a\u003E (CDC) (Dec 16\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/infections-spread-by-air-or-droplets.pdf\u0022 target=\u0022_blank\u0022\u003EHow Ebola is Spread\u003C\/a\u003E (\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003ECDC\u003C\/span\u003E) (Nov 1\u003Cspan\u003E\u003Cspan\u003E, 2014\u003C\/span\u003E\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/index.html\u0022\u003EWest Africa outbreak page\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E from CDC\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/maimunamajumder.wordpress.com\/tag\/ebola\/\u0022\u003EEbola visualizations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E by Maimuna Majumder, MPH\u003Cbr \/\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebola-virus-disease-evd-2014-west.html\u0022\u003EEbola disease page\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EVirology Down Under \u003C\/span\u003E\u003Ca href=\u0022http:\/\/virologydownunder.blogspot.com.au\/2014\/07\/ebolavirus-disease-evd-cases-clusters.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EEbola maps\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/healthmap.org\/ebola\/\u0022\u003EEbola outbreak map\u003C\/a\u003E from HealthMap\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/qas-pets.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola and pets\u003C\/a\u003E from CDC (Nov 12, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources for Healthcare Volunteers\u003C\/h4\u003E\u003Cp\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/advice-humanitarian-aid-organizations-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid organizations\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/page\/humanitarian-workers-ebola\u0022 target=\u0022_blank\u0022\u003EEbola advice for humanitarian aid workers\u003C\/a\u003E (Dec 11) \u003Cbr \/\u003ENIOSH: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/buddy-system.pdf\u0022 target=\u0022_blank\u0022\u003EThe buddy system\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014) \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137410\/1\/WHO_EVD_Guidance_PPE_14.1_eng.pdf\u0022 target=\u0022_blank\u0022\u003ERapid advice guideline on PPE\u003C\/a\u003E (Oct 2014)\u003Cbr \/\u003EMSF: \u003Ca href=\u0022http:\/\/www.doctorswithoutborders.org\/article\/msf-protocols-staff-returning-ebola-affected-countries\u0022 target=\u0022_blank\u0022\u003EProtocols for staff returning from Ebola-affected countries\u003C\/a\u003E (Oct 23, 2014)\u003Cbr \/\u003ECDC: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/index.html\u0022\u003ESafety training course for healthcare workers in West Africa\u003C\/a\u003E\u00a0(Oct 6, 2014)\u003Cbr \/\u003ETravel grants for health workers attending CDC training\u00a0 \u003Cbr \/\u003EWHO: \u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/maternal_perinatal\/ebola\/en\/\u0022 target=\u0022_blank\u0022\u003ESafe delivery services for mothers and newborns in Ebola outbreak areas\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003Cem\u003ESee more below under CDC\u003C\/em\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EHealth Agency Documents\u003C\/h4\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWorld Health Organization (WHO)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/gho\/data\/view.ebola-sitrep.ebola-summary-20150511?lang=en\u0022 target=\u0022_blank\u0022\u003ESituation update\u003C\/a\u003E (May 11, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/gb\/ebwha\/pdf_files\/WHA68\/A68_25-en.pdf\u0022 target=\u0022_blank\u0022\u003EEbola Interim Assessment Panel: Report by the Secretariat\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/one-year-report\/introduction\/en\/\u0022 target=\u0022_blank\u0022\u003EOne year into the Ebola epidemic\u003C\/a\u003E (Jan 2015) \u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/ebola\/en\/ebola-situation-report\/situation-reports\/ebola-situation-report-18-february-2015\u0022 target=\u0022_blank\u0022\u003ESituation roadmap\u003C\/a\u003E (WHO) (Feb 18, 2015) \u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/statements\/2014\/ebola-travel\/en\/\u0022 target=\u0022_blank\u0022\u003EStatement from Travel and Transport Task Force\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/factsheets\/fs103\/en\/\u0022 target=\u0022_blank\u0022\u003EFact sheet\u003C\/a\u003E \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/en\/\u0022\u003EEbola page \u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/faq-ebola\/en\/\u0022\u003EFrequently asked questions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/evd-guidance-summary\/en\/\u0022\u003EInfection prevention and control guidance summary\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/travel-guidance\/en\/\u0022\u003ETravel and transport risk assessment\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u00a0\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/clinical-management-patients\/en\/\u0022\u003EClinical management of patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/protective-measures-staff\/en\/\u0022\u003EProtective measures for medical staff\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/event-management-poe\/en\/\u0022\u003EInterim guidance on event management at points of entry\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/resources\/publications\/ebola\/ebola-case-definition-contact-en.pdf?ua=1\u0022\u003ECase definition recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 9, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.who.int\/csr\/disease\/ebola\/note-ebola-food-safety\/en\/\u0022\u003EEbola and food safety\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/mediacentre\/news\/ebola\/01-october-2014\/en\/\u0022\u003EExperimental vaccines\u003C\/a\u003E (Oct 1, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/apps.who.int\/iris\/bitstream\/10665\/137096\/1\/WHO_EVD_Preparedness_14_eng.pdf?ua=1\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Checklist\u003C\/a\u003E (Oct 30, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EEbola virus in semen of men recovered from Ebola\u003C\/a\u003E (Nov 26, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUnited Nations\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/liberia\/liberia-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Liberia\u003C\/a\u003E (Nov 17, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/sierra-leone\/sierra-leone-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Sierra Leone\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUNMEER: \u003Ca href=\u0022http:\/\/reliefweb.int\/report\/guinea\/guinea-fact-sheet-ebola-virus-disease-evd-outbreak-funding-17-november-2014\u0022 target=\u0022_blank\u0022\u003EEbola funding\u2014Guinea\u003C\/a\u003E (Nov 17, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=ATaQMNYpKoM\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EWorld Food Programme video: Keeping the Ebola crisis from becoming a food crisis\u003C\/a\u003E (Oct 29, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/ebolaresponse.un.org\/un-mission-ebola-emergency-response-unmeer\u0022\u003EUN Mission for Ebola Emergency Response (UNMEER)\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/UNICEF_Ebola_Waste_Management_Guidance_Note_26_09_2014.pdf\u0022\u003EUNICEF waste management guidance\u003C\/a\u003E (Sep 26, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/fao-in-action\/stories\/stories-detail\/en\/c\/251862\/\u0022 target=\u0022_blank\u0022\u003EFAO (Food and Agriculture Organization of the UN) Ebola page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.fao.org\/emergencies\/resources\/documents\/resources-detail\/en\/c\/253869\/\u0022 target=\u0022_blank\u0022\u003EFAO response summary\u003C\/a\u003E (Oct 2014)\u00a0 \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUS Centers for Disease Control and Prevention (CDC)\u003C\/h5\u003E\u003Cp\u003E\u003Cem\u003EGeneral resources \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-liberians-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Liberians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-guineans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Guineans living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/what-to-know-ebola-sierra-leoneans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EWhat to know about Ebola for Sierra Leonians living in the US\u003C\/a\u003E (Apr 22, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (CDC brochure) (Apr 21, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003EGetting to zero (video) (Apr 6, 2015) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022https:\/\/www2c.cdc.gov\/podcasts\/media\/pdf\/3-19-15_EbolaUpdate_Pets.pdf\u0022 target=\u0022_blank\u0022\u003ECDC podcast on risk to pets: transcript\u003C\/a\u003E (Mar 19, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/families\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for families and loved ones of responders\u003C\/a\u003E (Mar 13, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-safe-school-messages2015.pdf\u0022 target=\u0022_blank\u0022\u003EKey messages for safe school operations in countries with outbreaks of Ebola\u003C\/a\u003E (Feb 25, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/qa-business-travelers.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A about Ebola for US businesses, employers, and business travelers\u003C\/a\u003E (Feb 23, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/cumulative-cases-graphs.html\u0022 target=\u0022_blank\u0022\u003ECumulative reported cases graph\u003C\/a\u003E (CDC) (Feb 19, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/transporting-pediatric-patients.html\u0022 target=\u0022_blank\u0022\u003EQ \u0026amp; A re transport of pediatric patients with suspected or confirmed Ebola\u003C\/a\u003E (Feb 2, 2105)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/phlp\/docs\/interim-ebolascreening.pdf\u0022 target=\u0022_blank\u0022\u003EInterim table of state Ebola screening and monitoring policies\u003C\/a\u003E (Jan 8, 2015)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm63e1216a1.htm\u0022 target=\u0022_blank\u0022\u003ELatest\u003Cem\u003E MMWR\u003C\/em\u003E update\u003C\/a\u003E (CDC) (Dec 19, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-response-team.pdf\u0022 target=\u0022_blank\u0022\u003EEbola response team fact sheet\u003C\/a\u003E (Dec 2, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/mutations.pdf\u0022 target=\u0022_blank\u0022\u003EWhy Ebola is not likely to become airborne\u003C\/a\u003E (Dec 1, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/\u0022\u003EEbola page\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/guinea\/qa.html\u0022\u003EQuestions and answers\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 8, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/case-definition.html\u0022\u003ECase definitions\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 4, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/index.html\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EWest Africa outbreak page\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003EDemocratic Republic of the Congo outbreak page\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/transmission\/human-transmission.html\u0022 target=\u0022_blank\u0022\u003ESummary of human-to-human transmission\u003C\/a\u003E (Oct 17, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-and-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInformation on cleaning and decontamination\u003C\/a\u003E (Nov 10, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/communication-resources\/index.html\u0022 target=\u0022_blank\u0022\u003ECommunication resources for West African communities\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/information-for-west-africans-in-us.pdf\u0022 target=\u0022_blank\u0022\u003EEbola fact sheet for West Africans living in the US\u003C\/a\u003E (Nov 17) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/survivability-ebola-medical-waste.html\u0022 target=\u0022_blank\u0022\u003ESurvivability of Ebola virus in medical waste\u003C\/a\u003E (Nov 20) \u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cem\u003EGuidance documents \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/ebola-virus-semen\/en\/\u0022 target=\u0022_blank\u0022\u003EInterim advice on the sexual transmission of Ebola\u003C\/a\u003E (May 8, 2015)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E (Apr 8, 2015) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/laboratories\/safe-specimen-management.html\u0022 target=\u0022_blank\u0022\u003E\u003Cbr \/\u003EGuidance for US labs for managing and testing clinical specimens when there is concern about Ebola\u003C\/a\u003E (Feb 3, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/flu.html\u0022 target=\u0022_blank\u0022\u003EInterim recommendations for flu vaccination and post-exposure chemoprophylaxis in people being monitored for potential Ebola virus exposure\u003C\/a\u003E (Jan 26, 2015)\u003Cspan\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/business\/business-travelers.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US businesses, employers, and business travelers to prevent Ebola exposure\u003C\/a\u003E (Jan 23, 2015) \u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/bury-body-safely.pdf\u0022 target=\u0022_blank\u0022\u003EEbola must go: bury all dead bodies safely\u003C\/a\u003E (Dec 23, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/ebola-associated-waste.html\u0022 target=\u0022_blank\u0022\u003EProcedures for safe handling and management of Ebola-associated waste\u003C\/a\u003E (Dec 12, 2014) \u003Cbr \/\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for handling untreated sewage from Ebola patients in the US\u003C\/a\u003E (Nov 20\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/handling-sewage.html\u0022\u003EFAQs on interim guidance for managers and workers handling untreated sewage from suspected or confirmed individuals with Ebola in the US\u003C\/a\u003E (Dec 16, 2014) \u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-emergency-medical-services-systems-911-public-safety-answering-points-management-patients-known-suspected-united-states.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for EMS and 911 systems\u003C\/a\u003E (Dec 2, 2014)\u003C\/span\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-maternal-health.html\u0022 target=\u0022_blank\u0022\u003EScreening and caring for pregnant Ebola patients\u003C\/a\u003E (Nov 12\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E, 2014\u003C\/span\u003E) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/residental-decontamination.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for residence decontamination and removal of contaminated waste\u003C\/a\u003E (Nov 3, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/monitoring-and-movement-of-persons-with-exposure.html\u0022 target=\u0022_blank\u0022\u003ERevised interim guidance for monitoring and movement of people with potential Ebola exposure\u003C\/a\u003E (Oct 27, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1027-monitoring-symptoms-controlling-movement.html\u0022 target=\u0022_blank\u0022\u003EMonitoring symptoms and controlling movement to stop the spread of Ebola\u003C\/a\u003E (Oct 27)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procedures-for-ppe.html\u0022 target=\u0022_blank\u0022\u003EGuidance for donning and doffing PPE\u003C\/a\u003E (Oct 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/limiting-heat-burden.html\u0022 target=\u0022_self\u0022\u003EInterim guidance for limiting heat burden when wearing PPE\u003C\/a\u003E (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/interim-guidance-specimen-collection-submission-patients-suspected-infection-ebola.html\u0022\u003EInterim guidance for specimen collection\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/select-agent-regulations.html\u0022\u003EInterim guidance on compliance with select agent regulations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 8, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-safe-handling-human-remains-ebola-patients-us-hospitals-mortuaries.html\u0022\u003EGuidance for safe handling of human remains of Ebola patients\u003C\/a\u003E\u003Cspan\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/environmental-infection-control-in-hospitals.html\u0022\u003EInterim guidance for environmental infection control in hospitals\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003C\/span\u003E \u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003EResources for healthcare workers \u003Cbr \/\u003E\u003C\/em\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/safety-training-course\/training-toolkit.html\u0022 target=\u0022_blank\u0022\u003EPreparing healthcare workers to work in Ebola treatment units in Africa: Training toolkit announcement\u003C\/a\u003E (Feb 19, 2015)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/emergency-services\/emergency-department-training.html\u0022 target=\u0022_blank\u0022\u003EEbola preparedness: Emergency Department training modules\u003C\/a\u003E (Feb 17, 2015)\u003Cbr \/\u003ENon-CDC lab resources for Ebola (Jan 30, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/ppe\/supplies.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for US healthcare facilities to ensure adequate supplies of PPE for Ebola preparedness\u003C\/a\u003E (Dec 31, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/preparing-frontline-healthcare-facilities.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for frontline US healthcare facilities for potential Ebola patients\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/us-hospital-preparedness.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for US hospitals for potential Ebola patients: a tiered approach\u003C\/a\u003E (Dec 2, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/procuring-ppe.html\u0022 target=\u0022_blank\u0022\u003EBest practices for procuring PPE\u003C\/a\u003E (Nov 20, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/hand-hygiene.html\u0022 target=\u0022_blank\u0022\u003EHand hygiene in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/mixing-chlorine-solutions.html\u0022 target=\u0022_blank\u0022\u003EMixing and using chlorine solutions in non-ETU healthcare settings in West Africa\u003C\/a\u003E (Nov 13) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.youtube.com\/watch?v=8y19h1hecgY\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003ERespiratory protection video\u003C\/a\u003E (Nov 10, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/qa-infection-control-general-healthcare-widespread-ebola-transmission.html\u0022 target=\u0022_blank\u0022\u003EInfection control in countries with widespread Ebola\u003C\/a\u003E (Nov 3) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ambulatory-care-evaluation-of-patients-with-possible-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EAlgorithm for ambulatory care evaluation of patients with possible Ebola\u003C\/a\u003E (Oct 31, 2014)\u00a0\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/considerations-discharging-pui.html\u0022 target=\u0022_blank\u0022\u003EConsiderations for discharging persons under investigation for Ebola\u003C\/a\u003E (Oct 30) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/ed-management-patients-possible-ebola.html\u0022 target=\u0022_blank\u0022\u003EAlgorithm for emergency department management of patients with suspected Ebola\u003C\/a\u003E (Oct 27, 2014)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/fs1014-ebola-investigation-fact-sheet.html\u0022 target=\u0022_blank\u0022\u003EFact sheet on hospital preparedness\u003C\/a\u003E (Oct 14, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/caring-for-ebola-suspects.html\u0022 target=\u0022_blank\u0022\u003ECaring for patients under investigation for Ebola\u003C\/a\u003E (Oct 20, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/clinician-information-us-healthcare-settings.html\u0022\u003EDisease information for clinicians\u003C\/a\u003E\u003Cspan\u003E (Oct 4, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-facility-checklist-for-ebola.pdf\u0022\u003EHealthcare facility preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/healthcare-provider-checklist-for-ebola.pdf\u0022\u003EHealthcare provider preparedness checklist for EVD\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ems-checklist-ebola-preparedness.pdf\u0022\u003EEMS checklist for Ebola preparedness\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/coalition-checklist-ebola-preparedness.pdf\u0022\u003EChecklist for healthcare coalitions for Ebola preparedness\u003Cbr \/\u003E\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/index.html\u0022\u003EInformation for healthcare workers\u003C\/a\u003E (Oct 6, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00371.asp\u0022\u003EHealth Alert Network (HAN) advisory for healthcare workers\u003C\/a\u003E (Oct 2, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.phe.gov\/Preparedness\/responders\/Pages\/ebola-healthcare-webinar.aspx\u0022\u003EEbola preparedness for US healthcare system (webinar with ASPR)\u003C\/a\u003E (Sep 29, 2014)\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/drc\/2014-august.html\u0022\u003E\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/infection-prevention-and-control-recommendations.html\u0022\u003EInfection prevention and control recommendations\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 6, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ppe-poster.pdf\u0022\u003ESequence for removing personal protective equipment\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/s0914-ebola-surge.html\u0022\u003EFact sheet on surge\u003C\/a\u003E (Sep 16, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cem\u003ETravel\/flight information \u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\/alert\/ebola-liberia\u0022 target=\u0022_blank\u0022\u003EUpdated travel notice: Liberia\u003C\/a\u003E (CDC) (May 4, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/maritime\/cruise-ships.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cruise ships: managing a suspected case of Ebola onboard\u003C\/a\u003E\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Apr 8, 2015)\u003C\/span\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Feb 19, 2015)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/prevention\/cleaning-commercial-passenger-aircraft.html\u0022 target=\u0022_blank\u0022\u003EInterim guidance for cleaning, disinfection, and waste disposal in commercial passenger aircraft \u003C\/a\u003E(Dec 18, 2014)\u00a0\u003Cem\u003E \u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/airlines\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for airlines\u003C\/a\u003E (Dec 9, 2014)\u003Cem\u003E\u00a0 \u003C\/em\u003E\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/emergency.cdc.gov\/han\/han00372.asp\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening and monitoring for people entering US from Mali\u003C\/a\u003E (Nov 24)\u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/notices\u0022 target=\u0022_blank\u0022\u003ETravel health notices\u003C\/a\u003E (Nov 16) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/media\/releases\/2014\/p1116-travelers-from-mali.html\u0022 target=\u0022_blank\u0022\u003EEnhanced airport entry screening to begin for travelers to the US from Mali\u003C\/a\u003E (Nov 16)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/travelers\/index.html\u0022 target=\u0022_blank\u0022\u003EInformation for Travelers\u003C\/a\u003E (Nov 3, 2014) \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003ECheck and Report Ebola (CARE) kit for travelers arriving in US from West Africa\u00a0 \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/travel\/diseases\/ebola\u0022\u003EEbola Traveler\u0027s Health\u003C\/a\u003E\u00a0(Oct 7, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/pilots.html\u0022\u003ECDC death and disease reporting tool for pilots\u003C\/a\u003E (Aug 25, 2014) \u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/managing-sick-travelers\/ebola-guidance-airlines.html\u0022\u003EInterim guidance for airline crews, cleaning personnel, and cargo personnel\u003C\/a\u003E (Oct 2, 2014)\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/hcp\/guidance-air-medical-transport-patients.html\u0022\u003EGuidance on air medical transport for Ebola patients\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/guidance-reporting-onboard-deaths-illnesses.html\u0022\u003EGuidance for airlines on reporting onboard deaths or illnesses\u003C\/a\u003E (Aug 25, 2014)\u003Cbr \/\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/quarantine\/air\/reporting-deaths-illness\/cabin-crew.html\u0022\u003ECDC death and disease reporting tool for cabin crew\u003C\/a\u003E (Aug 25, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EUS Government \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Ca href=\u0022http:\/\/www.whitehouse.gov\/the-press-office\/2015\/02\/11\/fact-sheet-progress-our-ebola-response-home-and-abroad\u0022 target=\u0022_blank\u0022\u003EWhite House Ebola response fact sheet\u003C\/a\u003E (Feb 11, 2015) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/www.google.com\/url?sa=t\u0026amp;rct=j\u0026amp;q=\u0026amp;esrc=s\u0026amp;source=web\u0026amp;cd=2\u0026amp;cad=rja\u0026amp;uact=8\u0026amp;ved=0CCUQFjAB\u0026amp;url=http%3A%2F%2Fwww.fas.org%2Fsgp%2Fcrs%2Fmisc%2FR43809.pdf\u0026amp;ei=QB6KVLblMsmlyATqtYHwAg\u0026amp;usg=AFQjCNE2dHIgc_qruQur8MBr-U49sMQhDQ\u0026amp;bvm=bv.81456516,d.aWw\u0022 target=\u0022_blank\u0022\u003EPreventing the introduction and spread of Ebola in the United States: FAQs\u003C\/a\u003E (Dec 5, 2014) \u003Cbr \/\u003E\u003C\/span\u003E\u003Ca href=\u0022http:\/\/blogs.fda.gov\/fdavoice\/index.php\/2014\/10\/fda-as-part-of-a-coordinated-global-response-on-ebola\/\u0022 target=\u0022_blank\u0022\u003EFDA Commissioner\u0027s statement on agency\u0027s involvement with Ebola response\u003C\/a\u003E (Oct 28)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.hhs.gov\/news\/press\/2014pres\/09\/20140916b.html\u0022\u003EHHS statement on deployment of US Public Health Service Commissioned Corps\u003C\/a\u003E (Sep 16, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/sis.nlm.nih.gov\/dimrc\/ebola_2014.html\u0022\u003ENLM Disaster Information Management Research Center resource list\u003C\/a\u003E (Oct 8, 2014)\u00a0\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EInstitute of Medicine (IOM)\u00a0 \u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.nap.edu\/read\/19004\/chapter\/1\u0022 target=\u0022_blank\u0022\u003EResearch priorities to inform public health and medical practice for Ebola virus disease\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nationalacademies.org\/hmd\/Reports\/2014\/Enabling-Rapid-Sustainable-Public-Health-Research-During-Disasters.aspx\u0022 target=\u0022_blank\u0022\u003EEnabling rapid and sustainable public health research during disasters\u2014workshop summary\u003C\/a\u003E (Nov 14, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/nationalacademies.org\/hmd\/Global\/Topics\/Ebola.aspx\u0022 target=\u0022_blank\u0022\u003EVideo from IOM workshop on research priorities for Ebola\u003C\/a\u003E (Nov 4) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EAmerican Veterinary Medical Association (AVMA) \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/pets-of-ebola-contacts.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for public health officials on pets of Ebola contacts\u003C\/a\u003E (Nov 10, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/dog-cat-quarantine.pdf\u0022 target=\u0022_blank\u0022\u003EInterim guidance for dog or cat quarantine after exposure to a human with confirmed Ebola\u003C\/a\u003E (Nov 10) \u003Cbr \/\u003E\u003Cem\u003ENote:\u003C\/em\u003E The following resources require AVMA membership or site registration: \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071962:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EChecklist for vets when presented with patient or client with possible Ebola exposure\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/echo4.bluehornet.com\/ct\/50071963:28364964720:m:1:2014130080:6C2DB44DC5C51CFED58C8641A766E0E4:r\u0022 target=\u0022_blank\u0022\u003EHandout on Ebola for pet owners\u003C\/a\u003E\u00a0 \u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EEuropean Centre for Disease Prevention and Control (ECDC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/safe-use-of-ppe.pdf\u0022 target=\u0022_blank\u0022\u003ESafe use of PPE in the treatment of infectious diseases with high consequence\u003C\/a\u003E (Dec 2, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/ebola-public-health-contact-management-update-10-November.pdf\u0022 target=\u0022_blank\u0022\u003EGuidance for managing persons who have been exposed\u003C\/a\u003E (Nov 7, 2014, update) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/management-healthcare-workers-returning-Ebola-affected-areas.pdf\u0022 target=\u0022_blank\u0022\u003EPublic health management of healthcare workers returning from affected areas\u003C\/a\u003E (Nov 7, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1094\u0022 target=\u0022_blank\u0022\u003EGuide to medical air evacuation\u003C\/a\u003E (Oct 23, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1084\u0022 target=\u0022_blank\u0022\u003ERapid risk assessment\u003C\/a\u003E (Oct 15, 2014)\u00a0 \u003Cbr \/\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/healthtopics\/ebola_marburg_fevers\/EVDcasedefinition\/Pages\/default.aspx\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1076\u0022\u003EEpidemiological update - West Africa\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Oct 3, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1064\u0022\u003EEpidemiological update - Democratic Republic of the Congo\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/publications\/_layouts\/forms\/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90\u0026amp;ID=1178\u0022\u003ERisk of Ebola transmission via donated blood and other substances of human origin\u003C\/a\u003E (Oct 6, 2014) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.ecdc.europa.eu\/en\/press\/news\/_layouts\/forms\/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568\u0026amp;ID=1082\u0022 target=\u0022_blank\u0022\u003EEntry and exit screening messages\u003C\/a\u003E (Oct 13, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EUnited Kingdom agencies\u003C\/h5\u003E\u003Cp\u003EPublic Health England (PHE): \u003Ca href=\u0022https:\/\/www.gov.uk\/government\/collections\/ebola-virus-disease-clinical-management-and-guidance\u0022 target=\u0022_blank\u0022\u003EClinical management and guidance for healthcare professionals\u003C\/a\u003E \u003Cbr \/\u003ENational Health Service (NHS): \u003Ca href=\u0022http:\/\/www.nhs.uk\/conditions\/ebola-virus\/Pages\/Ebola-virus.aspx\u0022 target=\u0022_blank\u0022\u003EEbola resource page for consumers \u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EPublic Health Agency of Canada (PHAC)\u003C\/h5\u003E\u003Cp\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/national-case-definition-nationale-cas-eng.php\u0022\u003ECase definition\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 23, 2014)\u003C\/span\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Cbr style=\u0022line-height: 1.35em;\u0022 \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-ipc-pci-eng.php\u0022\u003EInterim guidance for infection prevention and control\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Sep 12, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/ebola-biosafety-biosecurite-eng.php\u0022\u003EInterim biosafety guidelines for laboratory specimen handling\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 22, 2014)\u003Cbr \/\u003E\u003C\/span\u003E\u003Ca style=\u0022line-height: 1.35em;\u0022 href=\u0022http:\/\/www.phac-aspc.gc.ca\/id-mi\/vhf-fvh\/evd_crf-mvd_fdc-eng.php\u0022\u003ECase report form\u003C\/a\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E (Aug 24, 2014)\u003C\/span\u003E\u003C\/p\u003E\u003Ch5\u003EFederal Ministry of Health (Nigeria)\u003C\/h5\u003E\u003Cp\u003EEbola Virus Information Unit website\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.health.gov.ng\/index.php\/news-media\/press-releases\u0022\u003ERecent press releases\u003C\/a\u003E\u003C\/p\u003E\u003Ch5\u003EMedecins sans Frontieres (MSF; Doctors Without Borders)\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.msf.org\/sites\/msf.org\/files\/msf1yearebolareport_en_230315.pdf\u0022 target=\u0022_blank\u0022\u003EPushed to the Limit and Beyond: A Year into the Largest Ever Ebola Outbreak\u003C\/a\u003E (Mar 23, 2015)\u003C\/p\u003E\u003Ch5\u003EMinistry of Health and Sanitation (Sierra Leone)\u003C\/h5\u003E\u003Cp\u003ECase updates\u003Cbr \/\u003E Situation reports\u003Cbr \/\u003E Frequently asked questions\u003C\/p\u003E\u003Ch5\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003EMinistry of Health (Liberia)\u003C\/span\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/moh.gov.lr\/\u0022\u003EMain page\u003C\/a\u003E\u003C\/p\u003E\u003Cp\u003E\u00a0\u003C\/p\u003E\u003Ch4\u003EProfessional Organizations\u003C\/h4\u003E\u003Ch5\u003E\u003Cstrong\u003EAmerican College of Chest Physicians (Nov 5, 2014) \u003C\/strong\u003E\u003C\/h5\u003E\u003Cp\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=GQgpul5czUY\u0022 target=\u0022_blank\u0022\u003EPreparing for Ebola\u003C\/a\u003E (1-hr video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=E_K-fYvHsO0\u0022 target=\u0022_blank\u0022\u003ECritical care of Persons with Ebola in Sierra Leone and at Emory University\u003C\/a\u003E ( 1-hr 15-minute video) \u003Cbr \/\u003E\u003Ca href=\u0022https:\/\/www.youtube.com\/watch?v=QPYwuwnYF4M\u0026amp;feature=youtu.be\u0022 target=\u0022_blank\u0022\u003EOpportunities, Lessons Learned, and Future Action Items\u003C\/a\u003E (48-minute video)\u003C\/p\u003E\u003Cp\u003E\u00a0\u003C\/p\u003E\u003Ch4\u003EAcademic Institutions\u003C\/h4\u003E\u003Cp\u003EIDS (Institute of Development Studies) in conjunction with UK universities: \u003Ca href=\u0022http:\/\/www.ebola-anthropology.net\/\u0022 target=\u0022_blank\u0022\u003EEbola Response Anthropology Platform \u003C\/a\u003E\u003Cbr \/\u003EGeorge Washington University: \u003Ca href=\u0022http:\/\/publichealthonline.gwu.edu\/ebola-public-health-crisis\/\u0022 target=\u0022_blank\u0022\u003EInfographic on ripple effects of Ebola outbreak\u003C\/a\u003E (Nov 12) \u003Cbr \/\u003EEmory University: \u003Ca href=\u0022http:\/\/www.emoryhealthcare.org\/ebola-protocol\/resources.html\u0022 target=\u0022_blank\u0022\u003EEbola Preparedness Protocols\u003C\/a\u003E (requires registration)\u003Cbr \/\u003EUniversity of Nebraska Biocontainment Unit: \u003Ca href=\u0022http:\/\/www.nebraskamed.com\/biocontainment-unit\u0022 target=\u0022_blank\u0022\u003EPatient care links\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u00a0\u003C\/h4\u003E\u003Ch4\u003ETools\/Posters\u003C\/h4\u003E\u003Cp\u003ECDC Flipbook: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/flipbook-survived-ebola.pdf\u0022 target=\u0022_blank\u0022\u003EYou\u0027ve survived Ebola: What\u0027s next?\u003C\/a\u003E (May 1, 2015)\u003Cbr \/\u003ECDC children\u0027s activity book: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-activity-book-general.pdf\u0022 target=\u0022_blank\u0022\u003EHelping people in West Africa\u003C\/a\u003E (CDC)(Apr 22, 2015) \u003Cbr \/\u003ECDC brochure: \u003Cspan\u003E\u003Cspan\u003E\u003Cspan\u003E\u003Cspan style=\u0022line-height: 1.35em;\u0022\u003E\u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ebola-condom-brochure.pdf\u0022 target=\u0022_blank\u0022\u003EEbola survivors: Read this before you have sex\u003C\/a\u003E (Apr 21, 2015)\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-liberia.pdf\u0022 target=\u0022_blank\u0022\u003ELiberians in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EGuineans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/poster-be-a-hero-guinea.pdf\u0022 target=\u0022_blank\u0022\u003ESierra Leoneans in the US: Be a hero\u003C\/a\u003E (Apr 15, 2015)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-guinea.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Guinea)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/do-not-travel-when-sick-liberia.pdf\u0022 target=\u0022_blank\u0022\u003EDo not travel when sick (Liberia)\u003C\/a\u003E (Mar 5, 2015) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/ors-instructions.pdf\u0022 target=\u0022_blank\u0022\u003EHow to safely give oral rehydration solution\u003C\/a\u003E (Dec 9, 2014) \u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/21-day-investigation-guinea.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts in Guinea\u003C\/a\u003E (Dec 4, 2014)\u003Cbr \/\u003ECDC slides and video: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/ppt\/what-you-really-need-know-ebola.pptx\u0022 target=\u0022_blank\u0022\u003EWhat you REALLY need to know about Ebola\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/sierra-leone-21-day-investigation.pdf\u0022 target=\u0022_blank\u0022\u003E21-Day investigation of Ebola patient\u0027s direct contacts\u2014Sierra Leone\u003C\/a\u003E (Nov 25)\u003Cbr \/\u003E\u003Cspan\u003E\u003Cspan\u003ECDC poster: \u003Ca href=\u0022http:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/top-10-things.pdf\u0022 target=\u0022_blank\u0022\u003ETop 10 things you really need to know about Ebola\u003C\/a\u003E (Nov 19, 2014)\u003C\/span\u003E\u003C\/span\u003E\u003Cbr \/\u003EMEDBOX:\u00a0\u003Ca href=\u0022http:\/\/www.medbox.org\/ebola-toolbox\/listing\u0022 target=\u0022_blank\u0022\u003EEbola Toolbox\u003C\/a\u003E \u003Cbr \/\u003EUniversity of Nebraska: \u003Ca href=\u0022https:\/\/www.nebraskamed.com\/sites\/default\/files\/documents\/biocontainment\/ebolappechecklist.pdf\u0022 target=\u0022_blank\u0022\u003EDonning \u0026amp; Doffing PPE\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EWorld Bank\u003C\/h4\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.worldbank.org\/en\/topic\/health\/brief\/world-bank-group-ebola-fact-sheet\u0022 target=\u0022_blank\u0022\u003EEbola Fact Sheet\u003C\/a\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/documents.worldbank.org\/curated\/en\/2014\/10\/20270083\/\u0022 target=\u0022_blank\u0022\u003EEconomic impact statement\u003C\/a\u003E\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003EResources from Journals\u003C\/h4\u003E\u003Cp\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E: \u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/article\/21\/5\/14-2016_article\u0022 target=\u0022_blank\u0022\u003EUsing lessons learned from previous Ebola outbreaks to inform current risk management\u003C\/a\u003E (May 2015) \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.springer.com\/biomed\/virology\/spotlight+on+ebola?SGWID=0-1771314-0-0-0\u0022 target=\u0022_blank\u0022\u003EBioMed Central \u0026amp; Springer Ebola Resource Center\u003C\/a\u003E (open-access articles) (launched Dec 5, 2014)\u003Cem\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003EDisaster Medicine and Public Health Preparedness \u003C\/a\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displaySpecialArticle?jid=DMP\u0026amp;bespokeId=11228\u0022 target=\u0022_blank\u0022\u003Especial edition on Ebola\u003C\/a\u003E \u003Cem\u003E\u003Cbr \/\u003E\u003C\/em\u003E\u003Ca href=\u0022http:\/\/journals.cambridge.org\/action\/displayFulltext?type=6\u0026amp;fid=9388028\u0026amp;jid=DMP\u0026amp;volumeId=-1\u0026amp;issueId=-1\u0026amp;aid=9388027\u0026amp;fulltextType=BT\u0026amp;fileId=S1935789314001153\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EDisaster Medicine and Public Health Preparedness: A primer on Ebola for clinicians\u003C\/em\u003E\u003C\/a\u003E\u00a0 (Oct 17, 2014)\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/wwwnc.cdc.gov\/eid\/page\/ebola-spotlight\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003EEmerging Infectious Diseases\u003C\/em\u003E\u003C\/a\u003E \u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.nature.com\/news\/ebola-by-the-numbers-the-size-spread-and-cost-of-an-outbreak-1.16144\u0022 target=\u0022_blank\u0022\u003E\u003Cem\u003ENature:\u003C\/em\u003E Ebola by the numbers\u003C\/a\u003E\u00a0 \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/www.nejm.org\/page\/ebola-outbreak\u0022\u003EN Engl J Med\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/ebola.thelancet.com\/\u0022\u003EThe Lancet\u003Cbr \/\u003E\u003C\/a\u003E\u003Ca href=\u0022http:\/\/www.sciencemag.org\/site\/extra\/ebola\/\u0022\u003E\u003Cem\u003EScience\u003C\/em\u003E\u003C\/a\u003E\u003C\/em\u003E\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/blogs.plos.org\/speakingofmedicine\/2014\/09\/05\/plos-resources-ebola\/\u0022\u003EPLoS journals\u003C\/a\u003E \u003Cbr \/\u003E\u003Cem\u003E\u003Ca href=\u0022http:\/\/jama.jamanetwork.com\/article.aspx?articleid=1905875\u0022\u003EJAMA\u003C\/a\u003E\u003C\/em\u003E\u00a0\u003C\/p\u003E\u003Ch4\u003E\u003Cbr \/\u003ETwitter\u003C\/h4\u003E\u003Cp\u003ECIDRAP (\u003Ca href=\u0022https:\/\/twitter.com\/cidrap\u0022 target=\u0022_blank\u0022\u003E@CIDRAP\u003C\/a\u003E)\u003Cbr \/\u003E Helen Branswell (\u003Ca href=\u0022https:\/\/twitter.com\/HelenBranswell\u0022 target=\u0022_blank\u0022\u003E@HelenBranswell\u003C\/a\u003E)\u003Cbr \/\u003E Michael Coston (\u003Ca href=\u0022https:\/\/twitter.com\/Fla_Medic\u0022 target=\u0022_blank\u0022\u003E@Fla_Medic\u003C\/a\u003E)\u003Cbr \/\u003E ECDC Outbreaks (\u003Ca href=\u0022https:\/\/twitter.com\/ECDC_Outbreaks\u0022 target=\u0022_blank\u0022\u003E@ECDC_Outbreaks\u003C\/a\u003E)\u003Cbr \/\u003E Martin Enserink (\u003Ca href=\u0022https:\/\/twitter.com\/martinenserink\u0022 target=\u0022_blank\u0022\u003E@martinenserink\u003C\/a\u003E) \u003Cbr \/\u003E Jason Gale (\u003Ca href=\u0022https:\/\/twitter.com\/jwgale\u0022 target=\u0022_blank\u0022\u003E@jwgale\u003C\/a\u003E) \u003Cbr \/\u003E HealthMap.org (\u003Ca href=\u0022https:\/\/twitter.com\/healthmap\u0022 target=\u0022_blank\u0022\u003E@healthmap\u003C\/a\u003E)\u003Cbr \/\u003E Crawford Kilian (\u003Ca href=\u0022https:\/\/twitter.com\/Crof\u0022 target=\u0022_blank\u0022\u003E@crof\u003C\/a\u003E)\u003Cbr \/\u003E Ian M Mackay, PhD (\u003Ca href=\u0022https:\/\/twitter.com\/MackayIM\u0022 target=\u0022_blank\u0022\u003E@MackayIM\u003C\/a\u003E)\u003Cbr \/\u003E Maia Majumder, MPH (\u003Ca href=\u0022https:\/\/twitter.com\/maiamajumder\u0022\u003E@maiamajumder\u003C\/a\u003E)\u003C\/p\u003E\u003Cp\u003E\u003Ca name=\u0022lit\u0022 id=\u0022lit\u0022\u003E\u003C\/a\u003E\u003C\/p\u003E"}]},"field_hp_size":{"und":[{"mode":"hp_large"}]},"field_bibliography":[],"field_body_biblio":[],"field_field_collection_biblio":[],"rdf_mapping":{"rdftype":["sioc:Item","foaf:Document"],"title":{"predicates":["dc:title"]},"created":{"predicates":["dc:date","dc:created"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"changed":{"predicates":["dc:modified"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"body":{"predicates":["content:encoded"]},"uid":{"predicates":["sioc:has_creator"],"type":"rel"},"name":{"predicates":["foaf:name"]},"comment_count":{"predicates":["sioc:num_replies"],"datatype":"xsd:integer"},"last_activity":{"predicates":["sioc:last_activity_date"],"datatype":"xsd:dateTime","callback":"date_iso8601"}},"path":{"pathauto":"1"},"cid":"0","last_comment_timestamp":"1362431979","last_comment_name":null,"last_comment_uid":"1","comment_count":"0","nodehierarchy_menu_links":[],"name":"admin","picture":"0","data":"a:8:{s:19:\u0022biblio_show_profile\u0022;i:0;s:19:\u0022biblio_my_pubs_menu\u0022;i:0;s:21:\u0022biblio_contributor_id\u0022;s:1:\u00220\u0022;s:22:\u0022biblio_id_change_count\u0022;s:1:\u00220\u0022;s:17:\u0022biblio_user_style\u0022;s:6:\u0022system\u0022;s:18:\u0022biblio_baseopenurl\u0022;s:0:\u0022\u0022;s:18:\u0022biblio_openurl_sid\u0022;s:0:\u0022\u0022;s:19:\u0022biblio_crossref_pid\u0022;s:0:\u0022\u0022;}","print_html_display":1,"print_html_display_comment":0,"print_html_display_urllist":1}},{"nid":"102","access":true,"node":{"vid":"260556","uid":"1","title":"VHF","log":"","status":"1","comment":"1","promote":"0","sticky":"0","vuuid":"be4d865e-8914-4d80-9ab3-26056a6009fc","nid":"102","type":"topics","language":"und","created":"1362432020","changed":"1496768999","tnid":"0","translate":"0","uuid":"0f616411-1ec2-4f74-98a8-bd0c6f438699","revision_timestamp":"1496768999","revision_uid":"61146","field_tab_collection":{"und":[{"value":"341","revision_id":"41541"},{"value":"346","revision_id":"41546"},{"value":"351","revision_id":"41551"},{"value":"356","revision_id":"41556"},{"value":"361","revision_id":"41561"},{"value":"366","revision_id":"41566"},{"value":"371","revision_id":"41571"},{"value":"376","revision_id":"41576"}]},"field_body":[],"field_overview":{"und":[{"value":"\u003Cp\u003E\u003Cem\u003ELast updated Jun 21, 2012\u003C\/em\u003E\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003E\u003Cem\u003ELast updated Jun 21, 2012\u003C\/em\u003E\u003C\/p\u003E"}]},"field_show_topic":{"und":[{"value":"1"}]},"field_related_topics":{"und":[{"nid":"64"},{"nid":"77"},{"nid":"104"}]},"field_ss_media_file":[],"field_last_updated":[],"field_file_attachments":[],"field_synonyms":{"und":[{"value":"Viral Hemorrhagic Fever","format":null,"safe_value":"Viral Hemorrhagic Fever"}]},"field_call_action":[],"field_related_links":[],"field_teaser":{"und":[{"value":"\u003Cp\u003ECIDRAP-authored overview\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003ECIDRAP-authored overview\u003C\/p\u003E"}]},"field_roundup_type":{"und":[{"value":"1"}]},"field_subtitle":{"und":[{"value":"\u003Cp\u003EViral hemorrhagic fever\u003C\/p\u003E","format":"full_html","safe_value":"\u003Cp\u003EViral hemorrhagic fever\u003C\/p\u003E"}]},"field_super_title":[],"field_resources":[],"field_hp_size":[],"field_bibliography":[],"field_body_biblio":[],"field_field_collection_biblio":[],"rdf_mapping":{"rdftype":["sioc:Item","foaf:Document"],"title":{"predicates":["dc:title"]},"created":{"predicates":["dc:date","dc:created"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"changed":{"predicates":["dc:modified"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"body":{"predicates":["content:encoded"]},"uid":{"predicates":["sioc:has_creator"],"type":"rel"},"name":{"predicates":["foaf:name"]},"comment_count":{"predicates":["sioc:num_replies"],"datatype":"xsd:integer"},"last_activity":{"predicates":["sioc:last_activity_date"],"datatype":"xsd:dateTime","callback":"date_iso8601"}},"path":{"pathauto":"1"},"cid":"0","last_comment_timestamp":"1362432020","last_comment_name":null,"last_comment_uid":"1","comment_count":"0","nodehierarchy_menu_links":[],"name":"admin","picture":"0","data":"a:8:{s:19:\u0022biblio_show_profile\u0022;i:0;s:19:\u0022biblio_my_pubs_menu\u0022;i:0;s:21:\u0022biblio_contributor_id\u0022;s:1:\u00220\u0022;s:22:\u0022biblio_id_change_count\u0022;s:1:\u00220\u0022;s:17:\u0022biblio_user_style\u0022;s:6:\u0022system\u0022;s:18:\u0022biblio_baseopenurl\u0022;s:0:\u0022\u0022;s:18:\u0022biblio_openurl_sid\u0022;s:0:\u0022\u0022;s:19:\u0022biblio_crossref_pid\u0022;s:0:\u0022\u0022;}","print_html_display":1,"print_html_display_comment":0,"print_html_display_urllist":1}}]},"field_file_attachments":[],"field_tags":[],"field_country":[],"field_organization":{"und":[{"tid":"221"},{"tid":"268"}]},"field_ss_media_file":{"und":[{"fid":"20351","uid":"801","filename":"papr.jpg","uri":"public:\/\/media\/article\/papr_0.jpg","filemime":"image\/jpeg","filesize":"52939","status":"1","timestamp":"1411044209","type":"image","uuid":"2858d463-8f51-4409-99b6-72777b4492a3","field_file_image_alt_text":{"und":[{"value":"PAPR - powered air-purifying respirator","format":null,"safe_value":"PAPR - powered air-purifying respirator"}]},"field_file_image_title_text":{"und":[{"value":"A powered air-purifying respirator (PAPR).","format":null,"safe_value":"A powered air-purifying respirator (PAPR)."}]},"field_credit":{"und":[{"value":"Courtesy of 3M Company","format":null,"safe_value":"Courtesy of 3M Company"}]},"rdf_mapping":[],"metadata":[],"alt":"PAPR - powered air-purifying respirator","title":"A powered air-purifying respirator (PAPR).","display":"1","description":null}]},"field_related_articles":[],"field_related_literature":[],"field_related_news":{"und":[{"vname":"news|entity_view_1","vargs":""}]},"field_byline":{"und":[{"tid":"881","taxonomy_term":{"tid":"881","vid":"21","name":"Lisa M Brosseau, ScD, and Rachael Jones, PhD","description":"","format":"full_html","weight":"19","uuid":"d7f5f545-e776-4984-90b9-5f48481d6f9f","vocabulary_machine_name":"bylines","rdf_mapping":{"rdftype":["skos:Concept"],"name":{"predicates":["rdfs:label","skos:prefLabel"]},"description":{"predicates":["skos:definition"]},"vid":{"predicates":["skos:inScheme"],"type":"rel"},"parent":{"predicates":["skos:broader"],"type":"rel"}}}}]},"field_super_title":[],"field_hp_size":{"und":[{"mode":"hp_large"}]},"field_th_asp_topic":[],"rdf_mapping":{"rdftype":["sioc:Item","foaf:Document"],"title":{"predicates":["dc:title"]},"created":{"predicates":["dc:date","dc:created"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"changed":{"predicates":["dc:modified"],"datatype":"xsd:dateTime","callback":"date_iso8601"},"body":{"predicates":["content:encoded"]},"uid":{"predicates":["sioc:has_creator"],"type":"rel"},"name":{"predicates":["foaf:name"]},"comment_count":{"predicates":["sioc:num_replies"],"datatype":"xsd:integer"},"last_activity":{"predicates":["sioc:last_activity_date"],"datatype":"xsd:dateTime","callback":"date_iso8601"}},"cid":0,"last_comment_timestamp":"1410995616","last_comment_name":"","last_comment_uid":"801","comment_count":0,"nodehierarchy_menu_links":[],"name":"Jim Wappes","picture":"0","data":"b:0;","print_html_display":1,"print_html_display_comment":0,"print_html_display_urllist":1,"entity_view_prepared":true,"service_links":{"service-links-facebook":{"title":"Share","href":"http:\/\/www.facebook.com\/sharer.php","query":{"u":"http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola","t":"COMMENTARY: Health workers need optimal respiratory protection for Ebola"},"attributes":{"title":"Share on Facebook","class":["service-links-facebook"],"rel":"nofollow"}},"service-links-twitter":{"title":"Tweet","href":"http:\/\/twitter.com\/share","query":{"url":"http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola","text":"COMMENTARY: Health workers need optimal respiratory protection for Ebola"},"attributes":{"title":"Share this on Twitter","class":["service-links-twitter"],"rel":"nofollow"}},"service-links-linkedin":{"title":"LinkedIn","href":"http:\/\/www.linkedin.com\/shareArticle","query":{"mini":"true","url":"http:\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola","title":"COMMENTARY: Health workers need optimal respiratory protection for Ebola","summary":"","source":"CIDRAP"},"attributes":{"title":"Publish this post to LinkedIn","class":["service-links-linkedin"],"rel":"nofollow"}},"service-links-forward":{"title":"Email","href":"http:\/\/www.cidrap.umn.edu\/forward","query":{"path":"node\/84276"},"attributes":{"title":"Send to a friend","class":["service-links-forward"],"rel":"nofollow"}},"service-links-printfriendly":{"title":"Print \u0026 PDF","href":"http:\/\/www.printfriendly.com","query":null,"attributes":{"class":["printfriendly","service-links-printfriendly"],"onclick":"window.print();return false;","title":"Print and PDF versions","rel":"nofollow"}}},"service_links_rendered":"\u003Cdiv class=\u0022service-links\u0022\u003E\u003Cdiv class=\u0022service-label\u0022\u003EShare this page: \u003C\/div\u003E\u003Cul class=\u0022links\u0022\u003E\u003Cli class=\u0022service-links-facebook link-share link-http--wwwfacebookcom-sharerphp link-idx-0 link-idx--4 first\u0022\u003E\u003Ca href=\u0022http:\/\/www.facebook.com\/sharer.php?u=http%3A\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola\u0026amp;t=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola\u0022 title=\u0022Share on Facebook\u0022 class=\u0022service-links-facebook\u0022 rel=\u0022nofollow\u0022\u003EShare\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-twitter link-tweet link-http--twittercom-share link-idx-1 link-idx--3\u0022\u003E\u003Ca href=\u0022http:\/\/twitter.com\/share?url=http%3A\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola\u0026amp;text=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola\u0022 title=\u0022Share this on Twitter\u0022 class=\u0022service-links-twitter\u0022 rel=\u0022nofollow\u0022\u003ETweet\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-linkedin link-linkedin link-http--wwwlinkedincom-sharearticle link-idx-2 link-idx--2\u0022\u003E\u003Ca href=\u0022http:\/\/www.linkedin.com\/shareArticle?mini=true\u0026amp;url=http%3A\/\/www.cidrap.umn.edu\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola\u0026amp;title=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola\u0026amp;summary=\u0026amp;source=CIDRAP\u0022 title=\u0022Publish this post to LinkedIn\u0022 class=\u0022service-links-linkedin\u0022 rel=\u0022nofollow\u0022\u003ELinkedIn\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-forward link-email link-http--wwwcidrapumnedu-forward link-idx-3 link-idx--1\u0022\u003E\u003Ca href=\u0022http:\/\/www.cidrap.umn.edu\/forward?path=node\/84276\u0022 title=\u0022Send to a friend\u0022 class=\u0022service-links-forward\u0022 rel=\u0022nofollow\u0022\u003EEmail\u003C\/a\u003E\u003C\/li\u003E\n\u003Cli class=\u0022service-links-printfriendly link-print--pdf link-http--wwwprintfriendlycom link-idx-4 link-idx--0 last\u0022\u003E\u003Ca href=\u0022http:\/\/www.printfriendly.com\u0022 class=\u0022printfriendly service-links-printfriendly\u0022 onclick=\u0022window.print();return false;\u0022 title=\u0022Print and PDF versions\u0022 rel=\u0022nofollow\u0022\u003EPrint \u0026amp; PDF\u003C\/a\u003E\u003C\/li\u003E\n\u003C\/ul\u003E\u003C\/div\u003E","fieldlayout_cache":[]},"referencing_entity_type":"node","referencing_field":"field_ss_media_file","entity_view_prepared":true},"#view_mode":"full","#language":"en","#contextual_links":{"file":["file",["20351"]]},"#prefix":"\u003Cdiv class=\u0022ss-media-item ss-media-item-image\u0022\u003E","#suffix":"\u003C\/div\u003E"}],"#attributes":{"class":["ui-slides-pager-item","view-mode-full"]}}}],"speed":"200","display_type_full":"colorbox","timeout":"0","loop":0,"autorotate":0,"order":"","controls":1,"pause":1,"display_type_pager":"carousel","carousel_visible":"1","carousel_scroll":"1","carousel_speed":"500","carousel_vertical":0,"carousel_circular":0,"image_style":null,"pager_image_style":null,"carousel_image_style":null,"theme_hook_original":"field_slidetabs","theme_hook_suggestions":[],"zebra":"odd","id":1,"directory":"sites\/default\/themes\/siteskin","classes_array":["field-slidetabs"],"attributes_array":[],"title_attributes_array":[],"content_attributes_array":[],"title_prefix":[],"title_suffix":[],"user":{"uid":0,"hostname":"138.201.51.213","roles":{"1":"anonymous user"},"cache":0},"db_is_active":true,"is_admin":false,"logged_in":false,"is_front":false}},"urlIsAjaxTrusted":{"\/news-perspective\/2014\/09\/commentary-health-workers-need-optimal-respiratory-protection-ebola":true}});
//--><!]]>
</script>
</head>
<body class="html not-front not-logged-in one-sidebar sidebar-second page-node page-node- page-node-84276 node-type-ss-news page-news-perspective-2014-09-commentary-health-workers-need-optimal-respiratory-protection-ebola page-news-perspective-2014-09 page-news-perspective-2014 page-news-perspective">
<div id="skip-link">
<a class="element-invisible element-focusable" href="http://www.cidrap.umn.edu/#main-content">Skip to main content</a>
</div>
<a id="top"></a>
<div id="page-wrapper"><div id="page">
<div class="cidrapResponsive-processed" id="header">
<div class="region region-header">
<div class="region-header-inner region-inner">
<div class="block block-block" id="block-block-10">
<div class="block-inner">
<div class="content block-content">
<p><a href="http://www.umn.edu" target="_blank">University of Minnesota. Driven to Discover.</a></p> </div>
</div>
</div>
<div class="block block-search-api-page block-with-title" id="block-search-api-page-site-search">
<div class="block-inner">
<h2 class="element-invisible block-title"><span class="first">Site</span> <span class="last">Search</span></h2>
<div class="content block-content">
<form accept-charset="UTF-8" action="/news-perspective/2014/09/commentary-health-workers-need-optimal-respiratory-protection-ebola" id="search-api-page-search-form-site-search" method="post"><div><div class="form-item form-type-textfield form-item-keys-1">
<input class="inputhelp form-text dimmed" id="edit-keys-1" maxlength="128" name="keys_1" size="15" title="Search CIDRAP" type="text" value=""/>
</div>
<input name="id" type="hidden" value="1"/>
<input class="form-submit" id="edit-submit-1" name="op" type="submit" value="Go"/><input name="form_build_id" type="hidden" value="form-wnSgczQVfXjRWMzOv_cKvsO46Qas8nPj5uev-gE9U_4"/>
<input name="form_id" type="hidden" value="search_api_page_search_form_site_search"/>
</div></form> </div>
</div>
</div>
<div class="block block-siteskeleton" id="block-siteskeleton-logo">
<div class="block-inner">
<div class="content block-content">
<a href="http://www.cidrap.umn.edu/" id="logo" rel="home" title="Home"><img alt="CIDRAP" src="http://www.cidrap.umn.edu/sites/default/themes/siteskin/inc/images/logo-internal.png"/><img alt="Center for Infectious Disease Research and Policy" class="tagline" src="http://www.cidrap.umn.edu/sites/default/themes/siteskin/inc/images/logo-tagline.png"/></a> </div>
</div>
</div>
<div class="block block-menu block-with-title" id="block-menu-menu-connect-with-us">
<div class="block-inner">
<h2 class="element-invisible block-title"><span class="first">Connect</span> with <span class="last">Us</span></h2>
<div class="content block-content">
<ul class="menu"><li class="first leaf link-newsletter-signup link-node-24141"><a href="http://www.cidrap.umn.edu/newsletter" title="Newsletter Signup">Newsletter Signup</a></li>
<li class="leaf link-facebook link-node-31191"><a href="http://www.cidrap.umn.edu/cidrap-facebook" title="Find us on Facebook">Facebook</a></li>
<li class="leaf link-twitter link-node-31154"><a href="http://www.cidrap.umn.edu/cidrap-twitter" title="Follow us on Twitter">Twitter</a></li>
<li class="leaf link-youtube link-https--wwwyoutubecom-user-cidrapasp"><a href="https://www.youtube.com/user/CIDRAPASP" target="_blank" title="Find us on YouTube">Youtube</a></li>
<li class="leaf link-email-alerts link-node-2439"><a href="http://www.cidrap.umn.edu/rss-feeds" title="RSS Page">Email Alerts</a></li>
<li class="last leaf link-contact-us link-node-5"><a href="http://www.cidrap.umn.edu/about-us/contact-us" title="Contact Us">Contact Us</a></li>
</ul> </div>
</div>
</div>
<div class="block block-siteskeleton block-with-title" id="block-siteskeleton-primary-nav">
<div class="block-inner">
<h2 class="element-invisible block-title"><span class="first">Main</span> <span class="last">Menu</span></h2>
<div class="content block-content">
<h2 class="element-invisible menu-title">Main menu</h2><div class="menu-block-wrapper menu-block-primary_flyout menu-name-main-menu parent-mlid-0 menu-level-0">
<ul class="menu"><li class="first leaf menu-mlid-1521 menu-dir-l menu-num-1 menu-num--7 link-home link-front"><a href="http://www.cidrap.umn.edu/" title="">Home</a></li>
<li class="leaf menu-mlid-1637 menu-dir-l menu-num-2 menu-num--6 link-news--perspective link-news-perspective"><a href="http://www.cidrap.umn.edu/news-perspective">News &amp; Perspective</a></li>
<li class="leaf menu-mlid-5021 menu-dir-l menu-num-3 menu-num--5 link-infectious-disease-topics link-node-68186"><a href="http://www.cidrap.umn.edu/infectious-disease-topics" title="">Infectious Disease Topics</a></li>
<li class="expanded menu-mlid-22151 menu-dir-r menu-num-4 menu-num--4 link-antimicrobial-stewardship link-node-106391"><a href="http://www.cidrap.umn.edu/asp" title="">Antimicrobial Stewardship</a></li>
<li class="expanded menu-mlid-1519 menu-dir-r menu-num-5 menu-num--3 link-ongoing-programs link-node-10 menu-flyout"><a href="http://www.cidrap.umn.edu/ongoing-programs" title="">Ongoing Programs</a><div class="menu-columns ss-columns menu-columns-1 ss-columns-1"><ul class="menu"><li class="menu-column ss-column menu-column-0 menu-column-first menu-column-last"><ul class="menu"><li class="first leaf menu-mlid-19486 link-antimicrobial-stewardship link-node-107291"><a href="http://www.cidrap.umn.edu/ongoing-programs/antimicrobial-stewardship" title="">Antimicrobial Stewardship</a></li>
<li class="leaf has-children menu-mlid-18086 link-ceirs-pandemic-planning link-http--wwwcidrapumnedu-ongoing-programs-ceirs-network-pandemic-planning"><a href="http://www.cidrap.umn.edu/ongoing-programs/ceirs-network-pandemic-planning" title="">CEIRS Pandemic Planning</a></li>
<li class="leaf menu-mlid-13621 link-cidrap-leadership-forum link-node-88331"><a href="http://www.cidrap.umn.edu/ongoing-programs/cidrap-leadership-forum" title="">CIDRAP Leadership Forum</a></li>
<li class="leaf has-children menu-mlid-1554 link-influenza-training link-node-29"><a href="http://www.cidrap.umn.edu/ongoing-programs/influenza-training" title="">Influenza Training</a></li>
<li class="leaf has-children menu-mlid-1525 link-news-publishing link-node-14"><a href="http://www.cidrap.umn.edu/ongoing-programs/news-publishing" title="">News Publishing</a></li>
<li class="leaf has-children menu-mlid-1524 link-public-health-practices link-node-13"><a href="http://www.cidrap.umn.edu/ongoing-programs/public-health-practices" title="">Public Health Practices</a></li>
<li class="leaf menu-mlid-22666 link-who-roadmap-development link-node-127941"><a href="http://www.cidrap.umn.edu/ongoing-programs/who-roadmap-development" title="">WHO Roadmap Development</a></li>
<li class="last leaf menu-mlid-30956 link-past-projects link-node-161521"><a href="http://www.cidrap.umn.edu/ongoing-programs/past-projects" title="">Past Projects</a></li>
</ul></li></ul></div></li>
<li class="expanded menu-mlid-1520 menu-dir-r menu-num-6 menu-num--2 link-about-us link-node-11 menu-flyout"><a href="http://www.cidrap.umn.edu/about-us" title="">About Us</a><div class="menu-columns ss-columns menu-columns-1 ss-columns-1"><ul class="menu"><li class="menu-column ss-column menu-column-0 menu-column-first menu-column-last"><ul class="menu"><li class="first leaf menu-mlid-1562 link-staff link-node-39"><a href="http://www.cidrap.umn.edu/about-us/staff" title="">Staff</a></li>
<li class="leaf menu-mlid-1529 link-mission link-node-18"><a href="http://www.cidrap.umn.edu/about-us/mission" title="">Mission</a></li>
<li class="last leaf menu-mlid-1531 link-contact-us link-node-5"><a href="http://www.cidrap.umn.edu/about-us/contact-us" title="">Contact Us</a></li>
</ul></li></ul></div></li>
<li class="last leaf menu-mlid-1593 menu-dir-r menu-num-7 menu-num--1 link-donate-now link-node-105"><a href="http://www.cidrap.umn.edu/donate-now">Donate Now</a></li>
</ul></div>
</div>
</div>
</div>
<div class="block block-menu block-with-title" id="block-menu-menu-featured-news">
<div class="block-inner">
<h2 class="element-invisible block-title"><span class="first">FEATURED</span> NEWS <span class="last">TOPICS</span></h2>
<div class="content block-content">
<ul class="menu"><li class="first leaf link-zika link-node-100856"><a href="http://www.cidrap.umn.edu/infectious-disease-topics/zika" title="">Zika</a></li>
<li class="leaf link-yellow-fever link-node-104"><a href="http://www.cidrap.umn.edu/infectious-disease-topics/yellow-fever" title="">Yellow Fever</a></li>
<li class="last leaf link-mers-cov link-node-84"><a href="http://www.cidrap.umn.edu/infectious-disease-topics/mers-cov" title="">MERS-CoV</a></li>
</ul> </div>
</div>
</div>
</div>
</div>
</div>
<div id="main-wrapper"><div class="clearfix" id="main">
<div class="column" id="content"><div class="content-inner section">
<div id="inset-wrapper">
<div id="inset-content">
<a id="main-content"></a>
<h1 class="page-title" id="page-title">COMMENTARY: Health workers need optimal respiratory protection for Ebola</h1> <div class="region region-content">
<div class="region-content-inner region-inner">
<div class="block block-system" id="block-system-main">
<div class="block-inner">
<div class="content block-content">
<div about="/news-perspective/2014/09/commentary-health-workers-need-optimal-respiratory-protection-ebola" class="node node-ss-news node-sticky node-full node-type-ss-news-full node-full clearfix" id="node-84276" typeof="sioc:Item foaf:Document"><div class="node-inner">
<div class="clearfix fieldlayout-region-before fieldlayout-region-before-full"><div class="fieldlayout-inline fieldlayout node-field-filed_under"><div class="field field-name-field-related-topics field-type-node-reference field-label-inline clearfix"><div class="field-label">Filed Under<span class="colon">: </span></div><div class="field-items"><div class="field-item even"><a href="http://www.cidrap.umn.edu/infectious-disease-topics/ebola">Ebola</a></div></div></div>; <div class="field field-name-field-related-topics field-type-node-reference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="http://www.cidrap.umn.edu/infectious-disease-topics/vhf">VHF</a></div></div></div></div><div class="byline fieldlayout-inline fieldlayout node-field-byline"><div class="field field-name-field-byline field-type-taxonomy-term-reference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="http://www.cidrap.umn.edu/ongoing-programs/news-publishing/news-publishing-staff">Lisa M Brosseau, ScD, and Rachael Jones, PhD</a></div></div></div>  | <div class="field field-name-field-date field-type-datetime field-label-hidden"><div class="field-items"><div class="field-item even"><span class="date-display-single" content="2014-09-17T00:00:00-05:00" datatype="xsd:dateTime" property="dc:date">Sep 17, 2014</span></div></div></div></div><div class="fieldlayout-inline fieldlayout node-field-service_links"><div class="service-links"><div class="service-label">Share this page: </div><ul class="links"><li class="service-links-facebook link-share link-http--wwwfacebookcom-sharerphp link-idx-0 link-idx--4 first"><a class="service-links-facebook" href="http://www.facebook.com/sharer.php?u=http%3A//www.cidrap.umn.edu/news-perspective/2014/09/commentary-health-workers-need-optimal-respiratory-protection-ebola&amp;t=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola" rel="nofollow" target="_blank" title="Share on Facebook">Share</a></li>
<li class="service-links-twitter link-tweet link-http--twittercom-share link-idx-1 link-idx--3"><a class="service-links-twitter" href="http://twitter.com/share?url=http%3A//www.cidrap.umn.edu/news-perspective/2014/09/commentary-health-workers-need-optimal-respiratory-protection-ebola&amp;text=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola" rel="nofollow" target="_blank" title="Share this on Twitter">Tweet</a></li>
<li class="service-links-linkedin link-linkedin link-http--wwwlinkedincom-sharearticle link-idx-2 link-idx--2"><a class="service-links-linkedin" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A//www.cidrap.umn.edu/news-perspective/2014/09/commentary-health-workers-need-optimal-respiratory-protection-ebola&amp;title=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola&amp;summary=&amp;source=CIDRAP" rel="nofollow" target="_blank" title="Publish this post to LinkedIn">LinkedIn</a></li>
<li class="service-links-forward link-email link-http--wwwcidrapumnedu-forward link-idx-3 link-idx--1"><a class="service-links-forward" href="http://www.cidrap.umn.edu/forward?path=node/84276" rel="nofollow" title="Send to a friend">Email</a></li>
<li class="service-links-printfriendly link-print--pdf link-http--wwwprintfriendlycom link-idx-4 link-idx--0 last"><a class="printfriendly service-links-printfriendly" href="http://www.printfriendly.com" onclick="window.print();return false;" rel="nofollow" target="_blank" title="Print and PDF versions">Print &amp; PDF</a></li>
</ul></div></div></div> <div class="content fieldlayout-contents">
<div class="fieldlayout-body clearfix">
<div class="node-right node-soft-right fieldlayout-region-soft-right fieldlayout-region-soft-right-full"><div class="field field-name-field-ss-media-file field-type-file field-label-hidden"><div class="field-items"><div class="field-item even"><div class="field-slidetabs field-slidetabs-1 display-type-full-colorbox display-type-pager-carousel timeout-0 with-pager with-controls field-slidetabs-wrapper" id="field-slidetabs-1-wrapper">
<div class="field-slidetabs-items">
<div class="field-slidetabs-item field-slidetabs-item-1 even first last">
<div class="ss-media-item ss-media-item-image"><div class="file file-image file-image-jpeg" id="file-20351">
<h2 class="element-invisible"><a href="http://www.cidrap.umn.edu/file/20351">papr.jpg</a></h2>
<div class="content">
<img alt=" PAPR - powered air-purifying respirator" src="http://www.cidrap.umn.edu/sites/default/files/public/styles/ss_media_popup/public/media/article/papr_0.jpg?itok=Z587-LKf" title="A powered air-purifying respirator (PAPR)." typeof="foaf:Image"/><div class="field field-name-field-credit field-type-text field-label-hidden"><div class="field-items"><div class="field-item even">Courtesy of 3M Company</div></div></div><div class="field field-name-field-file-image-title-text field-type-text field-label-hidden"><div class="field-items"><div class="field-item even">A powered air-purifying respirator (PAPR).</div></div></div> </div>
</div>
</div> </div>
</div>
<div class="field-slidetabs-pager clearfix ui-slides"><div class="slides-mask" style="position: relative; overflow: hidden; height: 702px;"><div class="slides-wrapper" style="position: absolute; height: 702px; width: 281px; left: 0px; top: 0px;">
<div class="field-slidetabs-pager-item slides-item slides-active cboxElement" style="float: left; width: 281px;"><div class="ss-media-item ss-media-item-image"><div class="file file-image file-image-jpeg" id="file-20351--2">
<h2 class="element-invisible"><a href="http://www.cidrap.umn.edu/file/20351">papr.jpg</a></h2>
<div class="content">
<img alt="PAPR - powered air-purifying respirator" src="http://www.cidrap.umn.edu/sites/default/files/public/styles/detail/public/media/article/papr_0.jpg?itok=nqDuVNCF" title="A powered air-purifying respirator (PAPR)." typeof="foaf:Image"/><div class="field field-name-field-credit field-type-text field-label-hidden"><div class="field-items"><div class="field-item even">Courtesy of 3M Company</div></div></div><div class="field field-name-field-file-image-title-text field-type-text field-label-hidden"><div class="field-items"><div class="field-item even">A powered air-purifying respirator (PAPR).</div></div></div> </div>
</div>
</div></div>
</div></div></div>
</div></div></div></div></div> <div class="fieldlayout-region-body fieldlayout-region-body-full"><div class="field field-name-field-body field-type-text-long field-label-hidden"><div class="field-items"><div class="field-item even"><p><strong><em>Editor's Note <strong><em>(Oct 16)</em></strong>:  </em></strong><em>See the </em><em><a href="http://www.cidrap.umn.edu/response-statements-falsely-attributed-cidrap-regarding-ebola-transmission" target="_blank"> statement</a> released today by CIDRAP related to this commentary.</em><strong><em> <br/></em></strong></p><p><strong><em>Editor's Note (Sep 17):</em></strong><em> Today's commentary was submitted to CIDRAP by the authors, who are national experts on respiratory protection and infectious disease transmission. In May they published a </em><a href="http://www.cidrap.umn.edu/news-perspective/2014/05/commentary-protecting-health-workers-airborne-mers-cov-learning-sars"><em>similar commentary on MERS-CoV</em></a><em>. Dr Brosseau is a Professor and Dr Jones an Assistant Professor in the School of Public Health, Division of Environmental and Occupational Health Sciences, at the University of Illinois at Chicago.</em></p><p><em><strong>Authors' disclaimer:</strong></em><em> This commentary reflects the personal opinions of the authors. It does not represent the opinion of the University of Illinois at Chicago or any other organization. The authors have not received any compensation for the preparation of this commentary or any associated public statements. The authors do not endorse any specific manufacturer or brand of personal protective equipment (PPE) and have no direct or indirect financial interest in the use of a specific brand of PPE. In the past one or both of the authors have received research funding from numerous government agencies and organizations, including 3M.</em></p><hr/><p><em><br/></em></p><div>Healthcare workers play a very important role in the successful containment of outbreaks of infectious diseases like Ebola. The correct type and level of personal protective equipment (PPE) ensures that healthcare workers remain healthy throughout an outbreak—and with the current rapidly expanding Ebola outbreak in West Africa, it's imperative to favor more conservative measures.</div><div> </div><div>The precautionary principle—that any action designed to reduce risk should not await scientific certainty—compels the use of respiratory protection for a pathogen like Ebola virus that has:</div><div> </div><ul><li>No proven pre- or post-exposure treatment modalities</li><li>A high case-fatality rate</li><li>Unclear modes of transmission</li></ul><p>We believe there is scientific and epidemiologic evidence that Ebola virus has the potential to be transmitted via infectious aerosol particles both near and at a distance from infected patients, which means that healthcare workers should be wearing respirators, not facemasks.<sup>1</sup></p><p>The minimum level of protection in high-risk settings should be a respirator with an assigned protection factor greater than 10. A powered air-purifying respirator (PAPR) with a hood or helmet offers many advantages over an N95 filtering facepiece or similar respirator, being more protective, comfortable, and cost-effective in the long run.</p><p>We strongly urge the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to seek funds for the purchase and transport of PAPRs to all healthcare workers currently fighting the battle against Ebola throughout Africa—and beyond.</p><p>There has been a lot of on-line and published controversy about whether Ebola virus can be transmitted via aerosols. Most scientific and medical personnel, along with public health organizations, have been unequivocal in their statements that Ebola can be transmitted only by direct contact with virus-laden fluids<sup>2,3</sup> and that the only modes of transmission we should be concerned with are those termed "droplet" and "contact."</p><p>These statements are based on two lines of reasoning. The first is that no one located at a distance from an infected individual has contracted the disease, or the converse, every person infected has had (or must have had) "direct" contact with the body fluids of an infected person.</p><p>This reflects an incorrect and outmoded understanding of infectious aerosols, which has been institutionalized in policies, language, culture, and approaches to infection control. We will address this below. Briefly, however, the important points are that virus-laden bodily fluids may be aerosolized and inhaled while a person is in proximity to an infectious person and that a wide range of particle sizes can be inhaled and deposited throughout the respiratory tract.</p><p>The second line of reasoning is that respirators or other control measures for infectious aerosols cannot be recommended in developing countries because the resources, time, and/or understanding for such measures are lacking.<sup>4</sup></p><p>Although there are some important barriers to the use of respirators, especially PAPRs, in developing countries, healthcare workers everywhere deserve and should be afforded the same best-practice types of protection, regardless of costs and resources. Every healthcare worker is a precious commodity whose well-being ensures everyone is protected.</p><p>If we are willing to offer infected US healthcare workers expensive treatments and experimental drugs free of charge when most of the world has no access to them, we wonder why we are unwilling to find the resources to provide appropriate levels of comparatively less expensive respiratory protection to every healthcare worker around the world.</p><h3>How are infectious diseases transmitted via aerosols?</h3><p>Medical and infection control professionals have relied for years on a paradigm for aerosol transmission of infectious diseases based on very outmoded research and an overly simplistic interpretation of the data. In the 1940s and 50s, William F. Wells and other "aerobiologists" employed now significantly out-of-date sampling methods (eg, settling plates) and very blunt analytic approaches (eg, cell culturing) to understand the movement of bacterial aerosols in healthcare and other settings. Their work, though groundbreaking at the time, provides a very incomplete picture.</p><p>Early aerobiologists were not able to measure small particles near an infectious person and thus assumed such particles existed only far from the source. They concluded that organisms capable of aerosol transmission (termed "airborne") can only do so at around 3 feet or more from the source. Because they thought that only larger particles would be present near the source, they believed people would be exposed only via large "droplets" on their face, eyes, or nose.</p><p>Modern research, using more sensitive instruments and analytic methods, has shown that aerosols emitted from the respiratory tract contain a wide distribution of particle sizes—including many that are small enough to be inhaled.<sup>5,6</sup> Thus, both small and large particles will be present near an infectious person.</p><p>The chance of large droplets reaching the facial mucous membranes is quite small, as the nasal openings are small and shielded by their external and internal structure. Although close contact may permit large-droplet exposure, it also maximizes the possibility of aerosol inhalation.</p><p>As noted by early aerobiologists, liquid in a spray aerosol, such as that generated during coughing or sneezing, will quickly evaporate,<sup>7</sup> which increases the concentration of small particles in the aerosol. Because evaporation occurs in milliseconds, many of these particles are likely to be found near the infectious person.</p><p>The current paradigm also assumes that only "small" particles (less than 5 micrometers [mcm]) can be inhaled and deposited in the respiratory tract. This is not true. Particles as large as 100 mcm (and perhaps even larger) can be inhaled into the mouth and nose. Larger particles are deposited in the nasal passages, pharynx, and upper regions of the lungs, while smaller particles are more likely to deposit in the lower, alveolar regions. And for many pathogens, infection is possible regardless of the particle size or deposition site.</p><p>It's time to abandon the old paradigm of three mutually exclusive transmission routes for a new one that considers the full range of particle sizes both near and far from a source. In addition, we need to factor in other important features of infectivity, such as the ability of a pathogen to remain viable in air at room temperature and humidity and the likelihood that systemic disease can result from deposition of infectious particles in the respiratory system or their transfer to the gastrointestinal tract.</p><p>We recommend using "aerosol transmissible" rather than the outmoded terms "droplet" or "airborne" to describe pathogens that can transmit disease via infectious particles suspended in air.</p><h3>Is Ebola an aerosol-transmissible disease?</h3><p>We recently published a <a href="http://www.cidrap.umn.edu/news-perspective/2014/05/commentary-protecting-health-workers-airborne-mers-cov-learning-sars">commentary</a> on the CIDRAP site discussing whether Middle East respiratory syndrome (MERS) could be an aerosol-transmissible disease, especially in healthcare settings. We drew comparisons with a similar and more well-studied disease, severe acute respiratory syndrome (SARS).</p><p>For Ebola and other filoviruses, however, there is much less information and research on disease transmission and survival, especially in healthcare settings.</p><p>Being at first skeptical that Ebola virus could be an aerosol-transmissible disease, we are now persuaded by a review of experimental and epidemiologic data that this might be an important feature of disease transmission, particularly in healthcare settings.</p><h3>What do we know about Ebola transmission?</h3><p>No one knows for certain how Ebola virus is transmitted from one person to the next. The virus has been found in the saliva, stool, breast milk, semen, and blood of infected persons.<sup>8,9</sup> Studies of transmission in Ebola virus outbreaks have identified activities like caring for an infected person, sharing a bed, funeral activities, and contact with blood or other body fluids to be key risk factors for transmission.<sup>10-12</sup></p><p>On the basis of epidemiologic evidence, it has been presumed that Ebola viruses are transmitted by contaminated hands in contact with the mouth or eyes or broken skin or by splashes or sprays of body fluids into these areas. Ebola viruses appear to be capable of initiating infection in a variety of human cell types,<sup>13,14</sup> but the primary portal or portals of entry into susceptible hosts have not been identified.</p><p>Some pathogens are limited in the cell type and location they infect. Influenza, for example, is generally restricted to respiratory epithelial cells, which explains why flu is primarily a respiratory infection and is most likely aerosol transmissible. HIV infects T-helper cells in the lymphoid tissues and is primarily a bloodborne pathogen with low probability for transmission via aerosols.</p><p>Ebola virus, on the other hand, is a broader-acting and more non-specific pathogen that can impede the proper functioning of macrophages and dendritic cells—immune response cells located throughout the epithelium.<sup>15,16</sup> Epithelial tissues are found throughout the body, including in the respiratory tract. Ebola prevents these cells from carrying out their antiviral functions but does not interfere with the initial inflammatory response, which attracts additional cells to the infection site. The latter contribute to further dissemination of the virus and similar adverse consequences far beyond the initial infection site.</p><p>The potential for transmission via inhalation of aerosols, therefore, cannot be ruled out by the observed risk factors or our knowledge of the infection process. Many body fluids, such as vomit, diarrhea, blood, and saliva, are capable of creating inhalable aerosol particles in the immediate vicinity of an infected person. Cough was identified among some cases in a 1995 outbreak in Kikwit, Democratic Republic of the Congo,<sup>11</sup> and coughs are known to emit viruses in respirable particles.<sup>17</sup> The act of vomiting produces an aerosol and has been implicated in airborne transmission of gastrointestinal viruses.<sup>18,19</sup> Regarding diarrhea, even when contained by toilets, toilet flushing emits a pathogen-laden aerosol that disperses in the air.<sup>20-22</sup></p><p>Experimental work has shown that Marburg and Ebola viruses can be isolated from sera and tissue culture medium at room temperature for up to 46 days, but at room temperature no virus was recovered from glass, metal, or plastic surfaces.<sup>23</sup> Aerosolized (1-3 mcm) Marburg, Ebola, and Reston viruses, at 50% to 55% relative humidity and 72°F, had biological decay rates of 3.04%, 3.06%. and 1.55% per minute, respectively. These rates indicate that 99% loss in aerosol infectivity would occur in 93, 104, and 162 minutes, respectively.<sup>23</sup></p><p>In still air, 3-mcm particles can take up to an hour to settle. With air currents, these and smaller particles can be transported considerable distances before they are deposited on a surface.</p><p>There is also some experimental evidence that Ebola and other filoviruses can be transmitted by the aerosol route. Jaax et al<sup>24</sup> reported the unexpected death of two rhesus monkeys housed approximately 3 meters from monkeys infected with Ebola virus, concluding that respiratory or eye exposure to aerosols was the only possible explanation.</p><p>Zaire Ebola viruses have also been transmitted in the absence of direct contact among pigs<sup>25</sup> and from pigs to non-human primates,<sup>26</sup> which experienced lung involvement in infection. Persons with no known direct contact with Ebola virus disease patients or their bodily fluids have become infected.<sup>12</sup></p><p>Direct injection and exposure via a skin break or mucous membranes are the most efficient ways for Ebola to transmit. It may be that inhalation is a less efficient route of transmission for Ebola and other filoviruses, as lung involvement has not been reported in all non-human primate studies of Ebola aerosol infectivity.<sup>27</sup> However, the respiratory and gastrointestinal systems are not complete barriers to Ebola virus. Experimental studies have demonstrated that it is possible to infect non-human primates and other mammals with filovirus aerosols.<sup>25-27</sup></p><p>Altogether, these epidemiologic and experimental data offer enough evidence to suggest that Ebola and other filoviruses may be opportunistic with respect to aerosol transmission.<sup>28</sup> That is, other routes of entry may be more important and probable, but, given the right conditions, it is possible that transmission could also occur via aerosols.</p><p>Guidance from the <a href="http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html" target="_blank">CDC</a> and <a href="http://www.who.int/csr/resources/publications/clinical-management-patients/en/" target="_blank">WHO</a> recommends the use of facemasks for healthcare workers providing routine care to patients with Ebola virus disease and respirators when aerosol-generating procedures are performed. (Interestingly, the 1998 WHO and CDC infection-control guidance for viral hemorrhagic fevers in Africa, still available on the <a href="http://www.cdc.gov/vhf/abroad/pdf/african-healthcare-setting-vhf.pdf" target="_blank">CDC Web site</a>, recommends the use of respirators.)</p><p>Facemasks, however, do not offer protection against inhalation of small infectious aerosols, because they lack adequate filters and do not fit tightly against the face.<sup>1</sup> Therefore, a higher level of protection is necessary.</p><h3>Which respirator to wear?</h3><p>As described in our earlier <a href="http://www.cidrap.umn.edu/news-perspective/2014/05/commentary-protecting-health-workers-airborne-mers-cov-learning-sars">CIDRAP commentary</a>, we can use a Canadian control-banding approach to select the most appropriate respirator for exposures to Ebola in healthcare settings.<sup>29</sup> (See <a href="http://www.isrp.com/americas/docs/st_paul_2011/mehes_use_care_standard.pdf" target="_blank">this document</a> for a detailed description of the Canadian control banding approach and the data used to select respirators in our examples below.)</p><p>The control banding method involves the following steps:</p><ol><li><strong><em>Identify the organism's risk group (1 to 4).</em></strong> Risk group reflects the toxicity of an organism, including the degree and type of disease and whether treatments are available. Ebola is in risk group 4, the most toxic organisms, because it can cause serious human or animal disease, is easily transmitted, directly or indirectly, and currently has no effective treatments or preventive measures.</li><li><strong><em>Identify the generation rate.</em></strong> The rate of aerosol generation reflects the number of particles created per time (eg, particles per second). Some processes, such as coughing, create more aerosols than others, like normal breathing. Some processes, like intubation and toilet flushing, can rapidly generate very large quantities of aerosols. The control banding approach assigns a qualitative rank ranging from low (1) to high (4) (eg, normal breathing without coughing has a rank of 1).</li><li><strong><em>Identify the level of control.</em></strong> Removing contaminated air and replacing it with clean air, as accomplished with a ventilation system, is effective for lowering the overall concentration of infectious aerosol particles in a space, although it may not be effective at lowering concentration in the immediate vicinity of a source. The number of air changes per hour (ACH) reflects the rate of air removal and replacement. This is a useful variable, because it is relatively easy to measure and, for hospitals, reflects building code requirements for different types of rooms. Again, a qualitative ranking is used to reflect low (1) versus high (4) ACH. Even if the true ventilation rate is not known, the examples can be used to select an appropriate air exchange rate.</li><li><strong><em>Identify the respirator assigned protection factor.</em></strong> Respirators are designated by their "class," each of which has an assigned protection factor (APF) that reflects the degree of protection. The APF represents the outside, environmental concentration divided by the inside, facepiece concentration. An APF of 10 means that the outside concentration of a particular contaminant will be 10 times greater than that inside the respirator. If the concentration outside the respirator is very high, an assigned protection factor of 10 may not prevent the wearer from inhaling an infective dose of a highly toxic organism.</li></ol><h3>Practical examples</h3><p>Two examples follow. These assume that infectious aerosols are generated only during vomiting, diarrhea, coughing, sneezing, or similar high-energy emissions such as some medical procedures. It is possible that Ebola virus may be shed as an aerosol in other manners not considered.</p><p><strong><em>Caring for a patient in the early stages of disease (no bleeding, vomiting, diarrhea, coughing, sneezing, etc).</em></strong> In this case, the generation rate is 1. For any level of control (less than 3 to more than 12 ACH), the control banding wheel indicates a respirator protection level of 1 (APF of 10), which corresponds to an air purifying (negative pressure) half-facepiece respirator such as an N95 filtering facepiece respirator. This type of respirator requires fit testing.</p><p><strong><em>Caring for a patient in the later stages of disease (bleeding, vomiting, diarrhea, etc).</em> </strong>If we assume the highest generation rate (4) and a standard patient room (control level = 2, 3-6 ACH), a respirator with an APF of at least 50 is needed. In the United States, this would be equivalent to either a full-facepiece air-purifying (negative-pressure) respirator or a half-facepiece PAPR (positive pressure), but standards differ in other countries. Fit testing is required for these types of respirators.</p><p>The control level (room ventilation) can have a big effect on respirator selection. For the same patient housed in a negative-pressure airborne infection isolation room (6-12 ACH), a respirator with an assigned protection factor of 25 is required. This would correspond in the United States to a PAPR with a loose-fitting facepiece or with a helmet or hood. This type of respirator does not need fit testing.</p><h3>Implications for protecting health workers in Africa</h3><p>Healthcare workers have experienced very high rates of morbidity and mortality in the past and current Ebola virus outbreaks. A facemask, or surgical mask, offers no or very minimal protection from infectious aerosol particles. As our examples illustrate, for a risk group 4 organism like Ebola, the minimum level of protection should be an N95 filtering facepiece respirator.</p><p>This type of respirator, however, would only be appropriate only when the likelihood of aerosol exposure is very low. For healthcare workers caring for many patients in an epidemic situation, this type of respirator may not provide an adequate level of protection.</p><p>For a risk group 4 organism, any activity that has the potential for aerosolizing liquid body fluids, such as medical or disinfection procedures, should be avoided, if possible. Our risk assessment indicates that a PAPR with a full facepiece (APF = 50) or a hood or helmet (APF = 25) would be a better choice for patient care during epidemic conditions.</p><p>We recognize that PAPRs present some logistical and infection-control problems. Batteries require frequent charging (which requires a reliable source of electricity), and the entire ensemble requires careful handling and disinfection between uses. A PAPR is also more expensive to buy and maintain than other types of respirators.</p><p>On the other hand, a PAPR with a loose-fitting facepiece (hood or helmet) does not require fit testing. Wearing this type of respirator minimizes the need for other types of PPE, such as head coverings and goggles. And, most important, it is much more comfortable to wear than a negative-pressure respirator like an N95, especially in hot environments.</p><p>A recent report from a Medecins Sans Frontieres healthcare worker in Sierra Leone<sup>30</sup> notes that healthcare workers cannot tolerate the required PPE for more than 40 minutes. Exiting the workplace every 40 minutes requires removal and disinfection or disposal (burning) of all PPE. A PAPR would allow much longer work periods, use less PPE, require fewer doffing episodes, generate less infectious waste, and be more protective. In the long run, we suspect this type of protection could also be less expensive.</p><h3>Adequate protection is essential</h3><p>To summarize, for the following reasons we believe that Ebola could be an opportunistic aerosol-transmissible disease requiring adequate respiratory protection:</p><ul><li>Patients and procedures generate aerosols, and Ebola virus remains viable in aerosols for up to 90 minutes.</li><li>All sizes of aerosol particles are easily inhaled both near to and far from the patient.</li><li>Crowding, limited air exchange, and close interactions with patients all contribute to the probability that healthcare workers will be exposed to high concentrations of very toxic infectious aerosols.</li><li>Ebola targets immune response cells found in all epithelial tissues, including in the respiratory and gastrointestinal system.</li><li>Experimental data support aerosols as a mode of disease transmission in non-human primates.</li></ul><p>Risk level and working conditions suggest that a PAPR will be more protective, cost-effective, and comfortable than an N95 filtering facepiece respirator.</p><p><strong>Acknowledgements</strong></p><p>We thank Kathleen Harriman, PhD, MPH, RN, Chief, Vaccine Preventable Diseases Epidemiology Section, Immunization Branch, California Department of Public Health, and Nicole Vars McCullough, PhD, CIH, Manager, Global Technical Services, Personal Safety Division, 3M Company, for their input and review.</p><p><strong>References</strong></p><ol><li><strong>Oberg L, Brosseau LM.</strong> Surgical mask filter and fit performance. Am J Infect Control 2008 May;36(4):276-82 [<a href="http://www.ajicjournal.org/article/S0196-6553(07)00774-2/abstract" target="_blank">Abstract</a>]</li><li><strong>CDC.</strong> Ebola hemorrhagic fever: transmission. 2014 Aug 13 [<a href="http://www.cdc.gov/vhf/ebola/transmission/index.html" target="_blank">Full text</a>]</li><li><strong>ECDC.</strong> Outbreak of Ebola virus disease in West Africa: third update, 1 August 2014. Stockholm: ECDC 2014 Aug 1 [<a href="http://www.ecdc.europa.eu/en/publications/Publications/ebola-outbreak-west-africa-1-august-2014.pdf" target="_blank">Full text</a>]</li><li><strong>Martin-Moreno JM, Llinas G, Hernandez JM.</strong> Is respiratory protection appropriate in the Ebola response? Lancet 2014 Sep 6;384(9946):856 [<a href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61343-X/fulltext" target="_blank">Full text</a>]</li><li><strong>Papineni RS, Rosenthal FS.</strong> The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 1997;10(2):105-16 [<a href="http://www.ncbi.nlm.nih.gov/pubmed/10168531" target="_blank">Abstract</a>]</li><li><strong>Chao CYH, Wan MP, Morawska L, et al.</strong> Characterization of expiration air jets and droplet size distributions immediately at the mouth opening. J Aerosol Sci 2009 Feb;40(2):122-33 [<a href="http://www.sciencedirect.com/science/article/pii/S0021850208001882" target="_blank">Abstract</a>]</li><li><strong>Nicas M, Nazaroff WW, Hubbard A.</strong> Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg 2005 Mar;2(3):143-54 [<a href="http://www.tandfonline.com/doi/abs/10.1080/15459620590918466?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed#.VBnXrS5dUZ4" target="_blank">Abstract</a>]</li><li><strong>Bauchsch DG, Towner JS, Dowell SF, et al.</strong> Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196:S142-7 [<a href="http://jid.oxfordjournals.org/content/196/Supplement_2/S142.full" target="_blank">Full text</a>]</li><li><strong>Formenty P, Leroy EM, Epelboin A, et al.</strong> Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006 Jun;42(11):1521-6 [<a href="http://cid.oxfordjournals.org/content/42/11/1521.full" target="_blank">Full text</a>]</li><li><strong>Francesconi P, Yoti Z, Declich S, et al.</strong> Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 2003 Nov;9(11):1430-7 [<a href="http://wwwnc.cdc.gov/eid/article/9/11/pdfs/03-0339.pdf" target="_blank">Full text</a>]</li><li><strong>Dowell SF, Mukunu R, Ksiazek TG, et al.</strong> Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of Congo, 1995. J Infect Dis 1999 Feb;179:S87-91 [<a href="http://jid.oxfordjournals.org/content/179/Supplement_1/S87.long" target="_blank">Full text</a>]</li><li><strong>Roels TH, Bloom AS, Buffington J, et al.</strong> Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis 1999 Feb;179:S92-7 [<a href="http://jid.oxfordjournals.org/content/179/Supplement_1/S92.long" target="_blank">Full text</a>]</li><li><strong>Kuhl A, Hoffmann M, Muller MA, et al.</strong> Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J Infect Dis 2011 Nov;204:S840-9 [<a href="http://jid.oxfordjournals.org/content/204/suppl_3/S840.full" target="_blank">Full text</a>]</li><li><strong>Hunt CL, Lennemann NJ, Maury W.</strong> Filovirus entry: a novelty in the viral fusion world. Viruses 2012 Feb;4(2):258-75 [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315215/" target="_blank">Full text</a>]</li><li><strong>Bray M, Geisbert TW.</strong> Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005 Aug;37(8):1560-6 [<a href="http://www.sciencedirect.com/science/article/pii/s1357272505000725" target="_blank">Full text</a>]</li><li><strong>Mohamadzadeh M, Chen L, Schmaljohn AL.</strong> How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 2007 Jul;7(7):556-67 [<a href="http://www.nature.com/nri/journal/v7/n7/full/nri2098.html" target="_blank">Abstract</a>]</li><li><strong>Lindsley WG, Blachere FM, Thewlis RE, et al.</strong> Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS One 2010 Nov 30;5(11):e15100 [<a href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0015100" target="_blank">Full text</a>]</li><li><strong>Caul EO.</strong> Small round structured viruses: airborne transmission and hospital control. Lancet 1994 May 21;343(8908):1240-2 [<a href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(94)92146-6/fulltext" target="_blank">Full text</a>]</li><li><strong>Chadwick PR, Walker M, Rees AE.</strong> Airborne transmission of a small round structured virus. Lancet 1994 Jan 15;343(8890):171 [<a href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(94)90959-8/fulltext" target="_blank">Full text</a>]</li><li><strong>Best EL, Snadoe JA, Wilcox MH.</strong> Potential for aerosolization of <em>Clostridium difficile</em> after flushing toilets: the role of toilet lids in reducing environmental contamination. J Hosp Infect 2012 Jan;80(1):1-5 [<a href="http://www.sciencedirect.com/science/article/pii/s0195670111003392" target="_blank">Full text</a>]</li><li><strong>Gerba CP, Wallis C, Melnick JL.</strong> Microbiological hazards of household toilets: droplet production and the fate of residual organisms. Appl Microbiol 1975 Aug;30(2):229-37 [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC187159/" target="_blank">Full text</a>]</li><li><strong>Barker J, Jones MV.</strong> The potential spread of infection caused by aerosol contamination of surfaces after flushing a domestic toilet. J Appl Microbiol 2005;99(2):339-47 [<a href="http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2672.2005.02610.x/full" target="_blank">Full text</a>]</li><li><strong>Piercy TJ, Smither SJ, Steward JA, et al.</strong> The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 2010 Nov;109(5):1531-9 [<a href="http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2672.2010.04778.x/full" target="_blank">Full text</a>]</li><li><strong>Jaax N, Jahrling P, Geisbert T, et al.</strong> Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995 Dec 23-30;346(8991-2):1669-71 [<a href="http://www.ncbi.nlm.nih.gov/pubmed/8551825" target="_blank">Abstract</a>]</li><li><strong>Kobinger GP, Leung A, Neufeld J, et al.</strong> Replication, pathogenicity, shedding and transmission of Zaire ebolavirus in pigs. J Infect Dis 2011 Jul 15;204(2):200-8 [<a href="http://jid.oxfordjournals.org/content/204/2/200.long" target="_blank">Full text</a>]</li><li><strong>Weingartl HM, Embury-Hyatt C, Nfon C, et al.</strong> Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2012;2:811 [<a href="http://www.nature.com/srep/2012/121115/srep00811/full/srep00811.html" target="_blank">Full text</a>]</li><li><strong>Reed DS, Lackemeyer MG, Garza NL, et al.</strong> Aerosol exposure to Zaire Ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microb Infect 2011 Oct;13(11):930-6 [<a href="http://www.sciencedirect.com/science/article/pii/S1286457911001225" target="_blank">Abstract</a>]</li><li><strong>Roy CJ, Milton DK.</strong> Airborne transmission of communicable infection—the elusive pathway. N Engl J Med 2004 Apr;350(17):1710-2 [<a href="http://www.nejm.org/doi/full/10.1056/NEJMp048051" target="_blank">Preview</a>]</li><li><strong>Canadian Standards Association.</strong> Selection, use and care of respirators. CAN/CSA Z94.4-11</li><li><strong>Wolz A.</strong> Face to face with Ebola—an emergency care center in Sierra Leone. (Perspective) N Engl J Med 2014 Aug 27 [<a href="http://www.nejm.org/doi/full/10.1056/nejmp1410179" target="_blank">Full text</a>]</li></ol></div></div></div></div> </div>
<div class="clearfix fieldlayout-region-bottom fieldlayout-region-bottom-full"><div class="fieldlayout-inline fieldlayout node-field-links_bottom"><div class="service-links"><div class="service-label">Share this page: </div><ul class="links"><li class="service-links-facebook link-share link-http--wwwfacebookcom-sharerphp link-idx-0 link-idx--4 first"><a class="service-links-facebook" href="http://www.facebook.com/sharer.php?u=http%3A//www.cidrap.umn.edu/news-perspective/2014/09/commentary-health-workers-need-optimal-respiratory-protection-ebola&amp;t=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola" rel="nofollow" target="_blank" title="Share on Facebook">Share</a></li>
<li class="service-links-twitter link-tweet link-http--twittercom-share link-idx-1 link-idx--3"><a class="service-links-twitter" href="http://twitter.com/share?url=http%3A//www.cidrap.umn.edu/news-perspective/2014/09/commentary-health-workers-need-optimal-respiratory-protection-ebola&amp;text=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola" rel="nofollow" target="_blank" title="Share this on Twitter">Tweet</a></li>
<li class="service-links-linkedin link-linkedin link-http--wwwlinkedincom-sharearticle link-idx-2 link-idx--2"><a class="service-links-linkedin" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A//www.cidrap.umn.edu/news-perspective/2014/09/commentary-health-workers-need-optimal-respiratory-protection-ebola&amp;title=COMMENTARY%3A%20Health%20workers%20need%20optimal%20respiratory%20protection%20for%20Ebola&amp;summary=&amp;source=CIDRAP" rel="nofollow" target="_blank" title="Publish this post to LinkedIn">LinkedIn</a></li>
<li class="service-links-forward link-email link-http--wwwcidrapumnedu-forward link-idx-3 link-idx--1"><a class="service-links-forward" href="http://www.cidrap.umn.edu/forward?path=node/84276" rel="nofollow" title="Send to a friend">Email</a></li>
<li class="service-links-printfriendly link-print--pdf link-http--wwwprintfriendlycom link-idx-4 link-idx--0 last"><a class="printfriendly service-links-printfriendly" href="http://www.printfriendly.com" onclick="window.print();return false;" rel="nofollow" target="_blank" title="Print and PDF versions">Print &amp; PDF</a></li>
</ul></div></div></div> </div>
</div></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div></div>
<div class="region region-sidebar-second">
<div class="region-sidebar-second-inner region-inner">
<div class="block block-block block-with-title" id="block-block-7">
<div class="block-inner">
<h2 class="block-title"><span class="first">Newsletter</span> <span class="last">Sign-up</span></h2>
<div class="content block-content">
<p>Get CIDRAP news and other free newsletters.</p><p><a href="http://www.cidrap.umn.edu/newsletter">Sign up now»</a></p> </div>
</div>
</div>
<div class="block block-block asp-underwriter block-with-title" id="block-block-76">
<div class="block-inner">
<h2 class="block-title"><span class="first">OUR</span> <span class="last">UNDERWRITERS</span></h2>
<div class="content block-content">
<p>Unrestricted financial support provided by</p><p><a href="http://www.bentsonfoundation.org/" target="_blank"><img alt="Bentson Foundation" height="62" src="http://www.cidrap.umn.edu/sites/default/files/public/bentson.png" width="198"/></a> <a href="http://www.3m.com/" target="_blank"><img alt="3M" height="50" src="http://www.cidrap.umn.edu/sites/default/files/public/3m.png" width="198"/></a><a href="http://acceleratediagnostics.com/" target="_blank"><img alt="Accelerate Diagnostics" height="44" src="http://www.cidrap.umn.edu/sites/default/files/public/accelerate.png" style="margin-bottom: 10px;" width="198"/></a><a href="http://www.gilead.com/" target="_blank"><img alt="Gilead" height="57" src="http://www.cidrap.umn.edu/sites/default/files/public/gilead.png" width="198"/></a> <br/><span style="line-height: 1.35em;">Grant support for ASP provided by<br/><br/></span><a href="http://www.merck.com/index.html" target="_blank" title="Merck"><img alt="" height="45" src="http://www.cidrap.umn.edu/sites/default/themes/siteskin/inc/images/merck_logo_image_-_google_search_480.png" style="line-height: 1.35em;" width="144"/></a><br/><a href="https://www.biomerieux.com/" target="_blank" title="bioMérieux"><img alt="bioMérieux" height="70" src="http://www.cidrap.umn.edu/sites/default/files/public/biomerieux.png" width="70"/></a></p><p></p><span style="line-height: 1.35em;">  </span><a class="more-link" href="http://www.cidrap.umn.edu/donate-now" style="line-height: 1.35em;">Become an underwriter»</a> </div>
</div>
</div>
</div>
</div>
</div></div>
<div id="page-bottom">
<div class="region region-bottom">
<div class="region-bottom-inner region-inner">
<div class="block block-fieldlayout" id="block-fieldlayout-related-news">
<div class="block-inner">
<div class="content block-content">
<div class="fieldlayout-region-related-news fieldlayout-region-related-news-full"><div class="view view-related-news view-id-related_news view-display-id-default view-dom-id-f40bcae2bba98aab6ec203121eed3699 view-related-news-default">
<div class="view-header">
<h2 class="block-title">Related News <a href="http://www.cidrap.umn.edu/news-perspective">All news</a></h2> </div>
<div class="view-content">
<div class="views-set">
<div class="views-rows">
<div class="views-row views-row-1 views-row-odd views-row-first">
<div about="/news-perspective/2019/07/drc-stick-just-1-vaccine-ebola-outbreak" class="node node-ss-news node-sticky node-not-full node-type-ss-news-not-full node-no-image clearfix" id="node-166401" typeof="sioc:Item foaf:Document"><div class="node-inner">
<div class="content fieldlayout-contents">
<div class="node-left node-hard-left fieldlayout-region-hard-left fieldlayout-region-hard-left-no-image"><div class="field field-name-field-date field-type-datetime field-label-hidden"><div class="field-items"><div class="field-item even"><span class="ss-event-minical-range"><span class="ss-event-minical"><span class="ss-event-minical-m">Jul</span> <span class="ss-event-minical-d">12</span> <span class="ss-event-minical-y">2019</span></span></span></div></div></div></div> <div class="fieldlayout-body clearfix fieldlayout-body-has-region-hard-left">
<div class="fieldlayout-region-body fieldlayout-region-body-no-image"><h3 class="node-title fieldlayout node-field-title"><a href="http://www.cidrap.umn.edu/news-perspective/2019/07/drc-stick-just-1-vaccine-ebola-outbreak">DRC to stick with just 1 vaccine in Ebola outbreak</a></h3></div> </div>
</div>
</div></div>
</div>
<div class="views-row views-row-2 views-row-even">
<div about="/news-perspective/2019/07/three-more-health-workers-infected-ebola-outbreak" class="node node-ss-news node-sticky node-not-full node-type-ss-news-not-full node-no-image clearfix" id="node-166331" typeof="sioc:Item foaf:Document"><div class="node-inner">
<div class="content fieldlayout-contents">
<div class="node-left node-hard-left fieldlayout-region-hard-left fieldlayout-region-hard-left-no-image"><div class="field field-name-field-date field-type-datetime field-label-hidden"><div class="field-items"><div class="field-item even"><span class="ss-event-minical-range"><span class="ss-event-minical"><span class="ss-event-minical-m">Jul</span> <span class="ss-event-minical-d">11</span> <span class="ss-event-minical-y">2019</span></span></span></div></div></div></div> <div class="fieldlayout-body clearfix fieldlayout-body-has-region-hard-left">
<div class="fieldlayout-region-body fieldlayout-region-body-no-image"><h3 class="node-title fieldlayout node-field-title"><a href="http://www.cidrap.umn.edu/news-perspective/2019/07/three-more-health-workers-infected-ebola-outbreak">Three more health workers infected in Ebola outbreak</a></h3></div> </div>
</div>
</div></div>
</div>
<div class="views-row views-row-3 views-row-odd">
<div about="/news-perspective/2019/07/cdcs-adapted-ebola-virus-works-trials-pressure-funds-grows" class="node node-ss-news node-sticky node-not-full node-type-ss-news-not-full node-no-image clearfix" id="node-166296" typeof="sioc:Item foaf:Document"><div class="node-inner">
<div class="content fieldlayout-contents">
<div class="node-left node-hard-left fieldlayout-region-hard-left fieldlayout-region-hard-left-no-image"><div class="field field-name-field-date field-type-datetime field-label-hidden"><div class="field-items"><div class="field-item even"><span class="ss-event-minical-range"><span class="ss-event-minical"><span class="ss-event-minical-m">Jul</span> <span class="ss-event-minical-d">10</span> <span class="ss-event-minical-y">2019</span></span></span></div></div></div></div> <div class="fieldlayout-body clearfix fieldlayout-body-has-region-hard-left">
<div class="fieldlayout-region-body fieldlayout-region-body-no-image"><h3 class="node-title fieldlayout node-field-title"><a href="http://www.cidrap.umn.edu/news-perspective/2019/07/cdcs-adapted-ebola-virus-works-trials-pressure-funds-grows">CDC's adapted Ebola virus works in trials, as pressure for funds grows</a></h3></div> </div>
</div>
</div></div>
</div>
<div class="views-row views-row-4 views-row-even views-row-last">
<div about="/news-perspective/2019/07/ebola-rages-drc-sees-more-displaced-people" class="node node-ss-news node-sticky node-not-full node-type-ss-news-not-full node-no-image clearfix" id="node-166196" typeof="sioc:Item foaf:Document"><div class="node-inner">
<div class="content fieldlayout-contents">
<div class="node-left node-hard-left fieldlayout-region-hard-left fieldlayout-region-hard-left-no-image"><div class="field field-name-field-date field-type-datetime field-label-hidden"><div class="field-items"><div class="field-item even"><span class="ss-event-minical-range"><span class="ss-event-minical"><span class="ss-event-minical-m">Jul</span> <span class="ss-event-minical-d">08</span> <span class="ss-event-minical-y">2019</span></span></span></div></div></div></div> <div class="fieldlayout-body clearfix fieldlayout-body-has-region-hard-left">
<div class="fieldlayout-region-body fieldlayout-region-body-no-image"><h3 class="node-title fieldlayout node-field-title"><a href="http://www.cidrap.umn.edu/news-perspective/2019/07/ebola-rages-drc-sees-more-displaced-people">As Ebola rages on, DRC sees more displaced people</a></h3></div> </div>
</div>
</div></div>
</div>
</div>
</div>
</div>
</div></div> </div>
</div>
</div>
</div>
</div>
</div>
</div></div>
<div id="footer">
<div class="region region-footer">
<div class="region-footer-inner region-inner">
<div class="block block-menu-block block-with-title" id="block-menu-block-6">
<div class="block-inner">
<h2 class="element-invisible block-title"><span class="first">Main</span> <span class="last">menu</span></h2>
<div class="content block-content">
<div class="menu-block-wrapper menu-block-6 menu-name-main-menu parent-mlid-0 menu-level-1">
<ul class="menu"><li class="first leaf menu-mlid-1521 link-home link-front"><a href="http://www.cidrap.umn.edu/" title="">Home</a></li>
<li class="leaf menu-mlid-1637 link-news--perspective link-news-perspective"><a href="http://www.cidrap.umn.edu/news-perspective">News &amp; Perspective</a></li>
<li class="leaf menu-mlid-5021 link-infectious-disease-topics link-node-68186"><a href="http://www.cidrap.umn.edu/infectious-disease-topics" title="">Infectious Disease Topics</a></li>
<li class="leaf menu-mlid-22151 link-antimicrobial-stewardship link-node-106391"><a href="http://www.cidrap.umn.edu/asp" title="">Antimicrobial Stewardship</a></li>
<li class="expanded menu-mlid-1519 link-ongoing-programs link-node-10"><a href="http://www.cidrap.umn.edu/ongoing-programs" title="">Ongoing Programs</a><ul class="menu"><li class="first leaf menu-mlid-19486 link-antimicrobial-stewardship link-node-107291"><a href="http://www.cidrap.umn.edu/ongoing-programs/antimicrobial-stewardship" title="">Antimicrobial Stewardship</a></li>
<li class="leaf has-children menu-mlid-18086 link-ceirs-pandemic-planning link-http--wwwcidrapumnedu-ongoing-programs-ceirs-network-pandemic-planning"><a href="http://www.cidrap.umn.edu/ongoing-programs/ceirs-network-pandemic-planning" title="">CEIRS Pandemic Planning</a></li>
<li class="leaf menu-mlid-13621 link-cidrap-leadership-forum link-node-88331"><a href="http://www.cidrap.umn.edu/ongoing-programs/cidrap-leadership-forum" title="">CIDRAP Leadership Forum</a></li>
<li class="leaf has-children menu-mlid-1554 link-influenza-training link-node-29"><a href="http://www.cidrap.umn.edu/ongoing-programs/influenza-training" title="">Influenza Training</a></li>
<li class="leaf has-children menu-mlid-1525 link-news-publishing link-node-14"><a href="http://www.cidrap.umn.edu/ongoing-programs/news-publishing" title="">News Publishing</a></li>
<li class="leaf has-children menu-mlid-1524 link-public-health-practices link-node-13"><a href="http://www.cidrap.umn.edu/ongoing-programs/public-health-practices" title="">Public Health Practices</a></li>
<li class="leaf menu-mlid-22666 link-who-roadmap-development link-node-127941"><a href="http://www.cidrap.umn.edu/ongoing-programs/who-roadmap-development" title="">WHO Roadmap Development</a></li>
<li class="last leaf menu-mlid-30956 link-past-projects link-node-161521"><a href="http://www.cidrap.umn.edu/ongoing-programs/past-projects" title="">Past Projects</a></li>
</ul></li>
<li class="expanded menu-mlid-1520 link-about-us link-node-11"><a href="http://www.cidrap.umn.edu/about-us" title="">About Us</a><ul class="menu"><li class="first leaf menu-mlid-1562 link-staff link-node-39"><a href="http://www.cidrap.umn.edu/about-us/staff" title="">Staff</a></li>
<li class="leaf menu-mlid-1529 link-mission link-node-18"><a href="http://www.cidrap.umn.edu/about-us/mission" title="">Mission</a></li>
<li class="last leaf menu-mlid-1531 link-contact-us link-node-5"><a href="http://www.cidrap.umn.edu/about-us/contact-us" title="">Contact Us</a></li>
</ul></li>
<li class="last leaf menu-mlid-1593 link-donate-now link-node-105"><a href="http://www.cidrap.umn.edu/donate-now">Donate Now</a></li>
</ul></div>
</div>
</div>
</div>
<div class="block block-menu-block block-with-title" id="block-menu-block-7">
<div class="block-inner">
<h2 class="element-invisible block-title"><span class="first">Connect</span> with <span class="last">Us</span></h2>
<div class="content block-content">
<div class="menu-block-wrapper menu-block-7 menu-name-menu-connect-with-us parent-mlid-0 menu-level-1">
<ul class="menu"><li class="first leaf menu-mlid-5876 link-newsletter-signup link-node-24141"><a href="http://www.cidrap.umn.edu/newsletter" title="Newsletter Signup">Newsletter Signup</a></li>
<li class="leaf menu-mlid-1514 link-facebook link-node-31191"><a href="http://www.cidrap.umn.edu/cidrap-facebook" title="Find us on Facebook">Facebook</a></li>
<li class="leaf menu-mlid-1511 link-twitter link-node-31154"><a href="http://www.cidrap.umn.edu/cidrap-twitter" title="Follow us on Twitter">Twitter</a></li>
<li class="leaf menu-mlid-25086 link-youtube link-https--wwwyoutubecom-user-cidrapasp"><a href="https://www.youtube.com/user/CIDRAPASP" target="_blank" title="Find us on YouTube">Youtube</a></li>
<li class="leaf menu-mlid-1512 link-email-alerts link-node-2439"><a href="http://www.cidrap.umn.edu/rss-feeds" title="RSS Page">Email Alerts</a></li>
<li class="last leaf menu-mlid-1515 link-contact-us link-node-5"><a href="http://www.cidrap.umn.edu/about-us/contact-us" title="Contact Us">Contact Us</a></li>
</ul></div>
</div>
</div>
</div>
<div class="block block-block" id="block-block-11">
<div class="block-inner">
<div class="content block-content">
<h2 class="block-title"><a href="http://www.cidrap.umn.edu/newsletter"><span class="first">Newsletter</span> <span class="last">Signup</span></a></h2> </div>
</div>
</div>
<div class="block block-block" id="block-block-1">
<div class="block-inner">
<div class="content block-content">
<p>CIDRAP - Center for Infectious Disease Research and Policy<br/>Office of the Vice President for Research, University of Minnesota, Minneapolis, MN</p><p><em>© 2019 Regents of the University of Minnesota. All rights reserved.</em><br/><em>The University of Minnesota is an equal opportunity educator and employer.</em></p><p style="text-align: left;"><em><a href="http://www.cidrap.umn.edu/">CIDRAP</a>  |  <a href="https://research.umn.edu/" target="_blank" title="Academic Health Center">Office of the Vice President for Research</a>  |  <a href="http://www.umn.edu/twincities/contact/" target="_blank">Contact U of M</a>  |  <a href="http://www.cidrap.umn.edu/privacy-policy" title="Privacy Policy">Privacy Policy</a></em></p> </div>
</div>
</div>
</div>
</div>
</div>
<div id="cboxOverlay" style="display: none;"></div><div class="" id="colorbox" role="dialog" style="display: none;" tabindex="-1"><div id="cboxWrapper"><div><div id="cboxTopLeft" style="float: left;"></div><div id="cboxTopCenter" style="float: left;"></div><div id="cboxTopRight" style="float: left;"></div></div><div style="clear: left;"><div id="cboxMiddleLeft" style="float: left;"></div><div id="cboxContent" style="float: left;"><div id="cboxTitle" style="float: left;"></div><div id="cboxCurrent" style="float: left;"></div><button id="cboxPrevious" type="button"></button><button id="cboxNext" type="button"></button><button id="cboxSlideshow"></button><div id="cboxLoadingOverlay" style="float: left;"></div><div id="cboxLoadingGraphic" style="float: left;"></div></div><div id="cboxMiddleRight" style="float: left;"></div></div><div style="clear: left;"><div id="cboxBottomLeft" style="float: left;"></div><div id="cboxBottomCenter" style="float: left;"></div><div id="cboxBottomRight" style="float: left;"></div></div></div><div style="position: absolute; width: 9999px; visibility: hidden; display: none; max-width: none;"></div></div></body></html>